<SEC-DOCUMENT>0001171843-18-002576.txt : 20180406
<SEC-HEADER>0001171843-18-002576.hdr.sgml : 20180406
<ACCEPTANCE-DATETIME>20180406160619
ACCESSION NUMBER:		0001171843-18-002576
CONFORMED SUBMISSION TYPE:	PRE 14A
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20180531
FILED AS OF DATE:		20180406
DATE AS OF CHANGE:		20180406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Anika Therapeutics, Inc.
		CENTRAL INDEX KEY:			0000898437
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				043145961
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PRE 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14027
		FILM NUMBER:		18743269

	BUSINESS ADDRESS:	
		STREET 1:		32 WIGGINS AVENUE
		CITY:			BEDFORD
		STATE:			MA
		ZIP:			01730
		BUSINESS PHONE:		(781) 457-9000

	MAIL ADDRESS:	
		STREET 1:		32 WIGGINS AVENUE
		CITY:			BEDFORD
		STATE:			MA
		ZIP:			01730

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANIKA THERAPEUTICS INC
		DATE OF NAME CHANGE:	19970114

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANIKA RESEARCH INC
		DATE OF NAME CHANGE:	19930309
</SEC-HEADER>
<DOCUMENT>
<TYPE>PRE 14A
<SEQUENCE>1
<FILENAME>pre14a_040518.htm
<DESCRIPTION>PRE 14A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">


<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 12pt"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 3pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 12pt"><B>UNITED STATES SECURITIES AND EXCHANGE
COMMISSION</B></FONT></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>Washington, D.C. 20549</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 16pt"><B>SCHEDULE 14A</B></FONT></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 12pt"><B>Proxy Statement Pursuant to<BR>
Section 14(a) of the Securities Exchange Act of 1934</B></FONT></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: middle">
    <TD COLSPAN="2" STYLE="text-align: left; padding-bottom: 4pt">Filed by the Registrant <FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">&#9746;</FONT></TD>
    <TD STYLE="padding-bottom: 4pt">Filed by a Party other than the Registrant &#9744;</TD></TR>
<TR>
    <TD COLSPAN="2" STYLE="vertical-align: bottom">Check the appropriate box:</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 3%">&#9746;</TD>
    <TD STYLE="vertical-align: middle; width: 50%">Preliminary Proxy Statement</TD>
    <TD STYLE="vertical-align: middle; width: 47%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&#9744;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: middle">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&#9744;</TD>
    <TD STYLE="vertical-align: middle">Definitive Proxy Statement</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&#9744;</TD>
    <TD STYLE="vertical-align: middle">Definitive Additional Materials</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&#9744;</TD>
    <TD STYLE="vertical-align: middle">Soliciting Material Pursuant to &sect;240.14a-12</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"></P>

<P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 18pt"><B>ANIKA THERAPEUTICS, INC.</B></FONT></P>

<P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt"><I>(Name of Registrant
as Specified in Its Charter)</I></FONT></P>




<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: middle">
    <TD COLSPAN="3" STYLE="text-align: left; padding-bottom: 4pt">Payment of Filing Fee (Check the appropriate box):</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; vertical-align: top; padding-bottom: 4pt">&#9746;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; padding-bottom: 4pt">No fee required.</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; vertical-align: top">&#9744;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and&nbsp;0-11.</TD></TR>
<TR>
    <TD STYLE="text-align: left; width: 3%; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; width: 3%">(1)</TD>
    <TD STYLE="vertical-align: middle; width: 94%">Title of each class of securities to which transaction applies:</TD></TR>
<TR>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; border-bottom: black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">(2)</TD>
    <TD STYLE="vertical-align: middle">Aggregate number of securities to which transaction applies:</TD></TR>
<TR>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; border-bottom: black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">(3)</TD>
    <TD STYLE="vertical-align: middle; border-top-color: black; border-top-width: 1pt">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):</TD></TR>
<TR>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; border-bottom: black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">(4)</TD>
    <TD STYLE="vertical-align: middle; border-top-color: black; border-top-width: 1pt">Proposed maximum aggregate value of transaction:</TD></TR>
<TR>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; border-bottom: black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">(5)</TD>
    <TD STYLE="vertical-align: middle; border-top-color: black; border-top-width: 1pt">Total fee paid:</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; vertical-align: top; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding-bottom: 4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; vertical-align: top; padding-bottom: 4pt">&#9744;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; padding-bottom: 4pt">Fee paid previously with preliminary materials.</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; vertical-align: top">&#9744;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">Check box if any part of the fee is offset as provided by Exchange Act Rule&nbsp;0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.</TD></TR>
<TR>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">(1)</TD>
    <TD STYLE="vertical-align: middle">Amount Previously Paid:</TD></TR>
<TR>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; border-bottom: black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">(2)</TD>
    <TD STYLE="vertical-align: middle; border-top-color: black; border-top-width: 1pt">Form, Schedule or Registration Statement No.:</TD></TR>
<TR>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; border-bottom: black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">(3)</TD>
    <TD STYLE="vertical-align: middle; border-top-color: black; border-top-width: 1pt">Filing Party:</TD></TR>
<TR>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; border-bottom: black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">(4)</TD>
    <TD STYLE="vertical-align: middle; border-top-color: black; border-top-width: 1pt">Date Filed:</TD></TR>
<TR>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; color: Red"><B></B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; color: Red"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 3pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0; color: Red">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; color: Red"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0; color: Red">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; color: Red">&nbsp;<IMG SRC="logo.jpg" ALT=""></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; color: Red">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; color: Red">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><FONT STYLE="font-size: 14pt; color: #395381"><B>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS</B></FONT></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; color: Red">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The 2018 Annual Meeting of Stockholders of Anika Therapeutics,&nbsp;Inc.,
a Massachusetts corporation (&ldquo;Anika&quot;), will be held at Anika&rsquo;s corporate headquarters, 32 Wiggins Avenue, Bedford,
Massachusetts 01730, on Thursday, May 31, 2018, at 11:30&nbsp;a.m., local time.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">At the Annual Meeting the following matters will be considered:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="vertical-align: top; width: 4%; text-align: justify; padding-bottom: 6pt"><FONT STYLE="font-size: 10pt">1.</FONT></TD>
    <TD STYLE="width: 96%; text-align: justify; padding-bottom: 6pt"><FONT STYLE="font-size: 10pt">election of two Class&nbsp;I directors;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify; padding-bottom: 6pt"><FONT STYLE="font-size: 10pt">2.</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 6pt"><FONT STYLE="font-size: 10pt">reincorporation of Anika in Delaware;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify; padding-bottom: 6pt"><FONT STYLE="font-size: 10pt">3.</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 6pt"><FONT STYLE="font-size: 10pt">increase in the number of authorized shares of common stock;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify; padding-bottom: 6pt"><FONT STYLE="font-size: 10pt">4.</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 6pt"><FONT STYLE="font-size: 10pt">ratification of the appointment of Deloitte &amp; Touche LLP as Anika&rsquo;s independent registered public accounting firm for the year ending December 31, 2018;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify; padding-bottom: 6pt"><FONT STYLE="font-size: 10pt">5.</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 6pt"><FONT STYLE="font-size: 10pt">advisory vote on executive compensation; and</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">6.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">any other matters that properly come before the Annual Meeting.</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Only stockholders of record of common stock at the close of business
on April&nbsp;2, 2018, the record date, will be entitled to receive notice of and to vote at the Annual Meeting.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Proxies are being solicited on behalf of the Board of Directors.
We have adopted the Securities and Exchange Commission rule that allows companies to furnish proxy materials over the Internet.
We are mailing a Notice of Internet Availability of Proxy Materials (the &ldquo;Internet Availability Notice&rdquo;) to most of
our stockholders instead of a paper copy of this Proxy Statement and our 2017 Annual Report. The Internet Availability Notice contains
instructions on how to access and review those documents over the Internet. This process allows us to provide stockholders with
the information they need in a more timely manner, while reducing the environmental impact and lowering the costs of printing and
distributing our proxy materials. If you received an Internet Availability Notice by mail and would like to receive a printed copy
of our proxy materials, you may request those materials by following the instructions included in the Internet Availability Notice.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><B>Your vote is very important.</B> Whether or not you plan to attend
the Annual Meeting, please complete and return your proxy card or vote by telephone or via the Internet by following the instructions
on the Internet Availability Notice. Returning a proxy card or otherwise submitting your proxy does not deprive you of your right
to attend the Annual Meeting and vote in person.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%"><FONT STYLE="font-size: 10pt">By Order of the Board of Directors,</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 6pt; padding-bottom: 6pt"><IMG SRC="cheung_sig.jpg" ALT=""></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Sylvia Cheung</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><I>Chief Financial Officer&nbsp;&amp; Secretary</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Bedford, Massachusetts </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">April [&bull;], 2018 </FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%">&nbsp;<IMG SRC="logo.jpg" ALT=""></TD>
    <TD STYLE="width: 50%; text-align: right; vertical-align: middle"><B>32 Wiggins Avenue<BR>
    Bedford, Massachusetts 01730</B></TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: left; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 16pt">Proxy
Statement dated April [&bull;], 2018</FONT></P>

<P STYLE="color: #365F91; font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0; color: #365F91"><FONT STYLE="font-size: 14pt"><B>2018 Annual Meeting
of Stockholders</B></FONT></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0; color: #365F91">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Anika Therapeutics, Inc., a Massachusetts corporation, is furnishing
this Proxy Statement and related proxy materials in connection with the solicitation by its Board of Directors of proxies to be
voted at its 2018 Annual Meeting of Stockholders and any adjournments. Anika Therapeutics, Inc. is providing these materials to
the holders of record of its common stock as of the close of business on April 2, 2018 and is first making available or mailing
the materials on or about April [&bull;], 2018.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Annual Meeting is scheduled to be held as follows:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: middle">
    <TD STYLE="font-size: 10pt; text-align: justify; width: 25%; padding-left: 40pt">Date</TD>
    <TD STYLE="font-size: 10pt; text-align: justify; width: 75%">Thursday, May 31, 2018</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="font-size: 10pt; text-align: justify; padding-left: 20pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="font-size: 10pt; text-align: justify; padding-left: 40pt">Time:</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">11:30 a.m., Eastern daylight saving time</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="font-size: 10pt; text-align: justify; padding-left: 20pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD NOWRAP STYLE="font-size: 10pt; text-align: justify; padding-left: 40pt">Meeting Address:&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">32 Wiggins Avenue, Bedford, Massachusetts 01730</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: -184.5pt; margin: 0pt 0 0pt 202.5pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: -184.5pt; margin: 0pt 0 0pt 202.5pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: -184.5pt; margin: 0pt 0 0pt 202.5pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: -184.5pt; margin: 0pt 0 0pt 202.5pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: -184.5pt; margin: 0pt 0 0pt 202.5pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: -184.5pt; margin: 0pt 0 0pt 202.5pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: -184.5pt; margin: 0pt 0 0pt 202.5pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: -184.5pt; margin: 0pt 0 0pt 202.5pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>Your vote is important.</B> Please see the detailed information
that follows.</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>


<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0; color: #365F91"><FONT STYLE="font-size: 14pt"><B><I>Table of Contents</I></B></FONT></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0; color: #365F91">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 90%; text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">2018 Proxy Summary</TD>
    <TD STYLE="width: 10%; text-align: right; padding-top: 0in; padding-bottom: 0pt">1</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">Questions and Answers about the Annual Meeting</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">4</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">PROPOSAL 1: ELECTION OF DIRECTORS</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">8</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">Vote Required</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">8</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">Board Recommendation</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">8</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">Information Regarding the Directors</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">8</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">The Board&rsquo;s Role in Risk Oversight</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">10</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">Board Leadership Structure</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">11</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">Corporate Governance, Board Matters and Committees</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">11</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">Communications with the Board</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">13</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">Code of Business Conduct</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">14</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">Majority Voting in Uncontested Director Elections Policy</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">14</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">Transactions with Related Persons and Conflict of Interest Policy</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">14</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">BENEFICIAL OWNERSHIP OF COMMON STOCK</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">15</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">Section&nbsp;16(a) Beneficial Ownership Reporting Compliance</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">16</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">EXECUTIVE OFFICERS</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">17</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">COMPENSATION DISCUSSION AND ANALYSIS</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">18</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">Executive Summary</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">18</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">Compensation Philosophy</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">19</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">Key Compensation Policies and Practices</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">20</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">2017 Compensation Decisions</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">22</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">Other Compensation Matters</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">24</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">COMPENSATION COMMITTEE REPORT</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">26</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">EXECUTIVE COMPENSATION</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">27</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">Summary Compensation Table</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">27</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">Option Grants and Plan Awards in 2017</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">28</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">Outstanding Equity Awards at December&nbsp;31, 2017</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">29</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">2017 Equity Award Exercises and Stock Vested</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">30</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">Potential Payments Upon Termination or Change in Control</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">30</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">CEO Pay Ratio</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">31</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">Director Compensation</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">31</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">Director and Executive Officer Stock Retention Guidelines</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">32</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">Compensation Committee Interlocks and Insider Participation</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">33</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">Equity Compensation Plan Information</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">33</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">PROPOSAL 2: DELAWARE REINCORPORATION</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">34</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">Principal Features of the Reincorporation</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">34</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">Reasons for the Reincorporation</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">34</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">Potential Anti-Takeover Implications of Reincorporation</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">34</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">Comparison of Stockholder Rights Before and After the Reincorporation</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">35</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">Regulatory Approvals and Effective Time</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">42</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in">Securities Law Consequences</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">43</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">PROPOSAL 3: APPROVAL OF INCREASE AUTHORIZED SHARES OF COMMON STOCK</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">44</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">AUDIT COMMITTEE REPORT</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">46</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">PROPOSAL 4: RATIFICATION OF APPOINTMENT OF INDEPENDENT AUDITOR FOR 2018</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">47</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">PROPOSAL 5: ADVISORY VOTE ON EXECUTIVE COMPENSATION</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">50</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">OTHER MATTERS</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">51</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">SOLICITATION EXPENSES</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">51</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">STOCKHOLDER PROPOSALS</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">51</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">APPENDIX A</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">52</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">APPENDIX B</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">54</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">APPENDIX C</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">58</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">References in this Proxy Statement to &ldquo;we,&rdquo; &ldquo;us,&rdquo;
&ldquo;our,&rdquo; &ldquo;our company&rdquo; and similar references refer to Anika Therapeutics, Inc. and its subsidiaries, unless
the context requires otherwise.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">ANIKA, ANIKA THERAPEUTICS, and CINGAL are our registered trademarks.
This Proxy Statement also contains registered trademarks that are the property of other companies.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid; border-top: Black 1pt solid"><FONT STYLE="font-size: 14pt">&nbsp;</FONT></P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 14pt">&nbsp;</FONT></P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 14pt">2018
Proxy Summary</FONT></P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid"><I>This summary highlights information contained elsewhere in this
Proxy Statement. This summary does not contain all of the information that you should consider, and you should read the entire
proxy statement carefully before voting.</I></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid"><I>&nbsp;</I></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid"><I>&nbsp;</I></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 12pt"><B>Annual
Meeting of Stockholders</B></FONT></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; border-left: Black 1pt solid; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="width: 35%; padding-bottom: 4pt; text-align: left; vertical-align: top">Time&nbsp;and&nbsp;Date&#9;</TD>
    <TD STYLE="width: 59%; padding-bottom: 4pt">11:30 a.m., Eastern daylight saving time, on May 31, 2018</TD>
    <TD STYLE="width: 3%; border-right: Black 1pt solid; padding-bottom: 4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-left: Black 1pt solid; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: left; vertical-align: top">Place&#9;</TD>
    <TD STYLE="padding-bottom: 4pt">32 Wiggins Avenue, Bedford, Massachusetts</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-bottom: 4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-left: Black 1pt solid; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: left; vertical-align: top">Record Date&#9;</TD>
    <TD STYLE="padding-bottom: 4pt">April 2, 2018</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-bottom: 4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-left: Black 1pt solid; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: left; vertical-align: top">Voting&#9;</TD>
    <TD STYLE="padding-bottom: 4pt">Stockholders will be entitled to one vote at the Annual Meeting for each outstanding share of common stock they hold of record as of the record date.</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-bottom: 4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-left: Black 1pt solid">&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: left; vertical-align: top">Outstanding Common Stock&#9;</TD>
    <TD>14,745,152 shares as of the record date</TD>
    <TD STYLE="border-right: Black 1pt solid">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 12pt"><B>Annual
Meeting Agenda</B></FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="border-left: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; border-left: Black 1pt solid; background-color: rgb(54,95,145); border-top: Black 1pt solid"><FONT STYLE="color: white"><B>Proposal</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; text-align: center; background-color: rgb(54,95,145); border-top: Black 1pt solid"><FONT STYLE="color: white"><B>Board Recommendation</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 3%; border-left: Black 1pt solid; padding-bottom: 6pt; padding-top: 6pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 7%; border-left: Black 1pt solid; padding-left: 12pt; text-align: center; text-indent: -12pt; padding-bottom: 6pt; padding-top: 6pt">1</TD>
    <TD STYLE="vertical-align: top; width: 58%; padding-left: 12.25pt; text-indent: -12.25pt; padding-bottom: 6pt; padding-top: 6pt">Election of directors&#9;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 29%; border-right: Black 1pt solid; text-align: center; padding-bottom: 6pt; padding-top: 6pt">FOR each nominee</TD>
    <TD STYLE="width: 3%; border-right: Black 1pt solid; padding-bottom: 6pt; padding-top: 6pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="border-left: Black 1pt solid; padding-bottom: 6pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-left: Black 1pt solid; padding-left: 12pt; text-align: center; text-indent: -12pt; padding-bottom: 6pt">2</TD>
    <TD STYLE="vertical-align: top; padding-left: 12.25pt; text-indent: -12.25pt; padding-bottom: 6pt">Reincorporation in Delaware&#9;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; text-align: center; padding-bottom: 6pt">FOR</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-bottom: 6pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="border-left: Black 1pt solid; padding-bottom: 6pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-left: Black 1pt solid; padding-left: 12pt; text-align: center; text-indent: -12pt; padding-bottom: 6pt">3</TD>
    <TD STYLE="vertical-align: top; padding-left: 12.25pt; text-indent: -12.25pt; padding-bottom: 6pt">Authorized share increase&#9;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; text-align: center; padding-bottom: 6pt">FOR</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-bottom: 6pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="border-left: Black 1pt solid; padding-bottom: 6pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-left: Black 1pt solid; padding-left: 12pt; text-align: center; text-indent: -12pt; padding-bottom: 6pt">4</TD>
    <TD STYLE="vertical-align: top; padding-left: 12.25pt; text-indent: -12.25pt; padding-bottom: 6pt">Ratification of independent auditors for 2018&#9;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; text-align: center; padding-bottom: 6pt">FOR</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-bottom: 6pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="border-left: Black 1pt solid; padding-bottom: 6pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-left: 12pt; text-align: center; text-indent: -12pt; padding-bottom: 6pt">5</TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; padding-left: 12.25pt; text-indent: -12.25pt; padding-bottom: 6pt">Advisory &ldquo;say on pay&rdquo; vote &#9;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 6pt">FOR</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-bottom: 6pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 12pt"><B>How
to Cast Your Vote</B></FONT><B> </B></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid">You can vote by any of the following methods:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid; border-right: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="color: white; font-weight: bold; vertical-align: middle; border-top: Black 1pt solid; background-color: rgb(54,95,145)">Until 11:59 p.m., EDST, on May 30, 2018</TD>
    <TD STYLE="color: white; font-weight: bold; vertical-align: middle; background-color: rgb(54,95,145); border-top: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="color: white; font-weight: bold; vertical-align: middle; border-right: black 1pt solid; text-align: left; background-color: rgb(54,95,145); border-top: Black 1pt solid">At the Annual Meeting on May 31, 2018</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid; padding-bottom: 4pt; padding-top: 4pt; border-right: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; padding-bottom: 4pt; padding-top: 4pt">&nbsp;&bull;</TD>
    <TD STYLE="vertical-align: bottom; padding-bottom: 4pt; padding-top: 4pt"><B>Internet:</B> <I>www.proxyvote.com</I></TD>
    <TD STYLE="font-weight: bold; vertical-align: middle; padding-bottom: 4pt; padding-top: 4pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; vertical-align: middle; padding-bottom: 4pt; padding-top: 4pt">&nbsp;&bull;&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: middle; border-right: Black 1pt solid; text-align: left; padding-bottom: 4pt; padding-top: 4pt"><FONT STYLE="font-size: 10pt; font-style: normal"><B>In person</B><FONT STYLE="font-weight: normal">:</FONT></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; padding-bottom: 4pt; padding-top: 4pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 3%; border-left: Black 1pt solid; padding-bottom: 4pt; border-right: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 2%; vertical-align: top; padding-bottom: 4pt">&nbsp;&bull;</TD>
    <TD STYLE="font-weight: bold; vertical-align: middle; text-align: left; width: 45%; padding-bottom: 4pt"><FONT STYLE="font-size: 10pt; font-style: normal"><B>Telephone</B><FONT STYLE="font-weight: normal">:
    +1-800-690-6903 if you are the stockholder of record or beneficially hold shares in &ldquo;street name&rdquo;</FONT></FONT></TD>
    <TD STYLE="font-weight: bold; vertical-align: middle; width: 5%; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; vertical-align: middle; width: 3%; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left; width: 3%; vertical-align: top; padding-bottom: 4pt"><FONT STYLE="font-family: Webdings">4</font></TD>
    <TD STYLE="vertical-align: middle; border-right: Black 1pt solid; text-align: left; width: 36%; padding-bottom: 4pt">If you are the stockholder of record, your admission ticket is attached to your proxy card</TD>
    <TD STYLE="vertical-align: bottom; width: 3%; border-right: Black 1pt solid; padding-bottom: 4pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid; border-right: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: middle">&nbsp;&bull;</TD>
    <TD STYLE="text-align: left; vertical-align: middle">Completed, signed, and returned <B>proxy card</b></TD>
    <TD STYLE="font-weight: bold; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="font-weight: bold; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left; vertical-align: top"><FONT STYLE="font-family: Webdings">4</font></TD>
    <TD STYLE="vertical-align: middle; border-right: Black 1pt solid; text-align: left">If you beneficially own shares held in &ldquo;street name,&rdquo; you must bring proof of ownership</TD>
    <TD STYLE="font-weight: bold; vertical-align: middle; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid; border-right: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-weight: bold; vertical-align: middle; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-weight: bold; vertical-align: middle; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 1pt solid; vertical-align: top">&nbsp;</TD>
    <TD STYLE="color: white; font-weight: bold; vertical-align: middle; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid"></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: -1.8in; margin: 0pt 0 0pt 1.8in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: -1.8in; margin: 0pt 0 0pt 1.8in"></P>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: -1.8in; margin: 0pt 0 0pt 1.8in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid; border-top: Black 1pt solid">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 3%; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 94%"><FONT STYLE="font-size: 12pt; color: #365F91"><B>Proposal 1: Election of Directors</B></FONT></TD>
    <TD STYLE="width: 3%; border-right: Black 1pt solid">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid"></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="width: 3%; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 12%; border-left: Black 1pt solid; background-color: rgb(54,95,145); text-align: left; vertical-align: bottom; border-top: Black 1pt solid; padding-left: 4.5pt"><FONT STYLE="font-size: 8pt; color: white"><B>Director
    Nominee</B></FONT></TD>
    <TD STYLE="width: 3%; text-align: center; background-color: rgb(54,95,145); vertical-align: bottom; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt; color: white"><B>Age</B></FONT></TD>
    <TD STYLE="width: 5%; background-color: rgb(54,95,145); text-align: center; vertical-align: bottom; border-top: Black 1pt solid"><P STYLE="font-size: 10pt; margin: 0pt 0; color: white"><FONT STYLE="font-size: 8pt"><B>Director</B></FONT></P>
        <P STYLE="font-size: 10pt; margin: 0pt 0; color: white"><FONT STYLE="font-size: 8pt"><B>Since</B></FONT></P></TD>
    <TD STYLE="width: 18%; background-color: rgb(54,95,145); text-align: left; vertical-align: bottom; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt; color: white"><B>Occupation</B></FONT></TD>
    <TD STYLE="width: 1%; background-color: rgb(54,95,145); text-align: left; vertical-align: bottom; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 12%; background-color: rgb(54,95,145); text-align: left; vertical-align: bottom; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt; color: white"><B>Experience /</B></FONT><FONT STYLE="font-size: 8pt"><BR>
    <FONT STYLE="color: white"><B>Qualifications</B></FONT></FONT></TD>
    <TD STYLE="width: 8%; background-color: rgb(54,95,145); text-align: center; vertical-align: bottom; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt; color: white"><B>Independent</B></FONT></TD>
    <TD STYLE="width: 13%; background-color: rgb(54,95,145); text-align: left; vertical-align: bottom; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt; color: white"><B>Committee <BR>
Memberships</B></FONT></TD>
    <TD STYLE="width: 22%; border-right: Black 1pt solid; background-color: rgb(54,95,145); text-align: left; vertical-align: bottom; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt; color: white"><B>Other
    Boards</B></FONT></TD>
    <TD STYLE="width: 3%; border-right: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-left: Black 1pt solid; padding-top: 4pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 4.5pt; padding-top: 4pt"><FONT STYLE="font-size: 8pt">Joseph L. Bower, D.B.A.</FONT></TD>
    <TD NOWRAP STYLE="text-align: center; padding-top: 4pt"><FONT STYLE="font-size: 8pt">79</FONT></TD>
    <TD NOWRAP STYLE="text-align: center; padding-top: 4pt"><FONT STYLE="font-size: 8pt">1993</FONT></TD>
    <TD STYLE="padding-top: 4pt"><FONT STYLE="font-size: 8pt">Donald Kirk Davis Professor Emeritus at Harvard Business School</FONT></TD>
    <TD STYLE="padding-top: 4pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 4pt"><P STYLE="font-size: 10pt; margin: 0pt 0 4pt"><FONT STYLE="font-size: 8pt; color: #365F91">&bull;</FONT><FONT STYLE="font-size: 8pt">&#9;&nbsp;Leadership</FONT></P>
        <P STYLE="font-size: 10pt; margin: 0pt 0 0pt 10pt; text-align: left; text-indent: -10pt"><FONT STYLE="font-size: 8pt; color: #365F91">&bull;</FONT><FONT STYLE="font-size: 8pt">&#9;&nbsp;General
        &#9;Experience</FONT></P>
        <P STYLE="font-size: 10pt; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P></TD>
    <TD NOWRAP STYLE="text-align: center; padding-top: 4pt"><FONT STYLE="font-size: 8pt">Yes</FONT></TD>
    <TD STYLE="padding-top: 4pt"><P STYLE="font-size: 10pt; margin: 0pt 0 4pt"><FONT STYLE="font-size: 8pt; color: #365F91">&bull;</FONT><FONT STYLE="font-size: 8pt">&#9;&nbsp;Compensation
        (Chair)</FONT></P>
        <P STYLE="font-size: 10pt; margin: 0pt 0"><FONT STYLE="font-size: 8pt; color: #365F91">&bull;</FONT><FONT STYLE="font-size: 8pt">&#9;&nbsp;Audit</FONT></P></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; padding-top: 4pt"><P STYLE="font-size: 10pt; margin: 0pt 0 4pt"><FONT STYLE="font-size: 8pt; color: #365F91">&bull;</FONT><FONT STYLE="font-size: 8pt">&#9;&nbsp;Loews
                                         Corporation</FONT></P>
        <P STYLE="font-size: 10pt; margin: 0pt 0 0pt 10pt; text-align: left; text-indent: -10pt"><FONT STYLE="font-size: 8pt; color: #365F91">&bull;</FONT><FONT STYLE="font-size: 8pt">&#9;&nbsp;New
        America High Income Fund</FONT></P></TD>
    <TD STYLE="border-right: Black 1pt solid; padding-top: 4pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-left: 4.5pt"><FONT STYLE="font-size: 8pt">Jeffery
    S. Thompson</FONT></TD>
    <TD NOWRAP STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt">52</FONT></TD>
    <TD NOWRAP STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt">2011</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Partner, Healthedge Investment Partner, LLC</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; margin: 0pt 0 4pt"><FONT STYLE="font-size: 8pt; color: #365F91">&bull;</FONT><FONT STYLE="font-size: 8pt">&#9;&nbsp;Leadership</FONT></P>
        <P STYLE="font-size: 10pt; margin: 0pt 0 0pt 10pt; text-align: left; text-indent: -10pt"><FONT STYLE="font-size: 8pt; color: #365F91">&bull;</FONT><FONT STYLE="font-size: 8pt">&#9;&nbsp;Industry
        &#9;Experience</FONT></P>
        <P STYLE="font-size: 10pt; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P></TD>
    <TD NOWRAP STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt">Yes</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; margin: 0pt 0 4pt"><FONT STYLE="font-size: 8pt; color: #365F91">&bull;</FONT><FONT STYLE="font-size: 8pt">&#9;&nbsp;Compensation</FONT></P>
        <P STYLE="font-size: 10pt; margin: 0pt 0"><FONT STYLE="font-size: 8pt; color: #365F91">&bull;</FONT><FONT STYLE="font-size: 8pt">&#9;&nbsp;Audit</FONT></P>
        <P STYLE="font-size: 10pt; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; margin: 0pt 0 4pt"><FONT STYLE="font-size: 8pt; color: #365F91">&bull;</FONT><FONT STYLE="font-size: 8pt">&#9;&nbsp;Sinclair
                                         Pharma, plc</FONT></P>
        <P STYLE="font-size: 10pt; margin: 0pt 0 4pt"><FONT STYLE="font-size: 8pt; color: #365F91">&bull;</FONT><FONT STYLE="font-size: 8pt">&#9;&nbsp;MNG
        Laboratories, LLC</FONT></P>
        <P STYLE="font-size: 10pt; margin: 0pt 0 4pt"><FONT STYLE="font-size: 8pt; color: #365F91">&bull;</FONT><FONT STYLE="font-size: 8pt">&#9;&nbsp;Westone
        Laboratories</FONT></P>
        <P STYLE="font-size: 10pt; margin: 0pt 0 4pt"><FONT STYLE="font-size: 8pt; color: #365F91">&bull;</FONT><FONT STYLE="font-size: 8pt">&#9;&nbsp;Lifesync
        Corp.</FONT></P>
        <P STYLE="font-size: 10pt; margin: 0pt 0 4pt"><FONT STYLE="font-size: 8pt; color: #365F91">&bull;</FONT><FONT STYLE="font-size: 8pt">&#9;&nbsp;The
        Columbus Organization, LLC</FONT></P>
        <P STYLE="font-size: 10pt; margin: 0pt 0 0pt 10pt; text-align: left; text-indent: -10pt"><FONT STYLE="font-size: 8pt; color: #365F91">&bull;</FONT><FONT STYLE="font-size: 8pt">&#9;&nbsp;Data
        Dimensions, LLC</FONT></P>
        <P STYLE="font-size: 10pt; margin: 0pt 4.55pt 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P></TD>
    <TD STYLE="border-right: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: -1.8in; margin: 0pt 0 0pt 1.8in"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="vertical-align: bottom; padding-bottom: 6pt; border-left: Black 1pt solid; width: 3%">&nbsp;</TD>
    <TD STYLE="font-style: italic; vertical-align: top; padding-bottom: 6pt; width: 20%">Board Recommendation<FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">:</FONT></TD>
    <TD STYLE="vertical-align: middle; padding-bottom: 6pt; width: 74%">The Board of Directors recommends a vote &ldquo;FOR&rdquo; the reelection of Dr. Bower and Mr.&nbsp;Thompson.&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-bottom: 6pt; border-right: Black 1pt solid; width: 3%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-style: italic; vertical-align: top">Vote Required for Approval<FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">:</FONT></TD>
    <TD STYLE="vertical-align: middle">Affirmative vote of a majority of votes cast. Abstentions and broker non-votes will not be treated as votes cast and will have no impact on the proposal, except to the extent that failure to vote for an individual results in another individual receiving a larger percentage of votes.</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="color: #365F91; font-weight: bold; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="color: #365F91; font-weight: bold; vertical-align: middle; text-align: left"><FONT STYLE="font-size: 12pt">Proposal
    2: Approval of Delaware Reincorporation</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-bottom: 6pt; border-left: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: middle; text-align: left; padding-bottom: 6pt">The Board of Directors has approved a proposal to change our state of incorporation from the Commonwealth of Massachusetts to the State of Delaware.</TD>
    <TD STYLE="vertical-align: bottom; padding-bottom: 6pt; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-bottom: 4pt; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-style: italic; vertical-align: top; padding-bottom: 4pt">Board Recommendation<FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">:</FONT></TD>
    <TD STYLE="vertical-align: middle; padding-bottom: 4pt">The Board recommends a vote &ldquo;FOR&rdquo; our reincorporation in Delaware.</TD>
    <TD STYLE="vertical-align: bottom; padding-bottom: 4pt; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-style: italic; vertical-align: top">Vote Required for Approval<FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">:</FONT></TD>
    <TD STYLE="vertical-align: middle">Affirmative vote of two-thirds of the issued and outstanding shares of common stock. Abstentions and broker non-votes, if any, will be counted as votes against the reincorporation in Delaware.</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-style: italic; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="color: #365F91; font-weight: bold; vertical-align: top"><FONT STYLE="font-size: 12pt">Proposal 3: Authorized
    Share Increase</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-bottom: 6pt; border-left: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: middle; text-align: left; padding-bottom: 6pt">The Board of Directors has approved a proposal to increase the aggregate number of shares of common stock that we are authorized to issue from 60,000,000 to 90,000,000. If approved, this increase will be implemented whether or not Proposal 2 is approved.</TD>
    <TD STYLE="vertical-align: bottom; padding-bottom: 6pt; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-bottom: 6pt; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-style: italic; vertical-align: top; padding-bottom: 6pt">Board Recommendation<FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">:</FONT></TD>
    <TD STYLE="vertical-align: middle; padding-bottom: 6pt">The Board recommends a vote &ldquo;FOR&rdquo; the increase in authorized shares.</TD>
    <TD STYLE="vertical-align: bottom; padding-bottom: 6pt; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-style: italic; vertical-align: top">Vote Required for Approval<FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">:</FONT></TD>
    <TD STYLE="vertical-align: middle">Affirmative vote of a majority of the issued and outstanding shares of common stock. Abstentions and broker non-votes, if any, will be counted as votes against the increase in authorized shares.</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="color: #365F91; font-weight: bold; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="color: #365F91; font-weight: bold; vertical-align: middle; text-align: left"><FONT STYLE="font-size: 12pt">Proposal
    4: Ratification of Auditors for 2018</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-bottom: 6pt; border-left: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: left; padding-bottom: 6pt">The Audit Committee has approved the retention of Deloitte &amp; Touche LLP as our independent registered public accounting firm with respect to our consolidated financial statements and the effectiveness of our internal control over financial reporting as of, and for the fiscal year ending, December 31, 2018.</TD>
    <TD STYLE="vertical-align: bottom; padding-bottom: 6pt; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-bottom: 6pt; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-style: italic; vertical-align: top; padding-bottom: 6pt">Board Recommendation:</TD>
    <TD STYLE="vertical-align: middle; padding-bottom: 6pt">The Board of Directors recommends a vote &ldquo;FOR&rdquo; the ratification of Deloitte &amp; Touche LLP as our independent auditor for 2018.</TD>
    <TD STYLE="vertical-align: bottom; padding-bottom: 6pt; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-style: italic; vertical-align: top">Vote Required for Approval:</TD>
    <TD STYLE="vertical-align: middle">Affirmative vote of a majority of the shares of common stock present or represented at the Annual Meeting and voting on the matter. This proposal is considered a routine matter, and broker non-votes will be counted.</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-align: justify; text-indent: -1.8in; margin: 0pt 0 0pt 1.8in"></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: -1.8in; margin: 0pt 0 0pt 1.8in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: -1.8in; margin: 0pt 0 0pt 1.8in"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: -1.8in; margin: 0pt 0 0pt 1.8in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: -1.8in; margin: 0pt 0 0pt 1.8in"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 3%; border-top: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 20%; border-top: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 3%; border-top: Black 1pt solid; text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="width: 31%; border-top: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 2%; border-top: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 3%; border-top: Black 1pt solid; text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="width: 35%; border-top: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 3%; border-top: Black 1pt solid; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-left: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="color: #365F91; font-weight: bold; vertical-align: middle"><FONT STYLE="font-size: 12pt">Proposal 5:
    Advisory &ldquo;Say on Pay&rdquo; Vote&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="color: #365F91; font-weight: bold; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="color: #365F91; font-weight: bold; text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="vertical-align: middle; text-align: left">The overall objective of our executive compensation policy is to attract and retain highly qualified executive officers and to motivate those officers to provide superior performance for the benefit of our company and stockholders.</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-weight: bold; vertical-align: middle; border-bottom: Black 1pt solid">Compensation Element</TD>
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 1pt solid; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font-weight: bold; vertical-align: middle; border-bottom: Black 1pt solid">Description&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 1pt solid; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font-weight: bold; vertical-align: middle; border-bottom: Black 1pt solid">Objectives</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid; padding-bottom: 8pt; padding-top: 6pt">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; padding-bottom: 8pt; padding-top: 6pt">Base Salary</TD>
    <TD STYLE="text-align: left; vertical-align: top; padding-bottom: 8pt; padding-top: 6pt">&nbsp;&bull;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 8pt; padding-top: 6pt"><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">Fixed
cash compensation&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt; padding-top: 6pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 8pt; padding-top: 6pt">&nbsp;&bull;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify; padding-bottom: 8pt; padding-top: 6pt"><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">Provide
appropriate level of fixed compensation based on role, responsibility, performance and competitive market practices</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; padding-bottom: 8pt; padding-top: 6pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; padding-bottom: 4pt">Cash Bonuses</TD>
    <TD STYLE="text-align: left; vertical-align: top; padding-bottom: 4pt">&nbsp;&bull;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 4pt"><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">Annual
cash award based on performance of company and individual&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 4pt">&nbsp;&bull;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify; padding-bottom: 4pt"><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">Reward
the achievement of financial results, organizational development, business and technical development, individual goals, and contribution
to stockholder value</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; padding-bottom: 4pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid; padding-bottom: 8pt">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; padding-bottom: 8pt">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; padding-bottom: 8pt">&nbsp;&bull;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 8pt"><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">Prorated
in the year of hire if employment begins before October 1</FONT></TD>
    <TD STYLE="padding-bottom: 8pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 8pt">&nbsp;&bull;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify; padding-bottom: 8pt"><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">Encourage
retention</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; padding-bottom: 8pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; padding-bottom: 4pt">Equity-Based Grants</TD>
    <TD STYLE="text-align: left; vertical-align: top; padding-bottom: 4pt">&nbsp;&bull;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 4pt"><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">Grants
of stock options, or other forms of equity securities, under our equity plan</FONT></TD>
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 4pt">&nbsp;&bull;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify; padding-bottom: 4pt"><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">Provide
executive officers with opportunity to be compensated based on common stock price appreciation</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; padding-bottom: 4pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; padding-bottom: 4pt">&nbsp;&bull;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 4pt"><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">Includes
stock appreciation rights, restricted stock awards and performance-based equity awards</FONT></TD>
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 4pt">&nbsp;&bull;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify; padding-bottom: 4pt"><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">Align
interests of our executive officers with those of our stockholders</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; padding-bottom: 4pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-align: justify; text-indent: -1.8in; margin: 0pt 0 0pt 1.8in"></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: -1.8in; margin: 0pt 0 0pt 1.8in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-left: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="27" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt">Summary
    Compensation Table</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-left: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><FONT STYLE="font-size: 9pt">Name
    and Principal Position</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Year</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><FONT STYLE="font-size: 9pt">Salary</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; font-style: normal; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.1pt solid"><FONT STYLE="font-size: 9pt">Bonus<FONT STYLE="font-style: normal"><B><SUP>&nbsp;</SUP></B></FONT></FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><FONT STYLE="font-size: 9pt">Option
    <BR> Awards</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><FONT STYLE="font-size: 9pt">Stock
    Awards</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><FONT STYLE="font-size: 9pt">All
    Other <BR> Compensation</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><FONT STYLE="font-size: 9pt">Total</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 3%; border-left: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 34%; font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">Charles
    H. Sherwood, Ph.D.</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; font-size: 10pt; text-align: center; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">2017</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">622,641</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">466,981</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">2,960,954</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">187,037</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">4,237,612</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 3%; border-right: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-left: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">Chief Executive Officer</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">2016</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">601,586</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">496,308</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">1,519,778</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">861,286</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">52,060</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">3,531,018</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-left: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">2015</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">581,242</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">508,587</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">864,043</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">535,815</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">52,118</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">2,541,805</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-left: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Sylvia Cheung</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 9pt">2017</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">359,085</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">185,827</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">709,054</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">18,720</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1,272,686</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-left: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Chief Financial Officer</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 9pt">2016</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">346,942</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">171,736</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">439,830</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">301,069</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">18,720</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1,278,297</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-left: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 9pt">2015</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">335,210</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">188,556</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">289,996</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">264,931</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">18,720</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1,097,413</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-left: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">Joseph G. Darling</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">2017</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">181,987</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">93,990</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">750,281</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">749,960</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">5,993</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">1,782,212</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-left: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">President</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-left: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Ed Ahn, Ph.D.</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 9pt">2017</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">347,243</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">125,007</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">599,331</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">19,080</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1,090,662</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-left: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Chief Technology and</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 9pt">2016</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">315,675</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">156,259</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">439,830</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">301,069</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">18,720</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1,231,553</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-left: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Strategy Officer</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 9pt">2015</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">305,000</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">137,250</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">43,953</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">18,720</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">504,923</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-left: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">Richard Hague</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">2017</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">326,025</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">102,698</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">599,331</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">27,096</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">1,055,150</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-left: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">Chief Commerical Officer</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">2016</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">315,000</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">127,575</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">439,830</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">301,069</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">84,799</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">1,268,273</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-left: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">2015</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">48,462</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">727,650</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">24,831</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">800,943</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: #CCECFF"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
</TABLE>



<P STYLE="font-size: 10pt; text-align: justify; text-indent: -1.8in; margin: 0pt 0 0pt 1.8in"></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: -1.8in; margin: 0pt 0 0pt 1.8in"></P>



<P STYLE="font-size: 10pt; text-align: justify; text-indent: -1.8in; margin: 0pt 0 0pt 1.8in"></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: -1.8in; margin: 0pt 0 0pt 1.8in"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="vertical-align: bottom; width: 3%; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-style: italic; vertical-align: top; text-align: left; width: 20%">Board Recommendation<FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">:</FONT></TD>
    <TD STYLE="vertical-align: middle; text-align: justify; width: 74%">The Board of Directors recommends a vote &ldquo;FOR&rdquo;&nbsp;the approval of executive compensation for the 2017 fiscal year.</TD>
    <TD STYLE="vertical-align: bottom; width: 3%; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-style: italic; vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-style: italic; vertical-align: top; text-align: left">Vote Required for Approval<FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">:&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: middle; text-align: justify">Affirmative vote of a majority of the shares of common stock present or represented at the Annual Meeting and voting on the matter. Abstentions and broker non-votes will not be treated as votes cast and will have no impact on this proposal. This vote is required by law, but it will not be binding on us or the Board.&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; padding-right: 20pt; padding-left: 20pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 14pt">Questions
and Answers about the Annual Meeting</FONT></P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; color: #365F91"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>Q:</B></TD><TD STYLE="text-align: justify">When and where will the Annual Meeting be held?</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>A:</B></TD><TD STYLE="text-align: justify">This year the Annual Meeting of Stockholders of Anika Therapeutics, Inc., which we refer to below
as the Annual Meeting, will be held at our corporate headquarters, 32 Wiggins Avenue, Bedford, Massachusetts 01730, on Thursday,
May 31, 2018, at 11:30 a.m., local time.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; color: #365F91"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>Q:</B></TD><TD STYLE="text-align: justify">What materials have been prepared for stockholders in connection with the Annual Meeting?</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>A:</B></TD><TD STYLE="text-align: justify">We are furnishing stockholders of record with access to, or copies of, the following proxy materials:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">our 2017 Annual Report to Stockholders, which includes our audited consolidated financial statements;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">this Proxy Statement for the 2018 Annual Meeting, which also includes a Notice of Annual Meeting
of Stockholders;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">for most stockholders, a Notice of Internet Availability of Proxy Materials; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">for other stockholders who are receiving printed copies of the 2017 Annual Report and Proxy Statement
by mail, a proxy card for the Annual Meeting.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 0.25in">These materials were first made available on the Internet
or mailed to stockholders on or about April&nbsp;[&bull;], 2018.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; color: #365F91"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>Q:</B></TD><TD STYLE="text-align: justify">Why was I mailed a Notice of Internet Availability of Proxy Materials rather than a printed set
of proxy materials?</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>A:</B></TD><TD STYLE="text-align: justify">In accordance with rules and regulations adopted by the Securities and Exchange Commission or SEC,
we are furnishing the proxy materials to most stockholders by providing access via the Internet, instead of mailing printed copies.
This e-proxy process expedites our stockholders&rsquo; receipt of proxy materials, lowers our costs, and reduces the environmental
impact of the Annual Meeting.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 0.25in">The Notice of Internet Availability of Proxy Materials
tells you how to access and review the proxy materials on the Internet and how to vote on the Internet. The Notice also provides
instructions you may follow to request paper or e-mailed copies of our proxy materials.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; color: #365F91"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>Q:</B></TD><TD STYLE="text-align: justify">Are the proxy materials available via the Internet?</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>A:</B></TD><TD STYLE="text-align: justify">You can access the proxy materials for the Annual Meeting at ir.anikatherapeutics.com/financial-information/annual-reports.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; color: #365F91"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>Q:</B></TD><TD STYLE="text-align: justify">What is a proxy?</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>A:</B></TD><TD STYLE="text-align: justify">Because it is important that as many stockholders as possible be represented at the Annual Meeting,
the Board of Directors asks that you review this Proxy Statement carefully and then vote by following the instructions set forth
on the Notice of Internet Availability of Proxy Materials or proxy card. In voting prior to the Annual Meeting, you will deliver
your proxy to Joseph Darling and Sylvia Cheung, which means you will authorize Mr. Darling and Ms. Cheung to vote your shares at
the Annual Meeting in the way you instruct. All shares represented by valid proxies will be voted in accordance with the stockholder&rsquo;s
specific instructions.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; color: #365F91"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>Q:</B></TD><TD STYLE="text-align: justify">What matters will the stockholders vote on at the Annual Meeting?</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"><B>A:</B></TD><TD STYLE="text-align: justify; width: 0.25in">&bull;</TD>
                                                                  <TD STYLE="text-align: justify">Proposal 1.&#9;Election of two director nominees: Joseph Bower and Jeffery Thompson.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">Proposal 2.<B>&#9;</B>Reincorporation of our company in Delaware.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">Proposal 3.&#9;Increase in number of authorized shares of common stock.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">Proposal 4.<B>&#9;</B>Ratification of appointment of our independent auditor for 2018.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">Proposal 5.&#9;Approval, as an advisory vote, of 2017 executive compensation as disclosed in this
Proxy Statement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; color: #365F91"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>Q:</B></TD><TD STYLE="text-align: justify">Why are we proposing to reincorporate in Delaware?</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>A:</B></TD><TD STYLE="text-align: justify">We believe that reincorporating in Delaware will give us a greater measure of flexibility and certainty
in corporate governance than is available under Massachusetts law. Delaware is recognized for adopting comprehensive, modern, and
flexible corporate laws, which are revised periodically to respond to the changing legal and business needs of corporations. Delaware&rsquo;s
specialized business judiciary is composed of experts in corporate law matters, and a substantial body of court decisions has developed
construing Delaware corporation law. As a result, Delaware law provides greater clarity and predictability with respect to our
corporate legal affairs than is currently the case under Massachusetts law. For these and other reasons, many major U.S. corporations
have incorporated in Delaware or have changed their corporate domiciles to Delaware in a manner similar to the manner outlined
in Proposal&nbsp;2.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; color: #365F91"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>Q:</B></TD><TD STYLE="text-align: justify">What is entailed by the reincorporation?</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>A:</B></TD><TD STYLE="text-align: justify">We are currently incorporated in Massachusetts and, as such, governed by Massachusetts law. As
a result of the reincorporation, we will be reincorporated in Delaware and governed by Delaware law. The reincorporation will be
effected by a plan of domestication that has been adopted by the Board of Directors. A copy of this plan of domestication is attached
as <FONT STYLE="font-variant: small-caps">Appendix</FONT>&nbsp;A.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 0.25in">The reincorporation will not involve any change in our
business, directors, officers, management, properties, or corporate headquarters.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; color: #365F91"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>Q:</B></TD><TD STYLE="text-align: justify">How will the reincorporation affect my rights as a stockholder?</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>A:</B></TD><TD STYLE="text-align: justify">Your rights as a stockholder currently are governed by Massachusetts law, our Restated Articles
of Organization, as amended, and our Amended and Restated By-Laws. As a result of the reincorporation, you will remain a stockholder
of our company with rights governed by Delaware law and our new Certificate of Incorporation and Bylaws, which differ in various
respects from your current rights. These important differences are discussed in this Proxy Statement under &ldquo;Proposal 2: Delaware
Reincorporation&#9472;Comparison of Stockholder Rights Before and After the Reincorporation.&rdquo; Forms of our new Certificate
of Incorporation and Bylaws after the reincorporation are attached to this Proxy Statement as <FONT STYLE="font-variant: small-caps">Appendixes
</FONT>B and C, respectively.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; color: #365F91"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>Q:</B></TD><TD STYLE="text-align: justify">How will the reincorporation affect my ownership percentage in our company?</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>A:</B></TD><TD STYLE="text-align: justify">Your proportionate ownership interest in our company will not be affected by the reincorporation.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; color: #365F91"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>Q:</B></TD><TD STYLE="text-align: justify">Are dissenters&rsquo; rights available in connection with the reincorporation?</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>A:</B></TD><TD STYLE="text-align: justify">No. Massachusetts law does not afford stockholders dissenters&rsquo; rights in connection with
a reincorporation.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; color: #365F91"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>Q:</B></TD><TD STYLE="text-align: justify">Why are we proposing to increase the number of authorized shares of our common stock to 90,000,000?</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>A:</B></TD><TD STYLE="text-align: justify">We believe that an increase in our number of authorized shares of common stock would place us in
a more equal position relative to our peers and competitors. We also believe that an approval of this proposal is desirable to
provide us greater flexibility to manage our business and support our growth plans. While we have no current specific plans for
the additional shares, future growth-supporting initiatives utilizing such shares may include raising additional capital through
stock offerings, issuing share dividends, providing equity incentives to attract or retain executives, employees, and directors,
or funding potential M&amp;A opportunities using common stock as consideration.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; color: #365F91"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>Q:</B></TD><TD STYLE="text-align: justify">Who can vote at the Annual Meeting?</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>A:</B></TD><TD STYLE="text-align: justify">Stockholders of record of common stock at the close of business on April&nbsp;2, 2018, the record
date, will be entitled to vote at the Annual Meeting. A total of 14,745,152 shares of common stock were outstanding as of the record
date. Each share outstanding on the record date will be entitled to one vote on each proposal.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; color: #365F91"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>Q:</B></TD><TD STYLE="text-align: justify">What is a stockholder of record?</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>A:</B></TD><TD STYLE="text-align: justify">A stockholder of record is a stockholder whose ownership of our common stock is reflected directly
on the books and records of our transfer agent, American Stock Transfer &amp; Trust Co.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; color: #365F91"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>Q:</B></TD><TD STYLE="text-align: justify">What does it mean for a broker or other nominee to hold shares in &ldquo;street name&rdquo;?</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>A:</B></TD><TD STYLE="text-align: justify">If you beneficially own shares held in an account with a broker, bank, or similar organization,
that organization is the stockholder of record and is considered to hold those shares in &ldquo;street name.&rdquo;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 0.25in">An organization that holds your beneficially owned shares
in street name will vote in accordance with the instructions you provide. If you do not provide the organization with specific
voting instructions with respect to a proposal, under the rules of the NASDAQ Stock Market, Inc., or NASDAQ, the organization&rsquo;s
authority to vote your shares will depend upon whether the proposal is considered a &ldquo;routine&rdquo; or non-routine matter.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">The organization generally may vote your beneficially owned shares on routine items for which you
have not provided voting instructions to the organization. The only routine matter expected to be voted on at the Annual Meeting
is the ratification of the appointment of our independent auditor for 2018 (Proposal 4).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">The organization generally may not vote on non-routine matters, including Proposals 1, 2, 3, and
5. Instead, it will inform the inspector of election that it does not have the authority to vote on those matters. This is referred
to as a &ldquo;broker non-vote.&rdquo;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 0.25in">For the purpose of determining a quorum, we will treat
as present at the Annual Meeting any proxies that are voted on any of the four proposals to be acted upon by the stockholders,
including abstentions or proxies containing broker non-votes.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; color: #365F91"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>Q:</B></TD><TD STYLE="text-align: justify">How do I vote my shares if I do not attend the Annual Meeting?</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>A:</B></TD><TD STYLE="text-align: justify"><B><I>If you are a stockholder of record,</I></B> you may vote prior to the Annual Meeting as follows:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify"><I><U>Via the Internet</U></I>: You may vote via the Internet at <I>www.proxyvote.com</I>, in accordance
with the voting instructions printed on the Notice of Internet Availability of Proxy Materials and the proxy card. Internet voting
is available 24 hours a day until 11:59 p.m., Eastern daylight saving time, on May&nbsp;30, 2018. You will be given the opportunity
to confirm that your instructions have been recorded properly. If you vote via the Internet, you do not need to return a proxy
card.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify"><I><U>By Telephone</U></I>: If you receive a proxy card by mail, you may vote by calling 1-800-690-6903
and following the instructions provided on the telephone line. Telephone voting is available 24&nbsp;hours a day until 11:59 p.m.,
Eastern daylight saving time, on May&nbsp;30, 2018. Easy-to-follow voice prompts allow you to vote your shares and confirm that
your instructions have been recorded properly. If you vote by telephone, you do not need to return a proxy card.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify"><I><U>By Mail</U></I>: If you receive a proxy card by mail, you may vote by returning the completed
and signed proxy card in the postage-paid return envelope provided with the proxy card.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 0.25in"><B><I>If you hold shares in street name,</I></B> you
may vote by following the voting instructions provided by your bank, broker, or other nominee. In general, you may vote prior to
the Annual Meeting as follows:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify"><I><U>Via the Internet</U></I>: You may vote at <I>www.proxyvote.com</I>, in accordance with the
voting instructions printed on the Notice of Internet Availability of Proxy Materials and the proxy card. Internet voting is available
24 hours a day until 11:59 p.m., Eastern daylight saving time, on May 30, 2018. You will be given the opportunity to confirm that
your instructions have been recorded properly.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify"><I><U>By Telephone</U></I>: If you receive a proxy card by mail, you may vote by calling 1-800-690-6903
and following the instructions provided on the telephone line. Telephone voting is available 24&nbsp;hours a day until 11:59 p.m.,
Eastern daylight saving time, on May&nbsp;30, 2018. Easy-to-follow voice prompts allow you to vote your shares and confirm that
your instructions have been recorded properly.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify"><I><U>By Mail</U></I>: You may vote by returning a completed and signed proxy card in accordance
with instructions provided by your bank, broker, or other nominee.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 0.25in">For your information, voting via the Internet is the
least expensive to us, followed by telephone voting, with voting by mail being the most expensive. Also, you may help us to save
the expense of a second mailing if you vote promptly.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; color: #365F91"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>Q:</B></TD><TD STYLE="text-align: justify">Can I vote at the Annual Meeting?</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>A:</B></TD><TD STYLE="text-align: justify">If you are a stockholder of record, you may vote in person at the Annual Meeting, whether or not
you previously voted. If your shares are held in street name, you must obtain a written proxy, executed in your favor, from the
stockholder of record to be able to vote at the Annual Meeting.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; color: #365F91"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>Q:</B></TD><TD STYLE="text-align: justify">May I change my vote or revoke my proxy?</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>A:</B></TD><TD STYLE="text-align: justify">If you are a stockholder of record, you may later change or revoke your proxy at any time before
it is exercised by:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">voting via the Internet or telephone at a later time; or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">submitting a completed and signed proxy card with a later date.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 0.25in">If you are a beneficial owner of shares held in street
name, you should contact your bank, broker, or other nominee for instructions as to whether, and how, you can change or revoke
your proxy.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; color: #365F91"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>Q:</B></TD><TD STYLE="text-align: justify">What happens if I do not give specific voting instructions?</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>A:</B></TD><TD STYLE="text-align: justify">If you are a stockholder of record and you return a proxy card without giving specific voting instructions,
the proxy holders will vote your shares in the manner recommended by the Board of Directors on all five proposals presented in
this Proxy Statement and as they may determine in its discretion on any other matters properly presented for a vote at the Annual
Meeting.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 0.25in">If you are a beneficial owner of shares held in street
name and do not provide specific voting instructions to the broker, bank, or other organization that is the stockholder of record
of your shares, the organization generally may vote on routine matters but not on non-routine matters. The only routine matter
expected to be voted on at the Annual Meeting is the ratification of the appointment of our independent auditor for 2018 (Proposal
4). If the organization does not receive instructions from you on how to vote your shares on one or more of Proposals 1, 2, 3 and
5, your shares will be subject to a broker non-vote and no vote will be cast on those matters. See &ldquo;Q. What does it mean
for a broker or other nominee to hold shares in &lsquo;street name&rsquo;?&rdquo; above.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; color: #365F91"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>Q:</B></TD><TD STYLE="text-align: justify">What if other matters are presented at the Annual Meeting?</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>A:</B></TD><TD STYLE="text-align: justify">If a stockholder of record provides a proxy by voting in any manner described in this Proxy Statement,
the proxy holders will have the discretion to vote on any matters, other than the five proposals presented in this Proxy Statement,
that are properly presented for consideration at the Annual Meeting. We do not know of any other matters to be presented for consideration
at the Annual Meeting.</TD></TR></TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 14pt">PROPOSAL
1: ELECTION OF DIRECTORS</FONT></P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Board of Directors is currently comprised of six directors and
is divided into three classes: Class&nbsp;I, Class&nbsp;II, and Class&nbsp;III. Each class of directors serves for a three-year
term, with one class of directors being elected by our stockholders at each annual meeting. Joseph Bower and Jeffery Thompson serve
as Class&nbsp;I Directors, with terms of office expiring at the Annual Meeting. Raymond Land and Glenn Larsen serve as Class&nbsp;II
Directors, with terms of office expiring at the 2019 Annual Meeting of Stockholders. Joseph Darling and Stephen Wheeler serve as
Class&nbsp;III Directors, with terms of office expiring at the 2020 Annual Meeting of Stockholders.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Dr. Bower and Mr. Thompson are our Board&rsquo;s nominees for election
to the Board at the 2018 Annual Meeting. The Class&nbsp;I Directors will be elected to hold office until the 2021 Annual Meeting
and until their successors are duly elected and qualified. Unless otherwise instructed, the persons named in the accompanying proxy
will vote, as permitted by our Amended and Restated By-laws, to elect Dr. Bower and Mr. Thompson as Class&nbsp;I Directors. If
either of the Class&nbsp;I Directors becomes unavailable or declines to serve, the persons acting under the accompanying proxy
may vote the proxy for the election of a substitute in their discretion. The Board has no reason to believe that any of the nominees
will be unable or unwilling to serve if elected. There are no arrangements or understandings between any nominee and any other
person pursuant to which such nominee was selected.&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Vote Required</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">At the Annual Meeting, the election of a director requires the affirmative
vote of a majority of votes cast by the holders of common stock entitled to vote pursuant to our Majority Voting in Uncontested
Director Elections Policy, which is described more particularly in &ldquo;&#9472;Majority Voting in Uncontested Director Elections
Policy&rdquo; below. Abstentions and broker non-votes, if any, will not be treated as votes cast and will have no impact on the
proposal, except to the extent that failure to vote for an individual in the election of directors results in another individual
receiving a larger percentage of votes.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Board Recommendation</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE &ldquo;FOR&rdquo; THE ELECTION
OF EACH OF THE DIRECTOR NOMINEES.</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Information Regarding the Directors</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The following table sets forth the name of each current director,
including the nominees for Class&nbsp;I Director, his age and the year in which he became a director of Anika Therapeutics, Inc.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 90%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Director</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Term</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid">Director Name</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Age</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Since</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Expires</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-left: 10pt">Class&nbsp;I Directors:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="width: 64%; font-size: 10pt; text-align: left; padding-left: 10pt">Joseph L. Bower</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: center">79</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: center">1993</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: center">2018</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Jeffery S. Thompson</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">52</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">2011</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">2018</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-left: 10pt">Class&nbsp;II Directors:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Raymond J. Land</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">73</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">2006</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">2019</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Glenn R. Larsen, Ph.D.</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">63</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">2015</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">2019</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-left: 10pt">Class III Directors:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Joseph G. Darling</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">60</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">2018</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">2020</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Steven E. Wheeler</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">71</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">1993</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">2020</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>



<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><FONT STYLE="background-color: white"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><FONT STYLE="background-color: white">&nbsp;</FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><FONT STYLE="background-color: white"><I>Joseph L. Bower, D.B.A.</I>,
joined the Board in February 1993. Dr. Bower has been the Chairman of the Board since March 9, 2018, and he previously served as
lead director from April 2005 through that date.&nbsp;Since July 2014, he has been the Donald Kirk David Professor Emeritus at
Harvard Business School. From 2008 through 2014, he was the Baker Foundation Professor of Business Administration at Harvard Business
School, and prior to 2008, he was the Donald Kirk David Professor of Business Administration. Throughout his tenure, Dr. Bower
also served in many administrative roles at Harvard Business School, including as Senior Associate Dean. Dr. Bower also serves
as a director of Loews Corporation and the New America High Income Fund, Inc. During the past five years, Dr. Bower also served
as a director of Brown Shoe Company, Inc. and Sonesta International Hotels Corporation. He holds an A.B., as well an M.B.A. and
a D.B.A. from Harvard University.&nbsp;Dr. Bower brings to the Board more than four decades of experience in business strategy,
corporate governance, leadership and management, during which time he has written books about and taught these subjects at the
Harvard Business School. Additionally, he has consulted with numerous organizations on matters related to strategy, organizational
development and succession planning. As a result, we believe he is well suited for his roles as our Chairman of the Board and as
Chairperson of the Compensation Committee. Dr. Bower also serves on the Audit Committee.</FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><FONT STYLE="background-color: white"><I>Joseph G. Darling</I> was
appointed Chief Executive Officer of Anika Therapeutics in March 2018 and simultaneously became a member of the Board. Mr. Darling
has served as President since July 2017. Mr. Darling served as the Executive Chairman of Arthrosurface, Inc., an orthopedic medical
technology company, from September 2016 to July 2017 and as the Chief Operating Officer of Interventional Spine, Inc. (formerly
Triage Medical, Inc.), a spinal medical device company, from May 2015 to September 2016. From 2008 through December 2014, Mr. Darling
held a series of senior management positions at CONMED Corporation and affiliated medical technology entities focused on surgical
devices for minimally invasive procedures, including acting as the Global President of Linvatec Corporation (d.b.a. CONMED Linvatec)
from 2008 through December 2014 and as the Executive Vice President of Global Commercial Operations for CONMED Corporation from
2011 through December 2014. Prior to 2008, Mr. Darling held leadership roles at Smith &amp; Nephew, Inc., including as the Senior
Vice President of Sports Medicine and Biologics where launched a portfolio of new and innovative sports medicine products, Baxter
International Inc., Wyeth Pharmaceuticals, Inc., and Abbott Laboratories. Mr. Darling holds a B.A. from Syracuse University. Mr.
Darling brings to the Board and our company an extensive career with broad general management skills and backgrounds in both the
pharmaceutical and medical device industries. He also has a strong understanding of all aspects of our business given his role
as our President and Chief Executive Officer and his prior industry background, and he provides invaluable insight to the Board
with respect to their decision-making functions. Mr. Darling&rsquo;s strengths in commercialization activities will position Anika
for success as we transform from a contract manufacturing company to a full directly commercialized company with the addition of
our next generation OA treatment and our regenerative medicine portfolio. In addition to Mr. Darling&rsquo;s commercial experience,
Mr. Darling brings a wealth of experience in strategy development and execution, research and development, business development,
and financial management. </FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><FONT STYLE="background-color: white"><I>Raymond J. Land</I> became
a member of the Board in January 2006. He also serves as chairman of the board of directors of BioAmber, Inc., a publicly traded
company developing chemicals from renewable feedstocks, and a director and chairman of the Audit Committee of Mountain View Pharmaceuticals,
Inc., a privately held company specializing in biopharmaceuticals. During 2017, Mr. Land also served as the interim Chief Financial
Officer of BioAmber, Inc. for approximately three months. From 2008 through 2010, Mr. Land served as the Senior Vice President
and Chief Financial Officer of Clarient, Inc., an advanced molecular diagnostics company. From June 2007 to June 2008, he was&nbsp;the
Senior Vice President and Chief Financial Officer of Safeguard Scientifics, Inc., a venture capital firm.&nbsp;Prior to Safeguard
Scientifics, Inc., Mr. Land held executive management and Chief Financial Officer positions at Medcenter Solutions, Inc., a pharmaceutical
marketing company where&nbsp;he was also a board member,&nbsp;and Orchid Cellmark, a provider of DNA testing services. Mr. Land
previously served as Senior Vice President and Chief Financial Officer for&nbsp;Genencor International, Inc., a biotechnology company
focusing on bioproducts and healthcare, from 1997 until its acquisition&nbsp;in April 2005. From 1991 to 1996, he served as Senior
Vice President and Chief Financial Officer for&nbsp;West Pharmaceutical Services, Inc. Previously, Mr. Land was with Campbell Soup
Company, Inc. where for nine years he held increasingly senior financial positions and also served as General Manager of a frozen
food division. Prior to joining Campbell Soup, he was with Coopers and Lybrand for nine years. Mr. Land is a retired Certified
Public Accountant and has a B.S. degree in accounting and finance from Temple University.&nbsp;Mr. Land's qualifications for membership
on the Board include his extensive prior experience as chief financial officer at multiple companies, including several in the
life science industry.&nbsp;He serves as the Chairperson and designated financial expert on the Audit Committee and as a member
of the Governance and Nominating Committee.</FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><I>Glenn R. Larsen, Ph.D.</I>, joined the Board in February 2015.
He is currently Chairman, President, and Chief Executive Officer of Aquinnah Pharmaceuticals, Inc., a pharmaceutical company focused
on the development of treatments for ALS, Alzheimer&rsquo;s, and other neurodegenerative diseases, which he co-founded in February
2014. He is also a co-founder and Chairman of the board of directors of 180 Therapeutics L.P., a clinical stage musculoskeletal
drug development company focusing on treating fibrosis, which he co-founded in 2013. He previously served as Chief Scientific Officer
and Executive Vice President of Research and Development at SpringLeaf Therapeutics, Inc., a producer of combination drug delivery
devices, from 2010 through 2013 and as Chief Operating Officer and Executive Vice President of Research and Development, and as
a member of the board of directors, at Hydra Biosciences, Inc., a biopharmaceutical company, from 2003 through 2010. During his
prior employment at Wyeth (now Pfizer)/Genetics Institute, Dr. Larsen served in various drug discovery and development leadership
positions, including Vice President Musculoskeletal Sciences where he directed Wyeth&rsquo;s second-largest therapeutic area with
responsibility for Enbrel, an anti-TNF therapeutic with multi-billion dollar annual sales used to treat rheumatoid arthritis and
other diseases. Dr. Larsen received his Ph.D. in Biochemistry from Stony Brook University and a PMD from Harvard University Business
School. Dr. Larsen&rsquo;s qualifications for membership on the Board include his strong scientific background in pharmaceuticals,
biotech, orthopedics <FONT STYLE="background-color: white">and</FONT> regenerative medicine, and his extensive experience in management,
product development <FONT STYLE="background-color: white">and</FONT> business development at multiple companies in the life science
industry, all of which provide the Board with innovative product and commercial development perspectives and insights. He serves
as a member of the Compensation Committee and a member of the Governance and Nominating Committee.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><FONT STYLE="background-color: white"><I>Jeffery S. Thompson</I>
joined the Board of Directors in January 2011. He is a Partner with HealthEdge Investment Partners, LLC or HealthEdge, a Tampa,
Florida based private equity firm that provides strategic capital exclusively in the healthcare industry. Mr. Thompson previously
served as President, CEO, and Chairman of Enaltus, a HealthEdge portfolio company specializing in unique skincare solutions. Mr.
Thompson currently serves as a director for various HealthEdge affiliated companies including Lifesync Corporation, MNG Laboratories,
Formulated Solutions, LLC, The Columbus Organization, LLC, and Data Dimensions, LLC. Mr. Thompson also serves as a non-executive
director for Sinclair Pharma, plc, a publicly traded, London-based, international aesthetic dermatology company. Prior to joining
Anika, he served as President, Chief Executive Officer and Chairman of Advanced Bio-Technologies, another HealthEdge portfolio
company specializing in skincare solutions. Mr. Thompson also served as a director and the Chief Operating Officer for Stiefel
Laboratories, Inc., an independent pharmaceutical company specializing in dermatology. Prior to his Chief Operating Officer role,
he was Senior Vice President of U.S. Business Services of Stiefel Laboratories, Inc and President of Glades Pharmaceuticals. Earlier
in his career, Mr. Thompson held sales and business management positions at Bausch &amp; Lomb Pharmaceuticals and SmithKline Beecham.
Mr. Thompson holds a B.S. in general science from the University of Pittsburgh. Mr. Thompson&rsquo;s qualifications for membership
on the Board include his prior experience in running a pharmaceutical company and his knowledge of the medical device industry,
both of which provide the Board with product and business development perspectives and insights. He serves on the Audit Committee
and the Compensation Committee.</FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><FONT STYLE="background-color: white"><I>Steven E. Wheeler</I> joined
the Board in 1993. Since 1997, he has been the President of Wheeler &amp; Co., a private investment firm.&nbsp;He is also currently
a director of HFF, Inc. During the past five years, Mr. Wheeler also served as a director of Bariston Partners, LLC, a private
equity investment firm, and PingTone Communications, Inc., a privately held VOIP telephone services provider.&nbsp;Between 1993
and 1996, he was Managing Director and a director of Copley Real Estate Advisors and President, Chief Executive Officer, and a
director of Copley Properties, Inc., a publicly traded real estate investment trust. From 1991 to 1993, he was Chairman and Chief
Executive Officer of Hancock Realty Investors, which manages an equity real estate portfolio. Earlier, he was an Executive Vice
President of Bank of New England Corporation from 1990 to 1991. Mr. Wheeler received a B.S. in engineering from the University
of Virginia, an M.S. in nuclear engineering from the University of Michigan and an M.B.A. from Harvard University Business School.
Mr. Wheeler brings to the Board a broad understanding of business and finance matters, as well as over 20 years of experience as
a member of the Board. He serves as a member of the Compensation Committee and as Chairperson of the Governance and Nominating
Committee.</FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">The Board&rsquo;s Role in Risk Oversight</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The role of the Board of Directors in our risk oversight process
includes receiving reports from management or a Board committee chairperson on areas of material risk to our company, including
operational, financial, commercial, legal, regulatory, strategic, and reputational risks. The Board has delegated primary responsibility
to the Audit Committee to review these reports and discuss with management the process by which management assesses and manages
our risk exposure, risk management, and risk mitigation strategies. The Audit Committee also works with other committees to assess
areas of risk under the particular purview of those committees. When the Audit Committee receives a report from management or another
committee, the Chairperson of the Audit Committee reports on his or her review of the report to the full Board. This enables the
Board and its committees to coordinate the risk oversight role to ensure that all directors receive all significant risk-related
information. The Board also administers its risk oversight function through the required approval by the Board (or a committee
of the Board) of significant transactions and other material decisions and through regular periodic reports from our independent
registered public accounting firm and other outside consultants regarding various areas of potential risk, including, among others,
those relating to our internal controls and financial reporting. In addition, as part of its charter, the Audit Committee discusses
with management and our independent registered public accounting firm significant risks and exposures, as well as the steps management
has taken to minimize those risks.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Board Leadership Structure</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Since March 9, 2018, Dr. Bower has served as the Chairman of the
Board.&nbsp;He previously served as lead director, and the Board of Directors did not have a Chairman. Separating the Chairman
role and the Chief Executive Officer role allows our Chief Executive Officer to focus on the strategic management of our day-to-day
business, while allowing the Chairman to focus on leading the Board in its fundamental role of providing advice to and independently
overseeing management. The Board recognizes the time, effort, and energy that the Chief Executive Officer is required to devote
to his position in the current business environment, as well as the commitment required to serve as our Chairman, particularly
as the Board&rsquo;s oversight responsibilities continue to grow. The Board believes that having separate positions, with an independent,
non-executive director serving as the Chairman, is the appropriate leadership structure for our company at this time and allows
the Board to fulfill its role with appropriate independence.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Corporate Governance, Board Matters,
and Committees</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Board of Directors has determined that each of its members,
except for Mr. Darling, is &ldquo;independent&rdquo; within the meaning of the director independence standards of NASDAQ and the
SEC. The Board based these determinations primarily on a review of the responses of each director to questions regarding employment
and compensation history, affiliations, and family and other relationships, and on other relevant discussions with the directors.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Independent directors meet regularly in executive sessions without
management participation. The executive sessions generally occur in connection with regularly scheduled meetings of the Board and
committees of the Board, and at other times the independent directors deem appropriate. The executive sessions are chaired either
by the Chairman of the Board or by the Chairperson of the Board committee having jurisdiction over the particular subject matter
to be discussed at the particular meeting or portion of a meeting.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Board reviews matters related to our corporate governance annually
at a regularly scheduled meeting of the Board. This includes an evaluation of our by-laws, committee charters, stockholder rights
plan, and other matters related to our governance. During this review, the Board assesses input from management and outside consultants
to discern whether any actions should be taken on any of these topics. Furthermore, the Board conducts periodic evaluations that
focus on the effectiveness of the Board as a whole and of its committees. Board members complete a detailed questionnaire that
(a)&nbsp;provides for quantitative rankings in key areas and (b) seeks subjective comments in each of those areas. In addition,
members of each Board committee complete a detailed questionnaire to evaluate how well their committee is operating and to make
suggestions for improvement. The evaluation process is managed by the Chairperson of the Nominating and Governance Committee, with
advice from outside counsel. Outside counsel conducts separate, confidential interviews with each of the directors to follow-up
on responses and comments reflected in the questionnaires. An anonymized summary of the principal findings from the questionnaires
and interviews is prepared by outside counsel and is used as the basis for self-assessment discussions by the Board and its committees.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Board met eight times during 2017. No director attended less
than 80% of the aggregate of (1)&nbsp;the total number of Board meetings and (2)&nbsp;the total number of meetings held by all
committees on which such director served. Our Annual Meetings of Stockholders are generally held to coincide with the Board&rsquo;s
regularly scheduled meetings. Directors are encouraged to attend the Annual Meeting. Each of the then-current directors attended
the 2017 Annual Meeting of Stockholders.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Board currently has three standing committees:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; text-align: center">&bull;</TD>
    <TD STYLE="width: 96%">Audit Committee;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&bull;</TD>
    <TD>Compensation Committee; and</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&bull;</TD>
    <TD>Governance and Nominating Committee.</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Board has adopted a written charter for each of the Audit Committee,
the Compensation Committee, and the Governance and Nominating Committee, which are reviewed yearly by each of the committees. You
can find links to these materials in the corporate governance section of our website at<I>&nbsp;www.anikatherapeutics.com</I>.
Please note that the information contained on the website is not incorporated by reference in, or considered to be a part of, this
Proxy Statement.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><B><I>Audit Committee</I></B></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The current members of the Audit Committee are Mr.&nbsp;Land, as
Chairperson, Dr.&nbsp;Bower, and Mr. Thompson. Messrs.&nbsp;Land and Thompson and Dr.&nbsp;Bower served on the Audit Committee
throughout 2017. The Board of Directors has determined that each member of the Audit Committee meets the independence requirements
promulgated by NASDAQ and the SEC, including Rule&nbsp;10A-3(b)(1) under the Securities Exchange Act of 1934 or the Exchange Act.
In addition, the Board has determined that each member of the Audit Committee is financially literate and has the requisite financial
sophistication to serve on the committee. The Board has also determined that Mr.&nbsp;Land qualifies as an &ldquo;audit committee
financial expert&rdquo; under the rules of the SEC. Stockholders should understand that this designation is a disclosure requirement
of the SEC related to Mr.&nbsp;Land&rsquo;s experience and understanding with respect to certain accounting and auditing matters.
The designation does not impose upon Mr.&nbsp;Land any duties, obligations, or liability that are greater than those that are generally
imposed on him as a member of the Audit Committee and the Board, and his designation as an audit committee financial expert pursuant
to this SEC requirement does not affect the duties, obligations, or liability of any other member of the Audit Committee or the
Board.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The purposes of the Audit Committee are, among other things, to
(1)&nbsp;oversee our accounting and financial reporting processes and the audits of our financial statements, (2)&nbsp;take, or
recommend that the Board take, appropriate action to oversee the qualifications, independence and performance of our independent
registered public accounting firm, (3) lead the review of our risk management processes and exposure to risk, and (4)&nbsp;prepare
an Audit Committee report as required by the SEC to be included in our annual proxy statement. The Audit Committee has direct authority
to appoint, retain, oversee, and, when appropriate, terminate our independent registered public accounting firm. The Audit Committee
also has the responsibility to confer with the independent registered public accounting firm regarding the scope, method, and result
of the audit of our books and records, to report the same to the Board, and to establish and monitor a policy relative to non-audit
services provided by the independent registered public accounting firm in order to ensure the firm&rsquo;s independence.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Audit Committee holds separate sessions of its meetings, outside
the presence of management, with our independent auditors in conjunction with each regularly scheduled Audit Committee meeting
in which the independent auditors participate. The Audit Committee met nine times during 2017.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><B><I>Compensation Committee</I></B></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The current members of the Compensation Committee are Dr.&nbsp;Bower,
as Chairperson, Dr. Larsen, Mr. Thompson, and Mr.&nbsp;Wheeler, each of whom is independent for purposes of NASDAQ listing standards
and applicable SEC regulations. Messrs.&nbsp;Thompson and Wheeler and Drs. Bower and Larsen served on the Compensation Committee
throughout 2017. The Compensation Committee, among other things, exercises on behalf of the Board of Directors all of the Board&rsquo;s
responsibilities relating to the development and implementation of our compensation programs which provide incentives that further
our long-term strategic plan with the goal of enhancing enduring stockholder value, including: (1) managing our overall compensation
structure, policies and programs, (2)&nbsp;reviewing and approving corporate goals and objectives relevant to the compensation
of our Chief Executive Officer and other executive officers, (3)&nbsp;reviewing the performance of and determining the compensation
of our Chief Executive Officer, (4)&nbsp;reviewing the performance of and determining, with the advice and assistance of the Chief
Executive Officer, the compensation of our executive officers other than the Chief Executive Officer, (5) annually reviewing and
recommending to the Board compensation for non-employee directors, (6)&nbsp;overseeing our overall compensation programs, including
granting awards under our stock option and equity incentive plan, (7)&nbsp;preparing a report on executive compensation to be included
in our annual proxy statement, and (8) appointing, retaining, compensating, terminating, and overseeing the work of any compensation
consultant or other compensation adviser, as well as considering the independence of any compensation consultant or other compensation
adviser. The Compensation Committee met five times during 2017.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><B><I>Governance and Nominating Committee</I></B></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The current members of the Governance and Nominating Committee are
Mr.&nbsp;Wheeler, as Chairperson, Mr. Land, and Dr. Larsen. Messrs.&nbsp;Wheeler and Land and Dr. Larsen served on the Governance
and Nominating Committee throughout 2017. The Governance and Nominating Committee is primarily responsible for (1)&nbsp;recommending
to the Board of Directors the criteria for Board and committee membership, (2)&nbsp;identifying, evaluating, and recommending nominees
to stand for election as directors at each Annual Meeting of Stockholders, including incumbent directors and candidates recommended
by stockholders, (3) matters related to executive and Board succession, (4) coordinating the evaluation of the Board and its committees,
and (5) Board education programs. The Governance and Nominating Committee met five times during 2017.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">When considering candidates for director, the Governance and Nominating
Committee takes into account a number of factors, including the following minimum qualifications: the nominee shall have the highest
personal and professional integrity, shall have demonstrated exceptional ability and judgment, and shall be most effective, in
conjunction with the other members of the Board, in collectively serving the long-term interests of the stockholders. In addition,
the Governance and Nominating Committee will take into consideration such other factors as it deems appropriate, including any
direct experience in the biotechnology, pharmaceutical, and/or life sciences industries or in the markets in which we operate.
The Governance and Nominating Committee may also consider, among other things, the skills of the candidate, his or her availability,
the candidate&rsquo;s depth and breadth of experience or other background characteristics, and his or her independence. In addition,
the Board believes that diversity is an important component of a board of directors and good corporate governance, including diversity
of background, skills, experience, gender, race, and ethnicity. Although we do not currently have formal diversity policy, the
Governance and Nominating Committee, guided by its charter, assesses and considers the diversity of the Board prior to nominating
candidates and seeks to identify director candidates who will enhance the Board&rsquo;s overall diversity. The Governance and Nominating
Committee and the Board select candidates on the basis of qualifications and experience without discriminating on the basis of
race, color, national origin, gender, sex, sexual preference, or religion. The Board has adopted a retirement policy providing
that directors will not be nominated for election to the Board after their 75<SUP>th</SUP> birthday, which was waived by the Board
in relation to the nomination of Dr. Bower for election at the 2018 Annual Meeting due to his distinguished experience and unique
leadership position with our company and the Board. We believe that our current Board members collectively possess diverse knowledge,
expertise, and experience in the disciplines that impact our business.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Governance and Nominating Committee will consider written recommendations
from stockholders of Anika Therapeutics regarding potential candidates for election as directors. The Governance and Nominating
Committee will review and evaluate the qualifications of director nominee candidates who have been recommended by stockholders
in compliance with procedures established from time to time by the Governance and Nominating Committee and will conduct such inquiries
as it deems appropriate. The Governance and Nominating Committee will consider for nomination any proposed director candidate who
is deemed qualified by the Governance and Nominating Committee in light of the minimum qualifications and other criteria for Board
membership described above or otherwise approved by the Board from time to time.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Stockholders wishing to suggest a candidate for director should
write to the Governance and Nominating Committee in care of our Chief Executive Officer, Anika Therapeutics,&nbsp;Inc., 32 Wiggins
Avenue, Bedford, Massachusetts 01730 and include:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; text-align: center; vertical-align: top; padding-bottom: 6pt">&#9679;</TD>
    <TD STYLE="width: 97%; text-align: justify; padding-bottom: 6pt">the name and address of record of the stockholder;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; vertical-align: top; padding-bottom: 6pt">&#9679;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 6pt">a representation that the stockholder is a record holder of our common stock, or if the stockholder is not a record holder, evidence of ownership in accordance with Rule&nbsp;14a-8(b)(2) under the Exchange Act;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; vertical-align: top; padding-bottom: 6pt">&#9679;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 6pt">the name, age, business and residential address, educational background, public company directorships, current principal occupation or employment, and principal occupation or employment for the preceding five&nbsp;full years of the proposed director candidate;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; vertical-align: top; padding-bottom: 6pt">&#9679;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 6pt">a description of the qualifications and background of the proposed director candidate which addresses the minimum qualifications and other criteria for Board membership approved by the Board from time to time;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; vertical-align: top; padding-bottom: 6pt">&#9679;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 6pt">a description of all arrangements or understandings between the stockholder and the proposed director candidate;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; vertical-align: top; padding-bottom: 6pt">&#9679;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 6pt">the written consent of the proposed director candidate (1)&nbsp;to be named in the proxy statement relating to the Annual Meeting of Stockholders, (2)&nbsp;to have all required information regarding such candidate included in the proxy statement relating to the Annual Meeting of Stockholders filed pursuant to the rules of the SEC and (3)&nbsp;to serve as a director if elected at such annual meeting; and</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; vertical-align: top">&#9679;</TD>
    <TD STYLE="text-align: justify">any other information regarding the proposed director candidate that is required to be included in a proxy statement filed pursuant to the rules of the SEC.</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Governance and Nominating Committee may solicit recommendations
for candidates for directors from non-management directors, the Chief Executive Officer, other executive officers, third-party
search firms, and such other sources as it deems appropriate, including stockholders. The Governance and Nominating Committee will
review and evaluate the qualifications of all such proposed candidates in the same manner and without regard to the source of the
recommendation.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Communications with the Board</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">If you wish to communicate with any of our directors or the Board
of Directors as a group, you may do so by writing to the Board, or such individual director(s), in care of our Chief Executive
Officer, Anika Therapeutics,&nbsp;Inc., 32 Wiggins Avenue, Bedford, Massachusetts 01730.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">We recommend that all correspondence be sent via certified U.S.
mail, return receipt requested. All correspondence received by the Chief Executive Officer will be forwarded promptly to the appropriate
addressee(s).</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Code of Business Conduct</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">It is our policy that all of our officers, directors, and employees
worldwide conduct our business in an honest and ethical manner and in compliance with all applicable laws and regulations. The
Board of Directors has adopted the Anika Therapeutics,&nbsp;Inc. Code of Business Conduct and Ethics in order to clarify, disseminate
and enforce this policy. The Code of Business Conduct and Ethics applies to all of our officers, directors, and employees worldwide,
including our Chief Executive Officer and Chief Financial Officer. The Code of Business Conduct and Ethics can be viewed on the
investor relations section of our website at&nbsp;<I>http://www.anikatherapeutics.com</I> under &ldquo;Corporate Governance.&rdquo;
Please note that the information contained on the website is not incorporated by reference in, or considered to be part of, this
Proxy Statement.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Majority Voting in Uncontested Director
Elections Policy</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">On December 8, 2015, the Board of Directors adopted our &ldquo;Majority
Voting in Uncontested Director Elections Policy.&rdquo; An uncontested election occurs when the number of director nominees is
equal to the number of Board positions to be filled through election and proxies are being solicited for such election of directors
solely by our company. Pursuant to our policy in such an election, if a director receives a greater number of votes &ldquo;withheld&rdquo;
than &ldquo;for&rdquo; his or her election, such director shall promptly offer his or her resignation for consideration by the
Governance and Nominating Committee. The Governance and Nominating Committee shall then consider all of the relevant facts and
circumstances, and the committee shall recommend to the Board whether or not to accept such offer of resignation. The final decision
of whether or not to accept such resignation shall be made by the Board, and, if required or determined by the Board to be desirable,
we shall appropriately disclose the decision of the Board along with the rationale for such decision.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Transactions with Related Persons
and Conflict of Interest Policy</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">It is our policy that all employees and directors, as well as their
family members, must avoid any activity that is or has the appearance of conflicting with our business interests. This policy is
included in our Code of Business Conduct and Ethics, and it is supplemented by our Conflict of Interest Policy, which was implemented
by the Board of Directors on October 6, 2015. Both the Code of Business Conduct and Ethics and the Conflict of Interest Policy
are reviewed annually. Among other things, this policy requires each director and officer of Anika Therapeutics to provide written
notice of any potential related party transaction, defined by our policy to mirror the definition of Item 404 of Regulation S-K
(with the exception that our policy includes a monetary threshold of $100,000 as opposed to the threshold of $120,000 set by Item
404 of Regulation S-K) to the Chairman of the Board (or to the Chief Executive Officer if such transaction involves the Chairman
of the Board) including all information that the Chairman of the Board or Chief Executive Officer may request. Upon receiving all
relevant information, the disinterested members of the Board may approve the transaction if they determine that the transaction
is in the best interests of, and fair to, us, may require modifications to the transaction to make it acceptable for approval,
or may reject it. The Board may also establish guidelines for ongoing management of a specific related party transaction. The policy
requires continuing related party transactions to be reviewed on at least an annual basis. Additionally, the policy requires all
of our executives and directors to complete a directors and officers questionnaire in connection with each of our annual proxy
statements, which asks them to disclose family relationships and other related party transactions.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">From January 1, 2017 through the date of this proxy statement, we
had one reportable related party transaction. Charles Sherwood III, an adult child of Dr.&nbsp;Charles Sherwood, a former director
and our former Chief Executive Officer through March 2018, is employed on an at-will basis as our Vice President Corporate Legal
Counsel and received total compensation for fiscal year 2017 of approximately $273,300, which included 3,000 incentive stock options
with an initial Black-Scholes value of $55,000, granted under our equity incentive plan on January 27, 2017 with an exercise price
of $50.13 on the date of grant and vesting occurring in three equal annual installments beginning one year from the date of grant.
He also received, and continues to receive, benefits generally available to all employees. For 2018, the Board approved a base
salary for Mr. Sherwood III of $230,000, 4,700 incentive stock options and 3,100 performance-based stock options under our equity
incentive plan with a total Black-Scholes value of approximately $156,000 on the date of grant, as well as a bonus initially targeted
to equal 35% of his base salary. Mr. Sherwood III was also granted a promotion-based equity award of 5,000 stock options under
our equity incentive plan with a total Black-Scholes value of approximately $99,000 on January 1, 2018. All equity awards granted
in 2018 vest in four equal annual installments beginning one year from the date of grant. The compensation for Mr. Sherwood III
was determined in accordance with our standard employment and compensation practices. The 2017 compensation was approved by the
Board in accordance with our Conflict of Interest Policy. In December 2017, the Board approved Mr. Sherwood III&rsquo;s 2018 compensation
in accordance with our Conflict of Interest Policy for ongoing related party transactions.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 14pt">BENEFICIAL
OWNERSHIP OF COMMON STOCK</FONT></P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The following table sets forth the beneficial ownership of common
stock as of April&nbsp;2, 2018, by:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; text-align: center; vertical-align: top; padding-bottom: 6pt">&#9679;</TD>
    <TD STYLE="width: 96%; text-align: justify; padding-bottom: 6pt">each director who served during 2017 or 2018;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; vertical-align: top; padding-bottom: 6pt">&#9679;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 6pt">each of the Named Executive Officers named in the Summary Compensation Table set forth under &ldquo;Executive Compensation;&rdquo;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; vertical-align: top; padding-bottom: 6pt">&#9679;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 6pt">each other person which is known by us to beneficially own 5% or more of our common stock; and</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; vertical-align: top">&#9679;</TD>
    <TD STYLE="text-align: justify">current directors and executive officers as a group.</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Unless otherwise noted below, the address of each person listed
on the table is in care of Anika Therapeutics,&nbsp;Inc., 32 Wiggins Avenue, Bedford, Massachusetts 01730.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid; padding-left: 0pt">Beneficial Owner</TD><TD STYLE="font-size: 10pt; font-weight: bold; font-style: normal; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.1pt solid">Amount and Nature <BR> of Beneficial <BR> Ownership <FONT STYLE="font-size: 10pt; font-style: normal"><B><SUP>(1)</SUP></B></FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; font-style: normal; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.1pt solid">Percentage of <BR> Common Stock <BR> Outstanding <FONT STYLE="font-size: 10pt; font-style: normal"><B><SUP>(2)</SUP></B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: normal; font-style: normal; text-align: left; padding-left: 0pt"><I>Directors and
    Named Executive officers<FONT STYLE="font-size: 10pt; font-weight: normal">:</FONT></I></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>&nbsp;</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="width: 68%; font-size: 10pt; text-align: left; padding-left: 20pt">Joseph L. Bower</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; font-size: 10pt; text-align: right">43,162</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;<SUP>(3)</SUP></FONT></TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; font-size: 10pt; text-align: right">&nbsp;*&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">Raymond J. Land</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: white">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: white">15,150</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: white; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;<SUP>(4)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: white">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: white">&nbsp;*&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: white">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">Glenn R. Larsen, Ph.D.</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">8,103</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;<SUP>(5)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;*&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">Jeffery S. Thompson</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">7,843</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;<SUP>(6)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;*&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">Steven E. Wheeler</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">34,594</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;<SUP>(7)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;*&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">Charles H. Sherwood, Ph.D.</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">789,547</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;<SUP>(8)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5.15</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">Sylvia Cheung</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">235,772</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;<SUP>(9)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1.58</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">Joseph G. Darling</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">21,436</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;<SUP>(10)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;*&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">Edward Ahn, Ph.D.</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">64,748</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;<SUP>(11)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;*&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">Richard Hague</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">48,646</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;<SUP>(12)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;*&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">Current directors and executive officers as a group (10 persons)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,269,001</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;<SUP>(13)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">8.08</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 0pt"><I>5% and Above Stockholders:</I></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>&nbsp;</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">Blackrock, Inc.</TD><TD STYLE="font-size: 10pt; color: red">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>&nbsp;</SUP></FONT></TD><TD STYLE="font-size: 10pt; color: red">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 30pt">55 East 52nd Street</TD><TD STYLE="font-size: 10pt; color: red">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>&nbsp;</SUP></FONT></TD><TD STYLE="font-size: 10pt; color: red">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 30pt">New York, NY 10055</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,876,645</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;<SUP>(14)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">12.73</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">Kayne Anderson Rudnick Investment Management LLC</TD><TD STYLE="font-size: 10pt; color: red">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>&nbsp;</SUP></FONT></TD><TD STYLE="font-size: 10pt; color: red">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 30pt">1800 Avenue of the Stars, 2nd Floor</TD><TD STYLE="font-size: 10pt; color: red">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>&nbsp;</SUP></FONT></TD><TD STYLE="font-size: 10pt; color: red">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 30pt">Los Angeles, CA 90067</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,777,502</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;<SUP>(15)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">12.05</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">Wellington Management Group LLP</TD><TD STYLE="font-size: 10pt; color: red">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>&nbsp;</SUP></FONT></TD><TD STYLE="font-size: 10pt; color: red">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 30pt">280 Congress Street</TD><TD STYLE="font-size: 10pt; color: red">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>&nbsp;</SUP></FONT></TD><TD STYLE="font-size: 10pt; color: red">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 30pt">Boston, MA 02210</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,211,678</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;<SUP>(16)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">8.22</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">Dimensional Fund Advisors LP</TD><TD STYLE="font-size: 10pt; color: red">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>&nbsp;</SUP></FONT></TD><TD STYLE="font-size: 10pt; color: red">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 30pt">Building One, 6300 Bee Cave Road</TD><TD STYLE="font-size: 10pt; color: red">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>&nbsp;</SUP></FONT></TD><TD STYLE="font-size: 10pt; color: red">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 30pt">Austin, TX 78746</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">901,304</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;<SUP>(17)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6.11</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">The Vanguard Group</TD><TD STYLE="font-size: 10pt; color: red">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>&nbsp;</SUP></FONT></TD><TD STYLE="font-size: 10pt; color: red">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 30pt">100 Vanguard Blvd.</TD><TD STYLE="font-size: 10pt; color: red">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>&nbsp;</SUP></FONT></TD><TD STYLE="font-size: 10pt; color: red">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; color: red; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 30pt">Malvern, PA 19355</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">834,970</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;<SUP>(18)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5.66</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">* Indicates less than 1%</P>




<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%"><FONT STYLE="color: black">(1)</FONT></TD>
    <TD STYLE="width: 96%; text-align: justify"><FONT STYLE="color: black">Beneficial ownership is determined in accordance with the rules of the SEC. Accordingly, the number of shares deemed beneficially owned includes (i) shares of common stock owned as of March 31, 2018 and (ii) shares that may be acquired within sixty days of March 31, 2018 through the exercise or vesting of equity awards granted under our equity incentive plans. Unless otherwise indicated below, to our knowledge, all persons listed above have sole voting and investment power with respect to their shares of common stock, except to the extent authority is shared by spouses under applicable law.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="color: black">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: black">As of March 31, 2018, there were 14,745,152 shares of common stock outstanding. Shares not outstanding, but deemed beneficially owned by virtue of the right of a person to acquire those shares are treated as outstanding only for purposes of determining the number and percent of shares of common stock owned by such person or group. </FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%"><FONT STYLE="color: black">(3)</FONT></TD>
    <TD STYLE="text-align: justify; width: 96%"><FONT STYLE="color: black">This amount includes (i) 2,004 shares subject to restricted stock units and (ii) 2,000 shares owned by Dr. Bower&rsquo;s spouse. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="color: black">(4)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: black">This amount includes 2,004 shares subject to restricted stock units. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="color: black">(5)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: black">This amount includes 1,626 shares subject to restricted stock units. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="color: black">(6)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: black">This amount includes 2,004 shares subject to restricted stock units. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="color: black">(7)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: black">This amount includes 2,004 shares subject to restricted stock units. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="color: black">(8)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: black">As noted elsewhere in this proxy statement, Dr. Sherwood retired from his roles as our Chief Executive Officer and as a director of our company effective March 9, 2018. Such information is provided based on an amended Schedule&nbsp;13G filed with the SEC on behalf of Dr. Sherwood on March 22, 2018. Dr. Sherwood beneficially owns and has sole voting power and sole dispositive power with respect to 789,547 shares. This amount includes 630,559 shares subject to stock options that are exercisable within sixty days of March 31, 2018.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="color: black">(9)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: black">This amount includes 198,164 shares subject to stock options and stock appreciation rights that are exercisable within sixty days of March 31, 2018 and 5,619 shares of restricted stock vesting in four equal annual installments commencing one year from the applicable grant date.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="color: black">(10)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: black">Mr. Darling was hired as our President on July 27, 2017. On March 9, 2018, Mr. Darling was appointed as our President and Chief Executive Officer, and he became one of our directors. This amount includes 20,114 unvested shares of restricted stock which vests in annual installments commencing from the applicable grant date in accordance with the terms of the Mr. Darling&rsquo;s employment agreement and the applicable grant instruments. 4,835 shares of these unvested shares will vest immediately if Mr. Darling&rsquo;s employment is terminated &ldquo;without cause&rdquo; or Mr. Darling terminates his employment with our company for &ldquo;good reason&rdquo; as defined in Mr. Darling&rsquo;s employment agreement with us.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="color: black">(11)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: black">This amount includes 57,488 shares subject to stock options that are exercisable within sixty days of March 31, 2018 and 3,950 shares of restricted stock vesting in four equal annual installments commencing one year from the applicable grant date.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="color: black">(12)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: black">This amount includes 24,996 shares subject to stock options that are exercisable within sixty days of March 31, 2018 and 14,450 shares of restricted stock vesting in four equal annual installments commencing one year from the applicable grant date.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="color: black">(13)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: black">This amount includes shares beneficially owned by Dr. Sherwood and reported on his behalf on the amended Schedule 13G filed with the SEC on March 22, 2018. This amount also includes 9,642 shares subject to restricted stock units, 44,133 shares of unvested restricted stock, and 280,648 shares in the aggregate subject to stock options that are exercisable within sixty days of March 31, 2018 owned by other Named Executives Officers and directors of the Company. If shares beneficially owned by Dr. Sherwood were not included in the calculation of percentage of common stock outstanding, current directors and executive officers as a group (9 persons) would beneficially own 2.94% of the outstanding shares of the Company.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="color: black">(14)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: black">Such information is provided based on an amended Schedule 13G filed with the SEC on behalf of Blackrock, Inc. on January 17, 2018. Blackrock, Inc. has sole voting power with respect to 1,851,158 shares and sole dispositive power with respect to 1,876,645 shares.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="color: black">(15)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: black">Such information is provided based on an amended Schedule&nbsp;13G filed with the SEC on behalf of Kayne Anderson Rudnick Investment Management LLC on February 13, 2018. Kayne Anderson Rudnick Investment Management LLC has sole voting power with respect to 1,423,680 shares, shared voting power with respect to 353,822 shares, sole dispositive power with respect to 1,423,680 shares, and shared dispositive power with respect to 25,878 shares.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="color: black">(16)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: black">Such information is provided based on an amended Schedule&nbsp;13G filed with the SEC on behalf of Wellington Management Group, LLP on February 8, 2018. Wellington Management Group LLP has shared power to vote or direct the vote with respect to 933,386 shares and shared dispositive power with respect to 353,822 shares.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="color: black">(17)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: black">Such information is provided based on an amended Schedule 13G filed with the SEC on behalf of Dimension Fund Advisors LP. on February 9, 2018. Dimensional Fund Advisors LP has sole voting power with respect to 847,712 shares and sole dispositive power with respect to 901,304 shares.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="color: black">(18)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: black">Such information is provided based on an amended Schedule&nbsp;13G filed with the SEC on behalf of The Vanguard Group on February 12, 2018. The Vanguard Group has sole voting power with respect to 25,578 shares, shared voting power with respect to 1,100 shares, sole dispositive power with respect to 809,092 shares, and shared dispositive power with respect to 25,878 shares.</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Section&nbsp;16(a) Beneficial Ownership
Reporting Compliance</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Exchange Act requires that our officers, directors, and persons
who own more than 10% of our common stock file initial reports of ownership and report of changes in ownership with the SEC and
NASDAQ. Officers, directors and persons who beneficially own more than 10% of our common stock are also required to furnish us
with a copy of all forms they file pursuant to Section&nbsp;16(a) of the Exchange Act. To our knowledge, based solely upon a review
of Forms&nbsp;3, 4 and 5 and other applicable forms as well as amendments thereto furnished to us under Rule&nbsp;16a-3(e) of the
Exchange Act for the year ended December&nbsp;31, 2017, no officer, director, or person who owns more than 10% of our outstanding
shares of common stock failed to file such reports on a timely basis during 2017.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 14pt">EXECUTIVE
OFFICERS</FONT></P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Board of Directors elects our executive officers annually at
a regular meeting held immediately preceding an Annual Meeting of Stockholders. The Board also elects executive officers throughout
the year as such individuals are hired by us. Such executive officers hold office until the next Annual Meeting of Stockholders
or until their successors are duly elected and qualified, unless they sooner resign or are removed from office. There are no family
relationships between any of our directors, director nominees, or executive officers.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The following table lists the current executive officers of Anika
Therapeutics and certain information concerning the executive officers of Anika Therapeutics. It is anticipated that each of these
officers will be re-appointed by the Board immediately preceding the Annual Meeting:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 85%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid">Name</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Age</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid">Position</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 44%; font-size: 10pt; text-align: left">Joseph G. Darling</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: center">60</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 40%; font-size: 10pt; text-align: left">President and Chief Executive Officer</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Sylvia Cheung</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">42</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">Chief Financial Officer, Treasurer, and Secretary</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Edward Ahn, Ph.D.</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">45</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">Chief Technology and Strategy Officer</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Thomas Finnerty</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">60</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">Chief Human Resource Officer</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Richard Hague</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">57</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">Chief Commerical Officer</TD></TR>
</TABLE>



<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><I>Mr. Darling&rsquo;s</I> biography is included above in the section
titled &ldquo;Proposal 1: Election of Directors &ndash; Information Regarding the Directors.&rdquo;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><I>Sylvia Cheung</I> was appointed Chief Financial Officer, Treasurer
and Secretary on April 1, 2013. Ms. Cheung served as our Vice President of Strategic Processes commencing in 2012. Since October
2014, she has also served as General Manager for our Italy-based subsidiary, Anika Therapeutics S.r.l., and she served in the same
role from 2010 to 2011. Ms. Cheung originally joined our company as its Controller in 2005, and, in addition to fulfilling these
financial responsibilities, she led our integration of Anika S.r.l. subsequent to its acquisition in 2009. Prior to joining Anika,
she held a series of progressively responsible financial management positions at Transkaryotic Therapies, Inc. From 1995 to 2000,
Ms. Cheung worked for PricewaterhouseCoopers LLP as an Audit Senior Associate with a focus in technology companies. Ms. Cheung
holds a B.S. in business administration and accounting from the University of Massachusetts in Amherst and an M.B.A. from Boston
University, and she is a Certified Public Accountant (inactive).</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><I>Edward Ahn, Ph.D.,</I> was appointed Chief Technology and Strategy
Officer on October 30, 2014. From 2012 through 2014, Dr. Ahn was Managing Director and Chief Science Officer at MedCap Advisors
where he built merger strategies, strategic partnerships and licensing agreements for emerging medical device, biotechnology and
biological organizations with a focus on regenerative medicine. Prior to his work at MedCap, Dr. Ahn was Vice President of Product
Development for Pioneer Surgical Biologics from 2007 through 2012. In this role Dr. Ahn directed Pioneer Surgical Biologic&rsquo;s
product development policies, objectives and initiatives. He has also served as Chief Executive Officer, Chief Technology Officer
and Founder of Angstrom Medica, Inc., a company based upon his doctoral thesis work and focused on commercializing nanotechnology
in the area of Orthopedics. Dr. Ahn holds a B.S. in chemical engineering from Stanford University and both an M.S. in chemical
engineering practice and a Ph.D. in chemical engineering from Massachusetts Institute of Technology.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><I>Thomas Finnerty</I> was appointed Chief Human Resources Officer
on October 30, 2017. From June 2017 through his appointment, Mr. Finnerty served as a human resources consultant to our company.
Prior to his work with Anika, Mr. Finnerty served as the Senior Vice President of Human Resources at Smith &amp; Nephew from 1999
through 2016 where he was responsible for delivering value-added programs, processes and leadership in global human capital management.
Mr. Finnerty has also held human resources positions at Novartis/Chiron Diagnostics and the Foxboro Company. Mr. Finnerty holds
B.S. in business from the University of Massachusetts Dartmouth and an M.B.A. from Babson College.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><I>Richard Hague</I> was appointed Chief Commercial Officer on October
26, 2015. From November 2014 through joining our company, Mr. Hague was the Vice President Sales and Marketing at TEI Medical where
he was responsible for driving the revenue growth of that corporation&rsquo;s dermal scaffold product, as well as for the build
out of its sales and marketing teams. From 2011 through 2014, Mr. Hague was Vice President Sales, Marketing, and Commercial Operations
for Sanofi Biosurgery&rsquo;s Cell Therapy and Regenerative Medicine group. In this role, Mr. Hague was responsible for the global
commercial operations of the group&rsquo;s products in the orthopedic sports medicine and burn markets. Prior to this, Mr. Hague
was the Senior Director and Head of Sales for Genzyme Biosurgery where he headed the U.S. sales team in the orthopedics and sports
medicine market. Mr. Hague holds a B.S. in marketing from the University of Connecticut.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 14pt">COMPENSATION
DISCUSSION AND ANALYSIS</FONT></P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">This section describes and analyzes the material elements of the
2017 compensation for our Named Executive Officers, or NEOs, identified in the Summary Compensation Table, as follows:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="background-color: #365F91">
    <TD STYLE="width: 44%; border-top: Black 1pt solid; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="color: white">Name</FONT></TD>
    <TD STYLE="width: 56%; border-top: Black 1pt solid; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="color: white">Title (as of December 31, 2017)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-left: Black 1pt solid; text-align: justify">&nbsp;Charles H. Sherwood, Ph.D.&#9;</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: justify">Chief Executive Officer</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="border-left: Black 1pt solid; text-align: justify">&nbsp;Sylvia Cheung&#9;</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: justify">Chief Financial Officer</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-left: Black 1pt solid; text-align: justify">&nbsp;Joseph G. Darling&#9;</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: justify">President</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-left: Black 1pt solid; text-align: justify">&nbsp;Edward Ahn, Ph.D.&#9;</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: justify">Chief Technology and Strategy Officer</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: justify">&nbsp;Richard Hague&#9;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify">Chief Commercial Officer</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Effective March 9, 2018, Dr. Sherwood retired as Chief Executive
Officer, and Mr. Darling was appointed to that position. That transition did not impact the compensation decisions for 2017 discussed
below.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">We have divided this discussion into five parts:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">Executive Summary</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify">Compensation Philosophy</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify">Key Compensation Policies and Practices</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">4.</TD><TD STYLE="text-align: justify">2017 Compensation Decisions</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">5.</TD><TD STYLE="text-align: justify">Other Compensation Matters</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Executive Summary</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><I><U>Our Fiscal Year 2017 Business Performance</U></I>. We generated
10% top line growth in 2017, and our total shareholder return, or TSR, for two-year period ended December 31, 2017 increased by
41%. We continued to execute on our key strategies to enhance our performance and set the stage for enhanced growth and profitability
over the next several years as we look to maximize returns from our key markets for our stakeholders. These efforts, which we believe
will strengthen our competitive position and drive long-term growth and stockholder value, included:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">
<TR>
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 0.25in; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="vertical-align: middle; text-align: justify">expanding our international presence, especially with respect to our viscosupplementation franchise;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="vertical-align: middle; text-align: justify">continuing to execute on activities associated with developing our direct commercial capability for the commercialization of Cingal in the United States;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="vertical-align: middle; text-align: justify">expanding our product pipeline by achieving 510(k) clearance from the Food and Drug Administration, or FDA, for our injectable bone repair product;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="vertical-align: middle; text-align: justify">completing enrollment in our Cingal Phase III clinical trial ahead of our scheduled year-end completion date;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="vertical-align: middle; text-align: justify">continuing to progress on the enrollment of patients in our Hyalofast Phase III clinical trial;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="vertical-align: middle; text-align: justify">expanding our R&amp;D pipeline through collaboration with the University of Massachusetts to continue development of a therapy for the treatment of rheumatoid arthritis and with the University of Liverpool to develop an injectable mesenchymal stem cell therapy for the treatment of osteoarthritis;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="vertical-align: middle; text-align: justify">completing all planned activities associated with the consolidation of our global manufacturing operations at our headquarters in Bedford, Massachusetts; and</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="vertical-align: middle; text-align: justify">implementing a new enterprise resource planning system to allow us to optimize processes and provide system capability for future growth.</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">In addition to these operational efforts, our financial highlights
for 2017 included:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">
<TR>
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 0.25in; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="vertical-align: middle; text-align: justify">revenue growth of 10% year-over-year to $113.4 million;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="vertical-align: middle; text-align: justify">international orthobiologics revenue growth of 22%;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="vertical-align: middle; text-align: justify">net income of $31.8 million;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="vertical-align: middle; text-align: justify">no debt as of December 31, 2017;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="vertical-align: middle; text-align: justify">product gross margin of 75% for the full year; and</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">
<TR>
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="vertical-align: middle; text-align: justify">cash, cash equivalents and investments totaling $157.2 million as of December 31, 2017.</TD></TR>
</TABLE>
<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><I><U>Compensation Decisions</U></I>. We made compensation decisions
for our NEOs for 2017 that were directly linked to our performance. In particular, the Compensation Committee awarded to the NEOs:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">cash bonuses based on the business performance results above and a review of individual performance
accomplishments, with awards ranging from 70% to 115% of target; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">stock options in early 2017 that became vested based on objective performance goals tied to our
2017 net income and specific 2017 business milestones and that, based on performance results, vested at 55% of target.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Mr. Darling, who was hired in 2017, received new hire stock option
and restricted stock awards in connection with accepting his offer of employment.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><I><U>Stockholder Outreach</U></I>. In our say-on-pay vote
last year, about 58% of the votes were cast in favor of our executive compensation. In order to achieve future results more
aligned with the over 90% support we have regularly received on say-on-pay votes in prior years, management reached out to
twenty-five of our largest stockholders, representing over 60% of our outstanding shares, in early 2018 to solicit feedback
on our executive compensation program and to understand issues or concerns pertinent to those investors. We were able to
connect with several of those investors for these conversations. The general theme from these conversations was that our
investors would prefer a clearer explanation of how we align performance and compensation through enhanced narrative
disclosure and the disclosure of the particular metrics that we consider. We appreciated the feedback that we received, and,
as a result of these discussions, we have, and will continue to, enhance our disclosure on these points, including in the
following discussion.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Compensation Philosophy</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Compensation Committee approves our compensation policies and
oversees our overall compensation program. The overriding goal of our compensation program is to drive long-term high performance
and stockholder value creation through our pay programs and corporate culture. As a result, the Compensation Committee ties performance
to many aspects of our compensation program, including pay levels, incentive payouts, and pay opportunities. The Compensation Committee,
utilizing both the structure of our compensation program and its discretion, as necessary, structures our executive compensation
program to reward our NEOs when performance exceeds goals. A significant portion of incentive compensation is weighted towards
overall leadership team achievement against targeted goals (rather than individual performance), so that if we meet or exceed our
goals, the teams earn target or better awards. Conversely, if the team fails to meet the minimum thresholds, components of performance-based
compensation will not be awarded. As a general matter, the Compensation Committee targets total NEO compensation at the median
of each position&rsquo;s market reference point. The Compensation Committee considers a NEO&rsquo;s total pay to be within the
range of market median if it is within 15% of the median. We have designed our compensation program to achieve the following:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">motivate and reward our executives to achieve or exceed our financial and operating performance
objectives;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify">propel our business forward through a focus on operational excellence and execution of our business
strategy;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify">link each NEO&rsquo;s compensation with specific business objectives;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">4.</TD><TD STYLE="text-align: justify">align each NEO&rsquo;s compensation with the interests of long-term stockholders by tying a significant
portion of total compensation opportunity to the value of our stock;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">5.</TD><TD STYLE="text-align: justify">reinforce accountability and cooperation by tying a significant portion of total NEO compensation
to overall company performance;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">6.</TD><TD STYLE="text-align: justify">attract and retain talented leaders who can drive and implement our growth and operational excellence
strategies;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">7.</TD><TD STYLE="text-align: justify">reward individual performance and accomplishments; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">8.</TD><TD STYLE="text-align: justify">keep the compensation packages competitive with those of our peers and other companies with whom
we compete for talent.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Key Compensation Policies and Practices</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><I><U>Key Features</U></I>. We believe that our executive compensation
program includes key features that align the interests of the NEOs with our stockholders and does not include features that misalign
their interests. During 2017, we arranged our compensation program in accordance with the practices set forth below:</P>


<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="background-color: #365F91">
    <TD STYLE="width: 50%; border-top: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="color: white"><B>What We Do</B></FONT></TD>
    <TD STYLE="width: 50%; border-top: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="color: white"><B>What We Don&rsquo;t Do</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: left">
        <P STYLE="font-size: 10pt; text-align: left; margin: 0pt 9pt 0pt 30pt; text-indent: -11pt"><FONT STYLE="font-family: Wingdings">&uuml;</FONT>
        Align NEO pay with our performance</P>
        <P STYLE="font-size: 10pt; text-align: left; text-indent: -0.25in; margin: 0pt 9pt 0pt 0.5in">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: left; margin: 0pt 9pt 0pt 30pt; text-indent: -11pt"><FONT STYLE="font-family: Wingdings">&uuml;</FONT>
        Align a significant portion of NEO pay with stockholders through long-term incentives, including performance-based option
        awards in 2017</P>
        <P STYLE="font-size: 10pt; text-align: left; text-indent: -0.25in; margin: 0pt 9pt 0pt 0.5in">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: left; margin: 0pt 9pt 0pt 30pt; text-indent: -11pt"><FONT STYLE="font-family: Wingdings">&uuml;</FONT>
        Balance short-term and long-term incentives</P>
        <P STYLE="font-size: 10pt; text-align: left; text-indent: -0.25in; margin: 0pt 9pt 0pt 0.5in">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: left; margin: 0pt 9pt 0pt 30pt; text-indent: -11pt"><FONT STYLE="font-family: Wingdings">&uuml;</FONT>
        Require NEOs to own significant amounts of stock through robust stock ownership guidelines (see pg. 32 of this Proxy
        Statement)</P>
        <P STYLE="font-size: 10pt; text-align: left; text-indent: -0.25in; margin: 0pt 9pt 0pt 0.5in">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: left; margin: 0pt 9pt 0pt 30pt; text-indent: -11pt"><FONT STYLE="font-family: Wingdings">&uuml;</FONT>
        Include, in our equity compensation plan, minimum vesting requirements for equity awards</P>
        <P STYLE="font-size: 10pt; text-align: left; text-indent: -0.25in; margin: 0pt 9pt 0pt 0.5in">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: left; margin: 0pt 9pt 0pt 30pt; text-indent: -11pt"><FONT STYLE="font-family: Wingdings">&uuml;</FONT>
        Impose caps on annual incentive awards</P>
        <P STYLE="font-size: 10pt; text-align: left; text-indent: -0.25in; margin: 0pt 9pt 0pt 0.5in">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: left; margin: 0pt 9pt 0pt 30pt; text-indent: -11pt"><FONT STYLE="font-family: Wingdings">&uuml;</FONT>
        Utilize a compensation consultant to annually review our compensation program</P>
        <P STYLE="font-size: 10pt; text-align: left; text-indent: -0.25in; margin: 0pt 9pt 0pt 0.5in">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: left; margin: 0pt 9pt 0pt 30pt; text-indent: -11pt"><FONT STYLE="font-family: Wingdings">&uuml;</FONT>
        Solicit say-on-pay votes annually</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 9pt 0pt 0.5in">&nbsp;</P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid">
        <P STYLE="font-size: 10pt; text-align: left; margin: 0pt 9pt 0pt 30pt; text-indent: -10pt"><FONT STYLE="font-family: Symbol">&Auml;</FONT>
        No automatic or guaranteed annual salary increases</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 9.05pt 0pt 0.5in">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: left; margin: 0pt 9pt 0pt 30pt; text-indent: -10pt"><FONT STYLE="font-family: Symbol">&Auml;</FONT>
        No guaranteed bonus or long-term incentive awards</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 9.05pt 0pt 0.5in">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: left; margin: 0pt 9pt 0pt 30pt; text-indent: -10pt"><FONT STYLE="font-family: Symbol">&Auml;</FONT>
        No repricing of stock options or SARs without stockholder approval</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 9.05pt 0pt 0.5in">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: left; margin: 0pt 9pt 0pt 30pt; text-indent: -10pt"><FONT STYLE="font-family: Symbol">&Auml;</FONT><FONT STYLE="font-size: 10pt"></FONT>
        No hedging/pledging of our stock per our insider trading policy</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 9.05pt 0pt 0.5in">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: left; margin: 0pt 9pt 0pt 30pt; text-indent: -10pt"><FONT STYLE="font-family: Symbol">&Auml;</FONT>
        No long-term incentive backdating</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 9.05pt 0pt 0.5in">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: left; margin: 0pt 9pt 0pt 30pt; text-indent: -10pt"><FONT STYLE="font-family: Symbol">&Auml;</FONT><FONT STYLE="font-size: 10pt"></FONT>
        No granting of stock options or SARs at an exercise price less than fair market value</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 9.05pt 0pt 0.5in">&nbsp;</P></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><I><U>Key Performance Factors</U></I>. In setting the compensation
for our executive officers, the Compensation Committee relies primarily on our overall financial performance and an assessment
of the individual&rsquo;s performance and contribution to our development and achievements. Typical achievement measures considered
by the Compensation Committee include, but may not be limited to, the following:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: middle; background-color: #365F91">
    <TD STYLE="color: white; font-weight: bold; border-top: Black 1pt solid; border-left: Black 1pt solid; text-align: center; width: 50%">Company Financial Performance</TD>
    <TD STYLE="color: white; font-weight: bold; border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; text-align: center; width: 50%">Individual Performance</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="border-left: Black 1pt solid; text-align: left; padding-left: 25pt; text-indent: -15pt; padding-bottom: 6pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">&nbsp;&nbsp;&nbsp;&nbsp;Revenue growth</font></TD>
    <TD STYLE="border-left: Black 1pt solid; text-align: left; padding-left: 25pt; text-indent: -15pt; padding-bottom: 6pt; border-right: Black 1pt solid"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">&nbsp;&nbsp;&nbsp;&nbsp;Franchise or geographic revenue growth</FONT></TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="border-left: Black 1pt solid; text-align: left; padding-left: 25pt; text-indent: -15pt; padding-bottom: 6pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">&nbsp;&nbsp;&nbsp;&nbsp;Net income achievement</font></TD>
    <TD STYLE="border-left: Black 1pt solid; text-align: left; padding-left: 25pt; text-indent: -15pt; padding-bottom: 6pt; border-right: Black 1pt solid"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">&nbsp;&nbsp;&nbsp;&nbsp;Clinical trial progress or completion</FONT></TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="border-left: Black 1pt solid; text-align: left; padding-left: 25pt; text-indent: -15pt; padding-bottom: 6pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">&nbsp;&nbsp;&nbsp;&nbsp;Product gross margin</font></TD>
    <TD STYLE="border-left: Black 1pt solid; text-align: left; padding-left: 25pt; text-indent: -15pt; padding-bottom: 6pt; border-right: Black 1pt solid"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">&nbsp;&nbsp;&nbsp;&nbsp;Achievement of regulatory approvals for new products or line extensions</FONT></TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="border-left: Black 1pt solid; text-align: left; padding-left: 25pt; text-indent: -15pt; padding-bottom: 6pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">&nbsp;&nbsp;&nbsp;&nbsp;Cash flow</font></TD>
    <TD STYLE="border-left: Black 1pt solid; text-align: left; padding-left: 25pt; text-indent: -15pt; padding-bottom: 6pt; border-right: Black 1pt solid"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">&nbsp;&nbsp;&nbsp;&nbsp;New product launches in key geographies</FONT></TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="border-left: Black 1pt solid; text-align: left; padding-left: 25pt; text-indent: -15pt; padding-bottom: 6pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">&nbsp;&nbsp;&nbsp;&nbsp;Share price performance</font></TD>
    <TD STYLE="border-left: Black 1pt solid; text-align: left; padding-left: 25pt; text-indent: -15pt; padding-bottom: 6pt; border-right: Black 1pt solid"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">&nbsp;&nbsp;&nbsp;&nbsp;Key employee recruitment or retention</FONT></TD></TR>
<TR>
    <TD STYLE="border-left: Black 1pt solid; vertical-align: top; padding-bottom: 6pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; text-align: left; padding-left: 25pt; text-indent: -15pt; padding-bottom: 6pt; border-right: Black 1pt solid"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">&nbsp;&nbsp;&nbsp;&nbsp;Completion of significant projects that drive company growth</FONT></TD></TR>
<TR>
    <TD STYLE="border-left: Black 1pt solid; vertical-align: top; padding-bottom: 0pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; text-align: left; padding-left: 25pt; text-indent: -15pt; padding-bottom: 0pt; border-right: Black 1pt solid"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">&nbsp;&nbsp;&nbsp;&nbsp;Procurement of patents or other intellectual property</FONT></TD></TR>
<TR>
    <TD STYLE="border-bottom: Black 1pt solid; border-left: Black 1pt solid; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: justify; padding-left: 25pt; text-indent: -15pt">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><I><U>Peer Group</U></I>. In addition to the company and individual
performance metrics set forth above, the Compensation Committee weighs other quantitative factors such as general compensation
trends. In this regard, the Compensation Committee periodically reviews surveys of executive compensation and information concerning
compensation at similarly situated companies. The Compensation Committee engaged Radford, an Aon Hewitt Company&mdash;a business
unit of Aon plc, a national executive compensation consulting firm (&ldquo;Radford&rdquo;), to assist the Company in selecting
an appropriate peer group for compensation comparisons and to perform an executive compensation review.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Compensation Committee, with the assistance of Radford, performed
this analysis in 2013, 2015, 2016, and 2017, and it has taken up the practice of performing this analysis yearly. In completing
its analysis for the 2017 compensation season, the Compensation Committee reviewed competitive data compiled by Radford from a
peer group comprised of 18 companies of similar size and related businesses. The Compensation Committee also reviewed market data
from the&nbsp;2016 Radford Global Life Sciences Executive Survey (the &ldquo;Radford Survey&rdquo;) covering over 55 public biopharmaceutical
and medical device companies.&nbsp;While the Compensation Committee does not determine compensation based on formulaic criteria,
it generally seeks to achieve an overall compensation level approximating the industry median, within 15%. The following is the
composition of the peer group utilized for our 2017 compensation analysis:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="3" ALIGN="CENTER" STYLE="width: 80%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top; background-color: #365F91">
    <TD COLSPAN="2" STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="color: white"><B>Peer Group Companies</B></FONT></TD></TR>
<TR>
    <TD STYLE="width: 50%; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="color: #365F91"><I><U>Biopharmaceutical Companies</U></I></FONT></TD>
    <TD STYLE="width: 50%; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="color: #365F91"><I><U>Medical Device Companies</U></I></FONT></TD></TR>
<TR>
    <TD STYLE="border-left: Black 1pt solid; text-align: justify">Exelixis, Inc.</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: justify">AtriCure, Inc.</TD></TR>
<TR>
    <TD STYLE="border-left: Black 1pt solid; text-align: justify">Halozyme, Inc.</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: justify">Atrion Corporation</TD></TR>
<TR>
    <TD STYLE="border-left: Black 1pt solid; text-align: justify">Macrogenics, Inc.</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: justify">Cerus Corporation</TD></TR>
<TR>
    <TD STYLE="border-left: Black 1pt solid; text-align: justify">MiMedx Group, Inc.</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: justify">CryoLife Inc.</TD></TR>
<TR>
    <TD STYLE="border-left: Black 1pt solid; text-align: justify">Momenta Pharmaceuticals, Inc.</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: justify">GenMark Diagnostics, Inc.</TD></TR>
<TR>
    <TD STYLE="border-left: Black 1pt solid; text-align: justify">Repligen Corporation</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: justify">Glaukos Corporation</TD></TR>
<TR>
    <TD STYLE="border-left: Black 1pt solid; text-align: justify">Spectrum Pharmaceuticals, Inc.</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: justify">Rockwell Medical, Inc.</TD></TR>
<TR>
    <TD STYLE="border-left: Black 1pt solid; text-align: justify">Sucampo Pharmaceuticals, Inc. </TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: justify">STAAR Surgical Company</TD></TR>
<TR>
    <TD STYLE="border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: justify">Vanda Pharmaceuticals, Inc.</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify">Vascular Solutions, Inc.</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">With Radford&rsquo;s assistance, we have further adjusted the peer
group for our 2018 compensation program. We believe the adjustments were appropriate to better reflect changes in our company over
time, based on our strong financial performance, growing product pipeline, and preparations to launch a direct commercial model
for our Cingal product in the United States. The 2018 peer group will be:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="3" ALIGN="CENTER" STYLE="width: 80%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top; background-color: #365F91">
    <TD COLSPAN="2" STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="color: white"><B>Peer Group Companies</B></FONT></TD></TR>
<TR>
    <TD STYLE="width: 50%; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="color: #365F91"><I><U>Biopharmaceutical Companies</U></I></FONT></TD>
    <TD STYLE="width: 50%; border-right: Black 1pt solid; text-align: justify"><FONT STYLE="color: #365F91"><I><U>Medical Device Companies</U></I></FONT></TD></TR>
<TR>
    <TD STYLE="border-left: Black 1pt solid; text-align: justify">Halozyme, Inc.</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: justify">AtriCure, Inc.</TD></TR>
<TR>
    <TD STYLE="border-left: Black 1pt solid; text-align: justify">MacroGenics, Inc.</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: justify">Atrion Corporation</TD></TR>
<TR>
    <TD STYLE="border-left: Black 1pt solid; text-align: justify">MiMedx Group, Inc.</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: justify">CONMED Corporation</TD></TR>
<TR>
    <TD STYLE="border-left: Black 1pt solid; text-align: justify">Momenta Pharmaceuticals, Inc.</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: justify">CryoLife Inc.</TD></TR>
<TR>
    <TD STYLE="border-left: Black 1pt solid; text-align: justify">Repligen Corporation</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: justify">Glaukos Corporation</TD></TR>
<TR>
    <TD STYLE="border-left: Black 1pt solid; text-align: justify">Spectrum Pharmaceuticals, Inc.</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: justify">K2M Group Holdings</TD></TR>
<TR>
    <TD STYLE="border-left: Black 1pt solid; text-align: justify">Sucampo Pharmaceuticals, Inc. </TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: justify">Orthofix, Inc.</TD></TR>
<TR>
    <TD STYLE="border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: justify">Vanda Pharmaceuticals, Inc.</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify">Wright Medical Group, Inc.</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><I></I></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">2017 Compensation Decisions</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Our NEO compensation is made up of three key components:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">base salary,</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">discretionary annual bonuses, and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">equity-based long-term incentive awards.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Compensation Committee separately reviews and decides each component,
but keeps in mind the overall intent that total compensation should approximate the competitive median, before adjusting for actual
performance.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><I><U>Base Salary</U>. </I>The primary component of compensation
for our executive officers is base salary, which is generally paid to our NEOs to recognize fulfillment of their job responsibilities.
Base salaries for our NEOs are subject to annual review by the Compensation Committee. For this purpose, the Compensation Committee
considers a number of factors, including the individual&rsquo;s level of responsibility, experience, performance, including both
past company performance and individual performance in accordance with the metrics previously discussed, as well as competitive
market practices as determined by our analysis of management compensation surveys, and a review of other published data relating
to executive compensation, including peer group data, and taking into account any contractual obligations.&nbsp;Salaries are reviewed
and determined at the discretion of the Compensation Committee on an annual basis, and there is no guaranteed year-over-year increase
to any of the NEOs salaries.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">For 2017, compensation increases for the NEOs were generally limited
to 3.5%. Dr. Ahn&rsquo;s base salary was increased at a higher rate in order to better align to market median for similar positions.
Mr. Darling&rsquo;s annual rate of base salary was set based on the employment agreement he entered with us upon being hired in
July 2017. The base salary included in the Summary Compensation Table for Mr. Darling reflects the amount actually paid for the
portion of 2017 he was employed by us. The following summarizes the base salary decisions for 2017 for the NEOs:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>2017 Base Salary Adjustments</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom; background-color: #365F91">
    <TD NOWRAP STYLE="font-size: 10pt; color: white; font-weight: bold; text-align: justify; border-left: Black 1pt solid; border-top: Black 1pt solid">&nbsp;Name</TD><TD STYLE="font-size: 10pt; color: white; font-weight: bold; border-top: Black 1pt solid">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; color: white; font-weight: bold; text-align: center; border-top: Black 1pt solid">2016 Salary</TD><TD STYLE="font-size: 10pt; color: white; font-weight: bold; border-top: Black 1pt solid">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; color: white; font-weight: bold; text-align: center; border-top: Black 1pt solid">2017 Salary</TD><TD STYLE="font-size: 10pt; color: white; font-weight: bold; border-top: Black 1pt solid">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; color: white; font-weight: bold; text-align: center; border-right: Black 1pt solid; border-top: Black 1pt solid">% Change</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 55%; font-size: 10pt; text-align: justify; border-left: Black 1pt solid">&nbsp;Charles H. Sherwood, Ph.D.</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: center">$601,586</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: center">$622,641</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; font-size: 10pt; text-align: right">3.5%</TD><TD STYLE="width: 5%; font-size: 10pt; text-align: left; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="font-size: 10pt; text-align: justify; border-left: Black 1pt solid">&nbsp;Sylvia Cheung</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">$346,942</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">$359,085</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3.5%</TD><TD STYLE="font-size: 10pt; text-align: left; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: justify; border-left: Black 1pt solid">&nbsp;Joseph G. Darling</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">N/A</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">$425,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">N/A</TD><TD STYLE="font-size: 10pt; text-align: left; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="font-size: 10pt; text-align: justify; border-left: Black 1pt solid">&nbsp;Edward Ahn, Ph.D.</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">$315,675</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">$347,243</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">10.0%</TD><TD STYLE="font-size: 10pt; text-align: left; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: justify; padding-bottom: 1.1pt; border-bottom: Black 1pt solid; border-left: Black 1pt solid">&nbsp;Richard Hague</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">$315,000</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">$326,025</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">3.5%</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left; border-right: Black 1pt solid">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><I><U>Cash Bonus</U>. </I>The second principal component of our
compensation policy for executive officers consists of cash bonuses, which are generally paid to our NEOs to motivate attainment
of our near-term goals that are consistent with our long-term strategic plan.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Each NEO has a target annual bonus amount established by the Compensation
Committee that is expressed as a percentage of the NEO&rsquo;s base salary. In 2017, these targets were consistent with the targets
from the prior several years. The Compensation Committee establishes the target bonus amounts consistent with its review of peer
group practices and to provide in its view an appropriate balance between fixed (salary) and variable (bonus) cash compensation.
Mr. Darling&rsquo;s 2017 cash bonus target was established in his employment agreement in connection with being hired. The 2017
target bonus amounts for the NEOs were as follows:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>2017 Cash Bonus Targets</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom; background-color: #365F91">
    <TD NOWRAP STYLE="font-size: 10pt; color: white; font-weight: bold; text-align: justify; border-left: Black 1pt solid; border-top: Black 1pt solid">&nbsp;Name</TD><TD STYLE="font-size: 10pt; color: white; font-weight: bold; border-top: Black 1pt solid">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; color: white; font-weight: bold; text-align: center; border-top: Black 1pt solid">% of Salary</TD><TD STYLE="font-size: 10pt; color: white; font-weight: bold; border-top: Black 1pt solid">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; color: white; font-weight: bold; text-align: center; border-right: Black 1pt solid; border-top: Black 1pt solid">Amount</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 68%; font-size: 10pt; text-align: justify; border-left: Black 1pt solid">&nbsp;Charles H. Sherwood, Ph.D.</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right">75</TD><TD STYLE="width: 7%; font-size: 10pt; text-align: left">%</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="width: 12%; font-size: 10pt; text-align: center">$466,981</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="font-size: 10pt; text-align: justify; border-left: Black 1pt solid">&nbsp;Sylvia Cheung</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">$161,588</TD><TD STYLE="font-size: 10pt; text-align: left; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: justify; border-left: Black 1pt solid">&nbsp;Joseph G. Darling*</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">50</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">$93,990</TD><TD STYLE="font-size: 10pt; text-align: left; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="font-size: 10pt; text-align: justify; border-left: Black 1pt solid">&nbsp;Edward Ahn, Ph.D.</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">$156,259</TD><TD STYLE="font-size: 10pt; text-align: left; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: justify; padding-bottom: 1.1pt; border-left: Black 1pt solid; border-bottom: Black 1pt solid">&nbsp;Richard Hague</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">45</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">%</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">$146,711</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left; border-right: Black 1pt solid">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 9.35pt"><FONT STYLE="font-size: 8pt">*</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 8pt">For Mr.
                                         Darling, the amount above reflects 50% of base salary actually paid in 2017 given his
                                         July start date.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Actual bonus amounts awarded depend on the Compensation Committee&rsquo;s
assessment of our business and individual NEO performance. The Compensation Committee considers our financial performance in accordance
with metrics previously discussed, our overall operational performance, and our contribution to increasing stockholder value at
its discretion to determine an appropriate level of baseline cash bonus compensation for our NEOs. Once the Compensation Committee
has established this baseline, it considers the applicable individual performance in its discretion to adjust each individual NEO&rsquo;s
cash bonus payment. See &ldquo;Key Performance Factors&rdquo; above regarding the key financial and individual performance factors
considered. Historically, cash bonuses for the most recently completed year are awarded contemporaneously with annual compensation
reviews for the subsequent year. Bonuses are prorated in the year of hire, provided that the employee begins their employment with
us prior to October 1. The Compensation Committee may also, in certain circumstances, grant cash bonuses for executive retention
purposes, taking into account, among other things, general industry practices, special performance bonuses in exceptional circumstances,
and any contractual obligations.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">After the completion of the 2017 fiscal year, the Compensation Committee,
with the assistance of the Chief Executive Officer, reviewed our performance, as well as the individual performance of each executive
officer. The accomplishments set forth in the Executive Summary section titled &ldquo;Our Fiscal Year 2017 Business Performance&rdquo;
were taken into account in this review. For the year, the Compensation Committee determined that while we made excellent overall
business progress, certain operational achievements fell short of our internal goals. As a result, the Compensation Committee,
using its informed judgment and without pre-established formulas, set a cash bonus payment baseline of 80% of the target for each
NEO, subject to adjustment based on individual performance achievement. The final, individual results, which are included in the
&ldquo;Bonus&rdquo; column in the Summary Compensation Table, were as follows:&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>2017 Cash Bonus Decisions</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom; background-color: #365F91">
    <TD NOWRAP STYLE="font-size: 10pt; color: white; font-weight: bold; text-align: left; border-left: Black 1pt solid; border-top: Black 1pt solid; vertical-align: bottom">&nbsp;Name</TD><TD STYLE="font-size: 10pt; color: white; font-weight: bold; border-top: Black 1pt solid">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; color: white; font-weight: bold; text-align: center; border-top: Black 1pt solid">Bonus Target</TD><TD STYLE="font-size: 10pt; color: white; font-weight: bold; border-top: Black 1pt solid">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; color: white; font-weight: bold; text-align: center; border-top: Black 1pt solid">% Achieved</TD><TD STYLE="font-size: 10pt; color: white; font-weight: bold; border-top: Black 1pt solid">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; color: white; font-weight: bold; text-align: center; border-right: Black 1pt solid; border-top: Black 1pt solid">Bonus Paid</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 58%; font-size: 10pt; text-align: justify; border-left: Black 1pt solid">&nbsp;Charles H. Sherwood, Ph.D.</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: center">$466,981</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right">100</TD><TD STYLE="width: 5%; font-size: 10pt; text-align: left">%</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: center">$466,981</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: center; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="font-size: 10pt; text-align: justify; border-left: Black 1pt solid">&nbsp;Sylvia Cheung</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">$161,588</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">115</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">$185,827</TD><TD STYLE="font-size: 10pt; text-align: center; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: justify; border-left: Black 1pt solid">&nbsp;Joseph G. Darling</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">$93,990</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">100</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">$93,990</TD><TD STYLE="font-size: 10pt; text-align: center; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="font-size: 10pt; text-align: justify; border-left: Black 1pt solid">&nbsp;Edward Ahn, Ph.D.</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">$156,259</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">80</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">$125,007</TD><TD STYLE="font-size: 10pt; text-align: center; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: justify; padding-bottom: 1.1pt; border-bottom: Black 1pt solid; border-left: Black 1pt solid">&nbsp;Richard Hague</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">$146,711</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">70</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">%</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">$102,698</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; border-right: Black 1pt solid">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><I>Equity-Based Grants. </I>The third principal component of our
compensation policy for executive officers consists of grants under our equity incentive plan, which are generally provided to
our NEOs to align their interests with those of our stockholders, to motivate attainment of our long-term strategic vision, and
for retention purposes. Under our equity compensation plan, NEOs may be granted stock options or other forms of equity securities,
including stock appreciation rights or SARs, restricted stock awards, and performance-based equity awards. Equity awards are granted
at a regularly-scheduled Compensation Committee meeting, generally during the first quarter of each year. Awards are generally
effective on the date of the meeting at which they were approved. Dates for Compensation Committee meetings are usually set during
the prior year, and the timing of meetings and awards is unrelated to the release of material non-public information.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The amount and form of equity-based grants each year are determined
by the Compensation Committee using its informed judgment and taking into account company performance, competitive practices, and
median total compensation levels. For the last several years, the Compensation Committee has increasingly used performance-based
equity awards. For 2017, other than the new hire grants made to Mr. Darling, the Compensation Committee awarded the NEOs a balanced
mix of time-vesting and performance-based stock options, as follows:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>2017 Stock Option Grants</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom; background-color: #365F91">
    <TD NOWRAP STYLE="font-size: 10pt; color: white; font-weight: bold; text-align: left; border-left: Black 1pt solid; border-top: Black 1pt solid; vertical-align: bottom">&nbsp;Name</TD><TD STYLE="font-size: 10pt; color: white; font-weight: bold; border-top: Black 1pt solid">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; color: white; font-weight: bold; text-align: center; border-top: Black 1pt solid">Time-Vesting Options <BR>(# of shares)</TD><TD STYLE="font-size: 10pt; color: white; font-weight: bold; border-top: Black 1pt solid">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; color: white; font-weight: bold; text-align: center; border-right: Black 1pt solid; border-top: Black 1pt solid">Performance-Based Options <BR>(# of shares at target)</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 58%; font-size: 10pt; color: black; text-align: justify; border-left: Black 1pt solid">&nbsp;Charles H. Sherwood, Ph.D.</TD><TD STYLE="width: 2%; font-size: 10pt; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; color: black; text-align: center">&nbsp;</TD><TD STYLE="width: 16%; font-size: 10pt; color: black; text-align: center">125,000</TD><TD STYLE="width: 1%; font-size: 10pt; color: black; text-align: center">&nbsp;</TD><TD STYLE="width: 4%; font-size: 10pt; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; color: black; text-align: center">&nbsp;</TD><TD STYLE="width: 16%; font-size: 10pt; color: black; text-align: center">50,880</TD><TD STYLE="width: 1%; font-size: 10pt; color: black; text-align: center; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="font-size: 10pt; color: black; text-align: justify; border-left: Black 1pt solid">&nbsp;Sylvia Cheung</TD><TD STYLE="font-size: 10pt; color: black">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; color: black; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; color: black; text-align: center">28,500</TD><TD STYLE="font-size: 10pt; color: black; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; color: black">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; color: black; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; color: black; text-align: center">14,160</TD><TD STYLE="font-size: 10pt; color: black; text-align: center; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; color: black; text-align: justify; border-left: Black 1pt solid">&nbsp;Joseph G. Darling*</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">41,609</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">0</TD><TD STYLE="font-size: 10pt; text-align: center; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="font-size: 10pt; color: black; text-align: justify; border-left: Black 1pt solid">&nbsp;Edward Ahn</TD><TD STYLE="font-size: 10pt; color: black">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; color: black; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; color: black; text-align: center">22,500</TD><TD STYLE="font-size: 10pt; color: black; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; color: black">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; color: black; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; color: black; text-align: center">14,160</TD><TD STYLE="font-size: 10pt; color: black; text-align: center; border-right: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; color: black; text-align: justify; padding-bottom: 1.1pt; border-bottom: Black 1pt solid; border-left: Black 1pt solid">&nbsp;Richard Hague</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">22,500</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">14,160</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; border-right: Black 1pt solid">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><FONT STYLE="font-size: 8pt">* Mr. Darling received a new hire
grant on July 27, 2017 consisting of 41,609 stock options and 14,506 shares of restricted stock.</FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The performance-based stock options were approved at a target level,
but were earned based on a combination of our 2017 net income results and achievement of specified business milestones, as follows:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>2017 Performance-Based Stock Options Goals and Results</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="3" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: middle; background-color: #365F91">
    <TD STYLE="color: white; font-weight: bold; border-bottom: Black 1pt solid; border-left: Black 1pt solid; width: 22%; text-align: center; vertical-align: bottom; padding-left: 3pt; border-top: Black 1pt solid">Goal</TD>
    <TD STYLE="color: white; font-weight: bold; border-bottom: Black 1pt solid; width: 11%; text-align: center; vertical-align: bottom; border-top: Black 1pt solid">Weight</TD>
    <TD STYLE="color: white; font-weight: bold; border-bottom: Black 1pt solid; text-align: center; width: 12%; vertical-align: bottom; border-top: Black 1pt solid">Threshold<BR>
50%</TD>
    <TD STYLE="color: white; font-weight: bold; border-bottom: Black 1pt solid; text-align: center; width: 13%; vertical-align: bottom; border-top: Black 1pt solid">Target<BR>
100%</TD>
    <TD STYLE="color: white; font-weight: bold; border-bottom: Black 1pt solid; text-align: center; width: 13%; vertical-align: bottom; border-top: Black 1pt solid">Max<BR>
150%</TD>
    <TD STYLE="color: white; font-weight: bold; border-bottom: Black 1pt solid; width: 13%; text-align: center; vertical-align: bottom; border-top: Black 1pt solid">2017 Results</TD>
    <TD STYLE="color: white; font-weight: bold; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 16%; text-align: center; vertical-align: bottom; border-top: Black 1pt solid">% of Award Earned</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-left: 3pt">2017 net income</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">50%</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">Achieved</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">Not achieved</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">Not achieved</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">$31.8M</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">25%</TD></TR>
<TR STYLE="vertical-align: middle; background-color: white">
    <TD STYLE="border-left: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 3pt">Complete enrollment in Cingal trial&nbsp;&nbsp;by November 1, 2017</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid">20%</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">N/A</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">Achieved</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">N/A</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">Achieved</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">20%</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="border-left: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 3pt">Achieve enrollment of 103 patients in Hyalofast trial by December 31, 2017</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">20%</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">N/A</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">Not achieved</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">N/A</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid">Not achieved</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">0%</TD></TR>
<TR STYLE="vertical-align: middle; background-color: white">
    <TD STYLE="border-left: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 3pt">Achieve 510(k) clearance of a new&nbsp;&nbsp;product through the FDA by&nbsp;&nbsp;December 31, 2017</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">10%</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">N/A</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">Achieved</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">N/A</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">Achieved</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">10%</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-left: 3pt">Total earned by NEOs</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">55%</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B></B>&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Due to his hire date, Mr. Darling did not receive performance-based
option awards. Instead, his employment agreement provided for two new hire equity grants with a total grant date value of $1,500,000,
provided 50% as stock options and 50% as shares of restricted stock, each vesting annually over three years following grant. The
Compensation Committee believed that these new hire grants were necessary to hire Mr. Darling and that they align his interests
with those of our stockholders.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">These 2017 equity grants are shown in the Summary Compensation Table
under the &ldquo;Option Awards&rdquo; and &ldquo;Stock Awards&rdquo; columns, and additional details are included in the Grants
of Plan-Based Awards Table.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Other Compensation Matters</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><I><U>Employment Agreements</U></I>. We have entered into employment
agreements with our Chief Executive Officer, our Chief Financial Officer, and our President providing severance benefits to be
competitive with our peer group, for retention purposes, and to attract well qualified and talented executives. In exchange for
such severance protection, these executives have agreed to be bound by certain restrictive covenants, including non-competition
and non-solicitation provisions. We believe that these agreements are fair to the executives and to our stockholders because these
agreements provide relatively modest severance in exchange for the restrictive covenants which protect our company. The following
summarizes the employment agreements. Additional information about severance protection under the employment agreements can be
found under &ldquo;Potential Payments Upon Termination or Change in Control.&rdquo;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Each of the employment agreement describes the executive&rsquo;s
position and provides for a level of salary and target bonus that is subject to review and increase by the Compensation Committee.
Each agreement also provides for severance benefits that may be triggered by an involuntary termination of employment by us without
&ldquo;cause&rdquo; or by the executive for &ldquo;good reason&rdquo; (as defined in each employment agreement). The level of severance
benefits depends on whether the involuntary termination occurs during or outside of a change in control protected period that runs
from three months before until 12 months after a change in control. In addition, the employment agreements provide for full vesting
of outstanding equity awards upon the occurrence of a change in control. If &ldquo;golden parachute&rdquo; excise taxes would be
triggered by payments due in connection with a change in control, the agreements for Mr. Darling and Ms. Cheung provide for a cut-back
in the payments to avoid the excise tax, if the cut-back would result in a greater after-tax benefit to the executive. Dr. Sherwood&rsquo;s
agreement, which was entered into in 2008, instead provides for a gross-up payment in case such &ldquo;golden parachute&rdquo;
excise taxes are triggered in connection with a change in control, but caps any such excise tax payment at $500,000.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The following summarizes the severance benefits provided under the
employment agreements:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="2" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom; background-color: #365F91">
    <TD STYLE="width: 20%; border: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: white"><B>Trigger</B></FONT></TD>
    <TD STYLE="width: 14%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: white"><B>Type of Severance</B></FONT></TD>
    <TD STYLE="width: 21%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: white"><B>Dr. Sherwood</B></FONT></TD>
    <TD STYLE="width: 21%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: white"><B>Ms. Cheung</B></FONT></TD>
    <TD STYLE="width: 24%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: white"><B>Mr. Darling</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid">
        <P STYLE="font-size: 10pt; margin: 0pt 0 0pt 4.5pt">Termination without cause or with good reason, not in</P>
        <P STYLE="font-size: 10pt; margin: 0pt 0 0pt 4.5pt">connection with a change</P>
        <P STYLE="font-size: 10pt; margin: 0pt 0 0pt 4.5pt">in control</P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt">Cash severance</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt">1.5x salary plus target bonus</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt">12 months of salary</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt">1.5x salary</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt">Health benefits</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt">18 months at active employee rates</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt">12 months at active employee rates</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt">12 months at active employee rates</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-left: 4.5pt"><FONT STYLE="font-size: 10pt">Termination without cause or with good reason, within 3 months before or 12 months after a change in control</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt">Cash severance</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt">2x salary plus target bonus</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt">1.5x salary plus target bonus </FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt">2x salary plus target bonus</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt">Health benefits</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt">24 months at active employee rates</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt">18 months at active employee rates</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt">18 months at active employee rates</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">According to the terms of Dr. Sherwood&rsquo;s equity award
agreements, if Dr. Sherwood&rsquo;s employment terminates due to the acceptance by the Board of Directors of his retirement
in good standing on or after the date on which Dr. Sherwood has reached the age of 63, on such date of retirement the vesting
of all of Dr. Sherwood&rsquo;s outstanding equity awards will automatically accelerate and shall become fully exercisable.
This treatment applied in connection with his retirement on March 9, 2018. According to the terms of Mr. Darling&rsquo;s
employment agreement, if Mr. Darling&rsquo;s employment is terminated without &ldquo;cause&rdquo; or Mr. Darling terminates
his employment with us for &ldquo;good reason,&rdquo; his initial, new-hire grant of restricted award shall vest and become
non-forfeitable with respect to the shares eligible to vest as of the next applicable vesting date after the date of
termination. Mr. Darling&rsquo;s employment agreement was amended on March 9, 2018 to provide that in the event of
termination by us without &ldquo;cause&rdquo; or by him for &ldquo;good reason&rdquo; in connection with a change in control,
Mr. Darling would be due two times the sum of his then-current base salary and target bonus amount. Prior to this amendment,
Mr. Darling would have been due one and a half times the sum of his then-current base salary and target bonus amount under
the same circumstances.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><I><U>Deductibility of Executive Compensation</U>.</I> Internal
Revenue Code Section 162(m) limits the deductibility of compensation in excess of $1 million paid to any one named executive officer
in any calendar year. Under the tax rules in effect before 2018, compensation that qualified as &ldquo;performance-based&rdquo;
under Section 162(m) was deductible without regard to this $1 million limit. In 2017 and prior years, the Compensation Committee
granted stock options under our equity incentive plans that were intended to qualify for this performance-based compensation exception.
However, the Tax Cuts and Jobs Act, which was signed into law December 22, 2017, eliminated this performance-based compensation
exception effective January 1, 2018, subject to a special rule that &ldquo;grandfathers&rdquo; certain awards and arrangements
that were in effect on or before November 2, 2017. As a result, compensation that is paid on or after January 1, 2018 may not be
fully deductible, depending on the application of the special grandfather rules. Moreover, from and after January 1, 2018, compensation
awarded in excess of $1 million to our named executive officers generally will not be deductible. While the Tax Cuts and Jobs Act
will limit the deductibility of compensation paid to the named executive officers, the Compensation Committee will&mdash;consistent
with its past practice&mdash;design compensation programs that are intended to be in the best long-term interests of Sealed Air
and our stockholders, with deductibility of compensation being one of a variety of considerations taken into account.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><I><U>Role of Management in Determining Compensation</U></I>. The
Compensation Committee, comprised entirely of independent members of our board of directors, is responsible for establishing and
implementing our executive compensation philosophy and for ensuring that the total compensation paid to our named executive officers
and other executives is fair, competitive and motivates high performance. The Compensation Committee is solely responsible for
compensation decisions regarding our CEO. When making compensation recommendations for NEOs other than the CEO, the Compensation
Committee expects to seek and consider the advice and counsel of the CEO, given his direct day-to-day working relationship with
those executives. Taking this feedback into consideration, the Compensation Committee will engage in discussions and makes final
determinations related to compensation paid to the named executive officers.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><I><U>Risk Considerations in Our Compensation Programs</U></I>.
The Compensation Committee believes that risks arising from our policies and practices for compensating employees are not reasonably
likely to have a material adverse effect on our company.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; color: #365F91"><B><I></I></B></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0; color: #365F91"><B><I>&nbsp;</I></B></P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 14pt">COMPENSATION
COMMITTEE REPORT</FONT></P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Compensation Committee of the Board of Directors of Anika Therapeutics,&nbsp;Inc.
has reviewed and discussed with the management of Anika Therapeutics, Inc. the section entitled &ldquo;Compensation Discussion
and Analysis&rdquo; contained in this Proxy Statement. Based on its review and discussions with management, the Compensation Committee
recommended to the Board that the section entitled &ldquo;Compensation Discussion and Analysis&rdquo; be included in this Proxy
Statement for the 2018 Annual Meeting of Stockholders. This report is submitted by the following independent directors who comprise
the Compensation Committee:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 31%">&nbsp;Joseph L. Bower, Chairperson</TD>
    <TD STYLE="width: 23%">Glenn R. Larsen, Ph.D.</TD>
    <TD STYLE="width: 23%">Jeffery S. Thompson</TD>
    <TD STYLE="width: 23%">Steven E. Wheeler</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><B>THE FOREGOING REPORT SHOULD NOT BE DEEMED INCORPORATED BY REFERENCE
INTO ANY FILING UNDER THE SECURITIES ACT OF&nbsp;1933 OR UNDER THE SECURITIES EXCHANGE ACT OF&nbsp;1934 BY ANY GENERAL STATEMENT
INCORPORATING BY REFERENCE THIS PROXY STATEMENT, EXCEPT TO THE EXTENT THAT ANIKA THERAPEUTICS, INC. SPECIFICALLY INCORPORATES THIS
INFORMATION BY REFERENCE, AND SHALL NOT OTHERWISE BE DEEMED FILED UNDER SUCH ACTS.</B></P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0"></P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0"></P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 14pt">EXECUTIVE
COMPENSATION</FONT></P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Summary Compensation Table</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">The following table summarizes the compensation information in respect
of our NEOs for the year ended December&nbsp;31, 2017.</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP COLSPAN="27" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Summary Compensation Table</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP COLSPAN="27" STYLE="font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Name and Principal Position</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Year</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">&nbsp;Salary <SUP>(1)&nbsp;</SUP></TD><TD STYLE="font-size: 10pt; font-weight: bold; font-style: normal; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.1pt solid">Bonus <FONT STYLE="font-size: 10pt; font-style: normal"><B><SUP>(2)</SUP></B></FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">&nbsp;Option <BR> Awards <SUP>(3)&nbsp;</SUP></TD><TD STYLE="font-size: 10pt; font-weight: bold; font-style: normal; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.1pt solid">Stock Awards <FONT STYLE="font-size: 10pt; font-style: normal"><B><SUP>(3)</SUP></B></FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; font-style: normal; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.1pt solid">All Other <BR> Compensation <FONT STYLE="font-size: 10pt; font-style: normal"><B><SUP>(4)</SUP></B></FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Total</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="width: 39%; font-size: 10pt; font-weight: normal; font-style: normal; text-align: left">Charles H. Sherwood, Ph.D. <FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal"><SUP>(5)</SUP></FONT></TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 6%; font-size: 10pt; text-align: center">2017</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right">622,641</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right">466,981</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right">2,960,954</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right">-</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right">187,037</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;<SUP>(9)</SUP></FONT></TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right">4,237,612</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left">Chief Executive Officer</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">2016</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">601,586</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">496,308</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">1,519,778</TD><TD STYLE="font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">861,286</TD><TD STYLE="font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">52,060</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;<SUP>(9)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">3,531,018</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">2015</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">581,242</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">508,587</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">864,043</TD><TD STYLE="font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">535,815</TD><TD STYLE="font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">52,118</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;<SUP>(9)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">2,541,805</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left">Sylvia Cheung</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">2017</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">359,085</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">185,827</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">709,054</TD><TD STYLE="font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">18,720</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>&nbsp;</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">1,272,686</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left">Chief Financial Officer</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">2016</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">346,942</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">171,736</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">439,830</TD><TD STYLE="font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">301,069</TD><TD STYLE="font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">18,720</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>&nbsp;</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">1,278,297</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">2015</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">335,210</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">188,556</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">289,996</TD><TD STYLE="font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">264,931</TD><TD STYLE="font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">18,720</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>&nbsp;</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">1,097,413</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; font-weight: normal; font-style: normal; text-align: left">Joseph G. Darling <FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal"><SUP>(6)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">2017</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">181,987</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">93,990</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">750,281</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;<SUP>(7)</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">749,960</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;<SUP>(7)</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">5,993</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;<SUP>(10)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">1,782,212</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt">President</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>&nbsp;</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left">Ed Ahn, Ph.D.</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">2017</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">347,243</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">125,007</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">599,331</TD><TD STYLE="font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">19,080</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>&nbsp;</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">1,090,662</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left">Chief Technology and</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">2016</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">315,675</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">156,259</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">439,830</TD><TD STYLE="font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">301,069</TD><TD STYLE="font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">18,720</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>&nbsp;</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">1,231,553</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left">Strategy Officer</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">2015</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">305,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">137,250</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">43,953</TD><TD STYLE="font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">18,720</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>&nbsp;</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">504,923</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left">Richard Hague</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">2017</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">326,025</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">102,698</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">599,331</TD><TD STYLE="font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">27,096</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>&nbsp;</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">1,055,150</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left">Chief Commerical Officer</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">2016</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">315,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">127,575</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">439,830</TD><TD STYLE="font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">301,069</TD><TD STYLE="font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">84,799</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;<SUP>(11)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">1,268,273</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">2015</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">48,462</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">727,650</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;<SUP>(8)</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">24,831</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;<SUP>(11)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">800,943</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: justify">(1)</TD>
    <TD STYLE="width: 95%; text-align: justify">The amounts in this column represent the annual base salary approved for the executive by the Board of Directors prorated based on employment dates during the indicated year.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">(2)</TD>
    <TD STYLE="text-align: justify">The amounts in this column represent discretionary cash bonuses earned in the indicated year, but paid in January or February of the following year.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">(3)</TD>
    <TD STYLE="text-align: justify">The amounts in this column reflect the grant date fair value computed with respect to the equity awards issued during the indicated year in accordance with ASC Topic 718. See the information appearing in Note 12 to our consolidated financial statements included as part of our Annual Report on Form 10-K for the year ended December 31, 2017 for certain assumptions made in the valuation of stock and option awards. The Board granted equity awards on January 27, 2017, February 4, 2016, and February 3, 2015, respectively. Awards granted in 2017 vest ratably over 3 years beginning one year from the date of grant, while awards granted in 2016 and 2015 vest ratably over 4 years beginning one year from the date of grant. For 2017 performance-based stock options, the fair value on the date of grant was determined at the &ldquo;target&rdquo; or 100% attainment level. If the fair value of these performance-based stock options had been determined at the &ldquo;maximum&rdquo; or 125% attainment level, the awards would have been valued at $843,825 for Dr. Sherwood and $234,838 for Ms. Cheung, Dr. Ahn, and Mr. Hague. These values would represent incremental increases over the amounts set forth in this column of $168,765 and $46,968, respectively. Please see the table in the section captioned &ldquo;Option Grants and Plan Awards in 2017&rdquo; for additional information.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">(4)</TD>
    <TD STYLE="text-align: justify">Unless otherwise noted, these amounts constitute group term life insurance premiums and matching contributions to our Employee Savings and Retirement Plan (401(k) plan). For 2017, 401(k) plan matching contributions equaled $24,000 for Dr. Sherwood, $18,000 for Ms. Cheung, $18,000 for Dr. Ahn, and $24,000 for Mr. Hague.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">(5)</TD>
    <TD STYLE="text-align: justify">As noted elsewhere in this proxy statement, Dr. Sherwood retired from his roles as our Chief Executive Officer and as a director of our company effective March 9, 2018.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">(6)</TD>
    <TD STYLE="text-align: justify">Mr. Darling was hired as our President on July 27, 2017. On March 9, 2018, Mr. Darling was appointed as our President and Chief Executive Officer, and he became one of our directors.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">(7)</TD>
    <TD STYLE="text-align: justify">Upon the commencement of Mr. Darling&rsquo;s employment with the company, his employment agreement provided for two new hire equity grants with a total grant date value of $1,500,000, provided 50% as stock options and 50% as shares of restricted stock, each vesting annually over three years following grant.&nbsp;&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">(8)</TD>
    <TD STYLE="text-align: justify">Mr. Hague&rsquo;s employment as our Chief Commercial Officer began on October 26, 2015. A restricted stock award of 21,000 shares was granted in connection with the commencement of Mr. Hague&rsquo;s employment.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">(9)</TD>
    <TD STYLE="text-align: justify">These amounts include reimbursement of life insurance premiums of $15,092, $15,114, and $15,413 in 2017, 2016, and 2015, respectively. In addition, the 2017 amount includes $69,615 related to the taxable benefit received from, and $61,859 from the tax gross-up payment associated with, certain travel of Dr. Sherwood&rsquo;s spouse, which was approved by our Board of Directors. </TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 5%">(10)</TD>
    <TD STYLE="text-align: justify; width: 95%">This amount includes $3,982 of relocation expense provided to Mr. Darling in 2017 in accordance with the terms of the Employment Agreement we entered with Mr. Darling on July 27, 2017. </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">(11)</TD>
    <TD STYLE="text-align: justify">This amount includes $57,611 and $22,416 of relocation expense reimbursement provided to Mr. Hague in 2016 and 2015, respectively, in accordance with the terms of the Offer Letter we entered into with Mr. Hague prior to the commencement of his employment.</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Option Grants and Plan Awards in 2017</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><FONT STYLE="background-color: white">The following table sets forth
each grant of equity awards made to the NEOs during the year ended December 31, 2017. All such equity awards vest over a three-year
period commencing on the first anniversary of the grant date, except for performance-based equity awards which vest over a three-year
period with the first vesting date occurring on the performance measurement date and the next two vesting dates occurring on January
1 of each subsequent calendar year following the calendar year in which the performance measurement date occurs.</FONT></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="11" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Estimated future payouts under <BR>
equity incentive plan awards</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Stock <BR> Awards:&nbsp;&nbsp;<BR> Number of <BR> shares of <BR> stock or</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">All Other <BR> Option Awards: <BR> Number of <BR> shares <BR> underlying</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Exercise <BR> Price or <BR> Base of <BR> Equity</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Grant Date <BR> Fair Value <BR> of</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid">Name</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Grant Date</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Threshold</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Target</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Maximum</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">units</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">awards</TD><TD STYLE="font-size: 10pt; font-weight: bold; font-style: normal; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.1pt solid">Awards <FONT STYLE="font-size: 10pt; font-style: normal"><B><SUP>(1)</sup></b></font></TD><TD STYLE="font-size: 10pt; font-weight: bold; font-style: normal; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.1pt solid">Awards <FONT STYLE="font-size: 10pt; font-style: normal"><B><SUP>(2)</sup></b></font></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="width: 22%; font-size: 10pt; text-align: left">Charles H. Sherwood, Ph.D.</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 14%; font-size: 10pt; text-align: center">January 27, 2017</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right">5,088</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right">50,880</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right">63,600</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;<SUP>(4)</SUP></TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right">-</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right">-</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right">50.13</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right">675,060</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">January 27, 2017</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">125,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">50.13</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">2,285,894</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left">Sylvia Cheung</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">January 27, 2017</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,416</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">14,160</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">17,700</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;<SUP>(4)</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">50.13</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">187,870</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">January 27, 2017</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">28,500</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">50.13</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">521,184</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; font-weight: normal; font-style: normal; text-align: left">Joseph Darling <FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal"><SUP>(3)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">July 27, 2017</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">14,506</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">51.70</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">749,960</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">July 27, 2017</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">41,609</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">51.70</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">750,281</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left">Ed Ahn, Ph.D.</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">January 27, 2017</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,416</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">14,160</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">17,700</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;<SUP>(4)</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">50.13</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">187,870</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">January 27, 2017</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">22,500</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">50.13</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">411,461</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left">Richard Hague</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">January 27, 2017</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,416</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">14,160</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">17,700</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;<SUP>(4)</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">50.13</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">187,870</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">January 27, 2017</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">22,500</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">50.13</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">411,461</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="color: black">(1)</FONT></TD>
    <TD STYLE="width: 95%; text-align: justify"><FONT STYLE="color: black">The exercise price of each award equals the grant date closing stock price, as reported on the NASDAQ stock exchange.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="color: black">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: black">This column represents the full grant date fair value of stock options and restricted stock under ASC 718 granted to each of the NEOs in the fiscal year ended December 31, 2017. Generally, the full grant date fair value is the amount that we will expense in our financial statements over the award&rsquo;s vesting period.&nbsp;For restricted stock, fair value was calculated using the closing price of our common stock on the grant date. For stock options and performance-based stock options, fair value was calculated using the Black-Scholes value on the grant date.&nbsp;See the information appearing in Note 12 to our consolidated financial statements included as part of our Annual Report on Form 10-K for the year ended December 31, 2017 for certain assumptions made in the valuation of these awards.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="color: black">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: black">Upon the commencement of Mr. Darling&rsquo;s employment with the company on July 27, 2017, his employment agreement provided for two new hire equity grants with a total grant date value of $1,500,000, provided 50% as stock options and 50% as shares of restricted stock, each vesting annually over three years following grant.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="color: black">(4)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: black">These amounts represent performance-based stock option awards granted by our Board of Directors on January 27, 2017. The &ldquo;Threshold&rdquo; is equal to 10% of the target, and the &ldquo;Maximum&rdquo; is equal to 125% of the target. On March 2, 2018, the Compensation Committee of our Board determined and certified that 55% of the stock options had been earned in accordance with the performance measures set forth for these awards. </FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Outstanding Equity Awards at December&nbsp;31,
2017</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The following table provides information on the holdings of outstanding
stock options and unvested stock awards held by the NEOs as of December&nbsp;31, 2017.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="16" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid; border-top: Black 1pt solid"><FONT STYLE="font-size: 9pt">Option
    Awards</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt; border-top: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="16" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid; border-top: Black 1pt solid"><FONT STYLE="font-size: 9pt">Stock
    Awards</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD NOWRAP STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><FONT STYLE="font-size: 9pt">Equity
    Incentive Plan Awards</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Number
    of</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Number
    of</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Option</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Option</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Number</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Market</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Number
    of</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Market
    or Payout</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Securities</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Securities</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Exercise</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Expiration</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">of</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Value of</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Unearned
    and</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Value of
    Unearned</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Underlying</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Underlying</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Price</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Date</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Unvested</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Unvested</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Unvested
    Shares,</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">and Unvested</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Exercisable</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Unexercisable</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Shares
    or</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Shares
    or</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Units,
    or Other</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Shares,
    Units,</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid"><FONT STYLE="font-size: 9pt">Name</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;Options
    <SUP>(1)&nbsp;</SUP></FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;Options
    <SUP>(1)</SUP>&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><FONT STYLE="font-size: 9pt">&nbsp;Units
    of Stock <SUP>(1)</SUP>&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><FONT STYLE="font-size: 9pt">Units
    of Stock</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><FONT STYLE="font-size: 9pt">Rights</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><FONT STYLE="font-size: 9pt">or
    Other Rights</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="width: 24%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Charles H. Sherwood, Ph.D.</FONT></TD><TD STYLE="width: 1%; font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">152,984</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;<SUP>(*)(3)</SUP></FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">50.13</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1/27/2027</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 5%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 5%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">25,719</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">77,156</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">38.11</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">2/4/2026</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">16,950</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">913,775</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">26,550</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">26,550</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">39.69</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">2/3/2025</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">6,750</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">363,893</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">38,700</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">12,900</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">32.02</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1/27/2024</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">3,875</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">208,901</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">100,000</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">10.87</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1/29/2023</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">75,000</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;<SUP>(*)</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">6.99</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">6/7/2021</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">95,000</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">6.98</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1/18/2021</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt"><FONT STYLE="font-size: 9pt">Total</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">360,969</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">269,590</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">27,575</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1,486,568</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Sylvia Cheung</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">36,288</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;<SUP>(*)(4)</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">50.13</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1/27/2027</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">7,450</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">22,350</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">38.11</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">2/4/2026</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">5,925</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">319,417</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">8,512</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">8,512</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">39.69</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">2/3/2025</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">3,337</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">179,898</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">13,800</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">4,600</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">32.02</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1/27/2024</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1,525</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">82,213</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">45,000</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">10.87</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1/29/2023</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">15,000</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">9.10</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1/25/2022</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">20,000</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;<SUP>(*)</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">6.99</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">6/7/2021</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">25,000</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">6.98</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1/18/2021</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">35,000</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">6.36</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1/26/2020</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt"><FONT STYLE="font-size: 9pt">Total</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">169,762</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">71,750</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">10,787</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">581,527</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">Joesph G. Darling</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">41,609</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;<SUP>(*)(5)</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">51.70</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">7/27/2027</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">14,506</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;<SUP>(*)(5)</SUP></FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">782,018</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt"><FONT STYLE="font-size: 9pt">Total</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">41,609</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">14,506</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">782,018</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Ed Ahn, Ph.D.</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">30,288</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;<SUP>(*)(4)</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">50.13</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1/27/2027</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">7,450</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">22,350</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">38.11</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">2/4/2026</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">5,925</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">319,417</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1,663</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1,662</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">39.69</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">2/3/2025</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">30,000</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">10,000</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">41.15</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">10/30/2024</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt"><FONT STYLE="font-size: 9pt">Total</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">39,113</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">64,300</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">5,925</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">319,417</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Richard Hague</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">30,288</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;<SUP>(*)(4)</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">50.13</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1/27/2027</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">7,450</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">22,350</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">38.11</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">2/4/2026</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">5,925</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">319,417</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: right; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">10,500</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">566,055</FONT></TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="padding-bottom: 1.1pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt"><FONT STYLE="font-size: 9pt">Total</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">7,450</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">52,638</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">16,425</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">885,472</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
</TABLE>



<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%">(1)</TD>
    <TD STYLE="width: 96%; text-align: justify">Vesting of equity awards commences on the first anniversary of the grant date and continues on each subsequent grant date anniversary until the equity award is fully vested, except as otherwise noted below. Except for those equity awards noted by an asterisk (*), which are subject to a three year vesting period, all equity awards are subject to a four year vesting period, in each case subject to the holder&rsquo;s continued employment with us. The expiration date of each equity award is ten years after its grant date.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>(2)</TD>
    <TD STYLE="text-align: justify">Based on the closing price of our common stock on the NASDAQ stock exchange on December 31, 2017 ($53.91) per share.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>(3)</TD>
    <TD STYLE="text-align: justify">This includes 27,984 performance-based stock options earned in connection with 55% achievement of the performance measures associated with such awards, which vest ratably over a three-year period with the first vesting date occurring on March 2, 2018 and the next two vesting dates occurring on January 1 of each subsequent calendar year.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>(4)</TD>
    <TD STYLE="text-align: justify">This includes 7,788 performance-based stock options earned in connection with 55% achievement of the performance measures associated with such awards, which vest ratably over a three-year period with the first vesting date occurring on March 2, 2018 and the next two vesting dates occurring on January 1 of each subsequent calendar year.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>(5)</TD>
    <TD STYLE="text-align: justify">Upon the commencement of Mr. Darling&rsquo;s employment with the company on July 27, 2017, his employment agreement provided for two new hire equity grants with a total grant date value of $1,500,000, provided 50% as stock options and 50% as shares of restricted stock, each vesting annually over three years following grant.</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><I></I></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">2017 Equity Award Exercises and Stock
Vested</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The following table provides information regarding options and SAR&rsquo;s
exercised and stock awards vested for the NEOs during the year ended December&nbsp;31, 2017.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 85%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Option and SAR's Awards</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Stock Awards</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Name</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number of <BR> Shares <BR> Acquired on <BR> Exercise</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Value <BR> Realized on <BR> Exercise</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number of <BR> Shares <BR> Acquired on <BR> Vesting</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Value <BR> Realized on <BR> Vesting</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="width: 48%; font-size: 10pt; text-align: left">&nbsp;Charles H. Sherwood, Ph.D.</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">-</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">-</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">12,900</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">648,663</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;Sylvia Cheung</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">8,883</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">254,271</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5,169</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">259,924</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;Edward Ahn</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,975</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">99,441</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;Richard Hague</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">7,225</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">400,371</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Potential Payments Upon Termination
or Change in Control</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Our Chief Executive Officer, our Chief Financial Officer, and our
President have certain termination or change in control benefits described in the Compensation Discussion and Analysis sections
captioned &ldquo;Other Compensation Matters &ndash; <I>Employment Agreements</I>.&rdquo; The following table provides estimates
of the potential payments and other post-termination benefits these individuals would receive assuming a change in control occurred
and/or their employment was terminated as of December 31, 2017:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 95%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Termination <BR> Without Cause</TD><TD STYLE="font-size: 10pt; font-weight: bold; font-style: normal; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.1pt solid">Termination Upon <BR> Change in <BR> Control <FONT STYLE="font-size: 10pt; font-style: normal"><B><SUP>(1)(2)</SUP></B></FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; font-style: normal; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.1pt solid">Change in <BR> Control Without <BR> Termination or <BR> Death or <BR> Disability <FONT STYLE="font-size: 10pt; font-style: normal"><B><SUP>(1)</SUP></B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="width: 24%; font-size: 10pt; text-align: left">Charles H. Sherwood, Ph.D.</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 35%; font-size: 10pt; text-align: left">Salary Continuation</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">933,962</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">1,245,282</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">-</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">Additional Cash Payment</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">700,471</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">933,962</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">Equity Awards Vesting</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6,352,725</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6,352,725</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Health Care Benefits</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">24,187</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">32,250</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,658,620</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">8,564,219</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">6,352,725</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left">Sylvia Cheung</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">Salary Continuation</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">359,085</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">781,010</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">Additional Cash Payment</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">351,454</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">Equity Awards Vesting</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,281,571</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,281,571</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Health Care Benefits</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">14,802</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">22,204</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">373,887</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,436,239</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,281,571</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left">Joseph G. Darling<SUP>(3)</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">Salary Continuation</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">637,500</TD><TD STYLE="font-size: 10pt; text-align: left; vertical-align: top"><FONT STYLE="font-size: 7pt"><SUP>&nbsp;</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">956,250</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">Additional Cash Payment</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">478,125</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">Equity Awards Vesting</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">260,655</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">873,974</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">873,974</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Health Care Benefits</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">16,125</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">24,187</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">914,280</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,332,537</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">873,974</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%"><FONT STYLE="color: black">(1)</FONT></TD>
    <TD STYLE="width: 96%; text-align: justify"><FONT STYLE="color: black">The indicated values for the accelerated vesting of stock options reflect the number of equity award shares that would vest on an accelerated basis, multiplied by the excess, if any, of the $53.91 closing price for our common stock as reported by NASDAQ on December&nbsp;31, 2017 over the applicable exercise price for each option or SAR. This calculation assumes equity awards with an exercise price higher than the closing price of our common stock on December 31, 2017 will not be exercised.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="color: black">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: black">According to the terms of the Employment Agreement with our Chief Executive Officer, in the event Dr. Sherwood becomes subject to the excise taxes imposed by Section 4999 of the Code, he would be entitled to a gross-up payment of up to $500,000. As a result of Dr. Sherwood&rsquo;s retirement on March 9, 2018, the provisions regarding potential gross-up payments upon a change in control are no longer applicable. According to the terms of the Employment Agreements with our Chief Financial Officer and our President, all payments otherwise due to Ms. Cheung or Mr. Darling would be subject to a modified economic cutback.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="color: black">(3)</FONT></TD>
    <TD>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">According to the terms of Mr. Darling&rsquo;s
        employment agreement, if Mr. Darling&rsquo;s employment is terminated without &ldquo;cause&rdquo; or Mr. Darling terminates
        his employment with us for &ldquo;good reason&rdquo; (each as defined in the employment agreement), his initial, new-hire
        grant of restricted award shall vest and become non-forfeitable with respect to the shares eligible to vest as of the next
        applicable vesting date after the date of termination. Mr. Darling&rsquo;s employment agreement was amended on March 9, 2018
        to provide that in the event of termination by us without &ldquo;cause&rdquo; or by him for &ldquo;good reason&rdquo; in
        connection with a change in control, Mr. Darling would be due two times the sum of his then-current base salary and target
        bonus amount. Prior to this amendment, Mr. Darling would have been due one and a half times the sum of his then-current base
        salary and target bonus amount under the same circumstances.</P></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">CEO Pay Ratio</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">As required by applicable SEC rules, we are providing the following
information about the relationship of the annual total compensation of our employees and the annual total compensation of Dr. Sherwood,
our year-end Chief Executive Officer or CEO.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">For 2017, our last completed fiscal year:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the median of the annual total compensation of all our employees (other than our CEO) was $83,351;
and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the annual total compensation of our CEO, as reported in the Summary Compensation Table included
elsewhere in this Proxy Statement, was $4,237,613.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Based on this information, for 2017 the ratio of the annual total
compensation of Dr. Sherwood, our year-end Chief Executive Officer, to the median of the annual total compensation of all our employees
was 51 to 1.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">We took the following steps to identify the median of the annual
total compensation of all our employees, as well as to determine the annual total compensation of our median employee and our CEO.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="font-size: 10pt; vertical-align: top; text-align: left; width: 5%">1.</TD>
    <TD STYLE="font-size: 10pt; vertical-align: middle; text-align: justify; width: 95%">We determined that, as of December 31, 2017, our employee population consisted of 123 individuals. This population consisted of our full-time, part-time, and temporary employees employed with us as of the determination date.<FONT STYLE="font-size: 10pt; font-style: normal"><B>&nbsp;</B></FONT></TD></TR>
<TR>
    <TD STYLE="font-size: 10pt; vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; vertical-align: middle; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="font-size: 10pt; vertical-align: top; text-align: left">2.</TD>
    <TD STYLE="font-size: 10pt; vertical-align: middle; text-align: justify">To identify the &ldquo;median employee&rdquo; from our employee population, we aggregated for each applicable employee, other than our CEO, (a) annual base salary (or hourly rate multiplied by estimated work schedule, for hourly employees), (b) the bonus amount earned for 2017, which was paid out in early 2018, and (c) the grant date fair value of equity granted in 2017. Once aggregated, we ranked this compensation measure for our employees from lowest to highest and selected the median employee.</TD></TR>
<TR>
    <TD STYLE="font-size: 10pt; vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; vertical-align: middle; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="font-size: 10pt; vertical-align: top; text-align: left">3.</TD>
    <TD STYLE="font-size: 10pt; vertical-align: middle; text-align: justify">For the annual total compensation of our median employee, we identified and calculated the elements of that employee&rsquo;s compensation for 2017 in accordance with the requirements of Item 402(c)(2)(x), resulting in annual total compensation of $83,351.<FONT STYLE="font-size: 10pt; font-style: normal"><B>&nbsp;</B></FONT></TD></TR>
<TR>
    <TD STYLE="font-size: 10pt; vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; vertical-align: middle; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="font-size: 10pt; vertical-align: top; text-align: left">4.</TD>
    <TD STYLE="font-size: 10pt; vertical-align: middle; text-align: justify">For the annual total compensation of our CEO, we used the amount reported in the &ldquo;Total&rdquo; column of our 2017 Summary Compensation Table included in this Proxy Statement.&nbsp;</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The pay ratio reported above is a reasonable estimate calculated
in a manner consistent with SEC rules based on our internal records and the methodology described above. The SEC rules for identifying
the median-compensated employee and calculating the pay ratio based on that employee&rsquo;s annual total compensation allow companies
to adopt a variety of methodologies, to apply certain exclusions, and to make reasonable estimates and assumptions that reflect
their employee populations and compensation practices. Therefore, the pay ratio reported by other companies may not be comparable
to the pay ratio reported above, as other companies have different employee populations and compensation practices and may utilize
different methodologies, exclusions, estimates and assumptions in calculating their own pay ratios.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Director Compensation</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><I>Cash Compensation.</I> For 2017, each of our non-employee directors
was entitled to annual retainers per the following schedule, with such amounts to be prorated based on the actual number of days
served if a director&rsquo;s service to us ended prior to the end of 2017:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 80%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 61%; border-bottom: Black 1pt solid"><B>Compensation Element</B></TD>
    <TD STYLE="width: 39%; border-bottom: Black 1pt solid; text-align: center"><B>2017 Cash Compensation</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><B>Board of Directors</B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Lead Director Retainer</TD>
    <TD STYLE="text-align: center">$65,000</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">Other Directors Retainer</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">$40,000</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><B>Audit Committee</B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Committee Chairperson Retainer</TD>
    <TD STYLE="text-align: center">$20,000</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">Other Committee Members Retainer</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">$10,000</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><B>Compensation Committee</B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Committee Chairperson Retainer</TD>
    <TD STYLE="text-align: center">$14,000</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">Other Committee Members Retainer</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">$7,000</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><B>Governance and Nominating Committee</B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Committee Chairperson Retainer</TD>
    <TD STYLE="text-align: center">$10,000</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Other Committee Members Retainer</TD>
    <TD STYLE="text-align: center">$5,000</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><I>Equity Compensation.</I> The Board of Directors approved a grant
of 1,994 restricted stock units to each non-employee director, valued at $99,959 under our equity compensation plan, based on the
fair market value of our common stock on January 27, 2017, the date of grant for the existing directors. The restricted stock units
granted to each non-employee director in 2017 vested in one installment one year from the date of grant. Each non-employee director
is eligible for an annual equity award grant with a value and vesting provisions as may be determined by the Board based on their
review of our compensation policies and general compensation trends.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The following table summarizes the compensation we paid to non-employee
directors for 2017.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 95%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Aggregate Number of Shares <BR> Outstanding</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid">Name</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Fees Earned or <BR> Paid in Cash ($)</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">&nbsp;Stock Awards ($) <SUP>(1)&nbsp;</SUP>&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Option Awards ($)</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Total ($)</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Options</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Restricted <BR> Stock Units</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="width: 30%; font-size: 10pt; text-align: left">&nbsp;Joseph L. Bower</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">89,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">99,959</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; font-size: 10pt; text-align: right">-</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; font-size: 10pt; text-align: right">188,959</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; font-size: 10pt; text-align: right">-</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; font-size: 10pt; text-align: right">3,217</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;Raymond J. Land</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">65,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">99,959</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">164,959</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,217</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;Glenn R. Larsen, Ph.D.</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">52,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">99,959</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">151,959</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,994</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left; background-color: white">&nbsp;Jeffery S. Thompson</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">57,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">99,959</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: white">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: white">156,959</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: white">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,217</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;Steven E. Wheeler</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">57,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">99,959</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">156,959</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,217</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B></B>&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%"><FONT STYLE="color: black">(1)</FONT></TD>
    <TD STYLE="width: 97%; text-align: justify"><FONT STYLE="color: black">An amount of 1,994 restricted stock units were awarded per director on January 27, 2017, based on the closing price of $50.13 per share, and which vest in their totality on January 27, 2018. The amounts in this column reflect the grant date fair value computed with respect to the restricted stock units, made during the indicated year in accordance with ASC Topic 718. See the information appearing in Note 12 to our consolidated financial statements included as part of our Annual Report on Form 10-K for the year ended December 31, 2017 for certain assumptions made in the valuation of these restricted stock unit awards.</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Director and Executive Officer Stock
Retention Guidelines</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Effective October 6, 2015, the Board of Directors adopted stock
retention guidelines that generally require each of our directors and executive officers to beneficially own certain amounts of
our common stock. We believe that ownership of shares of common stock by directors and executive officers helps align the financial
interests of these individuals with the interests of stockholders, promotes sound corporate governance, and evidences a commitment
to our company. These stock retention guidelines supersede the director stock retention guidelines previously adopted by the Board
on April 22, 2015. Generally, these guidelines require each director to beneficially own, at a minimum, either (a) 3,000 outstanding
shares of common stock or (b) a number of shares (or vested share equivalents) of common stock having a market value equal to three
times the amount of our annual board retainer for the non-lead or non-chairman directors.&nbsp;The minimum shareholding requirement
became effective immediately, except that any director initially elected after January 1, 2015 has three years from the date of
their election to achieve compliance.&nbsp;Compliance by each director will be reviewed annually by the Board&rsquo;s Governance
and Nominating Committee, which is authorized to approve exceptions upon a showing of serious hardship.&nbsp;A non-complying director
must retain at least 75% of the shares (net of shares sold or offset to pay the exercise price and taxes) he or she subsequently
acquires through exercise of equity grants, until he or she complies with the guidelines.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Generally, these guidelines require the Chief Executive Officer
to beneficially own, at a minimum, either (a) 50,000 outstanding shares of common stock or (b) a number of shares (or vested share
equivalents) of common stock having a market value equal to three times the amount of his or her base salary and they require any
other executive officer to beneficially own, at a minimum, either (a) 10,000 outstanding shares of common stock or (b) a number
of shares (or vested share equivalents) of common stock having a market value equal to the amount of his or her base salary.&nbsp;The
minimum shareholding requirement became effective immediately, except that any individual initially elected as an executive officer
after September 30, 2014 has five years to achieve compliance.&nbsp;Compliance by each executive officer will be reviewed annually
by the Board&rsquo;s Governance and Nominating Committee, which is authorized to approve exceptions upon a showing of serious hardship.&nbsp;A
non-complying executive officer must retain at least 75% of the shares (net of shares sold or offset to pay the exercise price
and taxes) he or she subsequently acquires through exercise of equity grants, until he or she complies with the guidelines.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Compensation Committee Interlocks
and Insider Participation</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Compensation Committee as of December 31, 2017 consisted of
Dr. Bower, Dr. Larsen, Mr. Thompson, and Mr.&nbsp;Wheeler. None of these individuals is or formerly was an officer or employee
of our company, nor have they engaged in any transactions involving our company that would require disclosure as a transaction
with a related person. There are no Compensation Committee interlocks between our company and any other entity involving our or
such entity&rsquo;s executive officers or board members.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">During the fiscal year ended December&nbsp;31, 2017, none of our
executive officers served as: (1)&nbsp;a member of the Compensation Committee (or other committee of the Board of Directors performing
equivalent functions or, in the absence of any such committee, the entire Board) of another entity, one of whose executive officers
served on the Compensation Committee; (2)&nbsp;a director of another entity, one of whose executive officers served on the Compensation
Committee; or (3)&nbsp;a member of the compensation committee (or other committee of the Board performing equivalent functions
or, in the absence of any such committee, the entire Board) of another entity, one of whose executive officers served as a director
on the Board.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Equity Compensation Plan Information</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The following table sets forth information concerning the Company&rsquo;s
equity compensation plan as of December 31, 2017.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD NOWRAP COLSPAN="13" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Equity Compensation Plan Information</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Plan category</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">&nbsp;Number of securities to be issued upon <BR> exercise of outstanding options, stock <BR> appreciation rights, performance <BR> shares and restricted stock units <SUP>(1)&nbsp;</SUP></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Weighted Average exercise price <BR> of outstanding options, stock <BR> appreciation rights, and <BR> performance shares</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Number of securities remaining <BR> available for future issuance under <BR> equity compensation plans</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="width: 46%; font-size: 10pt; text-align: left">Equity compensation plans approved by security holders</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; font-size: 10pt; text-align: right">1,342,062</TD><TD STYLE="width: 8%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 8%; font-size: 10pt; text-align: right">33.70</TD><TD STYLE="width: 7%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; font-size: 10pt; text-align: right">1,117,097</TD><TD STYLE="width: 8%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Equity compensation plans not approved by security holders</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">N/A</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">N/A</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">N/A</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 50pt">Total</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,342,062</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">33.70</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,117,097</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 8pt; color: black">(1)</FONT></TD>
    <TD STYLE="width: 95%; text-align: justify"><FONT STYLE="font-size: 8pt; color: black">Excludes 102,280 shares of unvested
    restricted stock awards as of December 31, 2017.</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 14pt">PROPOSAL
2: DELAWARE REINCORPORATION</FONT></P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Board of Directors has approved and recommends to stockholders
a proposal to change our state of incorporation from the Commonwealth of Massachusetts to the State of Delaware, which we refer
to below as the Reincorporation. If stockholders approve the Reincorporation, we will effect the Reincorporation by domesticating
in Delaware as provided in the Delaware General Corporation Law, or DGCL, and the Massachusetts Business Corporation Act, or MBCA.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Principal Features of the Reincorporation</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Reincorporation would be effected pursuant to the Plan of Domestication,
which is included as <FONT STYLE="font-variant: small-caps">Appendix&nbsp;A</FONT> to this Proxy Statement. Approval of Proposal&nbsp;2
will constitute approval of the Plan of Domestication. The Plan of Domestication provides that we will reincorporate from Massachusetts
to Delaware by domesticating in Delaware pursuant to Section 265 of the DGCL and Section 9.20 of the MBCA and that there will be
no change in the business, properties, assets, obligations, or management of the Company as a result of the Reincorporation. The
directors (after giving effect to the outcome of Proposal 1) and officers of the Company immediately prior to the Reincorporation
will serve as the directors and officers of the Company following the Reincorporation. We will continue to maintain our headquarters
in Massachusetts.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Plan of Domestication also provides that each outstanding share
of common stock will remain unaffected by the Reincorporation. You will not have to exchange your existing stock certificates for
new stock certificates. At the same time, each outstanding option or right to acquire shares of common stock will continue to be
an option or right to acquire an equal number of shares of common stock under the same terms and conditions.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">At the effective time of the Reincorporation, common stock will
continue to be traded on the NASDAQ Global Select Market under the symbol &ldquo;ANIK.&rdquo; There will be no interruption in
the trading of the common stock as a result of the Reincorporation.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Following the Reincorporation, the Company will be governed by the
DGCL instead of the MBCA, and we will be governed by the Certificate of Incorporation, or Delaware Charter, and the Bylaws, or
Delaware Bylaws, included as <FONT STYLE="font-variant: small-caps">Appendices&nbsp;b</FONT> and C, respectively, to this Proxy
Statement. Approval of Proposal&nbsp;2 will constitute approval of the Delaware Charter and Delaware Bylaws. Our current Restated
Articles of Organization, as amended, or the Massachusetts Charter, and Amended and Restated By-Laws, or the Massachusetts By-Laws,
will no longer be applicable following completion of the Reincorporation. Copies of the Massachusetts Charter and Massachusetts
By-Laws can be found under the &ldquo;Corporate Governance&rdquo; tab of the Investor Relations portion of our website at ir.anikatherapeutics.com/corporate-governance.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Reasons for the Reincorporation</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">For many years, Delaware has followed a policy of encouraging incorporation
in Delaware and, in furtherance of that policy, has been a leader in adopting, construing and implementing comprehensive, flexible
corporate laws responsive to the legal and business needs of corporations organized under its laws. Many corporations have chosen
to incorporate in Delaware, or to reincorporate in Delaware in a manner similar to the Reincorporation. The Reincorporation will
enable our company and stockholders to take advantage of the following benefits of incorporation in Delaware:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">a well-established body of case law construing the DGCL, which has been developed over the last
century, will provide a greater measure of predictability than exists in any other jurisdiction;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">the certainty afforded by the well-established principles of corporate governance under Delaware
law, which should, among other benefits, assist us in continuing to attract and retain outstanding directors and officers;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">the most advanced and flexible corporate statute in the country;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">the Delaware Court of Chancery, which brings to its handling of complex corporate issues a level
of experience, a speed of decision, and a degree of sophistication and understanding unmatched by any other court in the country;
and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">the Delaware General Assembly, which each year considers and adopts statutory amendments that are
designed to meet changing business needs.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Potential Anti-Takeover Implications
of Reincorporation</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Delaware, like many other states, permits a corporation to adopt
a number of measures designed to reduce a corporation&rsquo;s vulnerability to unsolicited takeover attempts through amendment
of the corporate certificate of incorporation or by-laws or otherwise. Like Massachusetts, Delaware has a statute limiting business
combinations with interested stockholders. Furthermore, the Delaware Charter and Delaware Bylaws will contain certain provisions
that are currently not in our organizational documents and that may be viewed as offering anti-takeover protections. For example,
as described under &ldquo;Comparison of Stockholder Rights Before and After Reincorporation,&rdquo; the Delaware Charter and Delaware
Bylaws will permit stockholders to remove directors only for cause with a vote of the holders of 75% of the outstanding shares
entitled to vote on the matter. The Massachusetts By-Laws, however, permit stockholders to remove directors with or without cause
with the vote of the holders of a majority of the outstanding shares entitled to vote on the matter. The Board of Directors is
proposing the Reincorporation, however, to allow us to avail ourselves of the favorable corporate environment in Delaware and not
to prevent a change in control of the Company.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Comparison of Stockholder Rights Before
and After the Reincorporation</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Due to differences between the MBCA and the DGCL, as well as differences
between the Massachusetts Charter and Massachusetts By-Laws and the Delaware Charter and Delaware Bylaws, the Reincorporation will
effect some changes in the rights of stockholders. Summarized below is a comparison of significant rights of stockholders before
and after the Reincorporation under the MBCA and the DGCL, the Massachusetts Charter and Delaware Charter, and the Massachusetts
By-Laws and the Delaware Bylaws.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The summary below is not intended to be relied upon as an exhaustive
list of all differences or a complete description of the differences between the DGCL, the Delaware Charter, and the Delaware Bylaws,
on the one hand, and the MBCA, the Massachusetts Charter, and the Massachusetts By-Laws, on the other hand. The summary below is
qualified in its entirety by reference to the actual text of the MBCA, the Massachusetts Charter, the Massachusetts By-Laws, the
DGCL, the Delaware Charter, and the Delaware Bylaws.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="3" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top; background-color: #365F91">
    <TD STYLE="width: 20%; border: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 41%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">
        <P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0; color: white"><FONT STYLE="font-variant: small-caps"><B>Massachusetts</B></FONT></P></TD>
    <TD STYLE="width: 39%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">
        <P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0; color: white"><FONT STYLE="font-variant: small-caps"><B>Delaware</B></FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt"><B>Authorized Capital Stock:</B></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 9pt">The Massachusetts Charter authorizes 61,250,000 shares, of which (a)&nbsp;60,000,000 are designated as common stock, par value $0.01 per share, and (b)&nbsp;1,250,000 shares are designated as preferred stock, par value $0.01 per share, of which 175,000 shares have been designated as Series&nbsp;B Junior Participating Cumulative Preferred Stock, par value $0.01.</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 9pt">If Proposal 3 is approved at the Annual Meeting, the Delaware Charter will authorize 91,250,000 shares, of which 90,000,000 shares will be designated as common stock, par value $0.01 per share, and 1,250,000 shares will be designated as preferred stock, par value $0.01 per share. If Proposal 3 is not approved, the Delaware Charter will authorize 61,250,000 shares, of which 60,000,000 shares will be designated as common stock, par value $0.01 per share, and 1,250,000 shares will be designated as preferred stock, par value $0.01 per share.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt"><B>Voting Rights:</B></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 9pt">Under the Massachusetts Charter, each holder of common stock is entitled to one vote for each share held on matters submitted to a vote of stockholders.</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 9pt">Under the Delaware Charter, each holder of common stock will be entitled to one vote for each share held on matters submitted to a vote of stockholders.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt"><B>Cumulative Voting Right:</B></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 9pt">Under the MBCA and the Massachusetts Charter, the holders of common stock do not have cumulative voting rights in the election of directors.</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 9pt">Under the DGCL and the Delaware Charter, the holders of common stock will not have cumulative voting rights in the election of directors.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt"><B>Rights of Holders of Preferred Stock:</B></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 9pt">The Massachusetts Charter provides that the Board is authorized to fix the designation and number of any series of preferred stock and to determine the rights, power, preferences, qualifications, limitations, restrictions, voting rights and the relative, participating, optional or other special rights of such preferred stock.</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 9pt">The Delaware Charter provides that the Board will be authorized to fix the designation and number of any series of preferred stock and to determine the rights, powers, preferences, qualifications, limitations, restrictions, voting powers, and the relative, participating, optional or other special rights of such preferred stock.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt"><B>Number and Classification of Directors:</B></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Massachusetts Charter and Massachusetts By-Laws provide
that all directors shall be elected to hold office for staggered three-year terms expiring at the third annual meeting following
the annual meeting at which such director was elected, which means that we have a classified board of directors.</P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Delaware Charter and Delaware Bylaws provide that all
directors will be elected to hold office for staggered three-year terms expiring at the third annual meeting following the annual
meeting at which such director was elected, which means that we will continue to have a classified board of directors.</P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="3" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top; background-color: #365F91">
    <TD STYLE="width: 20%; border: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 41%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">
        <P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0; color: white"><FONT STYLE="font-variant: small-caps"><B>Massachusetts</B></FONT></P></TD>
    <TD STYLE="width: 39%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">
        <P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0; color: white"><FONT STYLE="font-variant: small-caps"><B>Delaware</B></FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Massachusetts Charter and Massachusetts By-Laws provide
that the number of directors be not less than three nor more than nine, as determined by a majority of the stockholders or the
Board, and may be decreased either by the stockholders or by a majority of the Board, but only to eliminate vacancies.</P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">

        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Pursuant to the Delaware Charter and Delaware Bylaws, the number
        of directors will not be less than three nor more than nine, as determined by a majority of the authorized directors, and may be
        decreased either by the stockholders or a majority of the Board, but only to eliminate vacancies.</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt"><B>Removal of Directors:</B></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 9pt">Under the Massachusetts Charter, a director may be removed, only for cause, by the holders of at least 75% of the outstanding shares of capital stock then entitled to vote at an election of directors.</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 9pt">Under the Delaware Charter and Delaware Bylaws, a director may be removed, only for cause, by the holders of at least 75% of the outstanding shares of capital stock then entitled to vote at an election of directors.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt"><B>Special Meetings of Stockholders:</B></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Under the MBCA, a special meeting of stockholders of a corporation
        may be called by the board of directors or the persons authorized to do so by the corporation&rsquo;s articles of organization
        or by-laws, or unless otherwise provided in such articles of organization or by-laws, by the holders of at least 40% of the votes
        entitled to be cast on any issue to be considered at the proposed meeting.</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Massachusetts Charter and Massachusetts By-Laws provide that
        special meetings of stockholders may be called by:</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -20.05pt; margin: 0pt 0 0pt 20.05pt">(1)&nbsp;&nbsp;&nbsp;the
        Chairman of the Board; or</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -20.05pt; margin: 0pt 0 0pt 20.05pt">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -20.15pt; margin: 0pt 0 0pt 20.15pt">(2)&nbsp;&nbsp;&nbsp;the
        President,</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -20.15pt; margin: 0pt 0 0pt 20.15pt">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">and that this provision may only be amended with the affirmative
vote of the holders of at least 75% of the votes that all stockholders would be entitled to cast at any annual election of directors.</P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Under the DGCL, a special meeting of stockholders of a corporation
        may be called by the board of directors or such persons as may be authorized by the corporation&rsquo;s certificate of incorporation
        or bylaws.</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Delaware Charter and Delaware Bylaws provide that special meetings
        of stockholders may be called by:</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">(1)&nbsp;&nbsp;&nbsp;the
        Chairman of the Board; or</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">(2)&nbsp;&nbsp;&nbsp;the
        President,</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">and that this provision may only be amended with the affirmative
vote of the holders of at least 75% of the votes that all stockholders would be entitled to cast at any annual election of directors.</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt"><B>Special Meetings of Board:</B></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 9pt">The Massachusetts By-Laws provide that special meetings of the Board may be called by the Chairman of the Board, President, Treasurer, two or more Directors, any one Director who is a member of the Executive Committee or by one Director, in the event that there is only a single Director in office.</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 9pt">The Delaware Bylaws provide that special meetings of the Board may be called by the Chief Executive Officer or by any two members of the Board.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt"><B>Stockholder Action by Written Consent:</B></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The MBCA permits corporate action without a meeting of stockholders
        of a corporation upon the written consent of all stockholders entitled to vote on the action, or to the extent permitted by the
        corporation&rsquo;s articles of organization, by stockholders having not less than the minimum number of votes necessary to take
        the action at a meeting at which all stockholders entitled to vote on the action are present and voting.</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Massachusetts Charter and Massachusetts By-Laws provide
that stockholders may not take any action by written consent in lieu of a meeting.</P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The DGCL permits corporate action without a meeting of stockholders
        of a corporation upon the written consent of the holders of that number of shares necessary to authorize the proposed corporate
        action being taken, unless the corporation&rsquo;s certificate of incorporation expressly provides otherwise.</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Delaware Charter and Delaware Bylaws provide that stockholders
may not take any action by written consent in lieu of a meeting.</P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="3" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top; background-color: #365F91">
    <TD STYLE="width: 20%; border: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 41%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">
        <P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0; color: white"><FONT STYLE="font-variant: small-caps"><B>Massachusetts</B></FONT></P></TD>
    <TD STYLE="width: 39%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">
        <P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0; color: white"><FONT STYLE="font-variant: small-caps"><B>Delaware</B></FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt"><B>Quorum of Stockholders:</B></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 9pt">Under the Massachusetts By-Laws, the holders of a majority of the shares outstanding and entitled to vote at a stockholders meeting will constitute a quorum with respect to that matter, except that if two or more classes of stock are outstanding and entitled to vote as separate classes, with respect to each class, a quorum will consist of the holders of a majority of the shares of that class outstanding and entitled to vote.</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 9pt">Under the Delaware Bylaws, the holders of a majority in voting power of the shares outstanding and entitled to vote at a stockholders meeting, present in person or represented by proxy, will constitute a quorum.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt"><B>Advance Notice Procedures for Stockholder Proposal or Director Nomination:</B></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 9pt">A stockholder entitled to vote at an annual or special meeting may request business to be brought before that meeting and may nominate a person for election as a director, in each case, by providing written notice as set forth in the Massachusetts By-Laws to our Clerk not more than 10 days after the date of the meeting notice, in the case of business to be brought before a special meeting of stockholders, and not less than 30 days prior to the first anniversary date of the meeting notice to the previous year&rsquo;s annual meeting, in the case of business to be brought before an annual meeting of stockholders; provided, however, that such notice shall not be required to be given more than 60 days prior to an annual meeting of stockholders.</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 9pt">A stockholder entitled to vote at an annual meeting may request business to be brought before that meeting and may nominate a person for election as a director, in each case, by providing written notice as set forth in the Delaware Bylaws to our Secretary not less than 90 nor more than 120 days prior to the first anniversary of the date of our preceding year&rsquo;s annual meeting of stockholders. If the date of the annual meeting is advanced more than 30 days prior to or delayed by more than 70 days after the anniversary of the preceding year&rsquo;s annual meeting, however, notice by the stockholder must be delivered not earlier than the close of business on the one hundred-twentieth day prior to such annual meeting and not later than the close of business on the later of the ninetieth day prior to such annual meeting or the tenth day following the day on which public announcement of the date of such meeting is first made.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt"><B>Business Combinations with Interested Stockholders:</B></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Chapter 110F of the MBCA provides that a corporation may not engage
        in any business combination with any &ldquo;interested stockholder&rdquo; for a three-year period following the date that such
        stockholder became an interested stockholder unless:</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -19.55pt; margin: 0pt 0 0pt 19.55pt">(1)&nbsp;&nbsp;prior
        to such date, the board of directors approved either the business combination or the transaction that resulted in the stockholder
        becoming an interested stockholder;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -19.55pt; margin: 0pt 0 0pt 19.55pt">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -20.05pt; margin: 0pt 0 0pt 20.05pt">(2)&nbsp;&nbsp;upon
consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder
owned at least 90% of the voting stock of the corporation outstanding at the time the transaction commenced (excluding shares
held by directors who are also officers and employee stock plans in which employee participants do not have the right to determine
confidentially whether plan shares will be tendered in a tender or exchange offer); or</P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Section 203 of the DGCL provides that, subject to certain exceptions
        specified therein, a corporation may not engage in any business combination with any &ldquo;interested stockholder&rdquo; for a
        three-year period following the date that such stockholder becomes an interested stockholder unless:</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -18.8pt; margin: 0pt 0 0pt 18.8pt">(1)&nbsp;&nbsp;&nbsp;prior
        to such date, the board of directors approved either the business combination or the transaction that resulted in the stockholder
        becoming an interested stockholder;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -18.8pt; margin: 0pt 0 0pt 18.8pt">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">(2)&nbsp;&nbsp;upon consummation
of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least
85% of the voting stock of the corporation outstanding at the time the transaction commenced (excluding shares held by directors
who are also officers and employee stock purchase plans in which employee participants do not have the right to determine confidentially
whether plan shares will be tendered in a tender or exchange offer); or</P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="3" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top; background-color: #365F91">
    <TD STYLE="width: 20%; border: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 41%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">
        <P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0; color: white"><FONT STYLE="font-variant: small-caps"><B>Massachusetts</B></FONT></P></TD>
    <TD STYLE="width: 39%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">
        <P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0; color: white"><FONT STYLE="font-variant: small-caps"><B>Delaware</B></FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">

        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -20.05pt; margin: 0pt 0 0pt 20.05pt">(3)&nbsp;&nbsp;&nbsp;on
        or subsequent to such date, the business combination is approved by the board of directors and by the affirmative vote at an annual
        or special meeting, and not by written consent, of at least two-thirds of the outstanding voting stock which is not owned by the
        interested stockholder.</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -20.05pt; margin: 0pt 0 0pt 20.05pt">&nbsp;</P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">

        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">(3)&nbsp;&nbsp;on
        or subsequent to such date, the business combination is approved by the board of directors and by the affirmative vote at an annual
        or special meeting, and not by written consent, of at least two-thirds of the outstanding voting stock that is not owned by the
        interested stockholder.</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Except as specified in Section 203 of the DGCL, an interested
stockholder is defined to include (a) any person that is the owner of 15% or more of the outstanding voting stock of the corporation
or is an affiliate or associate of the corporation and was the owner of 15% or more of the outstanding voting stock of the corporation,
at any time within three years immediately prior to the relevant date, and (b) the affiliates and associates of any such person.</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt"><B>Mergers and Acquisitions:</B></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Under the MBCA, a merger, share exchange and sale of all or substantially
        all assets of a corporation must be approved by the board of directors and, unless (1)&nbsp;a greater percentage vote is required
        by the corporation&rsquo;s articles of organization, by-laws or board or (2)&nbsp;a lesser percentage vote is required by the articles
        of organization, the merger, share exchange or sale of assets must be approved by two-thirds of all the shares entitled to vote
        on the matter. The articles of organization may provide for a lesser vote than two-thirds but not less than a majority of the shares
        entitled to vote on the matter.</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Massachusetts Charter provides that a merger, consolidation
or sale of substantially all of the assets of the Company may be approved by a majority of all of the shares entitled to vote
on the matter.</P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Under the DGCL, a merger, consolidation, sale of all or substantially
        all of a corporation&rsquo;s assets other than in the regular course of business or dissolution must be approved by the corporation&rsquo;s
        board of directors and a majority of the outstanding shares entitled to vote.</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Delaware Charter and Delaware Bylaws do not specify a voting
        power requirement.</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt"><B>Charter Amendments:</B></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Under the MBCA, any amendments to a corporation&rsquo;s articles
        of organization must be adopted by the board of directors and, unless (1)&nbsp;a greater percentage vote is required by the corporation&rsquo;s
        articles of organization, by-laws or board or (2)&nbsp;a lesser percentage vote is required by the articles of organization, the
        amendment generally must be approved by the holders of two-thirds of all shares entitled to vote on the matter.</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Massachusetts Charter provides that, by vote of a majority
of the stock outstanding and entitled to vote (or if there are two or more classes of stock entitled to vote as separate classes,
then by vote of a majority of each such class of stock outstanding), we may authorize any amendment to the Massachusetts Charter,
except certain provisions cannot be amended without an affirmative vote of holders of 75% of the votes that all the stockholders
would be entitled to cast at any annual election of directors or class of directors, including provisions relating to:</P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The DGCL provides that a corporation may amend its certificate of
        incorporation upon the adoption of a resolution setting forth the proposed amendment by the board of directors and thereafter by
        the affirmative vote of holders of a majority of the outstanding shares entitled to vote on the matter, unless the certificate
        of incorporation provides for a different vote of the stockholders.</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Delaware Charter requires the affirmative vote of holders
of at least 75% of the voting power of the shares of the outstanding voting stock entitled to vote thereon, voting together as
a single class to approve certain amendments to the Delaware Charter, including provisions relating to:</P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="3" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top; background-color: #365F91">
    <TD STYLE="width: 20%; border: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 41%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">
        <P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0; color: white"><FONT STYLE="font-variant: small-caps"><B>Massachusetts</B></FONT></P></TD>
    <TD STYLE="width: 39%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">
        <P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0; color: white"><FONT STYLE="font-variant: small-caps"><B>Delaware</B></FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">(1)&nbsp;&nbsp;the
        authority and structure of the Board, as well as removal and vacancies of directors;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -20.05pt; margin: 0pt 0 0pt 20.05pt">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">(2)&nbsp;&nbsp;prohibition
        of action by written consent of stockholders; and</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -20.05pt; margin: 0pt 0 0pt 20.05pt">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">(3)&nbsp;&nbsp;requirements
        that special meetings may be called by the President or the Chairman of the Board and that business transacted at such special
        meetings shall be limited to matters related to the stated purposes of the meeting.</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -20.05pt; margin: 0pt 0 0pt 20.05pt">&nbsp;</P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">

        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">(1)&nbsp;&nbsp;the
        authority and structure of the Board, as well as removal and vacancies of directors;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">(2)&nbsp;&nbsp;prohibition
        of action by written consent of stockholders;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">(3)&nbsp;&nbsp;requirements
        that special meetings may be called by the President or the Chairman of the Board and that business transacted at such special
        meetings shall be limited to matters related to the stated purposes of the&nbsp;meeting;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">(4)&nbsp;&nbsp;amendment
        of the Delaware Charter or Delaware Bylaws;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">(5)&nbsp;&nbsp;prohibition
        of cumulative voting by stockholders; and</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">(6)&nbsp;&nbsp;indemnification
of certain covered persons.</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt"><B>Bylaw Amendments:</B></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The MBCA provides that stockholders have the power to make, amend
        or repeal the by-laws of a corporation.</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Massachusetts By-Laws may be amended by the vote of holders
        of a majority of the shares of each class of the capital stock entitled to vote at any annual or special meeting of stockholders,
        except that the following provisions of the Massachusetts By-Laws may only be amended by the affirmative vote of holders of 75%
        of the votes that all stockholders would be entitled to cast at any annual election of directors:</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -20.05pt; margin: 0pt 0 0pt 20.05pt">(1)&nbsp;&nbsp;&nbsp;prohibition
        of action by written consent of stockholders; and</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -20.05pt; margin: 0pt 0 0pt 20.05pt">(2)&nbsp;&nbsp;&nbsp;requirements
        that special meetings may be called by the President or the Chairman of the Board and that business transacted at such special
        meetings shall be limited to matters related to the stated purposes of the meeting.</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -20.05pt; margin: 0pt 0 0pt 20.05pt">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Massachusetts By-Laws may also be amended by the Board
except with respect to any provision that by law, the Massachusetts Charter or the Massachusetts By-Laws requires action by the
stockholders.</P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Under the DGCL, directors may amend the bylaws of a corporation
        only if such right is expressly conferred upon the directors in its certificate of incorporation.</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Delaware Bylaws may be amended by the vote of holders of a majority
        of the outstanding voting power of the shares of capital stock entitled to vote thereon, except that certain provisions of the
        Delaware Bylaws may only be amended by the affirmative vote of holders of 75% of the outstanding voting power of the shares of
        capital stock entitled to vote thereon, including those relating to:</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -20.05pt; margin: 0pt 0 0pt 20.05pt">(1)&nbsp;&nbsp;&nbsp;meetings
        of stockholders;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -20.05pt; margin: 0pt 0 0pt 20.05pt">(2)&nbsp;&nbsp;&nbsp;structure
        and meetings of the Board;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -20.05pt; margin: 0pt 0 0pt 20.05pt">(3)&nbsp;&nbsp;&nbsp;indemnification
        of certain covered persons;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -20.05pt; margin: 0pt 0 0pt 20.05pt">(4)&nbsp;&nbsp;&nbsp;exclusivity
        of the forum of the Delaware Court of Chancery.</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Delaware Bylaws may also be amended by the Board except with
        respect to any provision that by law, the Delaware Charter or the Delaware Bylaws requires action by the stockholders.</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt"><B>Dividends:</B></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 9pt">Under the Massachusetts Charter, dividends on common stock may be declared and paid from funds lawfully available, as and when determined by the Board and subject to any preferential dividend rights of any then outstanding preferred stock.</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 9pt">Under the Delaware Bylaws, dividends on common stock may be declared by the Board and are subject to any preferential dividend or other rights of any then outstanding preferred stock and to the requirements of applicable law.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt"><B>Limitation of Liability:</B></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The MBCA authorizes a corporation to adopt a charter provision
eliminating or limiting the personal liability of directors to the corporation for monetary damages for breach of fiduciary duty,
except for liability for:</P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The DGCL eliminates the liability of a director for monetary
damages for breach of fiduciary duty, except for liability:</P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="3" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top; background-color: #365F91">
    <TD STYLE="width: 20%; border: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 41%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">
        <P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0; color: white"><FONT STYLE="font-variant: small-caps"><B>Massachusetts</B></FONT></P></TD>
    <TD STYLE="width: 39%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">
        <P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0; color: white"><FONT STYLE="font-variant: small-caps"><B>Delaware</B></FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">(1)&nbsp;&nbsp;any
        breach of the director&rsquo;s duty of loyalty to the corporation or its stockholders;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">(2)&nbsp;&nbsp;acts
        or omissions not in good faith or involving intentional misconduct or knowing violations of law; or</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">(3)&nbsp;&nbsp;any
        improper distributions to stockholders under the MBCA, or any transaction from which the director derived any improper personal
        benefit.</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 20.05pt">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Massachusetts Charter limits the liability of our directors
in accordance with the MBCA.</P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">(1)&nbsp;&nbsp;for
        any breach of the director&rsquo;s duty of loyalty to the corporation or its stockholders;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">(2)&nbsp;&nbsp;for
        acts or omissions not in good faith or involving intentional misconduct or knowing violations of law;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">(3)&nbsp;&nbsp;under
        Section 174 of the DGCL; or</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">(4)&nbsp;&nbsp;for
        any transaction from which the director derived any improper personal benefit.</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Delaware Charter limits the liability of our directors in accordance
        with the DGCL.</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt"><B>Indemnification of Officers and Directors:</B></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The MBCA provides that a corporation may indemnify an individual
        who is a party to a proceeding because the individual is a director or officer against liability incurred if he or she acted in
        good faith and reasonably believed his or her conduct was in the best interests of the corporation.</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The MBCA also provides that a corporation must indemnify a director
        or officer who was successful, on the merits or otherwise, in the defense of any proceeding to which he or she was a party because
        he was a director of the corporation against expenses incurred in connection with the proceeding.</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The MBCA permits a corporation to advance expenses relating
to the defense of any proceeding to directors and officers contingent upon such individuals&rsquo; commitment to repay any advances
unless it is determined ultimately that such individuals are entitled to be indemnified.</P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Pursuant to the DGCL, a corporation has the power to indemnify its
        directors and officers against expenses, judgments, fines and amounts paid in settlement actually and reasonably incurred in connection
        with a third-party action, other than a derivative action, and against expenses actually and reasonably incurred in the defense
        or settlement of a derivative action, <I>provided</I> there is a determination that the individual acted in good faith and in a
        manner reasonably believed to be in or not opposed to the best interests of the corporation and, with respect to any criminal action
        or proceeding, had no reasonable cause to believe the individual&rsquo;s conduct was unlawful.</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The DGCL requires indemnification of directors and officers for
        expenses relating to a successful defense on the merits or otherwise of a derivative or third-party action.</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The DGCL permits a corporation to advance expenses relating to the
        defense of any proceeding to directors and officers contingent upon such individuals&rsquo; commitment to repay any advances unless
        it is determined ultimately that such individuals are entitled to be indemnified.</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Under the DGCL, the rights to indemnification and advancement
of expenses provided in the law are nonexclusive, in that, subject to public policy issues, indemnification and advancement of
expenses beyond that provided by statute may be provided by bylaw, agreement, vote of stockholders, disinterested directors or
otherwise.</P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="3" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top; background-color: #365F91">
    <TD STYLE="width: 20%; border: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 41%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">
        <P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0; color: white"><FONT STYLE="font-variant: small-caps"><B>Massachusetts</B></FONT></P></TD>
    <TD STYLE="width: 39%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">
        <P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0; color: white"><FONT STYLE="font-variant: small-caps"><B>Delaware</B></FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Massachusetts Charter and Massachusetts By-Laws contain
indemnification provisions consistent with the MBCA.</P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Delaware Charter and Delaware Bylaws contain indemnification
        provisions consistent with the DGCL.</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt"><B>Stock Redemption and Repurchases:</B></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 9pt">Under the MBCA, a corporation may acquire its own shares and those shares constitute authorized but unissued shares.</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 9pt">Under the DGCL, a corporation may purchase or redeem its own shares of capital stock, except when the capital of the corporation is impaired or when such purchase or redemption would cause any impairment of the capital of the corporation.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt"><B>Voting and Proxies: </B></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 9pt">Under the Massachusetts By-Laws, any election by stockholders shall be determined by a plurality of the votes cast by the stockholders entitled to vote at the election. No ballot shall be required for such election unless requested by a stockholder present or represented at the meeting and entitled to vote in the election.</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 9pt">Under the Delaware Bylaws, at meetings of stockholders for the election of directors at which a quorum is present where the number of director nominees is equal to the number of positions on the Board to be filled through election and proxies are solicited for such election of directors solely by the corporation, the affirmative vote of a majority in voting power of the shares of stock of the corporation that are voting in the election of directors shall be required to elect. In all other meetings of stockholders for the election of directors at which a quorum is present, a plurality of the votes cast shall be sufficient to elect a director.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt"><B>Duration of Proxies:</B></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 9pt">Under the MBCA, no proxy dated more than six months before the meeting named therein shall be valid and no proxy shall be valid after the final adjournment of such meeting. Unless otherwise provided in the appointment form, an appointment of a proxy will remain valid for a period of 11 months.</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 9pt">Under the DGCL, a proxy executed by a stockholder will remain valid for a period of three years unless the proxy provides for a longer period.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt"><B>Stockholders&rsquo; Right to Inspect Books and Records:</B></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The MBCA provides that upon five days written notice a stockholder
        of a corporation is entitled to inspect and copy, during regular business hours at the office where they are maintained, copies
        of any of the following records of the corporation:</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -20.05pt; margin: 0pt 0 0pt 20.05pt">(1)&nbsp;&nbsp;&nbsp;articles
        of organization and bylaws,</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -20.05pt; margin: 0pt 0 0pt 20.05pt">(2)&nbsp;&nbsp;&nbsp;resolutions
        adopted by the board of directors creating one or more classes or series of shares and fixing their rights and preferences,</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -20.05pt; margin: 0pt 0 0pt 20.05pt">(3)&nbsp;&nbsp;&nbsp;minutes
        and written consents of all stockholders&rsquo; meetings for the past three years,</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -20.05pt; margin: 0pt 0 0pt 20.05pt">(4)&nbsp;&nbsp;&nbsp;all
        written communications to stockholders generally within the past three years, including financial statements furnished,</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -20.05pt; margin: 0pt 0 0pt 20.05pt">(5)&nbsp;&nbsp;&nbsp;a
        list of the names and business addresses of the corporation&rsquo;s current directors and officers, and</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -20.05pt; margin: 0pt 0 0pt 20.05pt">(6)&nbsp;&nbsp;&nbsp;the
corporation&rsquo;s most recent annual report delivered to the secretary of state.</P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The DGCL provides that any stockholder of record may demand to examine
        the corporation&rsquo;s stock ledger, a list of its stockholders and its other books and records for any proper purpose. If management
        of the corporation refuses, the stockholder can compel release of the books by court order.</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">There is no related provision in the Delaware Bylaws.</P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="3" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top; background-color: #365F91">
    <TD STYLE="width: 20%; border: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 41%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">
        <P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0; color: white"><FONT STYLE="font-variant: small-caps"><B>Massachusetts</B></FONT></P></TD>
    <TD STYLE="width: 39%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">
        <P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0; color: white"><FONT STYLE="font-variant: small-caps"><B>Delaware</B></FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Under the Massachusetts By-Laws, records of all meetings
of the incorporators and stockholders, and stock records, shall be available at all reasonable times for the inspection of any
stockholder for any proper purpose.</P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt; width: 20%"><B>Appraisal and Dissenters Rights:</B></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt; width: 41%">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Under the MBCA, stockholders have appraisal rights in the event
        of certain corporate actions such as a merger, share exchange or action that materially and adversely affects the rights of a stockholder.</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">If a proposed corporate action requiring appraisal rights is submitted
        to vote at a stockholder meeting, a stockholder who wishes to assert appraisal rights must:</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -20.05pt; margin: 0pt 0 0pt 20.05pt">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -20.05pt; margin: 0pt 0 0pt 20.05pt">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -20.05pt; margin: 0pt 0 0pt 20.05pt">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">(1)&nbsp;&nbsp;deliver
        to the corporation, before the vote is taken, written notice of intent to demand payment for shares if the proposed action is effected;
        and</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">(2)&nbsp;&nbsp;not
        vote any shares in favor of the proposed action.</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -20.05pt; margin: 0pt 0 0pt 20.05pt">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The corporation is required to pay fair value to a stockholder exercising
        appraisal rights for the shares held by such stockholder. If fair value is unsettled, the MBCA provides for resolution of fair
        value in a single equitable proceeding in a court in the county in Massachusetts where the corporation&rsquo;s principal office
        or registered office is located.</P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt; width: 39%">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Under the DGCL, stockholders have appraisal rights in the event
        of certain corporate actions such as a merger or consolidation. These rights include the right to dissent from voting to approve
        such corporate action, and demand fair value for the shares of the dissenting stockholder.</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">If a proposed corporate action creating dissenters&rsquo; rights
        is submitted to a vote at a stockholder meeting, a stockholder who wishes to assert dissenters&rsquo; rights must:</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">(1)&nbsp;&nbsp;deliver
        to the corporation, before the vote is taken, written notice of his intent to demand payment for shares if the proposed action
        is effected; and</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">(2)&nbsp;&nbsp;not
        vote his shares in favor of the proposed action.</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">If fair value is unsettled, the DGCL provides for the dissenter
        and the corporation to petition the Delaware Court of Chancery.</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt"><B>Franchise Taxes:</B></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 9pt">Massachusetts imposes no franchise tax or similar fee on Massachusetts corporations.</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 9pt">Delaware will require that we pay annual franchise taxes determined by a formula based on the number of our authorized shares or our no-par capital, whichever would result in a lesser tax.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 9pt"><B>Exclusive Forum:</B></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 9pt">The Massachusetts Charter and Massachusetts By-Laws do not contain a provision relating to the forum to bring matters against us or on our behalf.</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 9pt">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Delaware Bylaws provide that, with specified exceptions, the
        Delaware Court of Chancery will be the sole and exclusive forum for all claims:</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">(a)&nbsp;&nbsp;based
        upon a violation of a duty by a current or former director or officer or stockholder in such capacity, or</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: -0.25in; margin: 0pt 0 0pt 18.1pt">(b)&nbsp;&nbsp;as to which the DGCL confers
        jurisdiction upon the Delaware Court of Chancery.</P></TD></TR>
</TABLE>
<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Regulatory Approvals and Effective
Time</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">If approved by the requisite vote of the holders of shares of common
stock, we expect the Reincorporation to become effective upon the filing of the Delaware Charter and a Certificate of Conversion
from a Non-Delaware Corporation to a Delaware Corporation with the Delaware Secretary of State in accordance with the DGCL and
the filing of Articles of Charter Surrender with the Massachusetts Secretary of the Commonwealth in accordance with the MBCA.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0"><FONT STYLE="font-size: 12pt">Securities Law Consequences</FONT></P>

<P STYLE="font-size: 10pt; font-style: italic; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">After the Reincorporation, we will continue to be a publicly held
company, shares of common stock will continue to be traded on the NASDAQ Global Select Market under the symbol &ldquo;ANIK,&rdquo;
and we will continue to file periodic reports and other documents with the SEC and provide to stockholders the same types of information
that we have previously filed and provided. We and our stockholders will be in the same respective positions under the federal
securities laws after the Reincorporation as we and our stockholders were prior to the Reincorporation.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><FONT STYLE="font-size: 12pt"><I>Vote Required</I></FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The affirmative vote of the holders of two-thirds of the issued
and outstanding shares of common stock as of the record date is required for the approval of the Reincorporation. Abstentions and
broker non-votes, if any, will be counted as votes against the Reincorporation.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><FONT STYLE="font-size: 12pt"><I>Effect of Not Obtaining the Required
Vote for Approval</I></FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">If the Reincorporation proposal fails to obtain the requisite vote
for approval, the Reincorporation will not be consummated and we will continue to be incorporated in Massachusetts.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><FONT STYLE="font-size: 12pt"><I>Abandonment, Deferral, and Amendment</I></FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Notwithstanding a favorable vote of the stockholders, the Board
of Directors may decide to abandon or defer the Reincorporation prior to its effectiveness. The Plan of Domestication, however,
may not be amended after stockholder approval if the amendment would have a material adverse effect on the rights of stockholders
or violate applicable law.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><FONT STYLE="font-size: 12pt"><I>Board Recommendation</I></FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><B>THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE &ldquo;FOR&rdquo;
THE REINCORPORATION OF OUR COMPANY IN DELAWARE.</B></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 14pt">PROPOSAL
3: APPROVAL OF INCREASE<BR>
AUTHORIZED SHARES OF COMMON STOCK</FONT></P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><FONT STYLE="font-size: 12pt"><I>General</I></FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Board of Directors has recommended an increase in the aggregate
number of shares of common stock, par value $0.01, that we are authorized to issue  from 60,000,000 to 90,000,000, which we refer
to below as the Authorized Share Increase.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">If Proposal 2 (Delaware Reincorporation) and this Proposal 3 are approved at the Annual Meeting,
the Authorized Share Increase will be reflected in the terms of the Delaware Charter. See &ldquo;Authorized Capital Stock&#9472;Delaware&rdquo;
in the table included under &ldquo;Proposal 2: Delaware Reincorporation&#9472;Comparison of Stockholder Rights Before and After
the Reincorporation&rdquo; above.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">If this Proposal 3 is approved at the Annual Meeting, but Proposal 2 is <I>not</I> approved, the
Authorized Share Increase will be effected by an amendment to the Massachusetts Charter. Pursuant to various sections of the MBCA
and the Massachusetts Charter, stockholder approval of this amendment is required to make it effective.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">As of April 2, 2018, the record date for this Annual Meeting, 14,745,152
shares of common stock were outstanding. Approximately 1.34 million shares were reserved for issuance upon the exercise of equity
awards granted or authorized under our equity compensation plans, and approximately an additional 1.11 million shares were reserved
for issuance under our shareholder approved equity compensation plan generally. Accordingly, we currently expect to have only approximately
42.7 million shares of common stock available for future issuance.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><FONT STYLE="font-size: 12pt"><I>Purpose and Effect of the Authorized
Share Increase</I></FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">We believe that an increase in the authorized shares of common stock
would place us in a more comparable position to our peers and our competitors, the large majority of which have a number of authorized
shares that far exceeds the 60,000,000 that we are currently authorized to issue, including many that have 100,000,000 or more
total shares authorized. Additionally, we believe that the Authorized Share Increase will result in greater flexibility and additional
potential opportunities in the future by allowing us to take any one or a combination of the following general corporate initiatives
to optimize shareholder value and support our growth plans:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">raise additional growth capital through common stock offerings;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">issue share dividends to common stock holders;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">provide equity incentives to attract and retain employees, officers, or directors;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">acquire businesses, technologies, product franchises, or other assets through merger and/or acquisition
activity using common stock as consideration; or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">issue common stock for other corporate purposes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Without an increase in the number of authorized shares of common
stock, the number of remaining common shares may be insufficient to complete one or more of the above transactions if and when
the Board of Directors deems it to be in the best interests of the stockholders to do so. We believe that having the additional
authorized shares available to the Company for issuance, upon approval of the Board, will be beneficial to us and our stockholders
by allowing us to promptly consider and respond to future business opportunities as they arise, including in relation to acquisition
opportunities, which are competitive and time-sensitive. Due to market, industry, and other factors, the delay involved in calling
and holding a stockholders&rsquo; meeting to approve an increase in authorized shares at the time a business opportunity presents
itself may prevent us from timely pursuing that opportunity, or may significantly adversely affect the economic or strategic value
of that opportunity.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">We currently have no specific plans, arrangements, or understandings
to issue additional shares of common stock, except for the routine and ongoing issuances under our equity incentive plans, and
we have not allocated any specific portion of the proposed increase in authorized common shares to any particular purpose. We continually
evaluate our capital structure and may consider an equity offering if, among other things, market conditions are favorable or there
is a favorable business opportunity.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The proposed Authorized Share Increase will not affect the rights
of existing stockholders, except to the extent that future issuances of common stock, including the additional shares that would
be authorized if the proposed Authorized Share Increase is approved, may dilute the current equity ownership position of current
holders of common stock and may be made without further stockholder approval, unless otherwise required by applicable laws or stock
exchange regulations. Although the Board is motivated by business and financial considerations in proposing the Authorized Share
Increase, stockholders should be aware that an increase in authorized shares could be viewed as an anti-takeover provision. While
increasing the shares that the Company is authorized to issue would place us more on par with our peers, the amendment might discourage
an attempt by a third party to gain control of us by acquiring a substantial number of shares of common stock in order to complete
a merger, sale of all or any part of our assets, or similar transactions, because the issuance of new shares could be used to dilute
the stock ownership of that third party.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">All shares of common stock, including those now authorized and those
that would be authorized by the approval of this proposed amendment, are equal in rank and have the same voting, dividend, and
liquidation rights. Existing stockholders have no preemptive rights to acquire or subscribe to any of the additional shares of
common stock that would be authorized by the approval of the Authorized Share Increase. If the amendment is approved, it will become
effective (a)&nbsp;If Proposal 2 is approved at the Annual Meeting, the filing of the Delaware Charter and other documents with
the Delaware Secretary of State in connection with the Reincorporation or (b)&nbsp;if Proposal 2 is not approved, the filing of
Articles of Amendment to the Massachusetts Charter with the Massachusetts Secretary of the Commonwealth.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Currently, the Massachusetts Charter authorizes us to issue 1,250,000
shares of preferred stock, of which 175,000 shares have been designated as Series B Junior Participating Cumulative Preferred Stock,
par value $0.01. No other class of our capital stock is authorized.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><FONT STYLE="font-size: 12pt"><I>Vote Required</I></FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The affirmative vote of the holders of a majority of the outstanding
shares of common stock as of the record date is required to approve the Authorized Share Increase, including, if Proposal 2 is
not approved, an amendment to the Massachusetts Charter to increase the aggregate number of shares of common stock that we are
authorized to issue from 60,000,000 to 90,000,000. Abstentions and broker non-votes, if any, will have the same effect on the result
of this vote as votes against the proposal.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><FONT STYLE="font-size: 12pt"><I>Board Recommendation</I></FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><B>THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE &ldquo;FOR&rdquo;
THE APPROVAL OF THE AUTHORIZED SHARE INCREASE.</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 14pt">AUDIT
COMMITTEE REPORT</FONT></P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The following report of the Audit Committee of the Board of Directors
of Anika Therapeutics, Inc., or Anika, is required by the rules of the SEC to be included in this Proxy Statement. The purpose
of the Audit Committee is to oversee Anika&rsquo;s accounting and financial reporting process and the audits of its financial statements.
For the fiscal year ended December&nbsp;31, 2017, the independent registered public accounting firm of Anika was Deloitte &amp;
Touche&nbsp;LLP or Deloitte. The Audit Committee operates pursuant to a written charter adopted by the Board, a copy of which is
available on Anika&rsquo;s website.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">As set forth in the Audit Committee Charter, management is responsible
for the preparation, presentation and integrity of Anika&rsquo;s financial statements, as well as for its financial reporting process,
accounting policies, internal controls, and disclosure controls and procedures. Deloitte is responsible for auditing the financial
statements and expressing an opinion as to their conformity with generally accepted accounting principles and as to the effectiveness
of Anika&rsquo;s internal control over financial reporting. The Audit Committee&rsquo;s responsibility is to monitor and oversee
this process.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">In the performance of its oversight function, the Audit Committee
has reviewed and discussed with management and Deloitte the audited financial statements and management&rsquo;s assessment of the
effectiveness of internal control over financial reporting and Deloitte&rsquo;s evaluation of internal control over financial reporting.
The Audit Committee has also discussed with Deloitte the matters required to be discussed by Auditing Standards No.&nbsp;16, as
adopted by the Public Accounting Oversight Board. Finally, the Audit Committee has received the written disclosures and the letter
from Deloitte required by applicable requirements of the Public Company Accounting Oversight Board regarding Deloitte&rsquo;s communications
with the Audit Committee concerning independence, has discussed with Deloitte its independence in relation to Anika, and has considered
the compatibility of non-audit services with such independence. Management has represented to the Audit Committee that the consolidated
financial statements of Anika were prepared in accordance with generally accepted accounting principles.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Based upon the review and discussions referred to above, the Audit
Committee recommended to the Board that the audited financial statements of Anika be included in the Annual Report on Form&nbsp;10-K
for the year ended December&nbsp;31, 2017 filed by Anika with the SEC.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">This report is submitted by the following independent directors
who comprise the Audit Committee:&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 38%; text-align: center">Raymond J. Land, Chairperson</TD>
    <TD STYLE="width: 33%; text-align: center">Joseph L. Bower</TD>
    <TD STYLE="width: 29%; text-align: center">Jeffery S. Thompson</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><B>THE FOREGOING REPORT SHOULD NOT BE DEEMED INCORPORATED BY REFERENCE
INTO ANY FILING UNDER THE SECURITIES ACT OF&nbsp;1933 OR THE SECURITIES EXCHANGE ACT OF&nbsp;1934 BY ANY GENERAL STATEMENT INCORPORATING
BY REFERENCE THIS PROXY STATEMENT, EXCEPT TO THE EXTENT THAT ANIKA SPECIFICALLY INCORPORATES THIS INFORMATION BY REFERENCE, AND
SHALL NOT OTHERWISE BE DEEMED FILED UNDER SUCH ACTS.</B></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 14pt">PROPOSAL
4: RATIFICATION OF APPOINTMENT<BR>
OF INDEPENDENT AUDITOR FOR 2018</FONT></P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Audit Committee has approved the retention of Deloitte &amp;
Touche LLP, or Deloitte, an independent registered public accounting firm, as our independent auditor to report on our consolidated
financial statements and the effectiveness of our internal control over financial reporting for the fiscal year ending December
31, 2018. The Audit Committee considers Deloitte to be well qualified. In the absence of contrary specification, the Proxy Committee
will vote proxies received in response to this solicitation in favor of ratification of the appointment. Even if the proposal is
approved, the Audit Committee may, in its discretion, appoint a different independent registered public accounting firm to serve
as independent auditor at any time during the year.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><FONT STYLE="font-size: 12pt"><I>Background</I></FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">In April 2017, the Audit Committee of the Board of Directors completed
a competitive process to determine which audit firm would serve as our independent registered public accounting firm for the year
ended December 31, 2017. The Audit Committee invited several firms to participate in this competitive process, including PricewaterhouseCoopers
LLP or PwC, which had been our independent registered public accounting firm since 2002. As a result of this process, and following
careful deliberation, on April 24, 2017, the Audit Committee dismissed PwC as our independent registered public accounting firm
effective immediately following the filing of our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2017.
On the same day, the Audit Committee approved the appointment of Deloitte &amp; Touche LLP, or Deloitte, to act as our independent
registered public accounting firm for the remainder of 2017 effective immediately following the filing of such Quarterly Report
on Form 10-Q.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Audit Committee is responsible for the appointment, retention,
termination, compensation, and oversight of the work of our independent registered public accounting firm for the purpose of preparing
or issuing an audit report or related work. Although ratification of the appointment of our independent registered public accounting
firm is not required by the Massachusetts By-laws or otherwise, the Board is submitting the appointment of Deloitte to our stockholders
for ratification because we value the views of our stockholders. In the event that stockholders fail to ratify the appointment
of Deloitte, the Audit Committee will reconsider the appointment of Deloitte. Even if the appointment is ratified, the ratification
is not binding and the Audit Committee may in its discretion select a different independent registered public accounting firm at
any time during the year if it determines that such a change would be in the best interests of our company and stockholders.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Representatives of Deloitte are expected to be present at the Annual
Meeting. They will have an opportunity to make a statement, if they desire, and will be available to respond to appropriate questions.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The reports of PwC on our consolidated financial statements for
the fiscal years ended December 31, 2016 and 2015, and in the subsequent interim period through April 24, 2017, did not contain
any adverse opinion or disclaimer of opinion, and were not qualified or modified as to uncertainty, audit scope, or accounting
principle, and included explanatory paragraphs. The 2015 report included an explanatory paragraph stating: &ldquo;As discussed
in Note 2 to the consolidated financial statements, we changed the manner in which we classify deferred taxes in 2015 and 2014
due to the adoption of Accounting Standards Update 2015-17, Balance Sheet Classification of Deferred Taxes.&rdquo;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">During the fiscal years ended December 31, 2016 and 2015, and through
April 24, 2017, (1) there were no disagreements (as that term is defined in Item 304(a)(1)(iv) of the SEC&rsquo;s Regulation S-K
and the related instructions) between PwC and our company on any matter of accounting principles or practices, financial statement
disclosure, or auditing scope or procedure, which, if not resolved to the satisfaction of PwC would have caused PwC to make reference
to the subject matter of the disagreement in connection with its reports on our consolidated financial statements for such years,
and (2) there were no &lsquo;&lsquo;reportable events&rsquo;&rsquo; (as that term is defined in Item 304(a)(1)(v) of Regulation&nbsp;S-K).</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">During the fiscal years ended December 31, 2016 and 2015, and through
April 24, 2017, neither we, nor anyone on our behalf, consulted Deloitte regarding matters or events set forth in Item 304(a)(2)
of Regulation S-K, including (1) any application of accounting principles to a specified transaction, either completed or proposed,
or the type of audit opinion that might be rendered with respect to our consolidated financial statements, in any case where a
written report or oral advice was provided to us by Deloitte that was an important factor considered by us in reaching a decision
as to any accounting, auditing or financial reporting issue or (2) any matter that was the subject of a disagreement (as that term
is defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions) or a &lsquo;&lsquo;reportable event&rsquo;&rsquo;
(as that term is defined in Item 304(a)(1)(v) of Regulation S-K).</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">We provided PwC with a copy of the disclosures we made in a Current
Report on Form 8-K prior to the time the Current Report on Form 8-K was filed with the SEC on April&nbsp;28, 2017. We requested
that PwC furnish a letter addressed to the SEC stating whether or not it agrees with the statements made therein. A copy of PwC&rsquo;s
letter dated April 27, 2017 was attached as Exhibit 16.1 to the Current Report on Form&nbsp;8-K.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">In deciding to engage Deloitte, the Audit Committee reviewed auditor
independence and existing commercial relationships with Deloitte, and concluded that Deloitte has no commercial relationship with
us that would impair its independence.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><FONT STYLE="font-size: 12pt"><I>Vote Required</I></FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The affirmative vote of the holders of a majority of the shares
of common stock present or represented at the Annual Meeting and voting on the matter is required for the ratification of the appointment
of Deloitte as our independent registered public accounting firm for the fiscal year ending December 31, 2018. Abstentions, if
any, will not be treated as votes cast and will have no impact on the proposal. Because this proposal is considered a routine matter,
broker non-votes will be counted.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><FONT STYLE="font-size: 12pt"><I>Board Recommendation</I></FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><B>THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE &ldquo;FOR&rdquo;
THE RATIFICATION OF THE APPOINTMENT OF DELOITTE &amp; TOUCHE LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL
YEAR ENDING DECEMBER 31, 2018. </B></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><FONT STYLE="font-size: 12pt"><I>Fees Paid to Our Principal Independent
Auditors</I></FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Our independent registered public accounting firm for the year ended
December 31, 2017 was Deloitte. Our independent registered public accounting firm for the year ended December 31, 2016 was PwC.
The following table summarizes the fees that we paid or accrued for audit and other services provided by our principal independent
auditors, Deloitte for 2017 and PwC for 2016.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid">Fee Category</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="width: 64%; font-size: 10pt; font-weight: normal; font-style: normal; text-align: left">Audit fees <FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal"><SUP>(1)</SUP></FONT></TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right">587,825</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right">919,663</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left">Audit-related fees</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left">Tax fees</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">86,719</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">All other fees</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: right">-</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: right">-</TD><TD STYLE="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total fees</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">587,825</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,006,382</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%"><FONT STYLE="font-size: 8pt; color: black">(1)</FONT></TD>
    <TD STYLE="width: 96%; text-align: justify"><FONT STYLE="font-size: 8pt; color: black">In 2017, we paid $75,000 to PwC to
    review the interim financial statements included in our Quarterly Report on Form 10-Q for the first quarter of 2017, which
    was filed on May 4, 2017.</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">For purposes of the preceding table:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">Audit fees consist of fees for the audit of our consolidated financial statements, the review of
the interim financial statements included in our Quarterly Reports on Form&nbsp;10-Q, and other professional services provided
in connection with statutory and regulatory filings or engagements for those years. In addition, Audit fees include: fees for comfort
letters, consents, assistance with and review of documents filed with the SEC, Section 404 attest services, other attest services
that generally only the principal independent auditor can provide, work done by tax professionals in connection with the audit
or quarterly review, and accounting consultations billed as audit services, as well as other accounting and financial reporting
consultation research work necessary to comply with the standards of the PCAOB.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">Audit-related fees consist of the aggregate fees billed by the principal accountant in each of
the last two fiscal years for assurance and related services reasonably related to the performance of the audit or review.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">Tax fees consist of fees for tax compliance, tax advice, and tax planning services for those years.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">All other fees consist of the aggregate fees billed by the principal accountant in each of the
last two fiscal years for products and services other than the services reported herein.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">In considering the nature of the services provided by a principal
independent auditor, the Audit Committee determined that such services are compatible with the provision of independent audit services.
The Audit Committee discussed these services with the independent auditor and management to determine that they are permitted under
the rules and regulations concerning auditor independence promulgated by the SEC to implement the Sarbanes-Oxley Act of 2002, as
well as the American Institute of Certified Public Accountants.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Under its charter, the Audit Committee must pre-approve all audit
and permitted non-audit services to be provided by our principal independent auditor unless an exception to such pre-approval exists
under the Exchange Act or the rules of the SEC. Each year, the Audit Committee approves the retention of the independent auditor
to audit our financial statements, including the associated fee. The Audit Committee evaluates other known potential engagements
of the independent auditor, including the scope of audit-related services, tax services, and other services proposed to be performed
and the proposed fees, and approves or rejects each service, taking into account whether the services are permissible under applicable
law and the possible impact of each non-audit service on the independent auditor&rsquo;s independence from management. All such
services were approved by the Audit Committee pursuant to Rule&nbsp;2-01 of Regulation&nbsp;S-X under the Exchange Act to the extent
that rule was applicable. Since May 2003, each new engagement of a principal independent auditor has been approved in advance by
the Audit Committee.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 14pt">PROPOSAL
5: ADVISORY VOTE ON EXECUTIVE COMPENSATION</FONT></P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">In accordance with Section&nbsp;14A of the Exchange Act, we are
providing our stockholders with the opportunity to vote on a non-binding, advisory resolution to approve the compensation of our
Named Executive Officers, which is described in the section titled &ldquo;Compensation Discussion and Analysis&rdquo; in this Proxy
Statement. We currently hold this vote annually.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">As described in &ldquo;Compensation Discussion and Analysis,&rdquo;
our executive compensation program is designed to attract and retain highly qualified executive officers and motivate them to provide
a high level of performance for the benefit of our company and stockholders. Stockholders are urged to read &ldquo;Compensation
Discussion and Analysis,&rdquo; which more thoroughly discusses how our compensation policies and procedures implement our compensation
philosophy and objectives. The Compensation Committee and the Board of Directors believe that these policies and procedures are
effective in implementing our compensation philosophy and in achieving our objectives.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Accordingly, the following resolution is submitted for a stockholder
vote at the Annual Meeting:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 1in">&ldquo;RESOLVED:</TD><TD STYLE="text-align: justify; padding-right: 0.25in">That the stockholders of Anika Therapeutics, Inc. approve, on an advisory
basis, the compensation paid to the Named Executive Officers of Anika Therapeutics, Inc. as disclosed pursuant to Item&nbsp;402
of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables, and narrative discussion set forth
in the Proxy Statement for the 2018 Annual Meeting of Stockholders.&rdquo;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">This vote is advisory and will not be binding upon us or the Board.
However, the Board values constructive dialogue on executive compensation, and on other important governance topics, with stockholders
and encourages all stockholders to vote their shares on this matter.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><FONT STYLE="font-size: 12pt"><I>Vote Required</I></FONT><I> </I></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The affirmative vote of the holders of a majority of the shares
of common stock present or represented at the Annual Meeting and voting on the matter is required to approve this resolution. Abstentions
and broker non-votes, if any, will not be treated as votes cast and will have no impact on this proposal. While this vote is required
by law, it will not be binding on us or the Board of Directors, nor will it create or imply any change in the fiduciary duties
of, or impose any additional fiduciary duty on, our company or the Board. However, the Compensation Committee will take into account
the outcome of the vote when considering future executive compensation decisions.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><FONT STYLE="font-size: 12pt"><I>Board Recommendation</I></FONT><I>
</I></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><B>THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT STOCKHOLDERS
VOTE TO APPROVE THE OVERALL COMPENSATION OF THE NAMED EXECUTIVE OFFICERS BY VOTING &ldquo;FOR&rdquo; THIS RESOLUTION.</B></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 14pt">OTHER
MATTERS</FONT></P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The Board of Directors does not know of any other matters that will
come before the Annual Meeting. However, if any other matters are properly presented at the Annual Meeting, it is the intention
of the persons named in the accompanying proxy card to vote, or otherwise act, in accordance with their judgment on such matters.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 14pt">SOLICITATION
EXPENSES</FONT></P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">All costs of solicitation of proxies will be borne by us. We have
retained Georgeson, Inc., an independent proxy solicitation firm, to assist us in soliciting proxies for an estimated fee of $15,000,
plus reimbursement of reasonable expenses. In addition to solicitation by mail, our directors, officers, and employees, without
additional remuneration, may solicit proxies in person or by telephone, e-mail, and facsimile. We will reimburse banks, brokerage
firms, and other custodians, nominees, trustees, and fiduciaries for reasonable out-of-pocket expenses incurred by them in sending
proxy materials to and soliciting proxies from beneficial holders of our shares.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 14pt">STOCKHOLDER
PROPOSALS</FONT></P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Stockholder proposals intended to be presented at the next Annual
Meeting of Stockholders must be received by us on or before December&nbsp;17, 2018 in order to be considered for inclusion in our
proxy statement. These proposals must also comply with the rules of the SEC governing the form and content of proposals in order
to be included in our proxy statement and form of proxy, and proposals should be directed to: Secretary, Anika Therapeutics,&nbsp;Inc.,
32 Wiggins Avenue, Bedford, Massachusetts 01730. A stockholder who wishes to present a proposal at the 2019 Annual Meeting of Stockholders,
other than a proposal to be considered for inclusion in our proxy statement described above, must have the proposal delivered personally
to or mailed to and received by the Secretary, Anika Therapeutics,&nbsp;Inc., 32 Wiggins Avenue, Bedford, Massachusetts 01730 U.S.A.
We must receive the proposal on or before March&nbsp;28, 2019, <I>provided</I> that such proposal shall not be required to be given
more than sixty days prior to the 2019 Annual Meeting of Stockholders. The proposal must also comply with the other requirements
contained in the Massachusetts By-laws, including supporting documentation and other information. Proxies solicited by the Board
of Directors will confer discretionary voting authority with respect to these proposals, subject to SEC rules governing the exercise
of this authority.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">The chairman of the meeting may, if the facts warrant, determine
and declare to the meeting that any proposed item of business was not brought before the meeting in accordance with the foregoing
procedure and, if such chairman should so determine, he or she shall so declare to the meeting that the defective item of business
shall be disregarded.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Pursuant to the rules of the SEC, services that deliver our communications
to stockholders that hold their shares through a bank, broker, or other nominee holder of record may deliver to multiple stockholders
sharing the same address a single copy of our 2017 Annual Report and this Proxy Statement. We will promptly deliver upon written
request a separate copy of the 2017 Annual Report and/or this Proxy Statement to any stockholder at a shared address to which a
single copy of the documents was delivered. Written requests should be made to Anika Therapeutics, Inc., 32 Wiggins Avenue, Bedford,
MA 01730, Attention: Secretary. Any stockholder who wishes to receive separate copies of the 2017 Annual Report or this Proxy Statement
in the future, or any stockholder who is receiving multiple copies and would like to receive only one copy per household, should
contact the stockholder&rsquo;s bank, broker, or other nominee holder of record.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">STOCKHOLDERS MAY OBTAIN, WITHOUT CHARGE, A COPY OF OUR ANNUAL REPORT
ON FORM&nbsp;10-K, INCLUDING THE FINANCIAL STATEMENTS CONTAINED THEREIN, FILED WITH THE SEC FOR THE YEAR ENDED DECEMBER 31, 2017,
BY WRITING TO OUR SECRETARY AT ANIKA THERAPEUTICS,&nbsp;INC., 32 WIGGINS AVENUE, BEDFORD, MA 01730.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 14pt">APPENDIX
A</FONT></P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>PLAN OF DOMESTICATION</B><BR>
<B>OF</B><BR>
<B>ANIKA THERAPEUTICS, INC.</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">This
Plan of Domestication</FONT> has been adopted by Anika Therapeutics, Inc., a Massachusetts corporation (the &ldquo;<I>Company</I>&rdquo;),
as of March&nbsp;[<FONT STYLE="font-family: Wingdings">&Yuml;</FONT>], 2018.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Whereas</FONT>,
the Company is a corporation duly organized and existing under the laws of the Commonwealth of Massachusetts and is authorized
to issue 60,000,000 shares of Common Stock, par value $0.01 per share (the &ldquo;<I>Common Stock</I>&rdquo;) and 1,250,000 shares
of Preferred Stock, par value $0.01 per share (the &ldquo;<I>Preferred Stock</I>&rdquo;);</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Whereas</FONT>,
the Company wishes to change its domicile of incorporation from Massachusetts to Delaware by domesticating in Delaware on the terms
set forth herein; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Whereas</FONT>,
the Board of Directors of the Company (the &ldquo;<I>Board</I>&rdquo;) has adopted a resolution approving this Plan of Domestication;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Now, therefore</FONT>, the
Company agrees as follows:</P>

<P STYLE="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 23.75pt; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><FONT STYLE="font-size: 10pt"><U>Domestication</U>. The Company shall reincorporate from Massachusetts to Delaware
by domesticating in Delaware pursuant to Section 265 of the Delaware General Corporation Law and Section 9.20 of the Massachusetts
Business Corporations Act. Following the domestication, the Company shall be governed by the laws of the State of Delaware. The
domestication of the Company in Delaware is referred to as the &ldquo;<I>Domestication</I>.&rdquo;</FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 23.75pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 23.75pt; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><FONT STYLE="font-size: 10pt"><U>Stockholder Approval</U>. T</FONT><FONT STYLE="font-size: 10pt">he Company shall
submit this Plan of Domestication to its stockholders for approval at the Company&rsquo;s 2018 Annual Meeting of Stockholders.</FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 23.75pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 23.75pt; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><FONT STYLE="font-size: 10pt"><U>Effective Date</U>. </FONT><FONT STYLE="font-size: 10pt">The Domestication shall
be effective upon the filing of a Certificate of Conversion from a Non-Delaware Corporation to a Delaware Corporation (the &ldquo;<I>Certificate
of Conversion</I>&rdquo;) with the Secretary of State of the State of Delaware and the filing of Articles of Charter Surrender
with the Secretary of the Commonwealth of the Commonwealth of Massachusetts, which filings shall be made as soon as practicable
after all required stockholder approvals have been obtained. The time of such effectiveness is referred to as the &ldquo;<I>Effective
Date</I>.&rdquo;</FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 23.75pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 23.75pt; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><FONT STYLE="font-size: 10pt"><U>Common Stock</U>. </FONT><FONT STYLE="font-size: 10pt">On the Effective Date, by
virtue of the Domestication and without any action on the part of the holders thereof, each share of Common Stock of the Company
issued and outstanding immediately prior thereto shall be unchanged, shall continue to represent one share of Common Stock of the
Company as a Delaware corporation, and shall remain issued and outstanding immediately after consummation of the Domestication.</FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 23.75pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 23.75pt; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><FONT STYLE="font-size: 10pt"><U>Options and Restricted Equity</U>. </FONT><FONT STYLE="font-size: 10pt">On the Effective
Date, by virtue of the Domestication and without any action on the part of the holders thereof, all stock options, stock appreciation
rights, restricted stock units and other restricted equity outstanding and unexercised as of the Effective Date and awarded under
the Company&rsquo;s equity plans in effect on the Effective Date shall continue and remain in effect upon the same terms and conditions
as were in effect immediately prior to the Domestication, and the Company shall continue to reserve that number of shares of Common
Stock with respect to each such equity plan as was reserved by the Company prior to the Effective Date with no other changes in
the terms and conditions thereof.</FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 23.75pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 23.75pt; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">6.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><FONT STYLE="font-size: 10pt"><U>Stock Certificates</U>. </FONT><FONT STYLE="font-size: 10pt">On and after the Effective
Date, all of the outstanding certificates that prior to that time represented shares of the Common Stock of the Company shall be
deemed for all purposes to continue to evidence ownership of and to represent the shares of the Company into which the shares represented
by such certificates have been converted as herein provided. The registered owner on the books and records of the Company or its
transfer agent of any such outstanding stock certificate shall, until such certificate shall have been surrendered for transfer
or conversion or otherwise accounted for to the Company or its transfer agent, have and be entitled to exercise any voting and
other rights with respect to and to receive any dividend and other distributions upon the shares of the Company evidenced by such
outstanding certificate as above provided.</FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 23.75pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 23.75pt; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">7.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><FONT STYLE="font-size: 10pt"><U>Succession</U>. </FONT><FONT STYLE="font-size: 10pt">On the Effective Date, all
of the rights, privileges, debts, liabilities, powers and property of the Company as a Massachusetts corporation shall continue
to be the rights, privileges, debts, liabilities, powers and property of the Company as a Delaware corporation in the manner and
as more fully set forth in Section 265 of the Delaware General Corporation Law. Without limiting the foregoing, upon the Effective
Date, all property, rights, privileges, franchises, patents, trademarks, licenses, registrations, agreements, contracts and other
assets of every kind and description of the Company shall continue to be vested in and devolved upon the Company without further
act or deed. All rights of creditors of the Company and all liens upon any property of the Company shall be preserved unimpaired,
and all debts, liabilities and duties of the Company shall continue to be obligations of the Company.</FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 23.75pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 23.75pt; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 23.75pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 23.75pt; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">8.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><FONT STYLE="font-size: 10pt"><U>Certificate of Incorporation and By-laws</U>. </FONT><FONT STYLE="font-size: 10pt">Immediately
prior to or simultaneously with the filing of the Certificate of Conversion, the Company shall file the Certificate of Incorporation
in the form of <FONT STYLE="font-variant: small-caps"><U>Exhibit A</U></FONT> hereto (the &ldquo;<I>Certificate of Incorporation</I>&rdquo;)
with the Secretary of State of the State of Delaware, which shall become the Certificate of Incorporation of the Company as of
the Effective Date. The Bylaws set forth as <FONT STYLE="font-variant: small-caps"><U>Exhibit B</U></FONT> hereto (the &ldquo;<I>Bylaws</I>&rdquo;)
shall become the Bylaws of the Company as of the Effective Date.</FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 23.75pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 23.75pt; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">9.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><FONT STYLE="font-size: 10pt"><U>Directors and Officers</U>. </FONT><FONT STYLE="font-size: 10pt">The members of
the Board and the officers of the Company immediately prior to the Effective Date shall continue in office following the Effective
Date until the expiration of their respective terms of office and until their successors have been elected and qualified.</FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 23.75pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 23.75pt; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">10.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><FONT STYLE="font-size: 10pt"><U>Amendment</U>. </FONT><FONT STYLE="font-size: 10pt">This Plan of Domestication may
be amended by the Board at any time prior to the Effective Date, provided that an amendment made subsequent to the approval of
this plan by the stockholders of the Company shall not alter or change (a) the amount or kind of shares or other securities, obligations,
rights to acquire shares or other securities, cash, or other property to be received by the stockholders hereunder, (b) any term
of the Certificate of Incorporation or the Bylaws, other than changes permitted by the Delaware General Corporation Law comparable
to those permitted by Section 10.05 of the Massachusetts Business Corporation Act, or (c) any of the terms and conditions of this
Plan of Domestication if such alteration or change would adversely affect the holders of any class or series of stock of the Company
in any material respect.</FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 23.75pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 23.75pt; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">11.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><FONT STYLE="font-size: 10pt"><U>Abandonment or Deferral</U>. </FONT><FONT STYLE="font-size: 10pt">At any time before
the Effective Date, this Plan of Domestication may be terminated and the Domestication may be abandoned by the Board, notwithstanding
the approval of this Plan of Domestication by the stockholders of the Company or the consummation of the Domestication may be deferred
for a reasonable period of time if, in the opinion of the Board, such action would be in the best interests of the Company. In
the event of termination of this Plan of Domestication, this Plan of Domestication shall become void and of no effect and there
shall be no liability on the part of the Company, the Board or the Company&rsquo;s stockholders with respect thereto, except that
the Company shall pay all expenses incurred in connection with the Domestication or in respect of this Plan of Domestication or
relating thereto.</FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 23.75pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0">This Plan of Domestication has been adopted by the
Board as of March 23, 2018.</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">In Witness
Whereof</FONT>, the undersigned has caused this Plan of Domestication to be signed as of _________________, 2018.</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; vertical-align: middle; text-align: left"><FONT STYLE="font-variant: small-caps">Anika Therapeutics, Inc.<FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">&nbsp;</FONT></FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: middle; text-align: left">&nbsp;&nbsp;(a Massachusetts Corporation)</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 50%">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left; width: 3%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: left; width: 27%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 20%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: left">By:</TD>
    <TD STYLE="vertical-align: bottom; text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: middle; text-align: left">Chief Executive Officer and President</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><I></I></B></P>

<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 14pt">APPENDIX
B</FONT></P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>CERTIFICATE OF INCORPORATION</B><BR>
<B>OF</B><BR>
<B>ANIKA THERAPEUTICS, INC.</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Article I</FONT></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The name of this corporation is Anika Therapeutics,
Inc. (the &ldquo;<I>Corporation</I>&rdquo;).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Article II</FONT></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The address of the Corporation&rsquo;s registered
office in the State of Delaware is 251 Little Falls Drive, Wilmington, County of New Castle, Delaware 19808. The name of its registered
agent at such address is Corporation Service Company.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Article III</FONT></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The purpose of the Corporation is to engage
in any lawful act or activity for which a corporation may be organized under the General Corporation Law of the State of Delaware
(the &ldquo;<I>General Corporation Law</I>&rdquo;).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Article IV</FONT></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Classes
of Stock and Authorized Shares</U>. The Corporation is authorized to issue two classes of capital stock to be designated, respectively,
Common Stock, par value $0.01 per share (&ldquo;<I>Common Stock</I>&rdquo;), and Preferred Stock, par value $0.01 per share (&ldquo;<I>Preferred
Stock</I>&rdquo;). The total number of shares of capital stock that the Corporation is authorized to issue is ____________, of
which ____________ shares shall be Common Stock and 1,250,000 shares shall be Preferred Stock.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Rights,
Powers, Preferences and Restrictions of Preferred Stock</U>. The Board of Directors is hereby expressly authorized, by resolution
or resolutions thereof and the filing of a certificate pursuant to the General Corporation Law (a &ldquo;<I>Preferred Stock Designation</I>&rdquo;),
to provide, out of the unissued shares of Preferred Stock, for one or more series of Preferred Stock and, with respect to each
such series, to fix the number of shares constituting such series and the designation of such series, the voting powers, if any,
of the shares of such series, and the preferences and relative, participating, optional or other special rights, if any, and any
qualifications, limitations or restrictions thereof, of the shares of such series. The number of authorized shares of Preferred
Stock may be increased or decreased (but not below the number of shares thereof then outstanding) by the affirmative vote of the
holders of a majority of the voting power of the capital stock of the Corporation entitled to vote thereon, voting as a single
class, irrespective of the provisions of Section&nbsp;242(b)(2) of the General Corporation Law.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Rights
of Common Stock</U>. The relative powers, rights, qualifications, limitations and restrictions granted to or imposed on the shares
of Common Stock are as follows:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0 0pt 0.25in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>General</U>.
The voting powers and dividend and liquidation rights and preferences, if any, of the holders of Common Stock are subject to and
qualified by the rights of the holders of Preferred Stock of any series as may be designated by the Board of Directors upon any
issuance of Preferred Stock of any series.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0 0pt 0.25in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Voting
Rights</U>. Except as may be otherwise provided by this Certificate of Incorporation, a Preferred Stock Designation or by applicable
law, the holders of Common Stock shall be entitled to one vote for each share upon each matter presented to the stockholders of
the Corporation&#894; <I>provided</I> that, except as otherwise required by law, holders of Common Stock shall not be entitled
to vote on any amendment to this Certificate of Incorporation or a Preferred Stock Designation that relates solely to the terms
of one or more outstanding series of Preferred Stock if the holders of such affected series are entitled, either separately or
together as a class with the holders of one or more other such series, to vote thereon pursuant to this Certificate of Incorporation,
a Preferred Stock Designation or the General Corporation Law. The number of authorized shares of Common Stock may be increased
or decreased (but not below the number of shares thereof then outstanding) by the affirmative vote of the holders of a majority
of the voting power of the capital stock of the Corporation entitled to vote thereon, voting as a single class, irrespective of
the provisions of Section 242(b)(2) of the General Corporation Law.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0 0pt 0.25in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Dividends</U>.
Dividends may be declared and paid on Common Stock from funds lawfully available therefor as and when determined by the Board of
Directors and subject to any preferential dividend or other rights of any then outstanding Preferred Stock and to the requirements
of applicable law.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0 0pt 0.25in"></P>

<!-- Field: Page; Sequence: 58; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0 0pt 0.25in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Liquidation</U>.
Upon the dissolution or liquidation of the Corporation, whether voluntary or involuntary, holders of Common Stock will be entitled
to receive all assets of the Corporation available for distribution to its stockholders, subject to any preferential or other rights
of any then outstanding Preferred Stock.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Article V</FONT></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment
of Bylaws by Board</U>. In furtherance and not in limitation of the powers conferred upon it by the General Corporation Law, and
subject to the terms of any Preferred Stock Designation, the Board of Directors is expressly authorized and empowered to adopt,
amend or repeal the Bylaws of the Corporation.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment
of Bylaws by Stockholders</U>. In addition to the amendment of the Bylaws by the Board of Directors pursuant to <U>Section A</U>
of this <U>Article V</U>, the stockholders of the Corporation also may amend the Bylaws pursuant to this Section B of this <U>Article
V</U>; <I>provided, however</I>, that, in addition to any other vote required by this Certificate of Incorporation, a Preferred
Stock Designation or the Bylaws of the Corporation, the stockholders may not adopt, amend, alter or repeal <U>Article I</U>, <U>II</U>,
<U>VI</U> or <U>VIII</U> or <U>Section&nbsp;7.6</U> of the Bylaws, or adopt any provision inconsistent therewith, unless such action
is approved by the affirmative vote of at least seventy-five percent of the outstanding voting power of the then-outstanding shares
of capital stock of the Corporation entitled to vote thereon.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Article VI</FONT></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Authority
of Board</U>. The business and affairs of the Corporation shall be managed by or under the direction of the Board of Directors.
In addition to the powers and authority expressly conferred by statute or by this Certificate of Incorporation or the Bylaws of
the Corporation, the Board of Directors is hereby empowered to exercise all such powers and do all such acts and things as may
be exercised or done by the Corporation.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Board
Size</U>. Subject to the rights of the holders of any series of Preferred Stock to elect additional directors pursuant to any Preferred
Stock Designation, the total number of authorized directors constituting the Board of Directors shall consist of not less than
three members nor more than nine members. The number of directors may be decreased at any time and from time to time by a majority
of the directors then in office, but only to eliminate vacancies existing by reason of the death, resignation, removal or expiration
of the term of one or more directors.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Classified
Board Structure</U>. The directors, other than any who may be elected by the holders of any series of Preferred Stock pursuant
to any Preferred Stock Designation (&ldquo;<I>Preferred Stock Directors</I>&rdquo;), shall be divided into three classes hereby
designated Class I, Class II and Class III, as nearly equal in number as possible. No one class shall have more than one director
more than any other class. The Board of Directors may assign members of the Board of Directors already in office to such classes
at the time such classification becomes effective. The term of office of the initial Class I directors shall expire at the first
annual meeting of the stockholders following the effectiveness of this Certificate of Incorporation (the &ldquo;<I>Effective Time</I>&rdquo;),
the term of office of the initial Class II directors shall expire at the second annual meeting of the stockholders following the
Effective Time, and the term of office of the initial Class III directors shall expire at the third annual meeting of the stockholders
following the Effective Time. At each annual meeting of stockholders, commencing with the first annual meeting of stockholders
following the Effective Time, each of the successors elected to replace the directors of a Class whose term shall have expired
at such annual meeting shall be elected to hold office until the third annual meeting next succeeding his or her election and until
his or her respective successor shall have been duly elected and qualified or until his or her earlier death, resignation, or removal.
In case of any increase or decrease, from time to time, in the number of directors (other than any Preferred Stock Directors),
the number of directors in each class shall be apportioned as nearly equal as possible so that no one class has more than one director
more than any other class.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Removal;
Vacancies</U>. Any director (other than any Preferred Stock Director) may be removed from office by the stockholders of the Corporation
only for cause by the affirmative vote of the holders of at least seventy-five percent of the outstanding voting power of the stockholders
entitled to vote thereon. Vacancies occurring on the Board of Directors for any reason and newly created directorships resulting
from an increase in the authorized number of directors may be filled exclusively pursuant to a resolution adopted by the Board
of Directors and not by the stockholders. A person elected to fill a vacancy or newly created directorship shall hold office until
the next election of the class for which such director shall have been chosen and until his or her successor shall be duly elected
and qualified.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">E.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Quorum;
Vote Required for Action</U>. At all meetings of the Board of Directors, the directors entitled to cast a majority of the votes
of the he total number of authorized directors, whether or not there exist any vacancies, in previously authorized directorships
shall constitute a quorum for the transaction of business. In the event one or more of the directors shall be disqualified to vote
at any meeting, then the required quorum shall be reduced by one for each such director so disqualified; <I>provided, however,</I>
that in no case shall less than one-third of the total number of directors constitute a quorum. In the absence of a quorum at any
such meeting, a majority of the directors present may adjourn the meeting from time to time without further notice other than announcement
at the meeting, until a quorum shall be present. Except in cases in which this Certificate of Incorporation, the Bylaws of the
Corporation or applicable law otherwise provides, a majority of the votes entitled to be cast by the directors present at a meeting
at which a quorum is present shall be the act of the Board of Directors.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 59; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Article VII</FONT></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">No stockholder will be permitted to cumulate
votes in any election of directors.&nbsp;The election of directors need not be by written ballot unless the Bylaws of the Corporation
shall so provide.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Article VIII</FONT></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Special
Meetings</U>. Special meetings of the stockholders may be called only by the President of the Corporation or the Chairman of the
Board of Directors of the Corporation. Business transacted at any special meeting of stockholders shall be limited to the purposes
stated in the notice.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Stockholder Action by Written Consent</U>. Subject to the rights of the holders of any series of Preferred Stock, any action required
or permitted to be taken by the stockholders of the Corporation must be effected at a duly called annual or special meeting of
the stockholders of the Corporation and may not be effected by any consent in writing (or by electronic communication) by such
stockholders.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Article IX</FONT></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Corporation shall indemnify (and advance expenses to) its officers and directors to the full extent permitted by the General Corporation
Law, as amended from time to time.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the fullest extent permitted by law, no director of the Corporation shall be personally liable to the Corporation or its stockholders
for monetary damages for any breach of fiduciary duty as a director, notwithstanding any provision of law imposing such liability.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">C. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
amendment to or repeal of this provision, nor the adoption of any provision of the Certificate of Incorporation inconsistent with
this&nbsp;<U>Article&nbsp;IX</U>, shall apply to or have any effect on (1) the liability or alleged liability of any director of
the Corporation or the (2) indemnification and advancement rights of any director or officer, in each case, for or with respect
to any acts or omissions of such director or officer occurring prior to such amendment or repeal. If the General Corporation Law
is amended to permit further elimination or limitation of the personal liability of directors or to permit greater indemnification
or advancement rights of directors and officers, then the directors and officers of the Corporation shall be protected from liability
(whether through exculpation, indemnification or advancement rights) to the fullest extent permitted by the General Corporation
Law as so amended.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Article X</FONT></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Corporation reserves the right to amend,
alter, change or repeal any provision contained in this Certificate of Incorporation, in the manner now or hereafter prescribed
by statute, and all rights conferred upon stockholders herein are granted subject to this reservation. Notwithstanding any other
provision of this Certificate of Incorporation or applicable law and in addition to any affirmative vote of the holders of any
particular class of capital stock of the Corporation required by applicable law or by a Preferred Stock Designation or this Certificate
of Incorporation, the affirmative vote of the holders of at least seventy-five percent of the voting power of the shares of the
then outstanding voting stock of the Corporation entitled to vote thereon, voting together as a single class, shall be required
to amend alter or repeal <U>Articles V</U>, <U>VI</U>, <U>VIII</U> or <U>IX,</U> or this <U>Article X</U>, of this Certificate
of Incorporation.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Article XII</FONT></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The name and mailing address of the incorporator
are as follows:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: middle">
    <TD STYLE="width: 20%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 15%"><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 65%"><FONT STYLE="font-size: 10pt">Joseph Darling</FONT></TD></TR>
<TR STYLE="vertical-align: middle">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD NOWRAP STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Mailing Address:&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">32 Wiggins Avenue</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; vertical-align: middle"><FONT STYLE="font-size: 10pt">Bedford, Massachusetts 01730</FONT></TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">* * *</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 60; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">In Witness
Whereof</FONT>, this Certificate of Incorporation has been signed on behalf of the Corporation by the sole incorporator as of March
__, 2018.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 28%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 22%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>Sole Incorporator</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><I></I></B></P>

<!-- Field: Page; Sequence: 61; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0"><FONT STYLE="font-size: 14pt">APPENDIX
C</FONT></P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #365F91; font-size: 10pt; font-style: italic; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>BYLAWS </B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>OF </B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>ANIKA THERAPEUTICS, INC.</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0"><I>(Adopted as of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2018)</I></P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 62; Options: NewSection; Value: 58 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Table
of Contents</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 9%">&nbsp;</TD>
    <TD STYLE="width: 82%">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-decoration: underline; text-align: right; width: 7%">Page</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD COLSPAN="3" STYLE="color: #010000"><FONT STYLE="text-transform: uppercase">ARTICLE I <FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">Meetings of Stockholders</FONT></FONT></TD>
    <TD STYLE="text-align: right">1</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 1.1.</TD>
    <TD STYLE="vertical-align: middle">Annual Meetings</TD>
    <TD STYLE="vertical-align: middle; text-align: right">1</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 1.2.</TD>
    <TD STYLE="vertical-align: middle">Special Meetings</TD>
    <TD STYLE="vertical-align: middle; text-align: right">1</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 1.3.</TD>
    <TD STYLE="vertical-align: middle">Notice of Meetings</TD>
    <TD STYLE="vertical-align: middle; text-align: right">1</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 1.4.</TD>
    <TD STYLE="vertical-align: middle">Adjournments</TD>
    <TD STYLE="vertical-align: middle; text-align: right">1</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 1.5.</TD>
    <TD STYLE="vertical-align: middle">Quorum</TD>
    <TD STYLE="vertical-align: middle; text-align: right">1</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 1.6.</TD>
    <TD STYLE="vertical-align: middle">Organization</TD>
    <TD STYLE="vertical-align: middle; text-align: right">1</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 1.7.</TD>
    <TD STYLE="vertical-align: middle">Voting; Proxies</TD>
    <TD STYLE="vertical-align: middle; text-align: right">1</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 1.8.</TD>
    <TD STYLE="vertical-align: middle">Fixing Date for Determination of Stockholders of Record</TD>
    <TD STYLE="vertical-align: middle; text-align: right">2</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 1.9.</TD>
    <TD STYLE="vertical-align: middle">List of Stockholders Entitled to Vote</TD>
    <TD STYLE="vertical-align: middle; text-align: right">2</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 1.10.</TD>
    <TD STYLE="vertical-align: middle">Action by Written or Electronic Consent of Stockholders</TD>
    <TD STYLE="vertical-align: middle; text-align: right">2</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 1.11.</TD>
    <TD STYLE="vertical-align: middle">Inspectors of Election</TD>
    <TD STYLE="vertical-align: middle; text-align: right">2</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 1.12.</TD>
    <TD STYLE="vertical-align: middle">Conduct of Meetings</TD>
    <TD STYLE="vertical-align: middle; text-align: right">3</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-bottom: 6pt">&nbsp;</TD>
    <TD NOWRAP STYLE="color: #010000; vertical-align: middle; padding-bottom: 6pt">Section 1.13.</TD>
    <TD STYLE="vertical-align: middle; padding-bottom: 6pt">Notice of Stockholder Business and Nominations</TD>
    <TD STYLE="vertical-align: middle; text-align: right; padding-bottom: 6pt">3</TD></TR>
<TR>
    <TD COLSPAN="3" STYLE="color: #010000; vertical-align: middle"><FONT STYLE="text-transform: uppercase">ARTICLE II </FONT><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">Board</FONT></TD>
    <TD STYLE="vertical-align: middle; text-align: right">5</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 2.1.</TD>
    <TD STYLE="vertical-align: middle">Number; Qualifications</TD>
    <TD STYLE="vertical-align: middle; text-align: right">5</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 2.2.</TD>
    <TD STYLE="vertical-align: middle">Classification; Resignation; Vacancies</TD>
    <TD STYLE="vertical-align: middle; text-align: right">6</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 2.3.</TD>
    <TD STYLE="vertical-align: middle">Removal</TD>
    <TD STYLE="vertical-align: middle; text-align: right">6</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 2.4.</TD>
    <TD STYLE="vertical-align: middle">Regular Meetings</TD>
    <TD STYLE="vertical-align: middle; text-align: right">6</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 2.5.</TD>
    <TD STYLE="vertical-align: middle">Special Meetings</TD>
    <TD STYLE="vertical-align: middle; text-align: right">6</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 2.6.</TD>
    <TD STYLE="vertical-align: middle">Telephonic Meetings Permitted</TD>
    <TD STYLE="vertical-align: middle; text-align: right">6</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 2.7.</TD>
    <TD STYLE="vertical-align: middle">Quorum; Vote Required for Action</TD>
    <TD STYLE="vertical-align: middle; text-align: right">6</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 2.8.</TD>
    <TD STYLE="vertical-align: middle">Organization</TD>
    <TD STYLE="vertical-align: middle; text-align: right">6</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 2.9.</TD>
    <TD STYLE="vertical-align: middle">Action by Unanimous Consent of Directors</TD>
    <TD STYLE="vertical-align: middle; text-align: right">6</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-bottom: 6pt">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle; padding-bottom: 6pt">Section 2.10.</TD>
    <TD STYLE="vertical-align: middle; padding-bottom: 6pt">Chair and Vice Chair of the Board</TD>
    <TD STYLE="vertical-align: middle; text-align: right; padding-bottom: 6pt">6</TD></TR>
<TR>
    <TD COLSPAN="3" STYLE="color: #010000; vertical-align: middle"><FONT STYLE="text-transform: uppercase">ARTICLE III </FONT><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">Committees</FONT></TD>
    <TD STYLE="vertical-align: middle; text-align: right">7</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 3.1.</TD>
    <TD STYLE="vertical-align: middle">Committees</TD>
    <TD STYLE="vertical-align: middle; text-align: right">7</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-bottom: 6pt">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle; padding-bottom: 6pt">Section 3.2.</TD>
    <TD STYLE="vertical-align: middle; padding-bottom: 6pt">Committee Rules</TD>
    <TD STYLE="vertical-align: middle; text-align: right; padding-bottom: 6pt">7</TD></TR>
<TR>
    <TD COLSPAN="3" STYLE="color: #010000; vertical-align: middle"><FONT STYLE="text-transform: uppercase">ARTICLE IV </FONT><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">Officers</FONT></TD>
    <TD STYLE="vertical-align: middle; text-align: right">7</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 4.1.</TD>
    <TD STYLE="vertical-align: middle">Officers</TD>
    <TD STYLE="vertical-align: middle; text-align: right">7</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 4.2.</TD>
    <TD STYLE="vertical-align: middle">Removal, Resignation and Vacancies</TD>
    <TD STYLE="vertical-align: middle; text-align: right">7</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 4.3.</TD>
    <TD STYLE="vertical-align: middle">Chief Executive Officer</TD>
    <TD STYLE="vertical-align: middle; text-align: right">7</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 4.4.</TD>
    <TD STYLE="vertical-align: middle">President</TD>
    <TD STYLE="vertical-align: middle; text-align: right">7</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 4.5.</TD>
    <TD STYLE="vertical-align: middle">Chief Operating Officer</TD>
    <TD STYLE="vertical-align: middle; text-align: right">7</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 4.6.</TD>
    <TD STYLE="vertical-align: middle">Chief Financial Officer</TD>
    <TD STYLE="vertical-align: middle; text-align: right">7</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 4.7.</TD>
    <TD STYLE="vertical-align: middle">Vice Presidents</TD>
    <TD STYLE="vertical-align: middle; text-align: right">8</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 4.8.</TD>
    <TD STYLE="vertical-align: middle">Treasurer</TD>
    <TD STYLE="vertical-align: middle; text-align: right">8</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 4.9.</TD>
    <TD STYLE="vertical-align: middle">Secretary</TD>
    <TD STYLE="vertical-align: middle; text-align: right">8</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 4.10.</TD>
    <TD STYLE="vertical-align: middle">Additional Matters</TD>
    <TD STYLE="vertical-align: middle; text-align: right">8</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-bottom: 6pt">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle; padding-bottom: 6pt">Section 4.11.</TD>
    <TD STYLE="vertical-align: middle; padding-bottom: 6pt">Execution of Contracts and Instruments</TD>
    <TD STYLE="vertical-align: middle; text-align: right; padding-bottom: 6pt">8</TD></TR>
<TR>
    <TD COLSPAN="3" STYLE="color: #010000; vertical-align: middle"><FONT STYLE="text-transform: uppercase">ARTICLE V </FONT><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">Stock</FONT></TD>
    <TD STYLE="vertical-align: middle; text-align: right">8</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 5.1.</TD>
    <TD STYLE="vertical-align: middle">Certificates</TD>
    <TD STYLE="vertical-align: middle; text-align: right">8</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-bottom: 6pt">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle; padding-bottom: 6pt">Section 5.2.</TD>
    <TD STYLE="vertical-align: middle; padding-bottom: 6pt">Lost, Stolen or Destroyed Stock Certificates; Issuance of New Certificates</TD>
    <TD STYLE="vertical-align: middle; text-align: right; padding-bottom: 6pt">9</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD COLSPAN="3" STYLE="color: #010000"><FONT STYLE="text-transform: uppercase">ARTICLE VI </FONT><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">Indemnification and Advancement of Expenses</FONT></TD>
    <TD STYLE="text-align: right">9</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 6.1.</TD>
    <TD STYLE="vertical-align: middle">Right to Indemnification</TD>
    <TD STYLE="vertical-align: middle; text-align: right">9</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 6.2.</TD>
    <TD STYLE="vertical-align: middle">Prepayment of Expenses</TD>
    <TD STYLE="vertical-align: middle; text-align: right">9</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 6.3.</TD>
    <TD STYLE="vertical-align: middle">Claims</TD>
    <TD STYLE="vertical-align: middle; text-align: right">9</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 6.4.</TD>
    <TD STYLE="vertical-align: middle">Nonexclusivity of Rights</TD>
    <TD STYLE="vertical-align: middle; text-align: right">9</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 6.5.</TD>
    <TD STYLE="vertical-align: middle">Other Sources</TD>
    <TD STYLE="vertical-align: middle; text-align: right">9</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 6.6.</TD>
    <TD STYLE="vertical-align: middle">Amendment or Repeal</TD>
    <TD STYLE="vertical-align: middle; text-align: right">9</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-bottom: 6pt">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle; padding-bottom: 6pt">Section 6.7.</TD>
    <TD STYLE="vertical-align: middle; padding-bottom: 6pt">Other Indemnification and Advancement of Expenses</TD>
    <TD STYLE="vertical-align: middle; text-align: right; padding-bottom: 6pt">9</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD COLSPAN="3" STYLE="color: #010000; padding-bottom: 6pt"><FONT STYLE="text-transform: uppercase">ARTICLE VII </FONT><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">Exclusive Forum</FONT></TD>
    <TD STYLE="text-align: right; padding-bottom: 6pt">10</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD COLSPAN="3" STYLE="color: #010000"><FONT STYLE="text-transform: uppercase">ARTICLE VIII </FONT><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">Miscellaneous</FONT></TD>
    <TD STYLE="text-align: right">10</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 8.1.</TD>
    <TD STYLE="vertical-align: middle">Fiscal Year</TD>
    <TD STYLE="vertical-align: middle; text-align: right">10</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 63; Options: NewSection; Value: 59 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="vertical-align: bottom; width: 2%">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle; width: 7%">Section 8.2.</TD>
    <TD STYLE="vertical-align: middle; width: 84%">Seal</TD>
    <TD STYLE="vertical-align: middle; text-align: right; width: 7%">10</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 8.3.</TD>
    <TD STYLE="vertical-align: middle">Method of Notice</TD>
    <TD STYLE="vertical-align: middle; text-align: right">10</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 8.4.</TD>
    <TD STYLE="vertical-align: middle">Waiver of Notice</TD>
    <TD STYLE="vertical-align: middle; text-align: right">10</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 8.5.</TD>
    <TD STYLE="vertical-align: middle">Form of Records</TD>
    <TD STYLE="vertical-align: middle; text-align: right">10</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 8.6.</TD>
    <TD STYLE="vertical-align: middle">Amendment of Bylaws</TD>
    <TD STYLE="vertical-align: middle; text-align: right">10</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 8.7.</TD>
    <TD STYLE="vertical-align: middle">Registered Stockholders</TD>
    <TD STYLE="vertical-align: middle; text-align: right">11</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 8.8.</TD>
    <TD STYLE="vertical-align: middle">Facsimile Signature</TD>
    <TD STYLE="vertical-align: middle; text-align: right">11</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="color: #010000; vertical-align: middle">Section 8.9.</TD>
    <TD STYLE="vertical-align: middle">Interpretation</TD>
    <TD STYLE="vertical-align: middle; text-align: right">11</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 64; Options: NewSection; Value: 60 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->60<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; font-weight: bold; text-align: right; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase; color: #010000">ARTICLE
I</FONT><BR>
Meetings of Stockholders</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 1.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Annual Meetings</U><FONT STYLE="font-size: 10pt">. If required by applicable law, an annual meeting of stockholders shall
be held for the election of directors at such date, time and place, if any, either within or without the State of Delaware, as
may be designated by resolution of the Board of Directors (the &ldquo;<I>Board</I>&rdquo;) of Anika Therapeutics, Inc., a Delaware
corporation (the &ldquo;<I>Corporation</I>&rdquo;) from time to time. Any other proper business may be transacted at the annual
meeting.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 1.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Special Meetings</U><FONT STYLE="font-size: 10pt">. Special meetings of stockholders for any purpose or purposes, unless
otherwise prescribed by statute or by the Corporation&rsquo;s certificate of incorporation, as amended, restated, supplemented
or otherwise modified (the &ldquo;<I>Certificate of Incorporation</I>&rdquo;), may be called at any time by the President or by the Chairman of the Board. Business transacted at any special meeting of stockholders shall be limited to the purposes
stated in the notice. </FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 1.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Notice of Meetings</U><FONT STYLE="font-size: 10pt">. Whenever stockholders are required or permitted to take any action
at a meeting, a notice of the meeting shall be given that shall state the place, if any, date and hour of the meeting, the means
of remote communications, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such
meeting, the record date for determining the stockholders entitled to vote at the meeting (if such date is different from the record
date for stockholders entitled to notice of the meeting) and, in the case of a special meeting, the purpose or purposes for which
the meeting is called. Unless otherwise provided by law, the Certificate of Incorporation or these Bylaws, the notice of any meeting
shall be given not less than ten nor more than sixty days before the date of the meeting to each stockholder entitled to vote at
the meeting as of the record date for determining the stockholders entitled to notice of the meeting. If mailed, such notice shall
be deemed to be given when deposited in the United States mail, postage prepaid, directed to the stockholder at such stockholder&rsquo;s
address as it appears on the records of the Corporation.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 1.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Adjournments</U><FONT STYLE="font-size: 10pt">. Any meeting of stockholders, annual or special, may adjourn from time
to time to reconvene at the same or some other place, and notice need not be given of any such adjourned meeting if the time and
place thereof are announced at the meeting at which the adjournment is taken. At the adjourned meeting the Corporation may transact
any business that might have been transacted at the original meeting. If the adjournment is for more than thirty days, a notice
of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting. If after the adjournment
a new record date for determination of stockholders entitled to vote is fixed for the adjourned meeting, the Board shall fix as
the record date for determining stockholders entitled to notice of such adjourned meeting the same or an earlier date as that fixed
for determination of stockholders entitled to vote at the adjourned meeting, and shall give notice of the adjourned meeting to
each stockholder of record as of the record date so fixed for notice of such adjourned meeting.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 1.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Quorum</U><FONT STYLE="font-size: 10pt">. Except as otherwise provided by law, the Certificate of Incorporation or these
Bylaws, at each meeting of stockholders the presence in person or by proxy of the holders of not less than majority in voting power
of the outstanding shares of stock entitled to vote at the meeting shall be necessary and sufficient to constitute a quorum. In
the absence of a quorum, then either (a)&nbsp;the chairperson of the meeting or (b) a majority in voting power of the stockholders
so present (in person or by proxy) and entitled to vote may adjourn the meeting from time to time in the manner provided in <U>Section&nbsp;1.4</U>
of these Bylaws until a quorum shall attend. Shares of its own stock belonging to the Corporation or to another corporation, if
a majority of the shares entitled to vote in the election of directors of such other corporation is held, directly or indirectly,
by the Corporation, shall neither be entitled to vote nor be counted for quorum purposes; <I>provided, however,</I> that the foregoing
shall not limit the right of the Corporation or any subsidiary of the Corporation to vote stock, including its own stock, held
by it in a fiduciary capacity.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 1.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Organization</U><FONT STYLE="font-size: 10pt">. Meetings of stockholders shall be presided over by the Chief Executive
Officer or, in his or her absence, by the President or, in his or her absence, by a Vice President or, in the absence of the foregoing
persons, by a chairperson designated by the Board or, in the absence of such designation, by a chairperson chosen at the meeting.
The Secretary shall act as secretary of the meeting, but in his or her absence the chairperson of the meeting may appoint any person
to act as secretary of the meeting.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 1.7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Voting; Proxies</U><FONT STYLE="font-size: 10pt">. Except as otherwise provided by or pursuant to the provisions of the
Certificate of Incorporation, each stockholder entitled to vote at any meeting of stockholders shall be entitled to one vote for
each share of stock held by such stockholder that has voting power upon the matter in question. Each stockholder entitled to vote
at a meeting of stockholders may authorize another person or persons to act for such stockholder by proxy, but no such proxy shall
be voted or acted upon after three years from its date, unless the proxy provides for a longer period. A proxy shall be irrevocable
if it states that it is irrevocable and if, and only as long as, it is coupled with an interest sufficient in law to support an
irrevocable power. A stockholder may revoke any proxy that is not irrevocable by attending the meeting and voting in person or
by delivering to the Secretary of the Corporation a revocation of the proxy or a new proxy bearing a later date. Voting at meetings
of stockholders need not be by written ballot. At meetings of stockholders for the election of directors at which a quorum is present
where the number of director nominees is equal to the number of positions on the Board to be filled through election and proxies
are solicited for such election of directors solely by the Corporation, the affirmative vote of a majority in voting power of the
shares of stock of the Corporation that are voting in the election of directors shall be required to elect. In all other meetings
of stockholders for the election of directors at which a quorum is present, a plurality of the votes cast shall be sufficient to
elect. All other questions presented to the stockholders at a meeting at which a quorum is present shall, unless otherwise provided
by the Certificate of Incorporation, these Bylaws, the rules or regulations of any stock exchange applicable to the Corporation,
or applicable law or pursuant to any regulation applicable to the Corporation or its securities, be decided by the affirmative
vote of the holders of a majority in voting power of the shares of stock of the Corporation that are voting on the matter.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 65; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 1.8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Fixing Date for Determination of Stockholders of Record</U><FONT STYLE="font-size: 10pt">.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><FONT STYLE="font-size: 10pt">In order that the Corporation may determine the stockholders entitled to notice of
any meeting of stockholders or any adjournment thereof, the Board may fix a record date, which record date shall not precede the
date upon which the resolution fixing the record date is adopted by the Board, and which record date shall, unless otherwise required
by law, not be more than sixty nor less than ten days before the date of such meeting. If the Board so fixes a date, such date
shall also be the record date for determining the stockholders entitled to vote at such meeting unless the Board determines, at
the time it fixes such record date, that a later date on or before the date of the meeting shall be the date for making such determination.
If no record date is fixed by the Board, the record date for determining stockholders entitled to notice of or to vote at a meeting
of stockholders shall be at the close of business on the day next preceding the day on which notice is given, or, if notice is
waived, at the close of business on the day next preceding the day on which the meeting is held. A determination of stockholders
of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the meeting, <I>provided,
however, </I>that the Board may fix a new record date for determination of stockholders entitled to vote at the adjourned meeting,
and in such case shall also fix as the record date for stockholders entitled to notice of such adjourned meeting the same or an
earlier date as that fixed for determination of stockholders entitled to vote in accordance herewith at the adjourned meeting.</FONT></P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><FONT STYLE="font-size: 10pt">In order that the Corporation may determine the stockholders entitled to receive payment
of any dividend or other distribution or allotment of any rights, or entitled to exercise any rights in respect of any change,
conversion or exchange of stock or for the purpose of any other lawful action, the Board may fix a record date, which shall not
be more than sixty days prior to such other action. If no such record date is fixed, the record date for determining stockholders
for any such purpose shall be at the close of business on the day on which the Board adopts the resolution relating thereto.</FONT></P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 1.9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>List of Stockholders Entitled to Vote</U><FONT STYLE="font-size: 10pt">. The officer who has charge of the stock ledger
shall prepare and make, at least ten days before every meeting of stockholders, a complete list of the stockholders entitled to
vote at the meeting (<I>provided, however,</I> if the record date for determining the stockholders entitled to vote is less than
ten days before the date of the meeting, the list shall reflect the stockholders entitled to vote as of the tenth day before the
meeting date), arranged in alphabetical order, and showing the address of each stockholder and the number of shares registered
in the name of each stockholder. Such list shall be open to the examination of any stockholder, for any purpose germane to the
meeting at least ten days prior to the meeting (a)&nbsp;on a reasonably accessible electronic network, provided that the information
required to gain access to such list is provided with the notice of meeting or (b)&nbsp;during ordinary business hours at the principal
place of business of the Corporation. If the meeting is to be held at a place, then a list of stockholders entitled to vote at
the meeting shall be produced and kept at the time and place of the meeting during the whole time thereof and may be examined by
any stockholder who is present. If the meeting is to be held solely by means of remote communication, then the list shall also
be open to the examination of any stockholder during the whole time of the meeting on a reasonably accessible electronic network,
and the information required to access such list shall be provided with the notice of the meeting. Except as otherwise provided
by law, the stock ledger shall be the only evidence as to who are the stockholders entitled to examine the list of stockholders
required by this <U>Section&nbsp;1.9</U> or to vote in person or by proxy at any meeting of stockholders.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 1.10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Action by Written or Electronic Consent of Stockholders</U><FONT STYLE="font-size: 10pt">. The stockholders of the Corporation
may not take any action by written or electronic consent of stockholders to action without a meeting.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 1.11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Inspectors of Election</U><FONT STYLE="font-size: 10pt">. The Corporation shall, in advance of any meeting of stockholders,
appoint one or more inspectors of election, who may be employees of the Corporation, to act at the meeting or any adjournment thereof
and to make a written report thereof. The Corporation may designate one or more persons as alternate inspectors to replace any
inspector who fails to act. In the event that no inspector so appointed or designated is able to act at a meeting of stockholders,
the person presiding at the meeting shall appoint one or more inspectors to act at the meeting. Each inspector, before entering
upon the discharge of his or her duties, shall take and sign an oath to execute faithfully the duties of inspector with strict
impartiality and according to the best of his or her ability. The inspector or inspectors so appointed or designated shall (a)
ascertain the number of shares of capital stock of the Corporation outstanding and the voting power of each such share, (b) determine
the shares of capital stock of the Corporation represented at the meeting and the validity of proxies and ballots, (c)&nbsp;count
all votes and ballots, (d) determine and retain for a reasonable period a record of the disposition of any challenges made to any
determination by the inspectors, and (e) certify their determination of the number of shares of capital stock of the Corporation
represented at the meeting and such inspectors' count of all votes and ballots. Such certification and report shall specify such
other information as may be required by law. In determining the validity and counting of proxies and ballots cast at any meeting
of stockholders of the Corporation, the inspectors may consider such information as is permitted by applicable law. No person who
is a candidate for an office at an election may serve as an inspector at such election.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 66; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 1.12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Conduct of Meetings</U><FONT STYLE="font-size: 10pt">. The date and time of the opening and the closing of the polls
for each matter upon which the stockholders will vote at a meeting shall be announced at the meeting by the person presiding over
the meeting. The Board may adopt by resolution such rules and regulations for the conduct of the meeting of stockholders as it
shall deem appropriate. Except to the extent inconsistent with such rules and regulations as adopted by the Board, the person presiding
over any meeting of stockholders shall have the right and authority to convene and (for any or no reason) to adjourn the meeting,
to prescribe such rules, regulations and procedures and to do all such acts as, in the judgment of such presiding person, are appropriate
for the proper conduct of the meeting. Such rules, regulations or procedures, whether adopted by the Board or prescribed by the
presiding person of the meeting, may include the following: (a) the establishment of an agenda or order of business for the meeting;
(b) rules and procedures for maintaining order at the meeting and the safety of those present; (c) limitations on attendance at
or participation in the meeting to stockholders entitled to vote at the meeting, their duly authorized and constituted proxies
or such other persons as the presiding person of the meeting shall determine; (d) restrictions on entry to the meeting after the
time fixed for the commencement thereof; and (e) limitations on the time allotted to questions or comments by participants. The
presiding person at any meeting of stockholders, in addition to making any other determinations that may be appropriate to the
conduct of the meeting, shall, if the facts warrant, determine and declare to the meeting that a matter or business was not properly
brought before the meeting and if such presiding person should so determine, such presiding person shall so declare to the meeting
and any such matter or business not properly brought before the meeting shall not be transacted or considered. Unless and to the
extent determined by the Board or the person presiding over the meeting, meetings of stockholders shall not be required to be held
in accordance with the rules of parliamentary procedure.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 1.13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Notice of Stockholder Business and Nominations</U><FONT STYLE="font-size: 10pt">.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><FONT STYLE="font-size: 10pt"><I>Annual Meetings of Stockholders</I>.</FONT></P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.75in; font-size: 10pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><FONT STYLE="font-size: 10pt">Nominations of persons for election to the Board of the Corporation and the proposal
of other business to be considered by the stockholders may be made at an annual meeting of stockholders only (A) pursuant to the
Corporation&rsquo;s notice of meeting (or any supplement thereto), (B) by or at the direction of the Board or any committee thereof
or (C)&nbsp;by any stockholder of the Corporation who was a stockholder of record of the Corporation at the time the notice provided
for in this <U>Section&nbsp;1.13</U> is delivered to the Secretary of the Corporation, who is entitled to vote at the meeting and
who complies with the notice procedures set forth in this <U>Section&nbsp;1.13</U>.</FONT></P>

<P STYLE="margin: 0pt 0 0pt 0.75in; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.75in; font-size: 10pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><FONT STYLE="font-size: 10pt">For any nominations or other business to be properly brought before an annual meeting
by a stockholder pursuant to clause (C) of paragraph (a)(i) of this <U>Section&nbsp;1.13</U>, the stockholder must have given timely
notice thereof in writing to the Secretary of the Corporation and any such proposed business (other than the nominations of persons
for election to the Board) must constitute a proper matter for stockholder action. To be timely, a stockholder's notice shall be
delivered to the Secretary at the principal executive offices of the Corporation not later than the close of business on the ninetieth
day, nor earlier than the close of business on the one hundred twentieth day, prior to the first anniversary of the preceding year's
annual meeting (<I>provided, however,</I> that in the event that no annual meeting was held in the previous year or if the date
of the annual meeting is more than thirty days before or more than seventy days after such anniversary date, notice by the stockholder
must be so delivered not earlier than the close of business on the one hundred twentieth day prior to such annual meeting and not
later than the close of business on the later of the ninetieth day prior to such annual meeting or the tenth day following the
day on which public announcement of the date of such meeting is first made by the Corporation). In no event shall the public announcement
of an adjournment or postponement of an annual meeting commence a new time period (or extend any time period) for the giving of
a stockholder's notice as described above. Such stockholder's notice shall set forth: (A) as to each person whom the stockholder
proposes to nominate for election as a director (I) all information relating to such person that is required to be disclosed in
solicitations of proxies for election of directors in an election contest, or is otherwise required, in each case pursuant to and
in accordance with Section&nbsp;14(a) of the Securities Exchange Act of 1934, as amended (the &ldquo;<I>Exchange Act</I>&rdquo;),
and the rules and regulations promulgated thereunder and (II) such person's written consent to being named in the proxy statement
as a nominee and to serving as a director if elected; (B) as to any other business that the stockholder proposes to bring before
the meeting, a brief description of the business desired to be brought before the meeting, the text of the proposal or business
(including the text of any resolutions proposed for consideration and in the event that such business includes a proposal to amend
the Bylaws of the Corporation, the language of the proposed amendment), the reasons for conducting such business at the meeting
and any material interest in such business of such stockholder and the beneficial owner, if any, on whose behalf the proposal is
made; and (C) as to the stockholder giving the notice and the beneficial owner, if any, on whose behalf the nomination or proposal
is made (I) the name and address of such stockholder, as they appear on the Corporation&rsquo;s books, and of such beneficial owner,
(II) the class or series and number of shares of capital stock of the Corporation which are owned beneficially and of record by
such stockholder and such beneficial owner, (III) a description of any agreement, arrangement or understanding with respect to
the nomination or proposal between or among such stockholder and/or such beneficial owner, any of their respective affiliates or
associates, and any others acting in concert with any of the foregoing, including, in the case of a nomination, the nominee, (IV)
a description of any agreement, arrangement or understanding (including any derivative or short positions, profit interests, options,
warrants, convertible securities, stock appreciation or similar rights, hedging transactions, and borrowed or loaned shares) that
has been entered into as of the date of the stockholder's notice by, or on behalf of, such stockholder and such beneficial owners,
whether or not such instrument or right shall be subject to settlement in underlying shares of capital stock of the Corporation,
the effect or intent of which is to mitigate loss to, manage risk or benefit of share price changes for, or increase or decrease
the voting power of, such stockholder or such beneficial owner, with respect to securities of the Corporation, (V) a representation
that the stockholder is a holder of record of stock of the Corporation entitled to vote at such meeting and intends to appear in
person or by proxy at the meeting to propose such business or nomination, (VI) a representation whether the stockholder or the
beneficial owner, if any, intends or is part of a group that intends (x) to deliver a proxy statement and/or form of proxy to holders
of at least the percentage of the Corporation&rsquo;s outstanding capital stock required to approve or adopt the proposal or elect
the nominee and/or (y) otherwise to solicit proxies or votes from stockholders in support of such proposal or nomination, and (VII)
any other information relating to such stockholder and beneficial owner, if any, required to be disclosed in a proxy statement
or other filings required to be made in connection with solicitations of proxies for, as applicable, the proposal and/or for the
election of directors in an election contest pursuant to and in accordance with Section&nbsp;14(a) of the Exchange Act and the
rules and regulations promulgated thereunder. The foregoing notice requirements of this <U>Section&nbsp;1.13</U> shall be deemed
satisfied by a stockholder with respect to business other than a nomination if the stockholder has notified the Corporation of
his, her or its intention to present a proposal at an annual meeting in compliance with applicable rules and regulations promulgated
under the Exchange Act and such stockholder's proposal has been included in a proxy statement that has been prepared by the Corporation
to solicit proxies for such annual meeting. The Corporation may require any proposed nominee to furnish such other information
as the Corporation may reasonably require to determine the eligibility of such proposed nominee to serve as a director of the Corporation.</FONT></P>

<P STYLE="margin: 0pt 0 0pt 0.75in; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.75in; font-size: 10pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0 0pt 0.75in; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.75in; font-size: 10pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><FONT STYLE="font-size: 10pt">Notwithstanding anything in the second sentence of paragraph (a)(ii) of this <U>Section&nbsp;1.13</U>
to the contrary, in the event that the number of directors to be elected to the Board of the Corporation at the annual meeting
is increased effective after the time period for which nominations would otherwise be due under paragraph (a)(ii) of this <U>Section&nbsp;1.13</U>
and there is no public announcement by the Corporation naming the nominees for the additional directorships at least one hundred
days prior to the first anniversary of the preceding year&rsquo;s annual meeting, a stockholder's notice required by this <U>Section&nbsp;1.13</U>
shall also be considered timely, but only with respect to nominees for the additional directorships, if it shall be delivered to
the Secretary at the principal executive offices of the Corporation not later than the close of business on the tenth day following
the day on which such public announcement is first made by the Corporation.</FONT></P>

<P STYLE="margin: 0pt 0 0pt 0.75in; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><FONT STYLE="font-size: 10pt"><I>Special Meetings of Stockholders</I>. Only such business shall be conducted at a
special meeting of stockholders as shall have been brought before the meeting pursuant to the Corporation&rsquo;s notice of meeting.
Nominations of persons for election to the Board may be made at a special meeting of stockholders at which directors are to be
elected pursuant to the Corporation&rsquo;s notice of meeting (i) by or at the direction of the Board or any committee thereof
or (ii) provided that the Board has determined that directors shall be elected at such meeting, by any stockholder of the Corporation
who is a stockholder of record at the time the notice provided for in this <U>Section&nbsp;1.13</U> is delivered to the Secretary
of the Corporation, who is entitled to vote at the meeting and upon such election and who complies with the notice procedures set
forth in this <U>Section&nbsp;1.13</U>. In the event the Corporation calls a special meeting of stockholders for the purpose of
electing one or more directors to the Board, any such stockholder entitled to vote in such election of directors may nominate a
person or persons (as the case may be) for election to such position(s) as specified in the Corporation&rsquo;s notice of meeting,
if the stockholder's notice required by paragraph (a)(ii) of this <U>Section&nbsp;1.13</U> shall be delivered to the Secretary
at the principal executive offices of the Corporation not earlier than the close of business on the one hundred twentieth day prior
to such special meeting and not later than the close of business on the later of the ninetieth day prior to such special meeting
or the tenth day following the day on which public announcement is first made of the date of the special meeting and of the nominees
proposed by the Board to be elected at such meeting. In no event shall the public announcement of an adjournment or postponement
of a special meeting commence a new time period (or extend any time period) for the giving of a stockholder's notice as described
above.</FONT></P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 68; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><FONT STYLE="font-size: 10pt"><I>General</I>. </FONT></P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.75in; font-size: 10pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><FONT STYLE="font-size: 10pt">Except as otherwise expressly provided in any applicable rule or regulation promulgated
under the Exchange Act, only such persons who are nominated in accordance with the procedures set forth in this <U>Section&nbsp;1.13</U>
shall be eligible to be elected at an annual or special meeting of stockholders of the Corporation to serve as directors and only
such business shall be conducted at a meeting of stockholders as shall have been brought before the meeting in accordance with
the procedures set forth in this <U>Section&nbsp;1.13</U>. Except as otherwise provided by law, the chairperson of the meeting
shall have the power and duty (A)&nbsp;to determine whether a nomination or any business proposed to be brought before the meeting
was made or proposed, as the case may be, in accordance with the procedures set forth in this <U>Section&nbsp;1.13</U> (including
whether the stockholder or beneficial owner, if any, on whose behalf the nomination or proposal is made solicited (or is part of
a group that solicited) or did not so solicit, as the case may be, proxies or votes in support of such stockholder's nominee or
proposal in compliance with such stockholder's representation as required by clause (a)(ii)(C)(VI) of this <U>Section&nbsp;1.13</U>)
and (B) if any proposed nomination or business was not made or proposed in compliance with this <U>Section&nbsp;1.13</U>, to declare
that such nomination shall be disregarded or that such proposed business shall not be transacted. Notwithstanding the foregoing
provisions of this <U>Section&nbsp;1.13</U>, unless otherwise required by law, if the stockholder (or a qualified representative
of the stockholder) does not appear at the annual or special meeting of stockholders of the Corporation to present a nomination
or proposed business, such nomination shall be disregarded and such proposed business shall not be transacted, notwithstanding
that proxies in respect of such vote may have been received by the Corporation. For purposes of this <U>Section&nbsp;1.13</U>,
to be considered a qualified representative of the stockholder, a person must be a duly authorized officer, manager or partner
of such stockholder or must be authorized by a writing executed by such stockholder or an electronic transmission delivered by
such stockholder to act for such stockholder as proxy at the meeting of stockholders and such person must produce such writing
or electronic transmission, or a reliable reproduction of the writing or electronic transmission, at the meeting of stockholders.</FONT></P>

<P STYLE="margin: 0pt 0 0pt 0.75in; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.75in; font-size: 10pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><FONT STYLE="font-size: 10pt">For purposes of this <U>Section&nbsp;1.13</U>, &ldquo;<I>public announcement</I>&rdquo;
shall include disclosure in a press release reported by the Dow Jones News Service, Associated Press or other national news service
or in a document publicly filed by the Corporation with the Securities and Exchange Commission pursuant to Section&nbsp;13, 14
or 15(d) of the Exchange Act and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="margin: 0pt 0 0pt 0.75in; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.75in; font-size: 10pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><FONT STYLE="font-size: 10pt">Notwithstanding the foregoing provisions of this <U>Section&nbsp;1.13</U>, a stockholder
shall also comply with all applicable requirements of the Exchange Act and the rules and regulations promulgated thereunder with
respect to the matters set forth in this <U>Section&nbsp;1.13</U>; <I>provided however, </I>that any references in these Bylaws
to the Exchange Act or the rules and regulations promulgated thereunder are not intended to and shall not limit any requirements
applicable to nominations or proposals as to any other business to be considered pursuant to this <U>Section&nbsp;1.13</U> (including
paragraphs (a)(i)(C) and (b) hereof), and compliance with paragraphs (a)(i)(C) and (b) of this <U>Section&nbsp;1.13</U> shall be
the exclusive means for a stockholder to make nominations or submit other business (other than, as provided in the penultimate
sentence of (a)(ii), business other than nominations brought properly under and in compliance with Rule 14a-8 of the Exchange Act,
as may be amended from time to time). Nothing in this <U>Section&nbsp;1.13</U> shall be deemed to affect any rights (A) of stockholders
to request inclusion of proposals or nominations in the Corporation&rsquo;s proxy statement pursuant to applicable rules and regulations
promulgated under the Exchange Act or (B) of the holders of any series of Preferred Stock to elect directors pursuant to any applicable
provisions of the Certificate of Incorporation.</FONT></P>

<P STYLE="margin: 0pt 0 0pt 0.75in; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase; color: #010000">ARTICLE
II</FONT><BR>
<FONT STYLE="font-weight: normal">Board</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Number; Qualifications</U><FONT STYLE="font-size: 10pt">. Subject to the Certificate of Incorporation, the Board shall
consist of not less than three members nor more than nine members, the number thereof to be determined from time to time by resolution
of the Whole Board (as defined below). Directors need not be stockholders. For purposes of these Bylaws, the term &ldquo;<I>Whole
Board</I>&rdquo; shall mean the total number of authorized directors, whether or not there exist any vacancies in previously authorized
directorships.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 69; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Classification; Resignation; Vacancies</U><FONT STYLE="font-size: 10pt">. The Board shall be divided into three classes
(Class I, Class II and Class III) and shall serve staggered three-year terms as set forth in the Certificate of Incorporation.
Any director may resign at any time upon notice given in writing or by electronic transmission to the Corporation. Such resignation
shall take effect when such notice is given unless the notice specifies (a)&nbsp;a later effective date, or (b)&nbsp;an effective
date determined upon the happening of an event or events. Unless otherwise specified in the notice of resignation, the acceptance
of such resignation shall not be necessary to make it effective. Unless otherwise provided by law or the Certificate of Incorporation,
any newly created directorship or any vacancy occurring in the Board for any cause may be filled only by a majority of the remaining
members of the Board, although such majority is less than a quorum, and each director so elected shall hold office until the expiration
of the term of office of the director whom he or she has replaced or until his or her successor is elected and qualified.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 2.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Removal</U><FONT STYLE="font-size: 10pt">.&#9;Any one or more or all of the directors may be removed, but only for cause,
by the holders of at least seventy-five percent of the then issued and outstanding shares of capital stock then entitled to vote
at an election of directors.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 2.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Regular Meetings</U><FONT STYLE="font-size: 10pt">. Regular meetings of the Board may be held at such places within or
without the State of Delaware and at such times as the Board may from time to time determine.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 2.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Special Meetings</U><FONT STYLE="font-size: 10pt">. Special meetings of the Board may be held at any time or place within
or without the State of Delaware whenever called by the Chief Executive Officer or by any two members of the Board. Notice of a
special meeting of the Board shall be given by the person or persons calling the meeting either by first class United States mail
at least three days before such special meeting, or by overnight mail, courier service, electronic transmission, or hand delivery
at least 48 hours before the special meeting or such shorter period as is reasonable under the circumstances.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 2.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Telephonic Meetings Permitted</U><FONT STYLE="font-size: 10pt">. Members of the Board, or any committee designated by
the Board, may participate in a meeting thereof by means of conference telephone or other communications equipment by means of
which all persons participating in the meeting can hear each other, and participation in a meeting pursuant to this by-law shall
constitute presence in person at such meeting.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 2.7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Quorum; Vote Required for Action</U><FONT STYLE="font-size: 10pt">. At all meetings of the Board the directors entitled
to cast a majority of the votes of the Whole Board shall constitute a quorum for the transaction of business. In the event one
or more of the directors shall be disqualified to vote at any meeting, then the required quorum shall be reduced by one for each
such director so disqualified; <I>provided, however,</I> that in no case shall less than one-third of the total number of directors
constitute a quorum. Except in cases in which the Certificate of Incorporation, these Bylaws or applicable law otherwise provides,
a majority of the votes entitled to be cast by the directors present at a meeting at which a quorum is present shall be the act
of the Board.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 2.8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Organization</U><FONT STYLE="font-size: 10pt">. Meetings of the Board shall be presided over by the Board Chair (as defined
in <U>Section 2.10</U>), if any, or, in the absence of a Board Chair, by another director chosen by the participating directors
to act as chairperson at the meeting. The Secretary shall act as secretary of the meeting, but in his or her absence, the Board
Chair or chairperson presiding at the meeting may appoint any person to act as secretary of the meeting.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 2.9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Action by Unanimous Consent of Directors</U><FONT STYLE="font-size: 10pt">. Unless otherwise restricted by the Certificate
of Incorporation or these Bylaws, any action required or permitted to be taken at any meeting of the Board, or of any committee
thereof, may be taken without a meeting if all members of the Board or such committee, as the case may be, consent thereto in writing
or by electronic transmission and the writing or writings or electronic transmissions are filed with the minutes of proceedings
of the board or committee in accordance with applicable law.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 2.10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Chair and Vice Chair of the Board</U><FONT STYLE="font-size: 10pt">. The Board may elect one or more of its members to
serve as Chair of the Board (the &ldquo;<I>Board Chair</I>&rdquo;) or as Vice Chair of the Board and may fill any vacancy in such
position at such time and in such manner as the Board shall determine. The Board Chair, if any, shall preside at all meetings of
the Board at which he or she is present and shall perform such duties and possess such powers as are designated by the Board. If
the Board of Director appoints a Vice Chair of the Board, he or she shall, in the absence or disability of the Board Chair perform
the duties and exercise the powers of the Board Chair and shall perform such other duties and possess such other powers as may
from time to time be designated by the Board. The fact that a person serves as Board Chair or Vice Chair of the Board shall not
make such person considered an officer of the Corporation. </FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 70; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase; color: #010000">ARTICLE
III</FONT><BR>
Committees</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Committees</U><FONT STYLE="font-size: 10pt">. The Board may designate one or more committees, each committee to consist
of one or more of the directors of the Corporation. The Board may designate one or more directors as alternate members of any committee,
who may replace any absent or disqualified member at any meeting of the committee. In the absence or disqualification of a member
of the committee, the member or members thereof present at any meeting and not disqualified from voting, whether or not he, she
or they constitute a quorum, may unanimously appoint another member of the Board to act at the meeting in place of any such absent
or disqualified member. Any such committee, to the extent permitted by law and to the extent provided in the resolution of the
Board, shall have and may exercise all the powers and authority of the Board in the management of the business and affairs of the
Corporation, and may authorize the seal of the Corporation to be affixed to all papers that may require it.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Committee Rules</U><FONT STYLE="font-size: 10pt">. Unless the Board otherwise provides, each committee designated by
the Board may make, alter and repeal rules for the conduct of its business. In the absence of such rules each committee shall conduct
its business in the same manner as the Board conducts its business pursuant to <U>Article&nbsp;II</U> of these Bylaws.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase; color: #010000">ARTICLE
IV</FONT><BR>
Officers</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 4.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Officers</U><FONT STYLE="font-size: 10pt">. The officers of the Corporation shall consist of a Chief Executive Officer,
a President, a Chief Financial Officer, a Treasurer, a Secretary, and such other officers as the Board may from time to time determine,
which may include and one or more Vice Presidents, Assistant Treasurers and Assistant Secretaries. Each of the Corporation&rsquo;s
officers shall be elected by the Board, each to have such authority, functions or duties as set forth in these Bylaws or as determined
by the Board. Each officer shall be chosen by the Board and shall hold office for such term as may be prescribed by the Board and
until such person&rsquo;s successor shall have been duly chosen and qualified, or until such person's earlier death, disqualification,
resignation or removal.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 4.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Removal, Resignation and Vacancies</U><FONT STYLE="font-size: 10pt">. Any officer of the Corporation may be removed,
with or without cause, by the Board, without prejudice to the rights, if any, of such officer under any contract to which it is
a party. Any officer may resign at any time upon notice given in writing or by electronic transmission to the Corporation. Such
resignation shall take effect when such notice is given unless the notice specifies (a)&nbsp;a later effective date, or (b)&nbsp;an
effective date determined upon the happening of an event or events, such as the failure to receive the required vote for reelection
as a director and the acceptance of such resignation by the Board. Unless otherwise specified in the notice of resignation, the
acceptance of such resignation shall not be necessary to make it effective. If any vacancy occurs in any office of the Corporation,
the Board may elect a successor to fill such vacancy for the remainder of the unexpired term and until a successor shall have been
duly chosen and qualified.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 4.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Chief Executive Officer</U><FONT STYLE="font-size: 10pt">. The Chief Executive Officer shall have general supervision
and direction of the business and affairs of the Corporation and shall be responsible for corporate policy and strategy. Unless
otherwise provided in these Bylaws, all other officers of the Corporation shall report directly to the Chief Executive Officer
or as otherwise determined by the Chief Executive Officer. The Chief Executive Officer shall preside at meetings of the stockholders.
In the absence of a separately appointed President, the Chief Executive Officer shall be the President.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 4.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>President</U><FONT STYLE="font-size: 10pt">. The President shall have such powers and duties as the Board may from time
to time determine and, in the absence of a separately appointed Chief Operating Officer, shall have the powers and duties ascribed
to the Chief Operating Officer. The President shall have the power to affix the signature of the Corporation to all contracts that
have been authorized by the Board or the Chief Executive Officer. The President shall, when requested, counsel with and advise
the other officers of the Corporation and shall perform such other duties as such officer may agree with the Chief Executive Officer.
</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 4.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Chief Operating Officer</U><FONT STYLE="font-size: 10pt">. The Chief Operating Officer shall exercise all the powers
and perform the duties of the office of the chief operating officer of the Corporation, with general responsibility for the management
and control of the operations of the Corporation. The Chief Operating Officer shall, when requested, counsel with and advise the
other officers of the Corporation and shall perform such other duties as such officer may agree with the Chief Executive Officer
or as the Board may from time to time determine.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 4.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Chief Financial Officer</U><FONT STYLE="font-size: 10pt">. The Chief Financial Officer shall exercise all the powers
and perform the duties of the office of the chief financial officer and in general have overall supervision of the financial operations
of the Corporation and shall keep and maintain, or cause to be kept and maintained, adequate and correct books and records of accounts
of the properties and business transactions of the Corporation, including accounts of its assets, liabilities, receipts, disbursements,
gains, losses, capital retained earnings, and shares. The Chief Financial Officer shall, when requested, counsel with and advise
the other officers of the Corporation and shall perform such other duties as such officer may agree with the Chief Executive Officer
or as the Board may from time to time determine. In the absence of a separately appointed Treasurer, the Chief Financial Officer
shall be the Treasurer.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 71; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 4.7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Vice Presidents</U><FONT STYLE="font-size: 10pt">. Each Vice President shall have such powers and duties as shall be
prescribed by his or her superior officer or the Chief Executive Officer. A Vice President shall, when requested, counsel with
and advise the other officers of the Corporation and shall perform such other duties as such officer may agree with the Chief Executive
Officer or as the Board may from time to time determine.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 4.8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Treasurer</U><FONT STYLE="font-size: 10pt">. The Treasurer shall supervise and be responsible for all the funds and securities
of the Corporation, the deposit of all moneys and other valuables to the credit of the Corporation in depositories of the Corporation,
borrowings and compliance with the provisions of all indentures, agreements and instruments governing such borrowings to which
the Corporation is a party, the disbursement of funds of the Corporation and the investment of its funds, and in general shall
perform all of the duties incident to the office of the Treasurer. The Treasurer shall, when requested, counsel with and advise
the other officers of the Corporation and shall perform such other duties as such officer may agree with the Chief Executive Officer
or as the Board may from time to time determine.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 4.9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Secretary</U><FONT STYLE="font-size: 10pt">. The powers and duties of the Secretary are to: (a) act as secretary at all
meetings of the Board, of the committees of the Board and of the stockholders and to record the proceedings of such meetings in
a book or books to be kept for that purpose; (b) see that all notices required to be given by the Corporation are duly given and
served; (c) act as custodian of the seal of the Corporation and affix the seal or cause it to be affixed to all certificates of
stock of the Corporation and to all documents, the execution of which on behalf of the Corporation under its seal is duly authorized
in accordance with the provisions of these Bylaws; (d) have charge of the books, records and papers of the Corporation and see
that the reports, statements and other documents required by law to be kept and filed are properly kept and filed; and (e) perform
all of the duties incident to the office of Secretary. The Secretary shall, when requested, counsel with and advise the other officers
of the Corporation and shall perform such other duties as such officer may agree with the Chief Executive Officer or as the Board
may from time to time determine.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 4.10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Additional Matters</U><FONT STYLE="font-size: 10pt">. The Chief Executive Officer and the Chief Financial Officer shall
have the authority to designate employees of the Corporation to have the title of Assistant Vice President, Assistant Treasurer
or Assistant Secretary. Any employee so designated shall have the powers and duties determined by the officer making such designation.
The persons upon whom such titles are conferred shall not be deemed officers of the Corporation unless elected by the Board.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 4.11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Execution of Contracts and Instruments</U><FONT STYLE="font-size: 10pt">. All contracts, deeds, mortgages, bonds, certificates,
checks, drafts, bills of exchange, notes and other instruments or documents to be executed by or in the name of the Corporation
shall be signed on the corporation&rsquo;s behalf by such officer or officers, or other person or persons, as may be so authorized
(a) by the Board or (b) subject to any limitations the Board may impose, by the Chief Executive Officer. Such authority may be
general or confined to specific instances and, if the Board or Chief Executive Officer (whichever grants authority) so authorizes
or otherwise directs, may be delegated by the authorized officers to other persons. Unless otherwise provided in such resolution,
any resolution of the Board or a committee thereof authorizing the Corporation to enter into any such instruments or documents
or authorizing their execution by or on behalf of the Corporation shall be deemed to authorize the execution thereof on its behalf
by the Chief Executive Officer, the President, the Chief Financial Officer or any Vice President (an &ldquo;<I>Authorized Officer</I>&rdquo;).
Furthermore, each Authorized Officer shall be authorized to enter into any contract or execute any instrument in the name of and
on behalf of the Corporation in matters arising in the ordinary course of the Corporation&rsquo;s business and to the extent incident
to the normal performance of such Authorized Officer&rsquo;s duties.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase; color: #010000">ARTICLE
V</FONT><BR>
Stock</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 5.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Certificates</U><FONT STYLE="font-size: 10pt">. The shares of the Corporation may be certificated or uncertificated in
accordance with the Delaware General Corporation Law, and shall be entered in the books of the Corporation and registered as they
are issued. The issue of shares in uncertificated form shall not affect shares represented by a certificate until the certificate
is surrendered to the Corporation. Any certificates representing shares of the Corporation&rsquo;s stock shall be in such form
as may be prescribed by law and by the Board, certifying the number and class of shares owned by such stockholder in the Corporation.
Every holder of stock represented by certificates shall be entitled to have a certificate signed by any two authorized officers
of the Corporation certifying the number of shares owned by such holder in the Corporation. Any of or all the signatures on the
certificate may be a facsimile. In case any officer, transfer agent or registrar who has signed or whose facsimile signature has
been placed upon a certificate shall have ceased to be such officer, transfer agent, or registrar before such certificate is issued,
it may be issued by the Corporation with the same effect as if such person were such officer, transfer agent, or registrar at the
date of issue.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 72; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 5.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Lost, Stolen or Destroyed Stock Certificates; Issuance of New Certificates</U><FONT STYLE="font-size: 10pt">. The Corporation
may issue (a) a new certificate of stock or (b) uncertificated shares in the place of any certificate theretofore issued by it,
alleged to have been lost, stolen or destroyed, and the Corporation may require the owner of the lost, stolen or destroyed certificate,
or such owner's legal representative, to give the Corporation a bond sufficient to indemnify it against any claim that may be made
against it on account of the alleged loss, theft or destruction of any such certificate or the issuance of such new certificate.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase; color: #010000">ARTICLE
VI</FONT><BR>
Indemnification and Advancement of Expenses</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 6.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Right to Indemnification</U><FONT STYLE="font-size: 10pt">. The Corporation shall indemnify and hold harmless, to the
fullest extent permitted by applicable law as it presently exists or may hereafter be amended, any person (a &ldquo;<I>Covered
Person</I>&rdquo;) who was or is made or is threatened to be made a party or is otherwise involved in any action, suit or proceeding,
whether civil, criminal, administrative or investigative (a &ldquo;<I>proceeding</I>&rdquo;), by reason of the fact that he or
she, or a person for whom he or she is the legal representative, is or was a director or officer of the Corporation or, while a
director or officer of the Corporation, is or was serving at the request of the Corporation as a director, officer, employee or
agent of another corporation or of a partnership, joint venture, trust, enterprise or nonprofit entity, including service with
respect to employee benefit plans, against all liability and loss suffered and expenses (including attorneys&rsquo; fees) reasonably
incurred by such Covered Person. Notwithstanding the preceding sentence, except as otherwise provided in <U>Section&nbsp;6.3</U>
of these Bylaws, the Corporation shall be required to indemnify a Covered Person in connection with a proceeding (or part thereof)
commenced by such Covered Person only if the commencement of such proceeding (or part thereof) by the Covered Person was authorized
in the specific case by the Board of the Corporation.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 6.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Prepayment of Expenses</U><FONT STYLE="font-size: 10pt">. The Corporation shall to the fullest extent not prohibited
by applicable law pay the expenses (including attorneys&rsquo; fees) incurred by a Covered Person in defending any proceeding in
advance of its final disposition, <I>provided</I>, <I>however</I>, that, to the extent required by law, such payment of expenses
in advance of the final disposition of the proceeding shall be made only upon receipt of an undertaking by the Covered Person to
repay all amounts advanced if it should be ultimately determined that the Covered Person is not entitled to be indemnified under
this <U>Article&nbsp;VI</U> or otherwise.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 6.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Claims</U><FONT STYLE="font-size: 10pt">. If a claim for indemnification (following the final disposition of such proceeding)
or advancement of expenses under this <U>Article&nbsp;VI</U> is not paid in full within thirty days after a written claim therefor
by the Covered Person has been received by the Corporation, the Covered Person may file suit to recover the unpaid amount of such
claim and, if successful in whole or in part, shall be entitled to be paid the expense of prosecuting such claim to the fullest
extent permitted by law. In any such action the Corporation shall have the burden of proving that the Covered Person is not entitled
to the requested indemnification or advancement of expenses under applicable law.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 6.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Nonexclusivity of Rights</U><FONT STYLE="font-size: 10pt">. The rights conferred on any Covered Person by this <U>Article&nbsp;VI</U>
shall not be exclusive of any other rights which such Covered Person may have or hereafter acquire under any statute, provision
of the Certificate of Incorporation, these Bylaws, agreement, vote of stockholders or disinterested directors or otherwise.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 6.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Other Sources</U><FONT STYLE="font-size: 10pt">. The Corporation&rsquo;s obligation, if any, to indemnify or to advance
expenses to any Covered Person who was or is serving at its request as a director, officer, employee or agent of another corporation,
partnership, joint venture, trust, enterprise or nonprofit entity shall be reduced by any amount such Covered Person may collect
as indemnification or advancement of expenses from such other corporation, partnership, joint venture, trust, enterprise or non-profit
enterprise.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 6.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Amendment or Repeal</U><FONT STYLE="font-size: 10pt">. Any right to indemnification or to advancement of expenses of
any Covered Person arising hereunder shall not be eliminated or impaired by an amendment to or repeal of these Bylaws after the
occurrence of the act or omission that is the subject of the civil, criminal, administrative or investigative action, suit or proceeding
for which indemnification or advancement of expenses is sought.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 6.7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Other Indemnification and Advancement of Expenses</U><FONT STYLE="font-size: 10pt">. This <U>Article&nbsp;VI</U> shall
not limit the right of the Corporation, to the extent and in the manner permitted by law, to indemnify and to advance expenses
to persons other than Covered Persons when and as authorized by appropriate corporate action.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 73; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase; color: #010000">ARTICLE
VII</FONT><BR>
Exclusive Forum</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">Unless the Corporation consents in writing
to the selection of an alternative forum, the Court of Chancery in the State of Delaware shall be the sole and exclusive forum
for all claims, including claims in the right of the Corporation, (a) that are based upon a violation of a duty by a current or
former director or officer or stockholder in such capacity or (b) as to which Title 8 of the Delaware Code confers jurisdiction
upon the Court of Chancery, except for, as to each of (a) and (b) above, any claim as to which the Court of Chancery determines
that there is an indispensable party not subject to the jurisdiction of the Court of Chancery (and the indispensable party does
not consent to the personal jurisdiction of the Court of Chancery within ten days following such determination), which is vested
in the exclusive jurisdiction of a court or forum other than the Court of Chancery, or for which the Court of Chancery does not
have subject matter jurisdiction. If any provision or provisions of this <U>Article&nbsp;VII</U> shall be held to be invalid, illegal
or unenforceable as applied to any person or entity or circumstance for any reason whatsoever, then, to the fullest extent permitted
by law, the validity, legality and enforceability of such provisions in any other circumstance and of the remaining provisions
of this <U>Article&nbsp;VII</U> (including each portion of any sentence of this <U>Article&nbsp;VII</U> containing any such provision
held to be invalid, illegal or unenforceable that is not itself held to be invalid, illegal or unenforceable) and the application
of such provision to other persons or entities and circumstances shall not in any way be affected or impaired thereby.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase; color: #010000">ARTICLE
VIII</FONT><BR>
Miscellaneous</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 8.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Fiscal Year</U><FONT STYLE="font-size: 10pt">. The fiscal year of the Corporation shall be determined by resolution of
the Board.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 8.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Seal</U><FONT STYLE="font-size: 10pt">. The corporate seal shall have the name of the Corporation inscribed thereon and
shall be in such form as may be approved from time to time by the Board.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 8.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Method of Notice</U><FONT STYLE="font-size: 10pt">. Whenever notice is required by law, the Certificate of Incorporation
or these Bylaws to be given by the Corporation to any director, committee member or stockholder, personal notice shall not be required
and any such notice may be given in writing (a)&nbsp;by mail, addressed to such director, committee member or stockholder at his
or her address as it appears on the books of the Corporation, or (b)&nbsp;by any other method permitted by law (including overnight
courier service, facsimile, electronic mail or other means of electronic transmission) directed to the addressee at his, her or
its address most recently provided to the Corporation. Any notice given by the Corporation by mail shall be deemed to have been
given at the time when deposited in the United States mail. Any notice given by the Corporation by overnight courier service shall
be deemed to have been given when delivered to such service. Any notice given by the Corporation by facsimile, electronic mail
or other means of electronic transmission that generally can be accessed by or on behalf of the receiving party at substantially
the same time as it is transmitted shall be deemed to have been given when transmitted, unless the Corporation receives a prompt
reply that such transmission is undeliverable to the address to which it was directed.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 8.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Waiver of Notice</U><FONT STYLE="font-size: 10pt">. Whenever any notice is required to be given under the provisions
of the statutes or of the Certificate of Incorporation or of these Bylaws, a waiver thereof in writing, signed by the person or
persons entitled to such notice, or a waiver by electronic transmission by the person entitled to such notice, whether before or
after the time stated therein, shall be deemed equivalent to notice. Attendance of a person at a meeting shall constitute a waiver
of notice of such meeting except when the person attends a meeting for the express purpose of objecting, at the beginning of the
meeting, to the transaction of any business because the meeting is not lawfully called or convened.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 8.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Form of Records</U><FONT STYLE="font-size: 10pt">. Any records maintained by the Corporation in the regular course of
its business, including its stock ledger, books of account, and minute books, may be kept on, or by means of, or be in the form
of, any information storage device or method, provided that the records so kept can be converted into clearly legible paper form
within a reasonable time.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 8.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Amendment of Bylaws</U><FONT STYLE="font-size: 10pt">. Subject to any additional votes set forth in the Certificate of
Incorporation or these Bylaws, these Bylaws may be altered, amended or repealed or new Bylaws may be adopted by the stockholders
or by the Board. Notwithstanding any provision of these Bylaws, the Certificate of Incorporation or any provision of law which
might otherwise permit a lesser vote or no vote, in addition to any vote of the holders of any class or series of stock of the
Corporation required by law or by the Certificate of Incorporation, the amendment or repeal of all or any portion of <U>Article&nbsp;I</U>,
<U>II</U>, <U>VI</U> or <U>VII</U> of these Bylaws or of this <U>Section&nbsp;8.6</U> by the stockholders of the Corporation shall
require the affirmative vote of the holders of at least seventy-five percent of the voting power of the then outstanding shares
of capital stock entitled to vote generally in the election of directors, voting together as a single class.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 74; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 8.7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Registered Stockholders</U><FONT STYLE="font-size: 10pt">. The Corporation shall be entitled to recognize the exclusive
right of a person registered on its books as the owner of shares to receive dividends and to vote as such owner and shall not be
bound to recognize any equitable or other claim to or interest in such share or shares on the part of another person, whether or
not it shall have express or other notice thereof, except as otherwise provided by the laws of Delaware.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 8.8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Facsimile Signature</U><FONT STYLE="font-size: 10pt">. In addition to the provisions for use of facsimile signatures
elsewhere specifically authorized in these Bylaws, facsimile signatures of any officer or officers of the Corporation may be used
whenever and as authorized by the Board or a committee thereof.</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #010000">Section 8.9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Interpretation</U><FONT STYLE="font-size: 10pt">. For purposes of these Bylaws:</FONT></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">headings used in these Bylaws are for convenience of reference only
and shall not, for any purpose, be deemed a part of these Bylaws;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the word &ldquo;day&rdquo; refers to a calendar day;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in">&nbsp;</TD>
    <TD STYLE="width: 0.5in">(c)</TD>
    <TD STYLE="text-align: justify">the words &ldquo;include,&rdquo; &ldquo;included,&rdquo; &ldquo;includes&rdquo; and
&ldquo;including&rdquo; as used herein shall not be construed so as to exclude any other thing not referred to or described;</TD></TR>
</TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the word &ldquo;or&rdquo; is not exclusive; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in">&nbsp;</TD>
    <TD STYLE="width: 0.5in">(e)</TD>
    <TD STYLE="text-align: justify">the definition given for any term in these Bylaws shall apply equally to both the singular
and plural forms of the term defined.</TD></TR>
</TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>



<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 75 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"></P>



<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;<IMG SRC="proxycard_1.jpg" ALT=""></P>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 76 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;<IMG SRC="proxycard_2.jpg" ALT=""></P>

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$ 7P!?  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  ^ )T# 2(  A$! Q$!_\0
M'P !  (" @,! 0            @*!@D!! (%!PL#_\0 -1   00" @ $! 4"
M!04     ! (#!08!!P ("1$2$Q05(3%!46%Q\!:!"A<9([$B4E:AT?_$ !P!
M  $$ P$                #! 4& 0('"/_$ "<1  ,  @(" @(" P$!
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M=B0%H;36LV#(%53(($Z,7CTK<M@$L^K-; :H17G+9K.)MDW!3+TP\Y0!7YJ
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#T__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>cheung_sig.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cheung_sig.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  0" P,# @0# P,$! 0$!0D&!04%
M!0L(" 8)#0L-#0T+# P.$!01#@\3#PP,$A@2$Q46%Q<7#A$9&QD6&A06%Q;_
MVP!# 00$! 4%!0H&!@H6#PP/%A86%A86%A86%A86%A86%A86%A86%A86%A86
M%A86%A86%A86%A86%A86%A86%A86%A;_P  1"  I (D# 2(  A$! Q$!_\0
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B,5[<6MFDN;RYC/*2SRSS/M;Y@NTM@D@>WT4 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>proxycard_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxycard_1.jpg
M_]C_X  02D9)1@ ! 0$"6 )8  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" /H P4# 2(  A$! Q$!_\0
M'@ !  ,! 0$! 0$!          <("08%! ,""@'_Q !P$  !! ("  $&! L1
M"@H%!PT& P0%!P((  $)$1(3%!46%QA6UR$W6'B4EYB9MM39&3$X4U155UEW
MD9*XN=+3UM@B-#9!47-VDY75(S4Y87%U>;2UMR0E,H&R"B8G*#-"4FATEN=B
MH;%#1$:S\'+_Q  4 0$                     _\0 %!$!
M         /_:  P# 0 "$0,1 #\ _P!_'''' <<<<!QQQP'''' <<<<!QQQP
M'''' <<<<!QQQP'''' <<<<!QQQP'''' <<<<!QQQP'''' <<<<!QQQP''''
M <<<<!QQQP'''' <<<<!QQQP'*#;CB@H;6YI ,FPJ+F@W(73;JK\>,!V&*8)
MZI&:F7Y+1^;J(GF,A'KY,Y-BR?M^U6^7HW35!;'R9IX]]7YY23:'Z>^BG[LM
MU_Q.]A^!Y'Q:-9_J:M<_M#U-_5#CXM&L_P!35KG]H>IOZH<FKC@0K\6C6?ZF
MK7/[0]3?U0X^+1K/]35KG]H>IOZH<FKC@0K\6C6?ZFK7/[0]3?U0X^+1K/\
M4U:Y_:'J;^J')JXX$*_%HUG^IJUS^T/4W]4./BT:S_4U:Y_:'J;^J')JXX$*
M_%HUG^IJUS^T/4W]4./BT:S_ %-6N?VAZF_JAR:,<L,NU<<<\,\D%<4%\<,\
M<LD%\FS9[BBMCCWWVDKDS>LW>*:G6.?;9VV7ZQ[272SR_K@0K\6C6?ZFK7/[
M0]3?U0X^+1K/]35KG]H>IOZH<FKC@0K\6C6?ZFK7/[0]3?U0X^+1K/\ 4U:Y
M_:'J;^J')HRSP3Q\]3/!/#M1!'K-3/%/'M5TX19M4NLL^\<>U7+MP@U;I]=^
M>LX6213ZR44PQ[_K@0K\6C6?ZFK7/[0]3?U0X^+1K/\ 4U:Y_:'J;^J')JXX
M$*_%HUG^IJUS^T/4W]4./BT:S_4U:Y_:'J;^J')JXX$*_%HUG^IJUS^T/4W]
M4./BT:S_ %-6N?VAZF_JAR://P\_I+S\/2Y)9K8I=YX^ER1343246Q3\OG]I
M)JK(IYJ=8]X8J*IX99=99X]=_P!<"%?BT:S_ %-6N?VAZF_JAQ\6C6?ZFK7/
M[0]3?U0Y-7' A7XM&L_U-6N?VAZF_JAQ\6C6?ZFK7/[0]3?U0Y-7/^]==]]]
M====]]]]]====?G]]]_0ZZZ_Y^^^!"GQ:-9_J:M<_M#U-_5#CXM&L_U-6N?V
MAZF_JAR:,,TU<,54E$U4L_.\Q1+/!1//S,\D\_-SP[RPR\Q3#-/+R=]^;GAE
MAWY,L>^NO^]Y8=9)X99X8YJ^D]%AEGCCFKZ'#I17T6'??62GHL.^LU/,ZR\S
M#OK++R==^7@0M\6C6?ZFK7/[0]3?U0X^+1K/]35KG]H>IOZH<FC//!)-597/
M!)%!)5=957/%-)%!!/)59953/O'!-))+#-153/+'###'+/+OK'KOOG]]]=]=
M^3OZ'?\ _O\ _OE_Q\"%/BT:S_4U:Y_:'J;^J''Q:-9_J:M<_M#U-_5#DU<<
M"%?BT:S_ %-6N?VAZF_JAQ\6C6?ZFK7/[0]3?U0Y-7' A7XM&L_U-6N?VAZF
M_JAQ\6C6?ZFK7/[0]3?U0Y-7' A7XM&L_P!35KG]H>IOZH<?%HUG^IJUS^T/
M4W]4.35QP**V;5-45OLIX:\Q7%4U=74O,;K'0S+RU?UR%A,G*CKCPV_$-(%X
M&2D!B#BG;Z'5G!H?F%(UTLJSRDX6+>]H^L,FZB>N7,RM@/T0?AC?7XFG\F)X
ME'--> XXXX#CCC@.... XXXX#CCC@.... XXXX#CCC@.... XXXX#CCC@...
M. XXXX#CCC@.... XXXX#CCC@.... XXXX#CCC@.... XXXX#CCC@.... XX
MXX#CCC@.... XXXX#CCC@.4DVA^GOHI^[+=?\3O8?EV^4DVA^GOHI^[+=?\
M$[V'X$I\<<<!QQQP'''' <<<<"&:MZZZ/-JN^NNNN^]B!;OOOKKR>7OXEVG7
M7E[_ ,O?DZZZ\O?^+KKK\[KKDS<AJK?\/-J?KAQ;^)?IWR9> XXXX$0WGCCD
M"0>.6/66/=]Z@^7K+KKOKOR;A4)WUY>N_+U]#OKKOK_)WUY>2_E^?W_T]_\
M\>1#>/\ @-!?N]Z@_P <*A>2]E^?W_T]_P#\>!_SCCC@....!$[G##O84=S[
MPQ[SZUXL3KK/S>O/ZZ[MNH/+UUEY/+UUW_CZZ[\G?)8Y%+G]$&/?6\V)_P";
M=0<E;@.... Y]D?UUV_9==_1Z[>-NN^O\O7:V'EY\?/LCO\ C!C_ /GC7_\
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MVVS^3LY7_>G7CQ%K$=T+-ZSWK&0Q+&U&90&PF0X76%2@(57!6[FN-@M?3$(
M,S6QL0X&L"\ZAE]?+I''!&9ECW6+8PR&YTS-DQ%@X6II*:!^+,K)!N,=MZ>,
MX6<#PR3NYNCLI<[A;.T-N:G$M<=VL*L=OR;.3&!'3_$"7V\THAHMZ+1@[;]I
ME,*.,V#=BU9(!J7YV]GU,VJ?W=ML_D[./.WL^IFU3^[MMG\G9S/ROM7O%:KN
M_ESR>M.7M*C*^L.Y)<*IMQL[8B,O8],ZVUA:8]H=7)*7$+EQEC9.R)[L'(EN
MW]@%Z1 QF7&KU%I%N14P4EF<E%2&K_B)W&?;6$XL<[)5N.S]W[15]'2!-N?L
MR']E==*[Q:XS59.Z<J28]CBM$,0>BZ[V&CQBT*E<I=%X6<#$)$3Q1$',G%5@
M&K'G;V?4S:I_=VVS^3LX\[>SZF;5/[NVV?R=G,\R[1[Q"HTEO]E75IVSTQE*
M\O@ JL_>^(;LU)HD4&5(UO :9-DZT.G!3$4L?:MIC>1!>]_0[DWL[8!(/FY0
MUZON>V8L\8#OCKFAMVGVPNMFM]M7%M#A"2VN!H>[O6,-VIL:F#RQE4!SLO6P
M(1TQ?,,R&0BN#W=DZVDA]E'^OX&30DAKG5&G-8TYT"-:U;!/>8:,>=O9]3-J
MG]W;;/Y.SG\]*;U9=Y=8ZT:HY=X9>;GUUO=;'?>&7>..?6.777AV^7'+O#/#
M/R=^3OS<L<O)Y,NN^\U##3#Q8RZAAG OO*9*[V*8B_F1S$USN3>NM(96=[]5
MCKU0VI6QP24UM&/I\CIX;BZ#/K[NC5F?;25>3=L;96&0O*_M&="H1N]_8J\/
M[?:*N&3F*E/28,!R#=&_;N)Y04W-OH04GG-PFFD1F"W0Y"5G)$,2@I5@366T
M58O]5#:*,Z6D9<O'HUA7$H*E;BP:\#2?SM[/J9M4_N[;9_)V<>=O9]3-JG]W
M;;/Y.SE:;HH??^RMBBNV *4G*UR)*!(ZZI*3^.)94'5FKEE-@O:T-^$6P=4A
M(9EJ4VS?EY$=:^V0,.+ @U9H76A9-@O/"JM1BS"T:E&V@_B-D]-6(/AME7S4
M;M<:V>)J7!$?$ZVKM,V ;D=ZG5B&T*Z*MC" A%#RQ@=_M8+%UAL:Y,7\[7 T
M*22,I.CS)N?%=1" :E^=O9]3-JG]W;;/Y.SCSM[/J9M4_N[;9_)V<D;2ZK+8
MIBIBJO+:)B<L6BK^V0D:QE3:TC.Z#!.B2>[SDHI.)([)L:7(CXAD8.NIB!B.
MDBTD(9:"9LF@[C*JL(ED@WMMP*!^=O9]3-JG]W;;/Y.SCSM[/J9M4_N[;9_)
MV<OYQP*!^=O9]3-JG]W;;/Y.SCSM[/J9M4_N[;9_)V<OYQP*!^=O9]3-JG]W
M;;/Y.SCSM[/J9M4_N[;9_)V<OYQP*!^=O9]3-JG]W;;/Y.SCSM[/J9M4_N[;
M9_)V<OYQP*!^=O9]3-JG]W;;/Y.SCSM[/J9M4_N[;9_)V<OYQP*!^=O9]3-J
MG]W;;/Y.SCSM[/J9M4_N[;9_)V<OYQP*!^=O9]3-JG]W;;/Y.SCSM[/J9M4_
MN[;9_)V<OYQP,TGE2;>69>&H1;8=5:[UN!Z][!%5TE4D&[/V-;)9+LY34/:O
M7N+A((5FM0:<B,ULB6_(*6?O'QHTQ:PT3)*MV[UYBW9.?;UM_O#8;Z\[9C\)
M8;FB7,[=;?[PV&^O.V8_"6&X%BN.<<6OK'9=QOP?A]>%72O3WN8R.[9+*SSC
M\D^VGL[&+2&:(N7&:Q=]9ONWJCQP/Y1_;9KB@C)]/5<V''^W-C/V(M?/NJ;4
M_L/<"8>.0][<V,_8BU\^ZIM3^P]R01AR7NXOM8X'Q(:G.GKA/&-"SR=L2&RC
ML4FV35WG/$-7U*_2?++9NTW$;B,+-VR:#=9.6=9.5$&H=!RH.\?TDP7Z^#PM
MOY433;EON5!WC^DF"_7P>%M_*B:;<#4;CCC@.... XXXX#CCC@.... XXXX%
M'+[_ $7NH'[GFW/X,U3R6^1)??Z+W4#]SS;G\&:IY+? <<<<!QQQP'''' <<
M<<!QQQP'''' <<<<!QQQP'''' <<<<!QQQP'''' <<<<!QQQP'''' <<<<"O
M5K?HA- OKC;9_B8;)\T-YGE:WZ(30+ZXVV?XF&R?-#> XXXX#CCC@.5)VL/Y
MZK'NM5A=2Y+!U6-[$)8[ 2@_%34VR8U>1T9>8? O3)@/QLM))@S"[R&GI CG
M5&F$('(-$C0KD842'9V:C[;<I]NCMC!Z<5S"6R41DW-"S->X)@IAAH=C)\CE
MQJFM4=BMG)^*'UYD_ 8D>GI.*HAVPA9J45(XU:5<,Q^1AHMC/.#D.#+IIN]O
M,'8X. &M"*[1\M0W\LJKPZ=UUV%>V58R4;>>_9'J]'?"9)J5Y5P+34[7U<:P
MPH1(0OPJV.W$CH:;D=8CXQ<E.VFTG9EL5N4=ZES)\[?C#*P!?>S3D%:&-2:_
M[(#,85:VSNP>H_=Y3K^N;]%0\P:1T.&'=TC-CE(LL5AHX#")"YR+H,Y@#)N"
M]<2>(5;$=<D.(-M;R&(&X!$P#3\6E9ZHIL\(+OE[QUFINFPL4*8R]XL3#Q?*
M%V0&;AL,KF(,X4R#W2@B/1B%E0*@P0>HZ\4.+4Z8M8'5N]IR<D+;(-><(3(H
MUXB56=_!&O-K[(617,A)2-UIP^#2O!&FC""G#I@^D0V=)LX;*OY0T&'S@D8A
M2"$W#\2JJZ1I:!EF 66$,KKYI+94O;%AZE[9$*X6E<U [JS1J$V]"5 56:8E
M]HC=IZR4>.%Y1&P@6I)$M_\ NM[B"Q0;UBBC;C:6]-PPVT=,)FI8#%D_LNBW
ML/:(R] ;2LBG!$^M?>;PF:>=DQ- -5*<-7DK4]07-LR2@V)2^KF7:0\,8D)7
M ,X@?+8IC]"'BU!:T O/J:Z72T3B)W/,JBLYRFI@D'*XPJ;4J[5+$R%@ZS"D
MEFV# !W+J]4E7'XB2" :<@C2+.[#&6SRJ9.U//'?$Y,TNIIJ9ZTG;RP(>I7=
MOS5+ \S3N4R)A I:^Y0<9$[BUBZ\H$ +W;@?UH&&T&#1D? OV1B>0"C\G?A\
ML?S=#A6HNW'\1<(3*IQLY!I:6D/@<CUFQ-I-MFO7E:,XJK=QT"DL;0=/DUKV
M#/M[YO2B0EN/0S?*2=U_$%HY4"DZ6GME508RDPE&VGB((.&LW$"51Q8_V&>(
M3:T@*=ZM;!%I WB]-MG:.IRKJ>8E[B\0+-V5[$ IG81F.V(_JJ'7?QT:Q(Q>
MFW\4.S3*1NI0&[PUL!9SVOHFJK(#XA]WLWC79^5.Z^5@+*QU"V-2UENUS%0X
MV:SQ<-M&!S,",D+>^D /OB(>(57"T?$2$,]C\X=1\4$+FJPJ>Q@>@;N-W=PU
MW3%E#(8P>4_ 3;:&N35VX]M6;"5DC*T1T;;2X[75(E ])H83"K1>P)<6C6[W
MH5=S9F/A7N#VJWI,;WAATK[#ZPK06W7@P@I8P6K6UCLE;U'(V)M)5 P%FY>8
M0\!5<@UM!(;U_)X:Y:^,9*%&Y$AB+!?"4W3MQ@&$3RU];>[_ -(W!MY!@PJI
M8 ] VA<4[1+66U:NJQ8\T=A&G_AVEE$ZIA$C6A?#IC.&PUHVSLXUSV$*W)()
M#I_5U@M?=])E"OQ4;T</MXJP!7 [Y!PX(HLJ::82,).Q,?%-(]S'[P;-#VK]
M8+K(SDO$RK-:!*"1D6%[)U').FPDDZ]E)RA GC!YT3*O& D'5'CMWAVN%@B
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MKU25K81!#VE*Z(3R=0D4J,QU86>!EC::"+#FBB /10""$(7<;Q"H88JAV_%
MY"%L\,(&K=#+4K9@G*:1<5YNEI'K4XGCE5U?1&76L]):=V$N:Y&S=XP#))PC
M5C4A5>3 ^+V _G9>*-KMJB+3[3R[0*#'2"X['M.SH$I?1]#[#1 )'M8*A-N<
MQ4N(M>4+=AK,'AY\< M<>UZZMBPI'.&DYO"%6>P]BMQ$D'/2/=]*PN"OWE=W
M-H'?)P,DDPJ-GE1WA4U=C8]-NV![KV,U^E'!VT4[6+>QHTNLN_ZL8BY&J.M
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M3#A5P<D)R)!0V$,]@,7#IBP!BVR1&Q @R93<0".Y^_5LW1U5H*.C($,&=W-
M:"L6WM%=@8OX+!+,(\2LIE4BN'2V9C!@PG8I75_56,]N(6&*]HO;H?/R0 &%
M+4JP1%^_<^*W+@CS8/&W-:3Z$6I>SIQC)A R2U*36(&4Z ZFZ0[!V:9E,&+V
MJ7.#I^-36W.;10AK%B_J<<&X>)2LX\KV6F!9T=R]8OB)Q>&M.^UR5& S3XET
MGUWNRPY?$TPA5PM:\J:ZV/ABFAY=86+EI/,G!B*@8^:,T47,3'R%=VU5I2)D
M<@T*<G$6$3ZJ;/[47YL_3WPHP$O7(+):SFYN2U0QUVO@*C1@L)J]T9,P]V7W
MD93\E5Q^\>2U@W>U$QZ!'QF>$^X\HKB94F3BJ+,>J5M@]J-_:(KV9;O4WMT6
M$W [AM_"")M/MJI%:WRN8L/<&6DO=2Q&=R$==T>#T8+US3'4=2KM5](DD(JP
M"AER.$^S%#/(>]^?B40:-PLZ*4U@VE?6-$VC 5K;$0(URE9<?2R9Y+5DC6A:
M?EU82AD!QXX4"%M#MHR\EF6)1H< "]H*3$EF7AK /)ZS4MXQ"DAK4%7C=%$'
M<CU(U<\.3N:J9M6D4-#E@R6C9)XF,'10X.FM\R)(4R<-J4U&8I>U\Y*)#S2S
MY^#7S@:UBY4S@*D"?=V;[W9USK.I$ZLCZFL(]GV5K.3^T9#7?9PJKGHE%!%V
M05C7T/3.O<A=UO#+^T)A7&)82[Z7,4'RPD^ H/!:R[0KMHUJ+ [@^(4!'A2%
MP=;,+2AF1SN>0B8S9E3;0IG]NKL=W?$?@0:MZ\ND*K\EIX.@J^J>G-9D!!U8
MK2'@^@@^%DITBCH^TZQ*XW1NE-WVMQ7L241GKYL,'/11L3QLQ:4M6I!)44G8
M( T!5#P";W#$QZX.X>,Y4W>#HH_QEL>RJ;K2T&Z\? (1P.XL&JH7XJ1&RFY]
M]>FNY'7M>#P$H7%<Z.D8"7/JS696QXB8BLD3HL#Y5\8I2PGI,..(UM7(_,NF
M)/8.2;U1>)2D<Q0(_9[-[LD!Z/>Y5S"QI'E T*A,)G*>&3MK2 8V*B+:34H.
ML>Q5X6TKZPGY7JM*BNDK;,XA8CCXF*)86<5G9:4>5=:HSC^D#N)XA!P7B0%
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M'BZLI\7@;#G$JW)*F&%9.Q:[/W2UR;5W]KFO"-P/CH)85GIA\-<1?=4R,I#
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M79X2NM4K+5D0=;7ZQ^(<-5Q,%;77Y2W98>%".EZAAZU [G/SG"O-<3)80K]
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MG)0FO:IML=+G$<4M/93 P?WQ)'@W*3D'9KPBF?)@?#CULU^K:RI,KN<ZB0/
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MB.W4Y4G4B+LUDVD\TE-A(VG!YA"32#V,G"2:@83!K[6D8MRW#/;'PM-D)N=
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MQN;"T"Y%ZZ/RNT['L$^UUG+LGHL'2QH6\&PKVZLB1$H2>"JH!XJMZW92I^5
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MT38)D+TV#57$]5ZU6DUHY7%.LZA'U7,:*X*XN\HF5GW."BBKQ?&CAOX9$S8
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M<?$GICY<;K_?//$X_MA<#3WE.MV .X+"K8*@J)F#,=L9S;8E"X$PF1J#K,.
M;#C2.IKHL,CZP(1SJ;7J^E;!L.S*HA5G$DAGL0(4S)JP4QC%]L\Z&[6:R 55
M:M[)VB!V5NE"G%;T1:AT&S"_B3^)!.H112+!LM,0,DM"$6V,M 2Z3"3:-G6<
M7-Q<C#R'27JDI'OF"SAHM>K>!AM2^K,.^*?*2L<2M;*:.+(0%ANN2D]EJR4!
M#]DFS 8VV+9HX!ZGF-I/*P(91:>M$:2S"H,L9MTB)T[1%IL*X=ZJ[?C=G2=C
M YJ"*J1EW6<<I1<]?NP*;&\ BRNMDV(C'V:Q=BA9'UG(ZWP-U!,( #@6V.8*
MP8RJAR*D)>LX@5J)A5/26-J7L7.L:X3@;!@2(C&=;@BK&Q:973LB%(U=;0/"
ME_1';$#!4Q.AA1<;N^G4^.")RX)+3JN<!AX(8$L>]L%>=FPE6O.55>*Z+OF0
M\ V)'PK5V'W]-MIE  J2<!%;U*;GVY.7)'8;@HO3 T"0ZQQ\OUU>5'#AE<;"
M8UU/Q$A$'#* &4RIH1=9!5?X@#ZYH<L&";8H*!"B*JQO-MM@C?4LBEX-E643
MXC\_D)'4+2L<10["*(+:L+3[J;EJHD"4\,*E@1B)*;(3D(FS1M$/9JK138N
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M.=#C"V#R+@Y&9+*NV&$![KH4&Z[E9:*2?E-I5W+FM@L;143E1^OFK0EIBPS
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M0,!EH!@Y#1:T0P8KR33(CEG<-D&239C-A@;VU>Q(?\W V1W"@+BD*TJ(2.&
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M_"B6R:EJ8AOZ(":3M(P !&W7NXGAJ=&K>==R#D,.!<-AJ4+-LV& >;O0@AD
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M+$FAA9<5>&R#N^H#"\:\&];JNE52.AH/&*JH +2/9K8%ZT&NB)"LXZDA4D=
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M' <<<<!QQQP*RWE].[0_ZX2YOXCVT/+-<K+>7T[M#_KA+F_B/;0\LUP''''
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M&239I)WP6,?AG^&SWSL_VG\&'P6?!Y\(1'\#'J/O7[V^^?P4^M>Z7PG^L?\
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ML'82PJ8,-5[ATL&:4.IJJXZOZPUPN^=93)<$U[,5_2X%9+Q^QBX^,#AXL/+
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M+R*'5U/XEFT9*Q#AF0JH:LZP+!++$' "< ZF)1$-*U->D16[+:;2'NKL#LX
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M=L">93,Y%#T"WF5/S'O%=JTB=BK=M0.Q";67M&KZD,IMO(ZN$H[4Y+=-Y %
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M2LN^'PN(BAB,=.N\UV\+&L6'6?:#5'' .L4546R[S54S5S[_ #\E,\L\N_\
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M... XXXX#CCC@.... XXXX#CCC@.... XXXX#CCC@.... XXXX#CCC@....
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MGY>_ LYL4'B"0B:P8.:O@R\C5L>TC"%PKD/080<X[:3/MA&%$[&L1J(5!8$
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MD5YOJWAWMMNLZO1>9';5W (>RM<^A#4FN<3?[/VM%2&O@_9A/;,K,[=^()#
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MR==9Y===?^[K@?CQQQP'''' <<<<!QQQP'''' <<<<!QQQP'*(>(M]).A_\
MM+_"?_E#=>^7OY1#Q%OI)T/_ -I?X3_\H;KWP-=^... XXXX#CCC@.... Y3
M;=_Z7%0_7DZ1?QJZFY<GE-MW_I<5#]>3I%_&KJ;@2#QQQP'''' <<<<!QQQP
M'''' <<<<!QQQP'''' <<<<!QQQP'''' <<<<!QQQP'''' <<<<!QQQP''''
M <<<<!QQQP'''' <<<<!QQQP'*V:W?W[M5]>O>?_ (#67+)\K9K=_?NU7UZ]
MY_\ @-9<")-MX\9C[AU4LRY 26L#6ZOD-@6Q\W;5H07*.!5FE@P#-*B/#&MA
M8?+9>2CT6\8=#<,2]BLTR%9R<;]K9Q2DPD]Y7TTAZN2"]5K!::TGE>Z2B>UF
MPAS9]5DM=%Y-&JM2P3/8NH[Y?T LB1D@=4;VSY!0LAA%41@XD)1FF#]H$LH^
M1CLW>NB2JJ&?2B*JB*G7YV:6>2>?7_1EAWUEU_[N^?UBX<8*^L8+K8+^7R^F
MQ5SQ5\O^7TG676?E_P"?SO+P,)#ZN1>UA?8M2N@(C&M0+UW!\/T>"H\> )JN
MHP@E>IJ*#ME+8KH"E!B'=0<#(-I(;:*F.(NVA9H@$Y6:Z6>^@=KY6PT_$#<K
MV$VP!MIP:(-B4+#]+*IG"<Q%FY$)W5A7$KLRY%K>CDB5A(Q;J4)Q$A$I^<Z:
M.G[F!+'DDGVI%N<L8]II;D[=YJ9+9N7&2V>/FYJY+*9*98__ (<L^\N\LL?^
M;OOOKG\=K+=XX8=K*]X)]^<GCVIGWBGE^?Y<,>^_)CWY?H^7'KKO@8:0M3->
M_#9\/MI!UL(PM@&=ZZ7X';J9J-.6]I2+8],F"$K<(Q&)#DZ8#,%A)JJS\9.3
M,;TK"OI9GC+Q7MA=YE]$M41=$UOX@ 5* 2BMKN[8U6G;<J6@:S4K^K+7U. B
MZ#D7,W00A$OGSTDE#JN%S1*WX),JD23VC'^X;[TJ>44UF]Q>G+GK++/IPOUG
MGCYN>?2JG66>/YWFY9>=Y<L?)]#R=]]]?\W/^=.%^L<,.EUNL,,O/PPZ4SZQ
MPS_/\[#'K+R8Y>7_ .]UUUW_ ,_ Q=LU*I[)>[4&NG5;J0%2-?#/VOKVW)T4
MI8HJ('.; FX]-[2]?1@K+AP?F4V6(Q+4P=NGD8/O7T)!SJ0Z]E<'#U&,4OYJ
M7>=46&'596PI/S#HR Z;K!$L@9>N+0$DHKH;'1 3F4\9HP"($:D<VDTNDT]5
MBIA\Z62RS=(-U6B#E9&U2CUZMG@JJ[=*JI__ &:BCA7/-/\ _P",\L^\L/S^
M_P#V>^OS^?\ 5W[YSCU@Y>NW&./?EZQ7<K*X]=_Y>NE,\NNN_H=?1ZZ\OT.!
MBUJ<&6L1[7,3\@B[<5B(62OZS"28-K8AI-%TL63G>J%:2[Q!Q4\$X)W60+K#
M.Q*[*.D&KJ9''@&7-',)$(*QT[L/.,7\I!3T5%3\B)RLK S<5%%<0Q@I.7%9
M63BW;&-)XJ-*8J=&9"3'GSA"8CV)%"3$&[=LD6\M%OV"CAJK[&:ZRG76*BRJ
MF/7YV.:F>?77Y_YW67??77Y_?YW^7O\ R\_+@5@^ J]?J_=B_M*Z+_V6^5LV
MU$;#KRDIYH7[;['76ZM)^SJ$%HMO2NC_ &[N,],6S]2%#L/5-7.G;6/:MHN0
M)YZ8:Y)O(&$@7TK'*=2K:/35TRY\RK)BN\CI%>/CW$C#J/%H>1<,6CB0AUI%
MBM&2"L2^61S=QBK^-<+Q[U1BLAFZ9+*M5^U$%,T^PS;I_7JV=:])+%!+:M1R
M<2+J)&G\, MNFT@)THT2(XWI^("I2OAE-$&$BL[:.IE+I1J'P\A'=-0V*315
ME)P@A_8W078*R-H-C.A*5&6%%;=[6>'-LN;7 C9KD9LN@D]#4Z_Q,@X2!<1*
M3=SY/8KBE*\RJLBB)52&@I4S/"0RRB<@H=@SW5RPA#&P 4J"<Y5:"Z)8OIAA
M,MV*$FM&+I/&D@U>8QSI=LW?8HNF2/:C55PABNEWFGZ9/O+K/KGUANZ5E55L
MKT&/.54S4R_^KY&=_P!UGEWEW]'NUO+W]'O\_OZ/?^/@8*C_ (6VX3V!UR,2
MI&KQZQM!]??"HU\J>M!F]GL@#;6Y^'=M9'7M99V0%2M7LNZTB;- QR!BZ1@B
MV"SF(*R),A:6%[ %HR-*YKR2+PI-Q)*!V\09]56I)>)C5E^5G<\;)7>]DXC3
ME2ZO$(V(VHCI46[SK6(^%F*@*4V1GHDBBQ/%NYDK_"VS*+65KLX=G@AOY[K7
M/^SH,?<]Q?SK<>ZUS_LZ#'W/<7\ZW P>V1\);:K9(;.Z25*:W  RN+1\5"_*
M,MY&U9EYW=Y?OO8LW9515I: >P 5"4 & EV>F\#>\OFA/I.?=X)F:_0+<2>?
MCPV=)[3W=%SLX\\0^' *[RMN7O78HLPT^?['H(C\57]P:"ZNZ=B!%)VJA6^0
M7E8T=8&K<.<%[*'2EF4/41W*,!Z2+3H:;CA!K;[K7/\ LZ#'W/<7\ZW'NM<_
M[.@Q]SW%_.MP,,Z-\([8RL0^CM1R6P1Z2HFOMFM5]MR?:<<MB3^$M-_KYX;=
M8:93U(BU72@ SEV>,E;%3P<P!3:DX^%XK7>;=Q$L_1.!9C D_@5UX8^Z(^6:
M47B30E6,SOPZZ=\-?7D4J(3V"5DQO: >TO&]O@6X;-2GI.KQV+!G10.;-PA!
M0@T=K1<C[>&"N L18)8R\40\WK]UKG_9T&/N>XOYUN/=:Y_V=!C[GN+^=;@8
M$.?"?W!2IVU:8Q>TX[;[OZZ,*BOHOB+7EV"NJ97,>(SM=NV:R 8TD0!N[N8?
MB0#< N" J6@L("8E+4K2 =3(] AA](D0/T>QOA3;7[&PTG569!6H$,T2>^)9
M=%#V?A;\S(9;$F&[6YXSMM4U?6@-LJWZ(:T%!*/0+02^91TV(?3S:(A-5\@7
MQ<I.8C>ZGNM<_P"SH,?<]Q?SK<>ZUS_LZ#'W/<7\ZW R$)]--U7M^%.\\)7M
M3.;5L.R-T'+C5Z6OQ-BR#038S37375JM""7M9L!R A+%4*4Z6#9C9<,.HOT8
M(!LZ:9!C\^*0EG"ED,U;X.=_ H=5.GLG84$XU]!-B*NVBE-K8BUW_5J9NP3P
MCX+P\)*HX*IW-=-Y)@^6MV"3-!N54)7(G':^N$X1W.J'D=C!O]X?=:Y_V=!C
M[GN+^=;CW6N?]G08^Y[B_G6X&3>N6H>P=*B21YL''@H9)U/I#X7/AX"PW6UI
M.;(A+*SU.V$GIDUOM\BJ#"?0M &$E9\''56-R;IT9QL,S+W!C%0;J5CF.&X#
MK^^7'^?6_P#\F7(*(*SLHMC<((FNN)>P*DX(S$DQBJ1BH-\_3$3" ,6[%&6[
ML>4Z8XO7H^V:KN/9SS))NJKFFCVKTGEC.*F?:BBBG?7D[SSRS[Z_R=Y9=Y=]
M?_OX'\<<<<!QQQP'''' <<<<!QQQP'''' <<<<!RB'B+?23H?_M+_"?_ )0W
M7OE[^40\1;Z2=#_]I?X3_P#*&Z]\#7?CCC@.... XXXX#CCC@.4VW?\ I<5#
M]>3I%_&KJ;ER>4VW?^EQ4/UY.D7\:NIN!(/''' <K;-[9TJ/3NSPM)2A"F3:
MD5W\*MK0.$&W[DGX.F#-3]],@".<LG[V)1$1(Q#*:QR[B^XR7FH=FX[Q3D6S
MC.R7,H=DM(+6M=WN>> JXV.6A81)&HTQ*+SK-%(ZJ8UU7"M?;TJ\\6[;.486
M)GO9S^;'\91J[48%@L,S,>ZB$W3YYV%[;'V.J6J"RB@HVEIEA/;%SB$#6Z+2
M#R?-\'#M\&Q#-X5N4WF&(Y&.YT^%8!N\SQ>8JRTGZOAAVDV=+H_/*;+5' W@
M0Z^S\G/0AX+U:[N"7?2$(BB'8B3".RFGB+8@[E.U5I]"$;R<QW%9Q:&.4?"R
MR^+OR,\NLJ>7UIK>>PA?<\V\L4;K2,1H:K:/I:/;PL49/)](*]D7#)34G-=2
MT>XK5;+8.''NFLO&(RDP\B Z#E5TF_39FT;\#L5J-M/?<V=V.@VK\.L6PZ^U
M>%Y;M,JB'[>.Z?T1M;1VU\+'K=HYH]1T9&W]&R LZ\Y%>=5AV#UATSD8Y'%,
M+4P6^M(E856)L("U[EZ=O&!\"@XF,58C,'C^?K2"1)2Q-<:;E?G(M&<*HN]2
M72>.<\TF#[)9!OBAYV5H@,QZ/1AH3]!=D@.+MW(-,1RUPY4&,$>H]QVV[>.(
M!9_)9IQ[WOKM6.=>M9=.D.O2>9AWY<>LORG3"V,, 5%E5PK8 P%[C[L6UG7D
M=?LC2:SZJ;ERFX^HNHRQ1?#H@&Y!DU?Q4E(Q48IT[1;Q*L%(9Y-)!?RZ#:^B
M\F%UBQ&).J<:9SBIX@Z9!GP\D>QRF3"0<(2_<XM918EA/*YR<G(2:6,$\6=8
M0Z+)+!HM@T70:MPFGCCC@.... XXXX#CCC@.... XXXX#CCC@.... XXXX#C
MCC@.... XXXX#CCC@.... XXXX#CCC@.... XXXX#E;-;O[]VJ^O7O/_ ,!K
M+ED^5LUN_OW:KZ]>\_\ P&LN!9/CCC@.... XXXX#CCC@.... XXXX#CCC@.
M... XXXX#CCC@.... XXXX#CCC@.... XXXX#CCC@.... XXXX#CCC@....
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M]5635RHIX@-:+W6WU.KW"4(1IR2;:,/5S<39K*2U>3#6B;Q?"ITV5;X8IQ^
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MY>3O: IL@I&ZW5D/2FPB!,S&+M,[/UTB-X1@>VWF8YQ8D9%!5FLKO?-L1NT
ML(9KNL<P5P6CT?$=& M#RB<UW%J-FX:A\<@G5^P&MJ:Z4T?M# I/\9\*01=&
M)P-Q B:SLJ.2DH)33HN@!^1EH!H2(S$"^9S3B#DW\1*/VR\M&NEF;Y'/N=N
MXXXX#CCC@.... XXXX#GX(NV+E650;R$<X6@7&;2>10D62RL"[3C6LRHUG$T
MU\LH9RG#OF4JHA)=-5<(UXV?98=-5TE<O^N4<G+5VUQ=OF&3MF[:8OXMSTSE
M&&3INJWQ?1KO))?IK(,^U.G#)SVBKT@Y225[3SZP\WO-:M@6G:EJOQ*!"QQ0
MX+:/B[RE^R:#DY,]+3ZV("4U>UV[G4_>A:61+S(FL0R=RD>\F.IY%JZGI1ZW
M=O(^+0<I-0T7:$@Q(#ZQ;'E(K("+9)VLY+F!-!/1-JC'YXIOU71,VD%8-LFQ
M4SPP>9KOT\6N>6.*_:>7?77/1:.FD@S9R4<]924;)-4GT=)QCQK(QLBR7Q\Y
M!Y'R#)5=F]:+8_W2+EJNJBKC]'#/+KZ/,D:$G*!DM<=@K2/P1NO$6->]:6%9
M-0!>M5E.JIUIE$8T*&:@75KTD$:WZM2(JW 0&CB\3@,A'P[-3S.051C'<3'-
M7SV?=(2D3K/7.G@PG3EQV/-=A[IJNHR90#+89C<N,U8]EGX]:3$.8C>;:G!6
MR(IL13@X/SW<4,0[1JR81,LY0DHGIR%[\WK!.09Q"DA')3$BS>2,?#JR#-.7
MD(Z.7:M9"08Q6:^+]XP8.7S)N]>-FZK9HN[;)+JIJ+I8Y>;$% H0RSR '2X0
M(I^.Z<]R4"/E8].3D;TR?(Q;W*1AXN2=R3#%G)N$(YWD[:H]-GRR31?M-PIB
MGWF74S>]?S28,L6W:4,X>>,ZQV)'&SGW_JLB! JG1\WKE6J8P5[@#"0[22;)
MQ6#LK0E_91@66%:I!--81J*#:R<-7+70.GV@=L]7]'P;.R#0GT.OM4DMQQJ
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M-1"+&&E9MPFT0=)A<W+)9PIUWEDJNKEY,>O.[R44R_Q=8]>7SLN_\G77T?\
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M3YW'NH7VPS>$$;/0;J,S^85TVEA?85I=>=H(OP:+O^W]E888^"]1C9>9_=
MYKXA#YN[,#Q9O*U1!,7&+N &&]>L))9JR@1Z8EGL8-QJG?\ 54Z<9U;<I;>L
MH15],E;V!N*'"90'UH :>)G[JWRB$*7Q9<<R,DS$=MXX'60S$A0^[1AJZ@W<
M:J2D<^V6*C&:F4P^^]=E_BNHQ0#6=0MC1(%URLF_"<7B+ CZCAJ^UQU^[%!B
M2]UFJ046MB(@R]LH18>#X-QB)4;0;O%X2Q2?J_G]58&T4,%6!KJ"C@*>&#38
MHGKJ.;'W35\+5V)B]GPQM,##UR6.8:5C2T\?(!<@\QK.$43>,8--><))X=0=
MC:))$5B:HW!? /7DX26O U]=T[J*9ZN;(R+:JFAW!$8;=;4.F;+2$(V$/12-
M#BV!)X&0Z'YA!^5C76,DYP]1?-6[9PXL38-'L39/7-A 32PO"ZXW36UIQ+!2
M$S(U)R K6O3ROHX.5<XS,)W#.'3(O:.\B/-.7Q0RB5DLX5SD^Z7:AQE@[-6%
M6EO 8!-TI-IU-85NUK18U::EKQJ$\3FED"<J2JS(;3;(3E59NNP!S&XPI^03
M1^*3D:IU(S$4)S$)%JO59"OBYL:-K.>LA<//+'?1+=\A!"(+%2,E(R4LW'I\
MB2[FYI!D_C@(-9,!V1>$QY/I]0X^Q1_N$)28>1,+)P[-ZT6_,;5Q&SK>_!KH
M=&DAD8%ZUG=<TRM8&K?#V9W: R"6"[N!FS%"VW.DYU$DLMJ!*$J,=)L(+#!S
M 0C>,7FB4 C(KKNZJ_+[!CYU>S^KF@0^9BZ[0'^J_ ;&A)* "A5_#-"I[V=R
M@"SDE/:!.I)#;HQRQ\JC"#S[ZSQ"-S79"SANEJWN2O:44,VAI43R[#]::NN/
MK0$J,3B:CC;2?(DQXJ"%4Q-RDPJ_R%@_-I7S"'D'K)W)%4P%QJ>*F7)69N44
M =?T=;(]2! 35]> S3<WWW+V^,A5BJE%W20NW&*9K>K$($M*;?N6/'YN:-9B
M SP!1;H6$IAPQ,W;U%TR8_-<.HE@6I4.OE(CEUPHJ*4O#A#8ZA":A.[0&KLD
MZT%A&"",S 1SMH.;H!\/*P4P3O ":>ET!.2<A!93/;OW7;9//2OG62Y=@P)A
M7)!L:Q2$R*JX*M[XC%==AB3:E)!'R[*8F+FJ?),T9R-/61)8H/X",:S4M9H>
M,Q3YE(14%T00B<B_#M+PV9@J0MJD:7;P$@9F-QVD% LSC&S6<''UH'G$O.P$
M(;D[K""GL'+XBEQV?0!@QQ[$5,&HH</V\_'H"SGISPL3N#*DVV!-JP,"=92<
M0%E#<7(""3VL#!^S57+>HQZT"27%=9G@4X,2R%%W1#T+/I",)<6BCJ(GW_3M
M#J'?L4/RNC1\'N&T(JVX@[MD%*N[IJ:V#O&*/K"D88HC*F#U@N+B(2"CC8:B
MP4M6B4HW%I93)M*R\3G[?[1CU^R.1[RZ2=UD.BVYA>Q2>U8Z4J8%OQ[LL(@D
M?2,*-GS&PW5>OP1J,S%RCA-&QA'748I)/9WI.6K1P=SB>;(>)3.681$<Z2"T
MW''' <<<<!QQQP'*(>(M]).A_P#M+_"?_E#=>^7OY1#Q%OI)T/\ ]I?X3_\
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M61*_;3+RKY(B(+)3@K$-%J]DVK>>:Q86ZZQ5=:5VO9@/2@,^*#A.2Z@,GT$
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M?&F!;0PS54/<-8,W$:LJ>PI8!O)Q,BP8I3L3-9018XB3+V9*HS+<>5:].UT
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M8!AL'L.S)S(/@! &'M8K/GK.?;-D]CT^BTN&NY1NWRD"FX9%!L&'^<B.-U+
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MD744[399O'@D9'G:ZB;2+QQ[OSLSK^E9.W&L)TV#YV>"I,C.HW8Q2-=KIA!
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M_.<I-G;B\"SG<;L'YFAHYW-3\,Y>7)!#97&P:@W'"L@QZFTHP<("%NJPFD)
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M[I @A1.HYNK8EY"E#N'N2(BY(EF,+-:K(2<1$QT2WRC'/GQW?2J2?=T.1;.
M8K)7  7"_+.F)#5X';-<L8#VN.(1+IC;$K6LI-NIA)UCW+I2<4O6<6C&IMW;
M5'S)!]T[;KY^K]IA0ZPO$42!1?;]D^PKMI<5+;$%574V%K"=J/8,M H25K"/
M:3IK+1\PO&^\>71&;8+]LRD0:9+1<*KA!X(**=/OHO+=*P@#938RFX\ZUJJT
M6IIQ5C<8DK6IW9"S2 K]_:KB3J66?O*?/HZ.8XPDJ[6;(8*03#)U&N6B:?;A
MVR=N7-CY[58#DJKVLJYY8!6R@-D+P(+JL"6Q?"J;T")I5S6#YV/1.2L=W',X
MIIC7<4GA@2(.Y3!&<?Y*.>\EFV6']E.O,RUNZ[KGKO;2U]?BB[E !P?#8O!Z
MU$,5TI7(*Q"1A1%*Y*I.YEACA'-W4BMZN[;8.G,DOVIZ1LBR3;AV6R=L$M/0
M(-' P\.$=G7#=@30-;M2U[+QX'%%QFS*9M8F,58;O,A<#(X-A1')J140X0EI
MAVDPBD'[/-WD[2C(PN+8ZD*=/B:XZXJ,K/VUA5;6E'2]8S90*UG;D_=!% A@
MVL2#I;+%QM6[0()YSS2WIR12WO%&,^U!Q=@HOBKA.5KTO 7@&Q :43)BSE1T
MC$K!#['"W\/ V$(6*%8+*0EB#CSJ"D!=O+]I/9=&09NAEZ-/HF<E8Y6(Z8N,
M,4HBCM1:_+*WM@9+K.MVZ9._200(RRYWYH)IF[$MJO.'QK>2K!:NQ2#KT%>U
MQ*0#*2BFT.).?6Y/UQ$KZG&"_<>F'"36P%_4S,6@ WO"T7/ES#5>[-DZA,ZD
MC[&@PB7D*3;-FQ179V'F9B0$WIFDC/#<HU(8(KBFLW"^U&N#:(D>F^:=?FOB
M$VX\@-4V2-?57E8=B6_. >Q[+%@<YCX"-MK\IRI!27!T,SM&2;/#0?NX/)(I
MT02!(TS55S6PC>V'7H^[<1&JL42J6X06'>]E[ 6'8-,FFL2U@$&-2QJE7 !P
MB\S(($5$JL"AD2CRV3EG+"8GILFCI.:EEH.'9YILX]-VV>1^VT-I1C-S-A(6
M*6IJSL[J9,=R?<B XPS5YJ?[EOH]HQ=XPN#?KNT'5;C,M8*?;K-TJ[C.W,3D
MQ\G7> 0@ZW]L9C<QN%9R&K<E@,;K.-88/7YKG83': X \S(;%TK1$\$K!(HA
M_P"QVY"[?RZKVO(P9<^Z))BG)QBG2#5.R4)M*0RVX<]1_8J.]T9U-FE*!UJ,
M\)K,@F-FZUKH'MXU#))PK,^PF@\F($)5 Q*70ZWD'I@$2S=M,/$TUFJ5@*9J
M^ HV;N%(=*965DKEV&.+\GX:>DX--]$D-C1H@@Z$8:/C4F#U2!;MAEHZCDWZ
M+N3<]2;A1=RX3S1[ZK1"^'Q10ZR#7C1U/=7N,6LVO-38ASW =7(7&#*T'ECD
M*I$CA'H#\@.3N4B\#YV.;CZ*.0TI@U6<=NT_6<@A4N\0PP%%-RAI\"@[$RI2
MQ">#H!^^9%GNC: P 677(394.18=%Z#Q_8@'"6*+E4@@-R\(W>198PD\!UK'
M0,AE(SE>VR-S5!:QK1\760D7V%:2XDGH\]:11TW#S1=W)8P=N15VO4B&15CG
ME#(X]V.4/AM^.M)^N'3%T@A!/\UNTO\ MD:(4I905;@J2$90DX+MER+:U4P;
MNQ)(DK H,84;1FAM@NM#J-6X+,"8VM@\9$2"JSYNZ2FU':CF$B'3.R9Q5T%9
M5O4K:#J;E&Y%0L[9Q1"#T*YB5V$QG<M:RM;N.B9%5N[DTF+*,E596"5CUV'3
ME\EAVNJZ:]]I<"$-P]A#_64!J0K$ J!M>:*+Q$*[,!UI%$+1W.BGP:VE8!PO
M6<:B6YNHDM>)5RIT'MB"2,6C7!UVQ?LIUUDDXYX#7<N 6"]U;<;]#$[4VND3
M6A'4<Q#MYYO(V9$V3K17EO#3*;R=2KG%27*; .6@=!MXF,'U&C=ZQ82#?.20
M=/LI_LFMQ6T\Z:)I4G<QC&D[L%[Z@I&%?P>41,S(J-G@,WA9N1?).VN, \Q/
MG^+M2/<-)#J19,VR+Q/SET5:ZI^'W2$7"V)6K"8+XBN[+V"!-AS:HFZPLF//
MXL%=Y+M:E[8>P\9-O44@4-(QTJTPSQDF2<&Q@HR9:M4.\.!X"^U%U,-0[3L>
M8 ZWA=I*;MN$HHZKY\V+.ZQ9'9%=-:!\#(-D<#+$G<#<]6EI#)-%2*9AFV<2
MJZSI%=Q&-\F.?AUAO :VCL/IY5\.% B -=-3BLY=TJLS+O>4)N.>JZ_CJ4KH
M264+&T<R;#TC1SEL]QFX<H?),9#-%T^1>JME<)0<:+4LA%70-5Z_FZN";==4
M?D4@X%G 9C T<Z[V0RLB/(X9*692SB((9]-M'P!LR>N5$W$6W8/.D&K]NW<X
M_97>G505C94)<X\:$7:[+9NX=BHYNZD0G$;<R]NUR55PI6C1XUB6_?8@%,24
MJE!1HT=^VD9%X]Q?O';;#-'$*[Z<[LV7L9,U(D8'.LL&ZL! W<RM2B]-[),[
M"02%HP[=(IPMCS%A$%5)+9(B:!&X5DT%T5(GUZ$02PGE&??)TOS9TVJ6P+J$
M8$>!G\96GA^6#MG#OB%F3.'[NP!&P9H6904QE%%,.T6"%HJ,26>,6+2/G\GV
M:BR)&BW[Q:X^O1&M,WK7"!-=B^XMNN:LKQY(=? R3C^KF$#(I3$E*3\I$2Y
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M(9>4G&N66:+I#IMJIW(/^^T\NWSSO)'OO)++MRMWVEEE_P"UVGWWGY<.\O\
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M[ZR\OE[[[\OY_? _SO=,3$$'"=\Q:N".DMD/$YZBB1EEBV]5J6]Z?\0>%(8
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M??6?7>&/?7777>./?77?7777?7DX&,>O1-J)-ZP;%6&:,ZJC:F/[]K(X-*-
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MW&!WJG1]B1LC&S@Z31"DG:BMVK3]=VG;%1FS.TW(0O6KPQA+!JDW##D=D'X
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MTA0^+@AQN#P(8()0^ X!A4; !6"T=T+ &?#Z"=KQEF%*&AV;:T"#->'!;#O
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M28QF"<DF9>Q30Y,W4@7DYQ83XH,)@IF)TA>3:LQ/3+Q\$R\<<<!QQQP''''
MRBW;J+9VPCVQQNG:]E92M;UJW6NL[7L"&GZL0(HFO*_L?98AM07 1\^-AM-P
M>SL%8PG'1\J0M4!1O$3,OVSE/;[;!:']K0&E[_IPG.Q2S@B9@JC#(%<:UY(2
MTAKR3/W0#.6$5F*(58#"O3$NB.B %PD6[- @CET(F<CGR&#=NP4CLF*6H?'
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MVB9T<IUJ#^%B[K3 V+L*U=G-J;:QQTZKG$BDL0-P<Q\!3<I ,3982ZAU"YG
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M6.B/' RQ!I3QM5#D&3LH'\+%I6F9L(X64[!K4VUD3EM7.1%&XGC@&CY^G(N
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MRBF^4A*OVC3%>3>-(]+M;I1ZY0;8J*X85&>DDN_L[(S%/#XDZNUU>J6!F.4
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M*DA4,]S$8HV=.A^>((;MPI&RDBV7DYQK3>%BZ=G 9>.J?A<F6RCC"6@@VLG
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M$U-C1%-5\7P#25C1[MLC+P[Y-226P;Y)8AH+QQQP'''' <<<<#@;6^E=9/\
MH"8_@[(\Y?7SZ3X;_F9C\(9?G46M]*ZR?] 3'\'9'G+Z^?2>#?\ ,S'X12_
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MQTS:2>8.,&93T/"\U<R@5K6<4G5J]Y-,V-NJA$!G8+1Q[L=22!)VQ2]=QG<
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M=D><OKY])X-_S,Q^$4OP)FYR9 >!8I. HR3%,% D-GD4B(UW"2LFU92AL3Q
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MN\Z&GE!^(K1M*0$W%U<=!NA<YJ]/[/K.:GF9)&.N^W\[^MW.QW[T&BYNY.X
MO!*SDYLV$NRY)1K)P3X;<[R<Q5TRJ"R 6\:^G<M3:[K51:$(HZW)AMJ'4-#M
M:I1=B+MWW%4_8H5L%9T@0-),]:P0NL,CL-/#DT'YNR&9,(YZ-0Z!/M5P''''
M <<<<#@;6^E=9/\ H"8_@[(\Y?7SZ3P;_F9C\(I?G46M]*ZR?] 3'\'9'G+Z
M^?2>#?\ ,S'X12_ F;CCC@...9T>)!5MSVL'ZTQ]$=3R)Z#[:U]<$>_BW<I'
MP"+ZH:_M>P1*$M"0AU$W[.G+%L6!"JHM15#+TR@6>RS9KUT]7;98AHOQS_+/
MK7)>*(#47K]1\(^VYK6:&==-#*J["EM;ZI?@U.TC\5;2B'M2ZX&U;!HTJ7+]
MP1;9J8OVM2&H;%.26(@*J&S<Z)->(%(6!;',;34*MXC$]7VI%JWBO<I)<T15
M^X$?8L*949KQ#9CIRX"I\GJ0QZ1'*0A"P.*'DC)Q=2P40,E40$EPJ.1+<V$B
MTT6F"^4#?+CG^;> LKQA!R:JL3)26^2>"3NZ$;/K%G*'JYE/&\B5:_\ AJV*
M-U=9S"J]1"P<A=<FMH6YX@(6:6+#P.NT@,-J2'1$GW&!SN%06LK^"BY/%=2B
M-H'S@JV)%4!W8^(BA1H.ZXM"=^/"CN?W09OPJIS6 \.JVIY_3RHW%::ST9;L
M#JIXATG$R<Q*#138;5(RL,DUT#_27QSC*XE"*;KP#FC >F!(MEPP7E"@4(7X
M]*SXR1/X-B[FQZ<E!'!,4DIB%DU74;)OQA/ >>/6R[B%PQC5&V/79\!QQQP'
M''' <<<<!QQQP'''' <<<<!QQQP'''' <<<<!QQQP'''' <<<<!QQQP''''
M<<<<!QQQP'''' <<<<!QQQP'''' <<<<!QQQP'''' <<<<!QQQP'''' <<<<
M!QQQP'''' <Y<X$XX^"R\%EUWK6)-!>?$Y1S&YM4Y%O'$<2[AWJ[!1ZT?LL'
MJ+9XJHUS=L7K7%?%/MPT<)=9HY]1QP,Z871&WAZ%A1Z)\3?>1M$C\/%0,2VS
MK7POW.3:+A6#>,CFW:[KPX5G"O3=DU01ZS55SS[ZPZ\O?^+KTOB47;^V>[Q?
M:O\ "X_)N\T$XX&??Q*+M_;/=XOM7^%Q^3=X^)1=O[9[O%]J_P +C\F[S03C
M@9]_$HNW]L]WB^U?X7'Y-WCXE%V_MGN\7VK_  N/R;O-!..!GW\2B[?VSW>+
M[5_A<?DW>/B47;^V>[Q?:O\ "X_)N\T$XX&??Q*+M_;/=XOM7^%Q^3=X^)1=
MO[9[O%]J_P +C\F[S03C@9]_$HNW]L]WB^U?X7'Y-WCXE%V_MGN\7VK_  N/
MR;O-!..!GW\2B[?VSW>+[5_A<?DW>/B47;^V>[Q?:O\ "X_)N\T$XX&??Q*+
MM_;/=XOM7^%Q^3=X^)1=O[9[O%]J_P +C\F[S03C@9]_$HNW]L]WB^U?X7'Y
M-WCXE%V_MGN\7VK_  N/R;O-!..!GW\2B[?VSW>+[5_A<?DW>11+ZU94+9K:
MR#?9B_+T)+3CZR"B0SMF/UT%WH* 482683PG06SUKUTH=DV?HOK_ #^8?2<S
M'D<EFX:PF,=DS[:+8O-6^55V)[?=%]'=Q?33N5Z+G/<5B_S<)Q^<I[3%/9N$
M@HTP4=8,,WOH,'N;=-1;%KDKVGAGGUUCV&7&D-15Y7]X:]D2]5?! P(!^<;T
M+8([J%KW04YL5B[J*8E>V5RV54=XVT:F>;RN6\Y:/N^6@5+P\F:P+$AEF?90
M.0PXEOCS$31^FC:OK[&"!AK2"5G-/X*?C]AYSX ]!:QP&^W(ZX>YLJR+M6[6
M*[>EG#ZT6<)'XP]@Q4^.O C.<?D)!%&D/!(SFW? <<<<!QQQP.!M;Z5UD_Z
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MK&6(L0UZ#57/G,IK1@=ZY1;BQ&0MJ9N-=CE.!$92N'>S*,])&%-A*'1R,G)
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MT)IJ@S5>!;'CE"]&[U]^:Q>Q%A7)(V&>0ES3]0ID1T2:_34@8&#:MH6X51X
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M\LF\21@+ #B6N2%1X@VQ@;(B5Z]F.V1FHW@U@M?QRM&M6VU)[;H6]+402HG
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M1?A97CD9Y7146%1*W_G9H)A1R (M:"]O*%,-A7"%<-H;,B<G2YCF\Z@4!1M
MIJ3#F=5?81K>.34=K.,$$\\\>!G]O-6!8Z%*R)-B:8@[".2^4K\0#I2QA5F0
M$)Q"SL(*2@E&1R\G@NX(6A>3#87G%=8]/,S8@A Y))0FE6$4N%BN.4;KOQ)M
M'[+JF+NR%V1JB+K2=NNPM?8(G)#@6AX^7LZMR4A@9>%9N,YA9OUA)Q0ZI8$(
MHZ6;*KUK+01I(-XR+DL<DY8V=V.B]8@&#.)"N+ MAZ3V$'5B- M9R520Q1-%
M)R^5CX5%&7O&U*9K:.:>G1RZ<.)P_BL\LLDF[%%Z[62;9A8SCF7)!XJ5?"K\
MYCB'6S9N+4!!EFL[?+*ZP*CT];F=;4U;TYKB,EK;9M<4D;6$Z[NX=(YTH<S3
M#7EPB,V,S&[T()$&FF:5P->MDPK8BD$+WC(8EK8=;D-P")7 6<X"FL^!D]#6
MD=TY:D432H,9'E=NFXR<5P5M>B42.R@.F(IDA/PA%(P[UL\4"PW'*<L?$-T0
MDV0O(QFX>MLDQ-R-\)!KN.N,$?(%A#&-JXD9&-&U&LVKU-J,8*X:J+72T;ZR
MU0![##SI1?$/GXZ<<?\ )3Q#M$86/,Y67W!UPCH^O2]S7YHX=V^#H=#QNVC+
M%E\A5ZGG,]*]SCAE3]M=1\<@FLXE'M7V)%QN#N3"B1G&A<?CE7I#=K3^+)RX
M)?;-T:B9 D8+S!4*=68)K$D8R-I"O(</ZQA$)162D'I/,W!3T-!1<8V>R<I,
M7#4<2S9JR%G@C8@^=MNOK!/RPT(UU=-96Q9EA5>A;E0U57]DUR[-[G$Y46*3
M,3[K/W@+1T6F'9R.!);,"2DD3PT2_A!@G)W<JP$Q8FGH@+4\<IY6V]6NIV#T
M66DIE%TK.;#H)?!Y6%Q%%?0MB+2:YNQK-K!/&XH:&0DO)2%C2X^ 0J\ 7SL*
M1G!2*" Y+RQ&30<8^]7<#;2 TVJY>WBNHKQM@/@VQ<1'[BE!88G^ZLK.O  J
MLJPK;L%^:FM?C\8%"(R)/,<HR+FYFQB^>D889K<"-9]]W'(A:[CCE8&NTD(M
MM<IJ8\JRWX6=<5P760.6Q,1(2TJ4U:@*M/8&L&)>8>K6M)+C75Z ",@:N*J8
MU I/.9@&8V6\L."DA%$+/\<<K5K-M95NV<3;!#4F!(X'*DNPOHQ\0SL6TCH@
MTG V'%YMR9UXX;2<CF25B0,"V-=A!HJE'-#2)\TH'&\@'RHZ0S865XY3Z;\0
M;1H:8GTD0[;Z]0C&KBA8)/EY2U@YCT,F"/=DI]##[!Q*IJJ3KE[3=O0\?&-,
M'+N3(:LL8<CDG4\$DL=&>_";BT&6['0NK8,;PA_9\A6!_;,VF$D@<018(-@:
M6N#]%N;8-";LBBY,['=IJJ+Z^[9#TI$3HFZD)EW+Q2*D!C/!:+CE.2+=BM![
M=L)T-]WB.2MPQJ%E=ZTVF84/ #8Z"RKNW(N&<Y"AO<PI>EA.WLS2Y7%2?5(4
MW:K (SD!>4L>0#1^=2F$KC<!QQQP'''' <<<<!QQQP'''' <<<<!QQQP''''
M <<<<!QQQP'''' <<<<!QQQP'''' <<<<!QQQP'''' <<<J 6;IU<"WQ95)&
M$20"D-2M+B%\W/?Q<1T\%4-58&>.K/9BJY;/&5JCYUDL_<5 :8O7\!7<X,CJ
M;5BN3D,,@_15Z"W_ !RNE=;?:IV\3BP15FR-&V(:FX*^LX/#@RT@LC*R:NHD
MK(@.:-X0<BIEU,R(O '8B4!!#--62C ?,A^7%IE9C.L7##"Q? <<K/MYM?5V
MD]"E^Q-PMC*2" QQ -Y"&KH97-3R3[G9V/AU5!L/9N&\D08#D>[?F12G&]K.
M88%&BDH5048P3SS1'NCJ"(6#,5,5;1:_CMHCXN]-IRNYFW@..-H@/C 25M*4
M)Y$8=3J<PS@HJM(62L*4E%V>#.-"44BE\JWA'C)\X"S''*+R'B2:6P:DQ-$^
MQ]$BU5,A %)(:Z)R\:>: )3,F4_L[ /P.*3Z.%"IB7A[G4NW,9MJ0#D/'R4F
M-E(J*2!"85M:D $=*1>(#I@,E@H#O-D*ID"DRN6NM?H>)'"V*)U4;=ML0)SN
MM0R96@7$@V@I$T&!":D('*66:(/N\8]JDKV[EXM%V%P^..9HSOBL:NPN=FY*
MO9]A'T[MK7FI-A$)CA!U\*1TQ8%@RE1=6W#DY?-QD//4V.W (6I3\N4MG*+O
M.TJ8M,/8Q3ER-)N'X:7<<I48>(SHV%0[">D-HJ6EXV2*-=A)NL)6",%W6,CM
M9)!K:BWCG(?DY!-K!FD$?B=AHSBZB<:QJF:86@_<-P=ZRG'/L36]6K\6OZ=G
M<E4S8K FA^#VR=M[CIR'%J.DJVJDPN F<67V5V /SB:+44#7SQ9L)PI5)QL0
MMF:3C&*KZ(("R)"WO*N7_P#X>Z^_N@M/PB"^3-6=J5G<X@SL&H; #;/!)&1(
M8B/,@$DB"T7?R@F0R@F3,&4[!.WT8Z<P)-"2\#*I(.5,F4K&O62_6"[=3#&&
M;_\ \/=??W06GX1!? M'QQQP'''' <<<<#@;6^E=9/\ H"8_@[(\Y?7SZ3P;
M_F9C\(I?G46M]*ZR?] 3'\'9'G+Z^?2>#?\ ,S'X12_ F;D,V+2\/8UD:_V5
M(S4O'2.OAR8'<!&,,&&4<0/S&I#ZH7;*<R<M5G>#-E$6!(RS3N-<,ULI1BRQ
M<**M.UT%)FY"Q[L;0]6V'6]2V-;@"$V5;RZ[:M HD)(Z*GS!9&2BH/'&)8NE
MD\\\7A#/0(Q%*+]H)3)7/08M$YO2&8C8UT&:>7@TUHWI,#I>%O>T8ED%537-
M&+3SD9JTK[GJH%-08[3$S&I,0-0XC!)!2Q*ZC6Q0^[(QPD@H\V;()/1P@ WI
M*#$=_-K-:V&TE?#@.\-)("<B=F ]I0L_'"5?'6&,V#/UWC)E(BMGC!>'RT:\
MQ<K)K8OH51TS7Z;R$:Y:/FB"^-F><38]D@-/@Y)9=I& ^ U^'Q_<J4&!3)MH
M> @H_P!,BVQ=2,B[S30;IJ.7#=LCUEEYZ[E=%NCCFLJGAD&68]X0PN#"O5>5
M_M-L$+U_"A \S HINE6C G#;@%-,J]T*@[D0/PT("R959#7NNTF*P'$.!T93
M+S4W(X?*&;)5O#5O,=<^&C4H,+VJ'2!J<$@_<]7[054<1J:8T,->H3;+8Z[=
MD['<C20_"MO=QQ%$=[$XN'(-<EFD,+1<$FX2D)1LXD7.C_' JGJKK*_UN9W,
M]([?+;P/;ZM: N"Q#LN' 817=%$!K[16NK9K#C=>0 X-Q$)B)4&+OD6:3!9V
MG(2$EZR_>^5-7E<PGPS!<1C26%<WK:L[$YRVL3&L6:L: 0^54U;JAM+,;6UM
M6S!U!BS%R89N2B=<@$^:&*DH0OJWA1=NGV@;X&IR=Z<<XFP+$#ZM'<BT[E58
M,;2DX:(=2_45,RC2/=3\HUAHQ:4[A8^1SBHO.1>M4'DY)8-86+P6Q<RL@R:]
M9+8A&>S]!-]EZB6JY4W(:W>M[)HFV!PY%HX<EYL<-=>KUK?8$#?(11=$S@W)
M->S2L(%O*L):*=MW<2N^0QZ264272@D>\/NN1=4'<1Q]83Z0$J'W>IF8()K
M+[(3^?W\N2G[]OJYBKW:$Q<49V#,6I5+LL0C@\1%@%H].R)I%B$5#,X.*CKP
MD)!!"<!.%11,1@Z,C,1)$!$033YM&0T%!0S)>1EYB6DGBB+2/C(R/;.'K]\Z
M52;-&J"JZZF"2>677K\#/8P\/<2*"35>?:VD:PJ.M075=>R$.I 5^41MK"M,
M6E2UV 71 Q,!><BQDCCK)HL5?YE8I&L9EG%3)$J-+#AW'5O8%=\4+>'*1 VN
M8_KL+[:VKC"U%,:TIZRRDX!4_(I4> ZGD$/*U4"NHV+#Q]Y:?<A$1" V?DIS
M/N90B:-XV0A4Q25;2#J7T^YS@>7#1^)"QX&3+(C#S8<A"X4(8U3M6.G1HDC&
MLS!3+!7+'#)1E*1;UJ^:J988]YH+IY=XX]]^3H,QGGA1 $E8V)K)W;:+^!&+
MKF[NJ,#5BP%"+K6:LSQ%-?O$ZOJ&RFV0PU(C.+M#8W7$(:12A)(*NZ\KYY-C
MD&J]>.4)AO85II=$,-R9+;^/LXLAY"91]-/5^+P8>%19@^3K*(JIC%V>0!4*
M/2UT!4%$P[8P$HZY43\]"K"Q;+"%FP=:0\!5L3=?C@0614*-E%V,[JE9><S>
MMZ+/*%7%T%D6D*[&[ +0PLEY?MZU21GFDXBJ&-(YHLRE&Z*;1XX5Z2Z>)-W"
M5":X\+!>I(:ONZ\VXN(7L,%C22N\[48UWKZY)IVBBNKM6JAF:^D8N6JV2%GY
MBJ-:9T---+;(84B(HDIB"&.A8V-J61'ZF$]4ER"";3\8*N)F,0)IF'G""('U
M7S9.9DX(9>CT:13+"-R4Z=NXR"D"T792[Y!+-M'NB*$0=*)*R;/%;\Q@E@3,
M;'C 6E&LV,%<'$DHY-,<LLV4O SK!O*1$HSSRQPRS:R$>Z;NV^66..622V'?
M>./??DZ#+V2\*81FR^%(YK8*VW<0!V87G52BS2%K*,:UX/FXIN0/S8%U*-0W
MVH6QW3C<XH[8SA2M(3;: JNJHO)=8@RL\QLN-A7P3ZB#AJ+@HF_[S5>#E*Z[
M5(,3+_&N\UHF1U=/+4L^J3U9NP"XWI_+-3FRTI2=A\EV\/-,!6-AE$46;Z1[
M5UGLZU:[ID2<G-HET0%BC5[&QF<O,*J8IK2DR]2CHF+8M6Z:[Z2E))ZNFW91
MT<U=/7&?>7:2&6":F6/3#9(.F0[ EXA/0I4)E4+%D@N4#<HQG!TD'9QBA)PD
M] S<8NZC9B%F(UTVD8N4CG+AC(,7"#MHNLW634R#*>4\'^FRQE+LCRU+*($S
M6JE*NLW*%B*U!>C9*?%O$G'K#).F8H%L8R$FSEYXG=RD+]\@Q>2G<T( \O,2
MI"0.#*=)_22\+QX]/X&V"W:^URBTOAQ9WF;V*V Z> C::ED1S3\6D1 (,*T#
M0\LK2O2<:TT!@4[ F$].!5GUR8F4-:XV>%\96A_7VL'' H1XANJDWN-5%<4[
M%0 (_B'-Z@$E99.8E4V.RH?0SYJ0!>RT?7T=#!);@6&5XZWF%M:MJPTI)@<?
M&"%\%9AB8HR PQ@YN("GPN8F</9$YB=B[.@>H"PS2SZ.&<A2LIB"I\IN'<^B
M-[[T]*N\%DR"PXJP;SH*"[AF)1-]*@ B8&T%!O'"O85(!6F)68BX-%M9HOG&
M _$OB4,#FC^25]"W<%%B&$%7X1!IY^3+SGY,:$T -Q27D_X>4EF:'EQ])YW7
M2\"M]::N5L!:EAVFD]@\M.HQNAHS76>1/T(A9[85>M0;"OIAL8MA^,@8154I
M'O6D)Q&(B8I@IZZYP:,VJ.6">--Q[PJQ(72J5G%;"W+DQ&YJES&^<Y./K67F
M=G+$H;;\IWT"C\PFY$+<+@L_,[26%9Q=8.%>(PL<5BEB3HFBSAGD4&DPOJQS
MS(6:B"2&B2(?DV$W ST8PFH29BW2+Z,EHB4:I/HV3CGK;-1N\8/V2Z+IHZ04
MS1<-U4U4L\L,\<NPRYL#PMXFQQ61$9K8,\;1SJWMS"QFLW!:QE^TJ7WS,9T\
MV"H.<@S(=*@HRB')$2RO0>4E8G**1<(WB!TG'3.'P(&I+=C8K7$!V<&@<-LM
MJUE10.MD!MAT-2D".DP^6NZ_D5I-@-$T*41<O&/8%^Z534>=8M<'J2C9NNR<
MMET\5.IOBIB)G6N;Z%DF,JR3?RT4H[CW2+MOA)P,J]@IMADLAGFGT[B9F.?Q
M4BW[R]*TD&3IHOC@N@IACZ7 S$-?"WJ8T++&=*GI7$U.<.^R"%U]CP^I>JJK
MPP?5Q2%-3LL*QZ@#E)J#S^I:.;!C(!F9"1$X]*U+B>.&,IA, +*M[+@>MK>G
MM6Y_6BNIQ>2'XT7M@2J5J4JXLF &%%TD6O*RJALZB6#M9O7U,#D]!U6#*X1C
M^885P&CB$E[=FVKR1DIRZL 1S/UJN2E<G)TU$V)S(P;..E7GL85EI:5@X.7G
MY-JQ6AQ],DEA\D9"[::D&#TH5%BOL?;228N09QWO.)J,:R\9!+N>DY68:2;Z
M.:>A7R[<M8;*/PDEO38)9-TNFV4HPZ[Q752S5[<=>@Q5\Q7S S@TT\/5[K<_
MK*Q3NYRFQ[9&@&8&B['&.$(\+?2)+16EE&/48O&##1-\ZCQ^#TH"G\7*.8Z*
M>34X6F4J[BH6+<CXF-5^D_";L$5-->"JF=K#"'D*3-P<>%R4M%*N?2M.ZVTG
MJ9XC])42$@0\G5\E!VL<#!MO?A'ET_;#II[W56,(N\Y%E8\,[F; VTXX&1B'
MA&U[%P2H+#W(7.ZI& G /IRJ3^LZ.L\0K[VE8VLML&+Z>4,:\?$)_F2G6K =
M+Q<BYG!\UKAP=61,5D;"1>RI0II60Z^\-R/#+7UHM&?V1O6TE-8<1*3#8>SY
MQ U7?%@_K[LCKI,RJQ.1=RA%'1!:*[(2Y!.Q#![C+2Q8'"3\E*"1G%QT?':8
M<<#,I/PT1B/D-57@]==@#F6KR^.,;+PPZ 1%@E$/W>(A>LL,?"O #T+8T"&'
M\@'-ZSM^MO>*:J:T*CFYR'GJ]3.D1:Q!>>]O-6)':L?K0>0N4KJEA6]FP]L9
M1D*)U^<"YT3B+"25KQ*P1&Q1TA@R:(KHZ<05M"44Y;XM&-H X(7YIJR8G#JM
M;4KR\4UDHZ&<R3!"7ET7[F+BUG:"<C(MHKIKW*.63++/IRY;1WKS'%^X13S1
M:9OF6#C-/-VWQ4_B)FHR<3>K1;GUI./E9*%>9>A<(^ADXAVHRD6WD<))9*>K
MNDE$O3)=9MU?-\]!51/OK/L.6&(D]9%]E29.5-9<1FID>4K8:0CV**XA"L1"
M%9$";V3;1<<\?+3A?A-2B;21<3RD<U[04;3>+:03'QZ!.M55UMN4]K9:Y#V?
M[A0@O$06J7\+7+(=!<#^(JR(+V$2;PX7'V;)@,FXJ*!-&];$Y5/C3>T"$L.W
MV$LNTK2+K:W'..S/Q/$\PK/"4S<F_NTB8.X1C&RTAW#C3R0D(J)ER218L7$2
M+MB*2AI]B*8D3^+6+7(R5)#*4KD+$/4:'/@PB8Y4L'@=RERIP?\ =7#XC:QX
M,J.@-8O,>Q-I#')</JAW0R]#%2":]J3,2H+=#[H=S=M\H/J)59M?5X=U'TVJ
MK2P:L,)IR3LAP%G!U#&4; V1:]H7 X!V ]4E84]!A@R3VX9G1?@*PXY5L/E$
MQSR><(Q*3GV)%ILQ^)A(R/MGQP,OPWPQ1D;NA6]9R_;@-CG$J1FFLF0YCKN2
M5A(F+\1*&%1^<G'D:_F)M09B?$;L.'C9'-XS:1\!5E1#L!"P$+!R;*5ZK6GP
M[AS6JX!JT8:Y;"+8D&J KJ,(KN=A@1G P;:Q1G4B&L@E=S40.-"J<F"F=T_#
M3%NA(3'<</RIH<QD8VZ',Q>(&K=US?5,V[,D8]6-E")U-B,>A*$T<-2R$FX@
MV#BQ;9J-)Q(]-^\L6_7PG43<8*KAEEZ5 EK@KBU\$W$6MCR6^!4ZPM6<+&V9
MIS826M,L:0M-.X\EAZA9#5<XCLF?P8!L+5\*5O#941SLY!K[G;-6&A-#"!=W
M$/I2%!G4-T-QV-F0]I6,#X><@!R-B20MD3J:9XNNGI7*QD%#2$MVL]<N$,G$
M:,QT3!MNV;59"/3Z8Q[;%5)HFNOTHZ5764Z7G.N2T;9EL(".IAF@7D8Z4%L&
M/YYY=2$F-A4D(0Y5,-4^L>\<F<%*'P:R?9]YXY)KD4=CCCGTIEW@'1<<<\V9
MF8D>B9*>GI)C#0D,Q=2<M+2;I%E'QL>R1S<.WKUVXS30;-6R">:JRRN>*::>
M.6667777 ]+CGD($$$YGY,5;S$8N30T/!D$N/I/FRDS&01,](8X=F'\;BIV[
M:1D[("10RB7RZ6#:0=#LT@U455C'F*/K\!QSSHJ8B9QJH]AI)C*LT9&8B%74
M<Z1>-TY4?EGL#.QV:R&:B>+V'FXV0B)-MEETLRDF+MDXP3<-U4\8_MJZJKHD
M>8%EN&L0"#DG-)C[*7F>W73565SBI>>51R[:-G6:#=@/P$\0R\BXP2CH4?A)
MB=EW;*)C'KQ )1XYR;\X%F(2M8N$IU,AB0[B6HS8HRD#1.4&U&&,HA+P#,1:
M3<B1M7<=G@]8=P#224D&RB:K+!Q@IAWEZ0T1P1B.0!<+RK.=&2F$BB,=FXY7
MI>/F(*<8H2<1*L5^O)TLSD(]TW=ME>NNNE$%L,^OH=\#VN... XXXX#CCC@.
M... XXXX#CCC@.... XXXX#CCC@.... XXXX#CCC@.... YGW>7AU5'>]DWA
M;T^0$$#9EM5UK($"IW!P-?NBNDI?5&VSN\:V,:YEB81G^UEW]DET-,F0F6($
M(05M F%AID?=Q+R6:.]!.5TV#VLI/6%,"2MB8-,YZTB"5&:X ZKIZX]@+3-9
M. ')(L(EAVIJ" ;,LN1@A@?BUY I*D13L6&,7,0WGYF-=ST&A(!$>I6BXMJ<
M9V98479)M8Q=<(K&Q1_)%K 4C47Y2IM-NOMZ7E45'"<)",8AN16EO/9D?'#V
M*+I$?#1H+BLI&9EV\U/S%Y^5;H;<JB-CBPPK^O7MHP5A@8Z,F)+75X:\["ZS
M6"B&&,H308T:1(3L?5U5$Y.'2DV'$T+B5"\7,P+.9B',1(2#23[3:9VDX%2-
MJ].*ZW%RJ**MHIM.-!ZG,B>P,!.J;//*4E"LIGZQ-:C9K2]H5$1A%M1,-%!E
ME'S!V.BAO Q!8F19L3%O.0S;J+6ROAO"$MX7LR! 0G8*SA?7&$K=\G(VF[N
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M) NW[6:MX0IE6 =1[E'_ -,JA%8CG 1\1K6,M/P*M7"6R=:DEI$_N17KV_\
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M ]WC$K"(.=)X/V%,K.)B%]DS;]\P]DRJZ\E&^K^IOEE'2*N>03+QQQP''''
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MNOO[H+3\(@OEH^5<O_\ P]U]_=!:?A$%\"T?''' <<<<!QQQP.!M;Z5UD_Z
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MJKB V(1(@$GKDKJ8J@R]5I4=PBQ?,)R,;$%XA&P$>3&?\7ML;:577=#P0]'
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M.5?,%PSY2\4<"%&UF1=KUD=#1H#V^05N*QBA#0(? 6[%+W9M[7 00@YG9.P
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MX@>\/74H69QC*%KHC12CGLHY<*O+FO&7?E#"<&*@")L1L.3F+(?R5G5O-!5
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MM4Q2JWV_ %>PYNH)!X.G@)ADQ><I7K[%K63^6ZQDH5=NH".">PB;!A&.[,M
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M6_I,%L^Q6LM8D5-N#DCMGI6 %56SWB%21*#%]6V=/6]NT4PMD5;X?A]$;$O
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MX>!_;O"X]S0R?L1)S9.R02/)60-!QE+"&M]>F<358T2;[:KU90\IK/*26O1
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M''' <<<<!QQQP'''' <<<<!QQQP'''' <<<<!QQQP'''' <<<<!QQQP''''
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M +[X^)'I[]3=6'V#,_[[X&E/',UOB1Z>_4W5A]@S/^^^/B1Z>_4W5A]@S/\
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MMN4L;'O5;S\*5^B5>(D8,R:^1D/$:U)G(!-CD."Y)G$/#O7^:>V!9JI8#=]
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MULS'HC<Q>X>(7 (&<B)/9Z)$H&_%!J&%+%'JYPX]GXFAW,S;\;PKZEJ]5E[
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MNS[*9MD_C!6O]#]?/I/!O^9F/PBE^9X:S0PL!05[5&H4WM(6;6.IP0&RU>[
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M)M.21.720L/%9)-P8$U)">9F"69@P2/&X!^0RTG..(O.4?NW:TF\!S.N[O\
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M3>2Q.1$A!+[*VM%-X,?S%@.,"6 5BX'90P;RQ"O'>KVXLW>FUFWE/RW;1L
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M Z6:YPDY)=XV;Y7+:](IRI.5=A8;&'!'!G5*E3.,EA<E.FL$W$+LKPHE;'3
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MMY!V*5C55,11G+&;H0[MZ9)/@LI@ $5XJ7LM]7N7LQX4) R)O*R).XD \U=
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M/#,EQZ#/C .$BLVB(=1E'E9(,0$Y/-Y"3AX]TWKA[D>(-]55HU][EV)_*O\
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M6''Z>M_K<_YW A[X=:Q_5Q_]H/8KYI>/AUK']7'_ -H/8KYI>3#ZPX_3UO\
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M4L1>P)%M&R$H2$]M(3IT3$<K)F<_TM!>K.KCNJC2O9*QK6"(^O-<1'6*O-=
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MSDQ<399,!1[\Q=TR^7N_?WQC;?YQ^/S%W3+Y>[]_?&-M_G'YIQ[[A7RP%O\
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MFV9 8/&$2UPGBN8[;M?5@IC^8NZ9?+W?O[XQMO\ ./Q^8NZ9?+W?O[XQMO\
M./S3CWW"OE@+?[?B_P :X]]PKY8"W^WXO\:X%.]<_#EUQU:L[&W:P(MH9LQ3
M$20)13N7;2\[O%V\(5N(1S,Y-Q.R2J=AF\FJJ/1?H9-!!)TCBCWUUEE_<=IW
MKYS'ON%?+ 6_V_%_C7'ON%?+ 6_V_%_C7 Z?CG,>^X5\L!;_ &_%_C7'ON%?
M+ 6_V_%_C7 \RS092R@ G!D#@^K1[/M6/4:?U>0KC!T)RT1-1A!%2L)*H?0S
M2ZD(ELTFX=WCG'$8\ZEAV3PSCY1SCW4 IT4SL86OI"T=@"HPM"_&-)PDU:,;
M5-;@K<?'Z*LYA:(NU9@ IFVC2&<E9AN\:SA243LC(]L%V#**1C8Z+Q8.;I>^
MX5\L!;_;\7^-<>^X5\L!;_;\7^-<""2;7\_M$#,J^O39HXLZ,FW860@LU"5C
M6-6%%2'P"5-C(9/!27&6DAU)2K";C(?+IC.-EV*C-FY9Y]=IR3K+D4#NE)*J
M>6*47-L63WW$6Y1MST0:-2D/<#I&.BER2,9(SZ-2R3"P)D:!&TBZ1=NY=@L)
M3,>WS:0<:(,16 9=Q'+F^^X5\L!;_;\7^-<>^X5\L!;_ &_%_C7 J1":922K
M>8PL[80OM)TVU@L;5"M'"M;@P.G7P!949#14R02:0XY6<6"9I,Q@;;).Y-["
M0G:+!XIC")/I'IZS]6+U<M!"D2/70BVU+"NGIC7DIUXC!5Q1]70KB @IFN%J
MW@)Y(CBWOO!)2(M'*8/4VSU_Z*9<I]XR#C'K+SNK1>^X5\L!;_;\7^-<>^X5
M\L!;_;\7^-<"MV.E]49W.VN1\YD9)63UVD==K,#7#)!& M&*DQ8?!79A,.V[
MW"3A2-Z$C<0+26$:HLW>1,/ I8*-EHKT[K^ '4Z3#G8VA/[.7Q8X=6U=E]8T
M^!$*8$-P8>.EPDT!^W)RYK\<%GUWS(Z,L&;$9=V%FHUBG&"DPDQ[G<TY5*RG
MON%?+ 6_V_%_C7'ON%?+ 6_V_%_C7 @>@Z)MRBX6N 3/:LG/ZBK<52#X^LY:
MEJP'\)&'C1IU!CJ3DVB5W16AG!O<HV8Z63<*K2.<7@P>J9MG;GO+G/B3U0ZO
MF3OR<</)Z:D;(*K0Z'5VKMC&,R*7 *S!!CU=\S(.G/JX;V('9&VPR;>9*S%K
MD23A-K%M$&"]F_?<*^6 M_M^+_&N/?<*^6 M_M^+_&N!U'??>7????Y_????
M?_3WWY>^1/87^&='?NCQWX0!O.P]]PKY8"W^WXO\:YP,O)QYQ9M1P@J\1FUX
M0JQ(95S'^5PP:,8^0A)-;O)]CY&V>6+:$=^?VFIEA@LLR;XYJ.7::' O;QQQ
MP'''' <<<<#XI*.93$>\BY%#IRPD&ZK1XWRS43Z6;K8=X*I]YI9IJX=98]]]
M><GGAGU^?CEUW]'D=N*4JQVNJZ=AD8[=+J9*KN7:CYRY75R[\N2BSA=VHLJI
MEW^?FIGEEW_C[Y*/' BCX#:D^0D)_ <?C''P&U)\A(3^ X_&.2OQP(H^ VI/
MD)"?P''XQQ\!M2?(2$_@./QCDK\<"*/@-J3Y"0G\!Q^,<? ;4GR$A/X#C\8Y
M*_' BCX#:D^0D)_ <?C''P&U)\A(3^ X_&.2OQP(H^ VI/D)"?P''XQQ\!M2
M?(2$_@./QCDK\<"*/@-J3Y"0G\!Q^,<? ;4GR$A/X#C\8Y*_' BCX#:D^0D)
M_ <?C''P&U)\A(3^ X_&.2OQP(H^ VI/D)"?P''XQQ\!M2?(2$_@./QCDK\<
M"*/@-J3Y"0G\!Q^,<? ;4GR$A/X#C\8Y*_' BCX#:D^0D)_ <?C''P&U)\A(
M3^ X_&.2OQP(H^ VI/D)"?P''XQQ\!M2?(2$_@./QCDK\<"*/@-J3Y"0G\!Q
M^,<? ;4GR$A/X#C\8Y*_' BCX#:D^0D)_ <?C''P&U)\A(3^ X_&.2OQP(H^
M VI/D)"?P''XQQ\!M2?(2$_@./QCDK\<"*/@-J3Y"0G\!Q^,<? ;4GR$A/X#
MC\8Y*_' BCX#:D^0D)_ <?C''P&U)\A(3^ X_&.2OQP(H^ VI/D)"?P''XQQ
M\!M2?(2$_@./QCDK\<"*/@-J3Y"0G\!Q^,<? ;4GR$A/X#C\8Y*_' BCX#:D
M^0D)_ <?C''P&U)\A(3^ X_&.2OQP(H^ VI/D)"?P''XQQ\!M2?(2$_@./QC
MDK\<"*/@-J3Y"0G\!Q^,<? ;4GR$A/X#C\8Y*_' BCX#:D^0D)_ <?C''P&U
M)\A(3^ X_&.2OQP(H^ VI/D)"?P''XQQ\!M2?(2$_@./QCDK\<"*/@-J3Y"0
MG\!Q^,<? ;4GR$A/X#C\8Y*_' BCX#:D^0D)_ <?C''P&U)\A(3^ X_&.2OQ
MP(H^ VI/D)"?P''XQQ\!M2?(2$_@./QCDK\<"*/@-J3Y"0G\!Q^,<? ;4GR$
MA/X#C\8Y*_' BCX#:D^0D)_ <?C''P&U)\A(3^ X_&.2OQP(H^ VI/D)"?P'
M'XQQ\!M2?(2$_@./QCDK\<"*/@-J3Y"0G\!Q^,<? ;4GR$A/X#C\8Y*_' BC
MX#:D^0D)_ <?C''P&U)\A(3^ X_&.2OQP(H^ VI/D)"?P''XQQ\!M2?(2$_@
M./QCDK\<"*/@-J3Y"0G\!Q^,<? ;4GR$A/X#C\8Y*_' BCX#:D^0D)_ <?C'
M'P&U)\A(3^ X_&.2OQP(H^ VI/D)"?P''XQQ\!M2?(2$_@./QCDK\<"*/@-J
M3Y"0G\!Q^,<? ;4GR$A/X#C\8Y*_' BCX#:D^0D)_ <?C''P&U)\A(3^ X_&
M.2OQP(H^ VI/D)"?P''XQQ\!M2?(2$_@./QCDK\<"*/@-J3Y"0G\!Q^,<? ;
M4GR$A/X#C\8Y*_' BCX#:D^0D)_ <?C''P&U)\A(3^ X_&.2OQP(H^ VI/D)
M"?P''XQQ\!M2?(2$_@./QCDK\<"*/@-J3Y"0G\!Q^,<? ;4GR$A/X#C\8Y*_
M' BCX#:D^0D)_ <?C''P&U)\A(3^ X_&.2OQP(H^ VI/D)"?P''XQQ\!M2?(
M2$_@./QCDK\<"*/@-J3Y"0G\!Q^,<]P>K$"%)+J7'!B.B)+I!5MTZ:>GQS]
MOWAVJGWCFMFGWUGZ/'Z/>'>77D[ZQ[ZZ[R\O=\<!QQQP'''' <<<<!QQQP''
M'' <<<<!QQQP'''' <<<<!QQQP'''' <<<<!QQQP'''' <<<<!QQQP'''' <
M<<<!QQQP'''' <<<<!QQQP'''' <<<<!QQQP'''' <<<<!QQQP'''' <<<<!
MQQQP'''' <<<<!QQQP'''' <<<<!QQQP'''' <<<<!QQQP'''' <<<<!QQQP
?'''' <<<<!QQQP'''' <<<<!QQQP'''' <<<<#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>proxycard_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxycard_2.jpg
M_]C_X  02D9)1@ ! 0$"6 )8  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" /H P4# 2(  A$! Q$!_\0
M'P !  (# 0$! 0$!          @)!@<*!00# @$+_\0 5Q   0,$ @  " D'
M"08""@ '!@0%!P " P@!"0H1%18969C7$A,4%SE8E+C6&!HA5WAYE3$U-U5U
MEI>VTR)!5+G8V5&T(R0E,CAR=G>!MU)Q89$GH<'_Q  : 0$! 0$! 0$
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M-4)?@6I'TH(X?D:Z;_4^U.]FJ$OP+3\C73?ZGVIWLU0E^!:D?2@CA^1KIO\
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MI2@4I2@4I2@]%G_G9K_M%%_YG%4=^IWZ++K3_8 TW^[K'-2(9_YV:_[11?\
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MW2I_RJ.S&I$5'?>#^G3JQ_;NE3_E4=F-2(H%*4H%*4H%: T&_GC?3]X/-O\
MD2'ZW_6@-!OYXWT_>#S;_D2'Z"P>E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"
ME*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"
ME*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"
ME*4"E*4"E*4"E*4"E*4"E*4"E*4%=^\'].G5C^W=*G_*H[,:D14=]X/Z=.K'
M]NZ5/^51V8U(B@4I2@4I2@5H#0;^>-]/W@\V_P"1(?K?]: T&_GC?3]X/-O^
M1(?H+!Z4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4
MI0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4
MI0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4
MI0*4I05W[P?TZ=6/[=TJ?\JCLQJ1%1WW@_ITZL?V[I4_Y5'9C4B*!2E*!2E*
M!6@-!OYXWT_>#S;_ )$A^M_UH#0;^>-]/W@\V_Y$A^@L'I2E I2E I2E I2E
M I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E
M I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E
M I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E!7?O!_3IU8_MW2I_
MRJ.S&I$5'?>#^G3JQ_;NE3_E4=F-2(H%*4H%*4H%: T&_GC?3]X/-O\ D2'Z
MW_6@-!OYXWT_>#S;_D2'Z"P>E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"
ME*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"
ME*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"
ME*4"E*4"E*4"E*4"E*4"E*4%=^\'].G5C^W=*G_*H[,:D14=]X/Z=.K']NZ5
M/^51V8U(B@4I2@4I2@5H#0;^>-]/W@\V_P"1(?K?]: T&_GC?3]X/-O^1(?H
M+!Z4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4
MI0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4
MI0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4
MI05W[P?TZ=6/[=TJ?\JCLQJ1%1WW@_ITZL?V[I4_Y5'9C4B*!2E*!2E*!6@-
M!OYXWT_>#S;_ )$A^M_UH#0;^>-]/W@\V_Y$A^@L'I2E I2E I2E I2E I2E
M I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E
M I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E
M I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E!7?O!_3IU8_MW2I_RJ.S
M&I$5'?>#^G3JQ_;NE3_E4=F-2(H%*4H%*4H%: T&_GC?3]X/-O\ D2'ZW_6@
M-!OYXWT_>#S;_D2'Z"P>E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"
ME*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"
ME*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"
ME*4"E*4"E*4"E*4"E*4%=^\'].G5C^W=*G_*H[,:D14=]X/Z=.K']NZ5/^51
MV8U(B@4I2@4I2@5H#0;^>-]/W@\V_P"1(?K?]: T&_GC?3]X/-O^1(?H+!Z4
MI0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4
MI0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4
MI0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I0*4I05W
M[P?TZ=6/[=TJ?\JCLQJ1%1WW@_ITZL?V[I4_Y5'9C4B*!2E*!2E*!6@-!OYX
MWT_>#S;_ )$A^M_UH#0;^>-]/W@\V_Y$A^@L'I2E I2E I2E I2E I2E I2E
M I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E
M I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E
M I2E I2E I2E I2E I2E I2E I2E I2E I2E!5GV62G&$*GW63)<RR3'\11N
M.[Y'N(AD.4C,;CT$8,C_ -8?8^-,=KZ8%[FSCK/Y8(GAI86SER<DUJYY=&]L
M3<Y%BQ/AR>+Z3?K2]8WH#[:>L_O0JV:E!4SZ3?K2]8WH#[:>L_O0IZ3?K2]8
MWH#[:>L_O0JV:E!4SZ3?K2]8WH#[:>L_O0IZ3?K2]8WH#[:>L_O0JV:E!4SZ
M3?K2]8WH#[:>L_O0K-.LL] Y38]S9(BXY"Y,CHUWRFE\#C^.BP?.0DJ9\@7$
MZ3AR'2L6<75A>4=JQ*K19<[>X*+,"U(J1YN<:E-FQ6694H%*4H%*4H%*4H%*
M4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*
M4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*
M4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*
M4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*
M4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*
M4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*
M4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*
M4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*
M4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*
M4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*
M4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*
M4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*
M4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*
M4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*
M4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*
M4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*
M4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*
M4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*
M4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*
M4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*
M4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*
M4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*
M4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*
M4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*
M4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*
M4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*
M4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*
M4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*
M4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H%*4H-%;1N+
MDSZS;%.S,Z.C(\-<%2XXM+RR.2YF>FAR1 ! I0NC0[MF=*Y-3H@58L2M Y-Z
MI,N0J\6)4DSX<^+'DMY8@+MA[!8DTR&2*/>=;9"']5] .AP^)KY[&YK*9?G@
MR[#<8W$IE@?Y<99G;4 PX)'5,M-[Y*<H[D)SQ+<>5"[!1DH?\STP=?KZQ,A0
MR/ T2L[41#A$U.#$0#[ZWI'=D?61W29F]U9WAJ<,*A YM3F@49T3@WK<&=(M
M29\R93ARX<M]EVB^=0=3.1M_#>=7M=N1 K'(A#BD4YA.->1LE$=?,N'/ @J_
ML7FSY+>1R$,R?!FB%C<4JELC7+@PY Q*RWXK.;0I%:NS'?=<0CT#KWO19@F7
M/V_RUUIO$QDD934Q0TX@XKJ!@V7"9'8HLS[$J2Q%*[XYNC4'((M53([,IT5Y
M&\#9S87R$J8[9_/".U3>&<E<4P9'671^'9SQ11V,R9+^QDW#,NO^ED@_D%[+
MN6L"1/KUF8IG!2_ *GS\G2R:=&I0:E-T.1=@>77&-R,K18<:BV&>.M_5'8,D
MBAT-8CC*\6 ]ASS9F0(QOB6+7>.=B).D.!#R 7T@G08?A%R0G;_</F38[VE+
MMC4D69R"16Q4OS8VIMO;]DEFBND1['D?Q$=:<:K&D3Q/Y2^:R,"S7J)"./(T
M\L9/C7?YOPIX$%@T&^5<O_I'+S=;&WY=D_VU7QMWZ:#G[E[L\[)]B]<MD9;U
M@MU?ULBR-^F6(>PHQ=9#"99D78P0+]A8'VF-FL0AQ:TR$$QFY7-SM O"L.DT
MZ&<2(;1+F,H<HND].[*!9HUDU]O^YVN.NVJF)4=0/L<^QWJ_U?&.RS"EULVU
M*I$SH]QY490S [S9M"_3>BA[7XS>H>* *T"=G?%LY(D[3:U2E(+S$T81VH:F
M1#U4V0?"N/.;*<<01=C4R6$,,92.HLC\3MSR!&XJW/K.,1\;9;6GC(5A XTE
M),UL(H^W+V%G;B-]1-Z!.F=W#$HAO(F@?5(-IXM9I%T'T;N1+GM##,3-KCIS
M#! B:UQ,Z&)VE"QY,DC%S3"C&Y/[B<%:FVZUH&[2![?75;GQNS\HS+0J6$.W
MO>1RF1>L(6K5"V!EO?#,'2\-AC/$DOXY<3-S./24X1UL"]R>LV-4ARM<Q.C$
M)8C2.440(<!PAP$5S(91QF=6RYD\W278K;F2O!D]LMGIOGAT-)T=-=NU0^ )
M<&E!@+R2)^9SSL@A'\R@NSE[HKQD08>C+^KC!R!4T?,D=QDGC"/QT81JP#,2
MO][L60YI',L:1W,D705KX3QQ+,ABF_,?%*2$0QMPDDV'XZA)1?;+"A=A%N=T
M4\/8Z[HEO$KNB!#*N#"J^3+W=.HMS8+,-%V_KQ M7ME)%"8XUQ#]37+G99WV
MJR"4,BK%&AI?$R\YC+:%PED-9 U,GD;.VJ([.1 \SO3"19BM Q+4-MSXV9TO
M"D.52 >R_;"!"_30-V:-9&F>2=)NL+L)W*>[O/:00<7WLUB>-5==]@=-Y%D%
MY<1K*Q/T@,US#,^NI>^O3=,3N(RK$1P?K7XN>RJ]U>-C=D/:WV+ FE6Q$<NL
MN:SH)8.^KW6+L%CC9#289E(%21^&S)LY&$ 2-&;$^%4Y2JY.+D1I)*P/4%;(
MC;F(9'I@%S=4BC@<(+F<C%.N5DU^UW0/,6' [!\--Y%$$?VQQ"A8TQD%(7Z*
MXN5-*=JM (Q>DK'A<@0#SL>%*V<B8LI:F"]KPX$-S?\ )<5F*W7 7H7HS&X9
M)4<QWIAJ>!1[,R!F:I@ PO76(!8,E9K',CGF'FV2A=C#D+(=(&+,]/.5F1E"
M%T3M>1V<[T./!<O5<Y0I@)-Y=IH>V4G^$&-TUQ33M)O8GUXZ/8Y?DQ?LFMU\
M&2&4.N$9V.E"2F#6XCV6>&QM6D3F(%$?1!#$22#"7)<4EH"HE.0I",VUY*"S
M5DR]S6\0B^BL3QP@T3DR3([ZZIVWGGB4H5LD.?M8Y.>8DV,,H"3@<7GSS-^M
MO&OD>,:F+BY3.<U2<Z32SPR6DS$)J1XE9A)V-R>]9BU@Z]Y$$Y9AX:UUTY-P
M5N* &.IRB]FB"%B(12F4.  /Q%X1*(8C'5;+:115%ZR.,0&/%+;Y1!0?,&IQ
M](U,?D?'Q[1CH1HO(@=&T=R!I=J:=1_#2!Y:X@!C'7.'R8.BEL(L[>J(&Z-A
ME[#ES*#('U2T-2EY2"Z%K3NF=L;\RW'GR(DUV(*L.YV49V==?NK]RAX:EAE.
MY][!=>1HF@X'VS--0RDS9CS6794F=H1+]E(+=5#R,,MCZWM/G Y"JMZ;W%Q&
MTF=G^5YN&M;CKRUAWWW,A:)3'*.M!2-R7L=VQY-,A[5W9J4=C>R GZ]G.*-8
MLA++PF12S(\APO(FQ!;.#E%6>2H-C0+FI+#Z,>DYK)1J5'5USFHQ;UK&T8QK
M)60,S2-'H.?YHY.&:3H\RFPFP%60#DH<2N:$?D(,O?6]?<+G#$B>7A&S%C'R
MA?VM*[.:=$X8,*Y59EU,?:;Z@RJJDI;*.JNMTD+)F<0)XF%6?0;&!@JE=WBM
MH5L$8.LE9R$7<<ITXQPPKU[(!+BB]T4A[0L5MH]E;D:C-AOE8XQZCG@L[J-Y
MS09&&ED%M,(/DB.^LS;/?^<R&3D1M+L2RP^:V[+&^NS3%D*.D=[  V**L!*G
MBU\D<\>"0LGMYBA)(P4%N X0/(F_.9)\0MWF[8%AQI':TM&M3N*S,_=0,<;"
M!@GK]M<\/8$==C,;Q=),@.SG/I::QS!$47-#1+0^K@F) W\L8N(V!$O>Y0+@
M13PI96VS_=;IYAW;EOAP9&#U/KC'T,!CE&HC&(!K/IG((*%@S_FR7$&:#V^;
M=>Y%<];Y$<$MK8VX9"A1W$5*=(/#%ZAF7KQMC6M\D0+K(T" 6.*6ZS4/70U)
M8<C2&XH$95DJ$XM/)DRBL!#(>*13<^R@_""DM>'<0; $/R-#FH<;<K<O'VI:
MVVHLK>B^3JQQ@5+H^RSLERQQ&!X^>CY#6O;KM(=.NC6!_>1:>\^..&D!G+;8
M /Y/F\84RZQ8)%."5HUF2!4-1!'Q['Z0KD4T:GM]DA@1+<8$BK!ASL&VP@I[
MGXZ,S1LG"58NG#PF^3VYV(I-VB40\WONF,7Z[EL>1\%12W[$-P>YZZ7$CJX6
MC,=R2AD%;'0]DQ*8E)X_,' @+7OL??\ 5_6<JB=R@8HUW@LD@UY?'$G>(8?X
MD 'B)W4E=S%5(CL0N4=.(^H$%SXZ2 N6G3B[*F?*O6F*Q43J5&5Z495U^!CV
MA6C(DPXA44TPU/&1? BE%MP#8]KI#[*PX6Z<!=D!YI08F=M#DS?C12^%#(X(
M2BEL3VX#\7'V0?+,;LTM2!(GM8XCG<(N\3>*&HN(G:6F'2<F.I ZP=$>P"&R
M5*.2] \.PT_;K;8C.K%X=/KD2S--#Q(,>Q3DD <DQ_/157#BQ>S"Y*/\L39R
M]H24>M<T*V^VAGK9/LPU>F@GUB)GK2@O@,$CR5H(C60Q@6*767874R,].1P%
M%<]2>KX5"[_F1,;D&L9ZV*61:U$(VK*7-;CPOF"3D[Z!Z]S%%1''8F&!$!$;
MK!XEK2P2Q$T,0&I-1+74)+V,R:M<439),5GX&^:TNBICM'2W7LG$'B*2$,>B
M)AY&T.1SL<4FE.O/1> .O4BEJ/AV86^2=D-@DH;*DE6*!:"(75YXYB 9880C
M?''^N6O0/&$;QO%80SI4+!:N8 CB][,WE]7O9"O5+D#8T:7=U>WTVXNKJ\O9
MN[NW>WD7=BU>3=W5W$3>7MN+,3]-W=Q,3;MVJ6;$9VIB$F8BE9B*S$16:5F=
M(CG.Z-[GHZ[MB^S^>&/IK(,>TH"0RWL&T]Y!0Z%$PLDYE,=K!Z-9^AUL&$LN
M18'3J"8II>Q8UPFXM#N)(3Q4%07#YN,(A8/>72)KVN3I$OO>MO.^1%%DMQ)
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MR7T<B2-/O#$PC+K@S$R80B@#;8BB[*@RO,-P*/NZAU2O_4I,NCVE>QA<F/\
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M\ C/&Y8"O1.\WA3EJQK#L\F'$6RNN,#[#(P[.YJA%).401]+*864O6-%B>5
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M>CM&K5'9J4<1G,H4 Q )NBHN<V^<=BI0E06&&YU< 5LA^$CYX<WYH9>CLZU
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MS#?KZ+D,;_/3,LJ:40=Q/4I#&S$L1ZS*E'4F<;IFIN\:^$.X25M:WLJ41&H
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M!4/Y_P!^=1=6YHUOUXGF9VF/YDVX*<H5KX$J1TU?%1X38WL8&L+;F=1<:>V
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M&P-!=W2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*".&N_T@N]/_ -A-!/\
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M 89QJ[9$K1FRK4,LX7Y>-,Q%NS2G=[?AEV#Z4+IJWE#]QXZ[>M?)SD21X?\
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MBS2[+T+6Y$*1LS-*%Q6I$2I7B4J,.*_DLEC>WM.#Y)[O-E!7:U"ZZX]8!?(
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M%F9DC2E8FT,$^)6,#7*%1PR-*2Q$.QB(96./!S'G<+V(9;\KJYY%>GXTZ_\
M52)4OR4.!"[+SPJ0J[7 UF^>)0?++VN^![VK!C(9-DPO?<2!JLUD@M,UMF-Q
MM;6U!'Z)N0I,"!V(DSP7+GRRY]>'7/+FT0N[?M*QY1Y2.C<CC<!=Q$(.0$[D
M6.). TTB!Y8T.!*Y'0PP&(2PORV-!,9RAKJ\R*F2JAFQ4;(1S*I2D[2\-";.
MR'LWU2:E9,.HBTHM-6*%Y*GC QET-[!B#=DC:-4LJWN!T[.'S.O;VWQZX+86
MD%&WFK0*DJ1SO;6%./(2!ZDF)&60<E8.N74L4^0<C(A)C!>TYFG T9F?9?9U
MO4,XBR)4J)NB%G4I9BQ9VG7K&D;FA.IUM;\B: G#$PC=KC&ZK@;8O)^1&6AF
MK<@W#&,R R5^:PP *8S&1A5,4V8@AK&#0&E6,B55C DDBIPM0:.,>3?*H7;)
MBQA422@&S-Q:6TL1I,#=C1":5RK3=EGYY_=A19V7:EA7!ER^/\O_  0-K3DS
M_F:=7]FW]'E E37.S\DE =<6.(G!N,(M<1[6>;"!AD(35O0L5M(DU*!-R?+Y
M&BS$;_PF[.-,',V-HU'I/?#*1 &17:*WD" 8KEF0#9<:CCI,;*6M8P(A82_$
M17YFN>OLRX"G*/-CCPSX0FUPS\<MAA'RTM\&/.M"#!8GGDF.G@[EOF=AVZ/%
M[$5F9DF&A&*<679+&A! UC0%'" +0)F#:Z6PVQMCO$"@;6+\"'(A'XF3LCH4
M$6WW;1S75YR%F52TRHCS%LDWS!\>Q;)[*#*@'DM6HD)0^%\+*!R7&K- #F9<
M2Q)2.0[8-OCQ))#4;$3,>IB-H<<R+D13?7=\Y^S_ !VVU96?0URWL5!CQ<.M
M>HRS;51'J=;8J?[F5##>28LP9A<4B!1C4O'*'%<R8UJ5LSV9EOP<^%!EMNM3
MW885=D.J8,X-C69/\J"RYW=R<?1(R#7/85F<5)&*^5\BL80LKC&*9]>BUS1-
M%KP/B+ V.I0]CY #$*)GO9)#!5Y%N]!K/$:2 B/5Y6SO#[!)-'CQ$"P"?2HD
M7X443/079'BB.F=_X<\)6VCJ8.MN9F_-@??+J.S-F68GGRC?PLMPYYTEUP?9
MA73PL$B]+);P^1V1D;@Q3/-PP,F#Q$A)E,(Q4G,<C4BM,;G.($)U"I[&$)>)
M/2!I7+5^1*ELX7K+<XRWUCAE7[QZ^S7ICV-ZP SZ9(74Q>"%H$$K-9<LB^+9
MXEQX<G;,W;0OQ18WM<<Q"0LST.##%J/,_P 83!Y466Y"P%+(_>6L;,,00UR#
MN2--K(6EV1R2*@9V,5I6,_.'SF4.T4RJ+AC]CB:1\D0R7D"Y()@QHCTWO")-
MPYQ @1BA.[.*-7:F=?D=XX[,CTY8 )]?.GH,PL@N(PNVL# .A:*/6=L0%1[8
MG1B3>S[&L6!M\=Y5?E4*+V[;;8>U:\*LF=[<EDDK71Q<E3HQ"BQB_""-*0^"
M9OE";6LW.2-<><&J0=$7A[=K0J/&F2I-<I?/DXV'XW;(%-;F2&Z]+D='X4%1
M!>2(6!H=S[@VDQ>:208$8.2=J&BH69Y0,WFW$"/Z=^)!Y3:>!,@@Z%-G%Y#-
M8C5N^9:6"S/BX$W64HVD,"%#.WX8H9/H8]7"SP[-?R!R7?T^]G^H(T1C0&4F
MQ=',D&F)E\U@&9X8G.&297G,7E<+1WD<F _C)I*&UID(O;5PH*.^$=<<+J1-
M[LQ(\*A]:'!JP;=7:3:TN!$E)E "ZVJ[4Y>A?6A))4JMX5(;4;F4A2&],4Q1
MX@-TP%-PZC.)9DLH$AR7QHW8@!X."16"-XW>YJ/A>*RZ&:VL3HUOB1LF!:^H
M,.9,Z/I#M)M(6/<@I..5]S,AF9X*)E>'*=$ 1D=7/-%Z"9E)VCB90X+5,98!
M-0JS9+PUX:=HVE$9!3<9R1,.,93*U/DQ0BX Y94*['=.OV*:UZ9 @7QXSO[@
MDY5:D;(*!]5>PHE)DT18X.@LW.EA"(87_84;;MQ%,D[LD*17C)3! [ $]&_,
MJV"ABRQDOSP%)\0Q*2LH&9OHRWB,JVW%TG.K:Y/$>$K\A&%@0HPO%MB8H&%R
M[]GG0W5UYQDU_ ,4CKP6F0*?O!B 3--\:2-B*HUA9/KN%+6&38\D<7D(31,\
M-8E81>Q"I,S,#HD(#!T>6MP?C<P=7S. ;52#8WEM]FX,&'YI/G]'(*'+QEDJ
M4'<&8\$M%HL?RKD!XF>C-QB>.5DF'H8/'$@N( $C3@9F2584D:IR?7E[7N(R
MI''?EEI&F?&OE2>4:B7=B^KR1X=QY*Y3"_/S9()I%R%G%]9]CR5Q,C:-7^:Q
MB2VF-DS-%:S))ED?O&NTP)BA<!\$"%)P,-=Z50MX/HW\[\78NR[7I\:[B-/@
MDM:P+3(Z A!$)0M.TEGDCO0&4SRUYGZ- J,XJ+OG$CPI#M<Y*D<'+P=\(LI,
M/-%R!,QXWQ2U-[IM(JT3UA+TJ' O""ED6-)E),@LA$ 3)-L7&H\9S =21(\F
M/XT>1K(HF:C:PQ*I?DW([VL3^WI[V$T>PW!AP!JBU@Q_ [: :J.B!0VIP$I$
MTWG+C+66^-IIG.*5P&]6(SANR<Q0Z1G)(DYP\TK4$FR2B=!R+%8>.NZ603C
MZ-2S&6/UJ\,FA+='6G8F2I8B"().;RN1X3<'-ND06Y:G]F<&G(R'YQ%3XH2<
M/K6VXWA*R21&YJ(.^5JO5\MRUK;7159C'#$%>B?4&;L1B8BDN%8LB5A-SU_E
M^81F/;79_CR9(W#FT#)8UV9DQOF<;+G^)U;'(@2_M^J,I,X$Y#*OD:,UMH^1
M6%S1'1&Q'#E)6)]=HH@]X-WF,VDF8N3]RO=7AA7R5)I4#LBG,]$)&LPQO'9>
M8/P%$+6Z/Q2]NSTR10-A;,]KE"90[H%M[6U<HL !](]:(Y.D4DB@"[)C!H,T
M9T.+W:3)7*6\-=6P2F\%9&0"'2HX>AH!CH;%=D9O:A6)0QH8HL%+9"=5@X&M
M;@E:%;<&J9%['(6B>6I.C,[%9C;&J&TY^ID20FB'93-A=G0Q]$^MDUO)(GR@
M(64\+ 9N MBTV4F,LBA(VBA(%+A!TQW$1<"H'_<<%;FZV;*GLO1E"LF-QL:P
M6N3(I(9TC:]H?)-BPSDB.DCBB6N;:B0/;4J.(@DE@2KVA2LPJK1G&_I^<HH3
M!C\1_:8:B:^'Q'+166@RUW=YSC(SA^4;+CJ1$;,2@,BC 8%G3?B&6\L2#0\\
ME8G'0 /O9F,-#*:KFL*%4N4AYQL+9PFRZ+H#C6&WL^( %,9(ULDNMCL1(R*5
M)5/1YORXGDH(,3:!"9\:$XM%0UA=S(C5X!&+V8/%</"[$FQ,UB5N:\"(=PA\
M#]H4 ELB3M'.=L.;7N))IQ0V)MX*'EDSD\K+K5L]A3BZ( F)ATL)@>]LF'4/
M;D%5H#9$V)4HU"Z"5')Y;@Z1Q;)SL$0['=2#EU&6L>-SF_&;-H$ZA3Z\0-/@
MP*EZ62BG7 ,%?-PH)HR:&-TR9B3;G7=L<^,"[FQESR"KM=;TG,>2IP#;##]+
M]:0%WUW?A&-;69XU5!WF.H0<,1>>J5 \+/XRD$'7&37+BE3Q*3ZH84V?!B,)
M7X-S!$N?"U[0OR9[-"UQ>L1R]>^I%X0)QXFC-X9QD#'&T4"O-N69F%B,49F4
MHU_-&>T>-AR0FLU:7-I*=68$>6Q_1$&%_0*H^2\)7/%A?"C$^!AY+V2:XMI@
M-1R-+RPED M(8<;1\?<P*00!*^CLK39"$,KC :?SD196DG: =1.XL_/&1BS+
M4B_(WD(J@<>289+$(Y]LY;T-<([ .L"JXK)B==CUH=9K%"-L(!] F/I85/I@
MU19JN+-;I?@5+)@FM!&TF.\=X^,_*)SX!'MMXQW.'*3$H^\2ZX=0@=^:R(<
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M8G:LB8>0DF%62KV]I:7=Y2^1+VC>L\[GKS),GA92]DQ)'ZN+R;"TS'-86(E
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M)$G*4YT(.D=G6;)+9Y)1%*'E,YC5R21@;/-I?:\%T7"$91J1+G(&B6,& 1#
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MC5-MJI N5B(.I&,]LUHUQQM:ICQZ_P )8V5<% D;+6>R*@2UK61U%J$C:XR
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M'_6RV+(R<5 G/ C IFK62-E0,SZR-T^[']:46CR)*B%7\F0Y71ECG?5Y?W_
MH6?),!L#-+2V+7<><%#QFL\41O':M&X-RL""U3>[&C))#H@4"S'F1N4B#+\P
ME0X>N"7(ANP+#0?)Q48(V0I469'QJ?AQA>$"Y.X,[>H3ZD"=.-1(TP)4L<:K
M:X1^F1.:)Z1)PF#HQ%,"1X;2"."QN=DN)B%T&-.YH"J'(B)42_%;8J2D$5QP
M\X,N-Q!QA2UERIIQ^W+=]T?I-['0"+Y&D..W*#=@'_@#GZ,-5$)H.8(.O$)
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M@343';A&',B?I"P\$Y,6ML-K240&(Q2'Q.Y"AH)D:QE;6MFE91&6]A'4'4P
MN++P/5[78)N/&-W&#FX1A2-1NXS&R"Q3C?AXLY9AE%R1,;W8M66.[2\<K$#E
M8K4VK$^;C/EXO_</U*U5CU[CTE =9M?0<CB1N(VB*7\/AF.1I[C)I,%Q0YEK
M7'KJRC:)<%MQ2Y&YHX$:(<SMJ9[7%Y0K<\2I0_NN16$.IP[&U8H^(X_BZ$I"
M7$A-,PY% 3)IGCBFZ)2-(Q[L:TZ6S\3-C$CG9@EK-\U1[L1@:6MI)Q,#R')
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M%.07?X]!WADN0N(FPJ4 1(C[LG'9*=HX'&'678Q 324 L\SHVA_>-56[&+P
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MD4.R25L#J8A;U$3JUM<3@$0:1R6<347-11)@80IF=F5[ILJ9($@+3(\BO(V
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M*XACEWF<10N>D3^5%[M\J 2(7&#7%G0AI.J$W1.NV%LG+<_Q'(\="!SLM"\
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M;'>H-D2V_(+W7-6VVV\>*VWBWCGFZ[GBWCCCCFZ^[F^^[Q<>+]-UUW-UW/\
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M"ET>&MC2[%'9!ED][BAN@00,$+/;P7R2X)7PE%7H[O<L(J^8189N(>A,5(W
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MI0'B@:=\;1DF>/GH/$KK*4-VG'/TR\ONH=42MVY9$I1@(XY(&5P=6?7Q0=N
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MBCV- ++)KU#&Y@Q(D2H5L=J&PTF74N,'S%K(50ZY'%Y#P9EQW@>CXO/"<95
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M]@L2N6.*XC8E H$3%D;PR*'=U:)!Y69,"QW1[+30U*6@S;M62*:=K[],!<Y
MD?R6J%P;8>17L#:5)$&"HNKC(?B_?"/VAH9F7B+8SP&"PH'5.L\HA(K-4G3-
M%!#/)-&"A\E"%,X?(@?'%_5*+6.$=,_M-?>GDH\DJ2>Q>.!V3Y=0.#J, 0"^
M;KN6 5+!F.U KECAK9NQ"2(AELL+I0+D90T<-:\%TU:AQC62%&$=L V7OXZ5
M,K6QO;:[11M*+IVGV8=+,TAQC)TCR2E5;-E(&U[!!<<0F^S*\ZP"TY+PA?,
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M[7.-RI8GG*26PEY>,S*/9F:.J2+^S)#EC5.6&9@<6,1K((BU.HE)\9"-S=B
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MBC(::Y1,'BJ@P(VEYP"C]'^SF^)@VBI$*-TVS0Y>=3-"TVP$Q/QC9+,G*SG
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M(2BD.&2F)I(31."[;,K^2.TO0EDSO\R""I'++XNSB)#J?<X:G 5&PP[&\BF
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MS'G!PEE@7!VKALR,HFGC*_>E$5XSS#&S\F;))5PY)LE!FNV(2AIJS-L;24T
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M0\Z(ESR4SI+QK)-R><01D<LDE!XC#)!@UFCAS@,1E V"Y+:5C%NK+%F%*+Y
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M"DD+#NML#IBMVFR9QMSC)HU%O"AR5I)@V-AMP?44K"F\3>(/4>94DJ'<./\
M'T686>1+4YNZ2"2A&'8B31+=N0WA(3S)-#(*J+)."WOD.B[9K9IU9VJ/FK)U
M>#1ZVMQ4G'(A7YR,]C_4_<=+QGM&&GD?5[3.+*E>E>$\EHE<[MJ4%)QAUJS^
M]1_(#2PSV1-)_B,-G\<$DG.R.U&%IC>*#8'GY)K&'W,B<JR,^%=#,E%T!FN9
M7@8W/.U*X<'W=C='1W!@3A+[@UUZ;"NDZ&Q'+L]GY3"Q7M"92@\AZ79J1$N
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MF-^^;*Z195%W46PY1@<*#)I'?-E7F:%B1=/VKVIC@R8G/-8U(X8F3?F/[F/
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M#:$3]&AEIL Z[-N4<FB)+)FPC@3BK(W:E.&9CMFQ^?AU#S!UNJR8WB?S/?\
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M?FN)2>"S"E5MB':?JV^&<@ Y:MD*+WP6E8-C 29SV'YE8RX_R'+%U^\,;O\
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MD9<-ZK;9R4'"[J-P<,;,$S6KD6,8/,8^5.(MK^8,,OE"%N)UJH; \KD_OF)
MC8'^]L)2>'/RXK$J5 ]V[*]0&60#^)EYE*'SJ1L>"$;/L9H=8-IG:0'LI//G
MJSBO$9!K5"ZTCF8;<VG7.<"K(<Q VG(.V@T:$I\ZD2$*387[/B^G':'JUN:J
MC(&!R1X'YV/-=(WV,>(?>@V0\> 48SV'->)M<19'+2X):(C/2D&#MIH16%C*
M$%SL^M20Z9U[FR-N&]98B+2>$\=)TXK&*573LKV60]K+,JN#":/IR*S%H;-2
MR9\<P:*#$P$$8MM[L86ZU!%R!Z$6DC6/!PS%X4]O66,4S1C,S8<PJU<7H#;.
M*R+@",0%^X+2$C? UIXDAXS63-(8&!:Y8Q:)9_.R.9K9!UJU8V@:'[$'"\.K
M'\';DX!MY$JETS%F!*WL*5VM4DSHPN*0@8QT4GA.>F6JT6E10FG=W6S7N58_
MA66#,G89"DQ&Q.8TA9X@F<Y'4+*224*0^S$)T?@,>D\?Q:,J9*.!,4RDTG%
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MM8VY+>7E<7CD5-B!1E2.:4QE,4P*T7QJ=:BY%)C6)CR6*4JF=H[@ADI+9/
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M( M=<R3*CM<$J]AMD_AXL;G!,DNX6(+$;C\FXYS<6EFN5?+VG[PBBFZ=>O\
M1@K+':2,Y:3L PE &D3<<.X.YF,[#1.+(PEV&(_C@*E&W8#B3 Z)!B,9]FH1
M00^,%S5%]Z"3S-0K$5#B^+%E\UY.U[AB92Z&#N3X^9#$NUZ/5,G0X^.?*ZQ4
M$FZL:>1/,\);$:M*G=,/+4]YU.-G?L+JQ8"1M%C+ V8R\,$'QCB)K+V>P9LY
M#TMS8WA<J0X*0W"\8;$DF&<\D.B>99"$R0IQ/D=R2D(1R8#*/F-@> +$Y9'.
MT]-0UR#W%F<[39O'&O$G=5.NXV[?83E'"DS,$%[,8<8^BD-_GW->SP:_(=7
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MN\1F/FK@D5$AX+L)K9&0Q)AE*<?B1>OC<I5AUDY!$2EA*RI<;TUBN=NNRJ,
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MW13#L(0$ MLB#C9,B-KD\<88EUPA<4\TY%3% NZ<A.!_>F=R)GHE>GGT8C[
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M*).,BQ/G67HTK\*95-X:;&P^114Y[BXHS7.J-KU@VT>7X9QQTQ&0XB1ZQI7
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MPF[ZX4>8LP3%KM"<N3>/VQJ>F&497)QB+R)<8A)X(A;O%V-T+B2T?'C$+:3
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MQ(_I6^=-@V :+?.X=A(5-A,X"Q^5&L..HMD!EUQA+%(L.&#$]Q-(2Z/FAZ-
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MP.^G"UC;5J[_ -22+W9,QY4"-4L_]53J%&/*H_\ 167U4@F[NAR]HDAXY@;
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M<D?5.E9SRUUG\K+V?0+1P<:'X?&]0];QMB*0(QBXD9QR&@%@;'R.I!: @>-
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ME.NVCJT,Q?7G7*%PK;!\!C/6_J_V8ZZ!2:!&-US$6X'Z?6+5]K'=C!BQOE;
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M%B]6VR2W7/OY/N3FVSB2>>ZCY:HM;?GRXOYRMUO<(IX3_P#M+CC-?KYAOO\
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M-!/^E0 ]$[U9>K3T ]C?77W<T]$[U9>K3T ]C?77W<T$_P"E0 ]$[U9>K3T
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M-!/^E0 ]$[U9>K3T ]C?77W<T]$[U9>K3T ]C?77W<T$_P"E0 ]$[U9>K3T
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M:@G_ $J 'I8NK+UEF@'MD:Z^\:GI8NK+UEF@'MD:Z^\:@G_2H >EBZLO66:
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M:@G_ $J 'I8NK+UEF@'MD:Z^\:GI8NK+UEF@'MD:Z^\:@G_2H >EBZLO66:
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M,UE^(>!F=DPPRU.[<$D#W)#E?8=NG[^#"?08:*_V?L']ZZ=JG?VQ?19=EG[
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M%,@21K%"9R;DBM(A2MB54_E9.$.C\\*$S:A1-Z?.XKU.7"A1I4F.ZW GQ8[
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MQC7"=]5IT=7E.C-C%87[:%&I1AG:FU"-,IK&.T4-."+7UN#2U*Q<VAXC*^*
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M!^2?GHC$:D+AF830136ON!3S:L!Y)2M".1H[?K$:E+:3QI(.,=&,YS&Q)P[
MI>X"0>Z$(^XN0D-JVO7$L:5PQ)4<&H P-]T/N)J([# F:18Y'8]<#1@&-N9,
M8Y;VD0L2.4@J20#+?.QPPI'X\N) 8B3KG?GAWPI,+DG2*<$N*4&H$D!0VAB>
M.H+21X/8(BB3B&.(V K,&;R"'_D\$@:7PEY'PW9^<V+F-R:/0IZ&^<N;+RG6
MCC;DS<Y[<=]M^MI%T@U)EPF<3&3( C@U)7DMO.7UU?F7A9E(B6\>AT9Y6$N'
MG+:E(T=C?KQ *S"ROF!>QX":$(C,\+;C+XX#WQGE12@BNQ:0:DC+R2D+# ,<
MMKT6E08:/;A@9OA9KW^/)EQ[%!&1MXRYLF-@:AB?>%4TM(VP6-@VFE)X(SOA
MIY)2<B<G3V#;3_5Z29+NF"08(C4UD/,T\LR]])QE"]8'I)P,% .F4$3"OLSC
MA*\-@*<G0*R$+^T.3^Q!!T;A[,YH1LP)&QSDA2@A1=URZ/Y!=L#E&MT>+6)J
M6D"G%8XIW5R=%[<7!@;&I:&D!$O=%)$41F61?'$;124Q02NKM&A%%$;QU&#R
M)K0(#$QYGWE.&O4)[)BB((G:-1>3A=L>+W]K:R9%<HX:WC.PO@FO7-:Q/E3N
M#;E> \I*@I_M1*\&(A"2LJ#7S&X#!*^-2_<M*",3]I9J82">8%=M>(FN$,CM
MF($X^WAS2RMS0098X:XAQOXYB9<#?R+OK=&S&QB+(\CES6YL#8R,W+(J;U34
M@4)_H'M.-6A9(_(V."(X2XRR]7G+\^<>3.+@8KW(N;9">G@Q=7/Y8YEC^22"
MTHS\K(2%6Y/A6=<K3$C<'0D<W-S5R5I05JQ9U9:Y #G,3D6J'J8.)AXCKY4B
M)@R"HQ2!*J*I;F>< HD N=:8?@I2/R U23.IB0X9%QJ,I@D<$3$]-3HV%.0L
M(2R08#I#J/%1F(GT9:]QA'Q,!M+*T"&4,&TPTSL7FV".D5CCZC%F?E&*\FH[
M%3X_Q4P2!G9<ITRQ>0$,<MA$E"WYW8UDIZ4$>3[4[7&4I&;9:D.(! OD%IS1
MBL1D#TD4*N?*L*&KC(D-D"QK^4VLKD41,8/A,[1J4N3<K(@:PS/&P8<VQH/#
M% ]XR3:-:AF \T"I%KU&3@P, Q&X0S-_ _B16MH7$@O((( !R50@O2J\8HR1
M]+<K1NH'/C^69^C63I#CHC1.P2:DK$YRLI0:!;=5M<&J/3F)DD*1W?%\EBX\
M#GD>KQM ZAI.$"<=C\3C(6Y#KIC6-5P@Q1X+L@PUC&%+B8T:1,H484%K@Y.:
MM9^\9:Q0!#:P;<XSBH4$GD3:Y.:&8@0),V<EY3S64!!M+ZMW)'!0L?21\DXP
MC8#)SLD(W%V(2E\%FAS>718K3_&W;WI0:#G'5G739;@8^?R&(^EGD-\NX!V\
MU'D;OE0M!9C;,!J)Y<N6SC(X@9^E969#(L?.EZT(D-N:&IN-1]^0MR-/AP=U
MT.TT?GTR)'W6F(7MX/7!>ZDJAX#VUT3YG%Z/&V52A6T-R[&H;1?*<RJSM4IR
M+R+I&;B1Y,;D<@G7!"8)\;S;+2E!%=!H[I^U$2LN:M;H@:BA>6>?:X@:PIH;
MG=87_/( ;"^<"E<B3X%&=QYFZ*XYD^[+DONMN+PUA=;K><J''Q7Y1[HQI_%*
M^YUCS72*Q9SXMP)4KD@&$F1>T,2$/*8_9 D>6+/E*D;C84!SDT$@B,&#(VQX
M"CY:2M0>,L:-[<L2F5M*"+;UI-J81I%C:^0#&[FT.4),&N#NPJF+'>.OL&".
M%WP!T9D [QDX9" 9#,1 _P!H8G>D"[.(\OSW>.*&R]V<+E.<LFN<'C\.D^OZ
M&-AU3#QPV'S2>A#[B4E""0DTK97E1**B0UI*I=G<]=Y)5D3^N/GXO<7I\,7!
MZ=7 B<7%:O4Y\NZZ4$+7GKKTC)<63&4:X1X695KL3OC^O+4SF4O!LZ';+%0W
M(JJ2'P@<G%XDWB4!^#XH9)7P2"N)4TI-82U(9!PDB:Y;C59K;I=JAP[RP^7:
M_P 7YW"<1:20>4OE0PA6(2D.FES\O38,W-*JW,TL[)-Q+QC+IJ;F!$U)I=,\
M"4RD;&2E"1,[XI.TH(XONH6L!*71N<O,%1LJ)(C;0-GCY3B&T2%O86F)G9:0
MPZVWL""Q*/O*&%"9S=2N$4K\UNF&&BYW=RR,;!0B=7%S4[(BR+!2'AET$@W&
MOQM#O(\Q2FLM<EG*Y1R5SG+AO-AWDQY^<>+X"#*<2"196I'\'GAN:[T;?QDS
M<)N,U^QJ4$'M>.NW537'7+G647C)A) =]U\ -9Y3<BYL;%S_ #/%X!'SE'B9
MED/(A1M[8H;7Y&2GI,_#C$VL8FI.I0E(U3,*4ED4P<GC8AOI=JC)1P62,?P#
M&9@7'C"^CQLO(1M(YHBY,31JOA5_=21@4\7CKV7ND*.SK"JH\<6I0;W0VZN<
M4VD%L?N"P=S2=I00^<= M.7E->G?(##'_*M?GTC)'4@O>WXB/W(N'HX%3O'*
MI.[NRTCEMGDEAAZ)T,ICDFNA8.RES&H*LD)K)5PJR*46R@;6'7V,Y-*YD HD
M#!63#2PHQOA8TM=N%;98>E"4ZDBUA377WMPCQ*A\@;I!EKS21,GSK2"VMAU(
MGG,6MJ%X3[WI010?=%M0":U_\NZ\QHY*"5\5%+HY9V*VUYX+%)_.LKXB]J?,
M67&\#Y>U2=LS/4A#A6P+FPA%C.4"8E&W)J=\R56EV)'6N,%1*YH7R.(M$!%]
M;T9\BP/S4V6VOV:R52EA.I05.#WGNSNCLZ20<C+(;GKTZ*UCN8&22\J(5SB_
MK5[@IW72@U''D"0U$N=@4QE' N#9QB(X^@1CO&F^UKX10U$U[QDBZ.+K$UUF
M-6+QU>1DW(0WK;5-HOYT%'#+<BM)'SA?JI=HKJ$Y.<D/2S7^/,KQ*ZFY>8NE
MK7FPN'+IEDI+-:EY$UF!3BSQT^KIP0()U<7V.\@L[N4YM[?,Z]:IDY"D*L,L
M:4&G(LUZ@^$,N3-$$6!4;WY@@0CC-R(,:1DMSA(&22.9"; HQH[,>/.G:2Z7
MY1*.,^:V]:N(3TI>7)4L<7=6HR8*;Z8:KR/$D;00;0:!D$10\P-PE& ,J;<N
M%I"!%N!5<6\B+#>C4)ER03=XO<72-"H9^5WL9G';R]@Y:@>Q=Z=6I9)VE! .
M6>LG326&\L1*8;%1#(?$T5/IQE#V5H1-Q,U1K+\#2\\ARH2<4#H$-X_,F?6V
M(0B;<[(--A#(H*$B+4\OEZP&!7$:V@DT;U'0N$=.^" H]Y=XJ=;GX.>%+7E6
MN]K]=)+A-5KZ4.BU2H7R ]X)O=7&=$CN?J"=Q13DKS3,D4X9.YX*N)64H(IN
M&CFI#FQ"@ZI@0 QMH$'0M'X'>WMRAI=@8.UU22&VPFQA9"U*T;^)IX[99;E0
M<8\P^YMRSD6D@Z%5ZE8.E;XV+LI5:H:VK A'&ZB%(]O!&[7QZU00"]H^EQ-*
M+6TB:&1A>X428,7%G*>/7)G&V%N4C^&^Q+<F:4-EO%OQ%G/$@Z4%<>WG5_KA
MN3R^8CO$L$$1]:=X)BQ!H# ;L\2XDD83@@ )^'PVE2&Y*/PQSSQ_KA%04D?8
MD*H\=T3>.L1-@5<27'D.'T92@G?5K7C9U"P-T_Q $RLD%N2*T<M+6JU;G9DQ
MBS9!DV;4"O'?A5X&8Z$E"X+/&2W/Y(-P=V>PHJ1.XJ^O#0NWY2@BJYZ.ZAO3
MY(Q"[:\1<X.,N,3P,238J&DN5I+QPI<1=U.V)V'[O_8%S3**L'".)A;\#9A2
MS$C"Q!ME#$6MPPQI$&W$\*Q(G 3F*N8X#ED8R8NE%QD*.G5A0/(.:*)N?2,H
MF'&2"CMA6L3LADXC,"U[.FQ8ARMI.Z%!"L=TBK.\N-ZG9U*"+;1I+J:R#1")
M(X$CS.SF(U(@@;7/#/R0O)T/2WYE6R6B/"9_S.9*;Y33#&\>HWYP*W=W<UC>
M$"C;RLM0,#6F2[0F&$8HGX2Q@TP@[*=C29[:B9M1NMBC"K8R9CR9,C02C;TW
M*$3X-$3=QG58$CZP.+:ZX4:U>AM5\(UZW!GVI2@CB_ZA:PE+4I9"2#(Y?&E6
MFFM+F0N8\E68.+-BY=')^FW-@XS<7W)%TAS:("DKO3DENPN-A\-L9.WJD3JU
MHU.'(&S6Z"FB$277!!&(Q9")J/GXR:Q]G39UK2:M<KWON>4LADI7*%+L5O4E
M+B@E=C\E('%Q)#%]('I^(G9Q>71:NS[NI0:"F35G7?81W$7V;(?"9,=0>U2G
M'E)4TV.%N-J6O@P4K1IW2\WV)"<-6EH0#&"P*)\#P)*S &"2Q0RY"(0'')L_
MDOU7UW/&^16XIB,0<+)8D(5EL]<,"+*TO[S*P(/AXJ#R:G)V90WD;%((8PQ^
M&(1,S'75I(QSD<;53,Y(EN*Y3?O^E!H44U:UN!AIX"Q&"XJ'PL@AX4U\?@QN
M!Q_"'O<' ^20\HK%#L+<H;F%Q VB^69,YQ#:QOS-N?@Z)[5F!1:[*N,FJ5?7
M=I.X@Z6.G77, >1-,^NI#>D>\+J].CDK?@IAC%_;G\G='-64$HL_Q0*"</OP
M20/+F&O4-B8K$3HPJXW&F,7030I0:;ES7R&IV%V,-E8!9RH?&'*]W%TWQC@R
M+1APSC#\#K\XT]#BUH>Q^UX!"LK 7_ SN*),0@164A#YA<!4D>VA=\KUK5KX
M1M)(P/L*QBZCY?#S5KZ3#RP,8<P^\P:Q<OUS+$JUCY1>2KX_:?.<@M;1:U'8
MTHK'57C3IL=E]MMN[J4$,E/7AI*M8F$:<=;(T=64?)"XOM2O#6I=\A&12$]B
M)3([E(2YS6*E\HW2681\!'$EII)5%:.1#P'#SDT3OA:,,CRAV#+NKT72_&&P
M43."'.+C>U>>W'L,I%K$"=WE!C= H'B,Z87E<Y(G/E%:?P6!,\+N[^R8VPK8
M1#X#D%/HR9-C*3-LC*4"E*4"E*4"E*4"E*4"E*4"E*4"N0GPCGZ43P93]X,H
M^\-H577M7(3X1S]*)X,I^\&4?>&T*H.O:E*4"E*4"E*4$ .V+Z++LL_8 W(^
M[K(U00\&$^@PT5_L_8/[UT[5._MB^BR[+/V -R/NZR-4$/!A/H,-%?[/V#^]
M=.U!?=2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E
M*#F?BV0NY3L%:IZW#T\W/U_@8& MKY/AC67324]>AXEB"5XOUYEIUCPE*]H9
MM2MI1L*%&DI<M[VH4#L.7M:$70CC&G:%^)09+7X7E%L-W9B>OT@["X,FH^PL
MHZY:4%8& ;N[81HYQ2YQW!YM(K&#N[<U!P0\'#+*\X(P?+(#%AF90&!J-VC!
MOM6/+BP.*7%@QJ/ZESHBUSEM?/XOFV*W%!M8MKM@$^S.R.F8-)@$A@23Y4RO
MH\5%N>UU>HJ?9U!Q>42EBO(I*%P*91Q YN:U/<+7!J4;$DK%D6P/2O$$]'VP
MBO\ *+V2B_7O<HLC0TW)U)C9RBQHA^<WJ)6X,;1[(U/ZR,%TMPQP:I05A;IN
M51+(8RZRPQI^&IP<FB_'B76!ADT]WXO"\T3['KAI[L.111JGLA .O^QNS#0_
MPS@B^/\ 'LJU@7S8%C./.,AII4D%3F)9"8VXB%Q #<+QP=S)"5P?+5CJV#2F
M'Y1VQ[;$H3V!/!<+G>L0QK'VOPMI[%,NQ6+ZTS$H?@5?+,$AA/$I:"2)*S@J
MMD N%) O+R.0D2#$+C+9(+4U!KCE*@$A;,UC\P]04.3*Q;P,+W+LOM";>G8'
M6[84]S,_F#QF"2#6=3%:@2'P?A<&+,7#&\<10R87?D@QO*VS%ENX29\=UF?E
M;AQETP1\9.6U+7FV:GEHB#:C:^,]V'V&FQEA+*SAVQ(.=14:/YB/&SK%CE(Z
MIO,,$/"HUC%'0ISC(VU9WE2D:USJOM7)PU*G[ZPS).;?&V?3?87'$W/:H4]0
M3WL<G+H(4A;=M0D>TC&#X6\#ODQ-+;F*D5F923%)"K"F5C#A7&D\D.YT:+,@
M0CVXH[GXL3)A]3DA21^;7[N<=.F&RVQY%.><,IM[H2-=LU6\W+;>,T<7Y![G
M(H9LGR8JP6YL]N!&M^3)[G!;TG0-99GMMEF7N/CNYW'W8\?[07SQQ/-N9/EO
MB:_CD7YYNB&[XJ_BRVR[$:67W8[KBC)9CR8L^!9NB*,L\W)Y0OV^VJNCQI[.
M..V ?UWOQP'=&#=M Y$>8G*<RQ[MA2R4W04<E&?./,3'<?I4HN)+73#BQ.9@
MZ+C;*&MXD\)-TJE"8U8@H&RD7A$B#=HSZ&=A+#N&CBV1P_3(1.SF>"HL@6/C
M\EV!@D:S"4:F!7#BZ78_'7&71AOP.#8SLS@N3LUWS:]]J&Q^U78=H(&)H-F?
M5O6'9O478G9!A&)2_)P-FG82/;T<3D&NLJL!I&15(1L E"(9)W1>?1(\.8@L
M%;B4:P.V$NM6X5S=OB%^C/7J&W5:'IYHGPFU&;179P&CG254Y1^)0F(!6WWG
MI;,HB6D<=@8A,,XL+:ED$M:(:XFB131YB!F>E]C ]*WE1>^5DNJ_3N-ZS3IK
M5.+EN)M1.ZC437TJU5U^CV5<<!MT?@<"NB5D9Q89Q-T60E';N\%(\.CC&V/L
M@OKRXDIOG9&/*Z9D;6SHF/&&-=G_ '6 '5P:#S=*6O$A',;>01,F.)+9Y5UZ
M!'#"WF)>I$$K-"$22?)XK*VS!D,9461\DAEB\8S,T<#;F//A83M[:O=%+%X.
MQG>&*ZZR_M*!NFGFPYC%^DLSZT1AM#L4/D$*HHXCUBVH8P3+&Q2QCK_(S9*<
MBOG!9(3"/O00% CI<RL]_G2]D;5:L;&9=_.]W0Q >^<M['2B93Y.T98=K(@B
M>*9F%P!D@%]Y><4$ES*;1;G&#N6X8DF2XL%,!$/,CS(<?P^7Q\S2F]#XVZE:
MO+G:LUB_;\]]/<,[ LG86QD<MRZQ8>QB2=4I+DU0P< G&8 =-2\T79@]''7#
MD(+\5J8DNBMHM(KRJPDNXL59?)]B;)9DR*@@!O-W3RNKM.AG3.(YM&@6%>RV
M!=!)(W.X;(!(8VXFI!,@$T;%PDZQ7(!"YRPQBO 04V#3%-Z&,EK*['"_ S#K
MHQVYF<K7SV[4-Y]G=.#CK\$]<]?+)Q2;1[7)(@D?Y.41HP$V)E;!-T.$L;QY
M9)LDQR.(I E% PD=[28DJQ6#CK(%$C([JV,P,H]<N-;2?T6P_(!O)J]@VCVC
MBJ&)6W8$>Q0MUK E$(W1F[[=M3L/N1H?O!05PT2S,ZB9[D$QYXRQ=FD["#C1
MMA7%;,V<8K1QC&)O;TZ0(MU&.![T$U2+KW)>M4^CFQ,12K&K+'12[,9HPBAD
M$Y$CF)RN('(,_M"Y@.7B^W Z#^;,C>4C.NLRY4.!Q:78(6MW=J"K9>94.?53
M81#I^5;@JM Q'>OESB%RB<AVHP'SQ&Z5"F!6>1'"3<,"O)8QKAUGV*R,-P5D
M)[TC Y(VO-FS*$WC]G.[VV&KW87U)P[KF'ELTB>RS?V'992UG!OF)8"2=GF%
M=? PKB!OP2A.C@+-<9M(07OZTQ)GEE/AI4L&T#K@O9Y 7X&8(>,X;NE>($$J
MLCK?L5LBNU?&=PEV_P -Z09W"*D<%,&UJDL=S9 ^M1 RQ<U3"FA=A+GI2;M&
MNWSB7QGY_8L)&YH7-)>K8U6]MW>N)HW)FW4?8]IV/G/6>;-*>9Z5PJ<PHFB=
MSRXW:?1,2$"7,5L4O1M)8X1,^%I$<#:I8,K2G2O+(]D34LS8LBU$X-H5Z2)X
M1Q (5%40%2+7^0\TNF;//Y)+\!R-,NL$"DFO#)JQ+'$)S4F+2^9)A$PXT-5!
M_C<,$.QU'J]^,)/8V5Z<UK:$+&W.T<6!SOVD0)"76HV=H6,>.SR$">-84D82
M&6"T0;C%7CG]^!Q0$9BE>^E:$%!\K,1R S()(<WLNY;PVUO?\>+(^/"%"RNL
M05'0?$S0&PWAC#;+9V+YOC@4V-!I V7;$<"E<LSP-[82YQ-\RYC[,<PT0LK(
M9))"RKG2)9# &\5,XTM779O+!([HVYV1V3R9IRTR#IZQZ>-$^;-Q:V# +%P*
MPSS&DL9F78[&GBGS9L;WE^D-P9W9 8.AJE&;6R4\)4-NS.?M;^3I'5KLO=;<
MZ4*GW_MR)9T@34J5 9!(&KCE(/:KI_J 4*HY?].-U(SE,?E8IQ7DX:/S;'<I
M'47J@ C'5=HR<GT>N'$OQ(<IKVI$**;D*U0JSM%WK#;J<0[F:M*]D%>LFR.^
M3!H%KMM[<2P7@C.49(RG)U&A>7X@KF3+Y;8 II+H])E @X+PG-:;BK$0+E.8
M3+FFP%7?Q%'@_NML9<(B3)+LG/,JN&[VIF],@FP\#:_0X(FD@:;YB+YK0AN@
MZ$HCCZ'8_!W3$5D#D?+PH4;)#.C%W<"TF.7-3FQHL-;#/U?;POVT^K<:,VO^
MPL%:I:V=N)+O>B4&NZFJ4XZ:"<;-#X8R=DPZ]Q>"Q9#VV+.^R\=%3BS"01+;
M 3,<%H5;NX(WM6LE62WE*%H,&=X(U-$Q08#*M-]C(WB2?-DIVU!"]C2U\AE:
M"N.PD)JC?->,-8>+2&^RBM%"!F GKC,?.0<Q,;(669!G%:]H&UY)VW3$%^$Q
M:53&_%69Q!Y !8Q5P[M'.D#G=YE"1T530$:9BC\;SNA?H. Y,?)?U\+[Q 8(
MC*(F*=!<.22R'CSX[M3RU+DJ-F<)EQ]U PU';)K"QM<N3"NP:M;M3)O$)YW#
MD!^/)3R9U<F*WT.)OD@6FQ^:#=S)SMB0W-%C:\WV8O'D<;;LB;E!K*">BZ H
M0&#"&>)\V4.M4ET,;'0)&VK[\01^/!D;1YM?\OXEW"ZG4?QZ)2W-+^TI'DB'
M85(9L.3EPAH1)R%I'+E3HX\O^(-4Z7]F>RFWO9W%49D\-3!JUKS(W5(2[C"\
M+RJD@,EO/5Q!LS& K$,TM<A1N]F1NQJW.)RQ<WE4.&#B"/ (09N<)"%.=]S$
M4N&_]J^X)CU\E[9>,HQU0G/:=GT-C4'F/?\ /(N*80#D&M4>R,#E<GBMS2-S
M#)8"3347Y8R"7T]=F"/D&1E9V+,R)5);>0KE[&SY+IQU-L6I4_Q[L<[;:[+[
M&'$6::9="P)KF/!!R 5%]=&:2!$^CYF0(HKAZ.WEU,!C&&MS40R 9OQ:6'ZE
M0I='QRP8$[2T-OD;3=/0%L5*^S<G!6SNQNL*7>N+@.&MZ F%\<+.;'L@"1L)
ME@ +7YW67(CDHIC(KLCPN61Z[O4=/C*T/ >B1I%8SR\*7I\=PB].WA$L/10Y
M;//T>:H[ ;%0%J&-Z4R?,^Q<7$L)-08BA/>./6"1(ID 7$9'D8+DPL<G)N*F
M-"SBC4(WV*<V)^<3,ACMD:T#D]6:=AN^(OUY0N&3,51)*LVX#:<XK@EFC^%T
M8^Z2(Z$LK.BQJ8_-UE)'L=0/SCE6([6]L8L;LC4N[PO;4%JE%@SJ%Z2&,C]#
M^K1L!]@D8#9U*,7Q_P!@,9:.1*0"H;<'Y&R$PC083: B(&&)_+PT[*>6QT&F
M%J;2?&8J"5==BQ*;F9R:<N5/D1V#[@:@!NY S"PP:%Q@')H1V>@G:5@5AO+!
M\J=RV!"ZPN'AUYX(&9ZP<CCNLM^*=?D&)&Z6_%X+TRZS';G3J0J+ECPB^#=>
MI@QP]L-KU(40N\5L&NBO=120R_KKPZZKDVT+2.NT=CS%'ZF3&Z2=ID(H@*&D
M@F@@UU$C''%P=GY?5S:ZN.!:/)):HNW -7G39$"77V6<LVK>S\@ZU<\5\N0<
MG)L>(3 ;YM)-M4"!:[)7EUUP:-?LC;+*E\PLF%ZX0NS>V<-OQ*M&\JOUF'J&
MC24-LI+VF'=B-B8<YV(>8!?MIXMC5PC3"/3>NUB3-#;%.!">DD<$$QPJUNHV
MSIP296R%)""4\OQ]\(9??D%RET<G/:N+J]UJQ]EV;M)Y1/66>+X8SQ;@'%%S
M6J D)<N0M0>YSRW(U3=G>VR8G&'&!A@I6]-;TA:%,7MMK0K9E*[-<XVA7#"W
MA+.HDVF;XRCT8R&E$">*MIY7UC+K3J$B @GYKTY#BDVE]G)H?&)%=Y:UB=GU
M@#G\@AOG8H3!D,H"K8M>4BMF6XT[(K\0N\(X&Q&'=8I2?=&)DCI5N7YXDVN#
M9L5/^I&L08:Q#',<PV8%LJO$O31,8R ":%\();\@1$-.*_*^R6/CMAG?C%N"
MD<'E<D(6Z*X6@H=*(M#=EMG>-=DT3;-1!!NOV1SBA 'P@Q;9X2'B2G=42LL6
MMLASZ1"&4J(4D'.6QI9*',5,+Z^M27&]JG=:[9-DS%U&#DF:U:D:V#>T\]1T
M+ZD06/Z^MS3D8(,E^'IS!V$(!P!*JV+UGGB*9*@23R1G9 KY2%/JL)0+@MY(
M7QQ;LBCG(CPI C]M=X05 NK%\*M;OK_+ST:2/JDDWD/P G/M<X<(XGUDN>G,
M<6."-;*<QCPA-,V+'MF=TP1 L+E!B5R D:E[JPN'DZYLSN<V]LNSF#M7](X[
MWI0LQ)+<735\Q^*&N&%4/1^TD?.QF%J4Q4_R!(<LNP7'T&1PK1O3<O+)*EU_
M%Q@,2*,6%WS^5U2!I6PLQ^#VZV @M!X_K=L5M3K8\1#J^3:7O<AAY#%!Q(,D
M:[&TK$TXE")2\2O$QLVQ?,&&5S(J, 6;(298Y*HWSD3@TB:9&PH!5K&;0=@M
M3&R;]>F& 1F9)P@.P+R@*L&D6(C6S$6H<L<<)<+0Q'K4:MQ>"SA&Q2UILHY*
M<432*'(%)@XY.*4C9LCKY,>FL*H3/M=+I9A3KKF@102=JRGG;ML@/3@T9 ]1
MJ'MJ*S6*&(8>O#FPB<SA<IFL:98**7E.TMQ'-<9NN.6QE\ RT:%Q&^_GAS7Z
MD%^Z*5ML]FNKY9KW$TUPCI=M=LILT*M,UGC=K^^!&UD101$,J6/>3*W<$13,
M^OKTRRV!Y7,?9B,:!78S#6M8^X2+*D3NPTEDW%?0SKW& '$XHGF&45[Y'/9%
M$_9R\$;$&0%%3 531$(#ECMC!&J(X?B0$B*.HH=F>ZU:0M@4&-Y>YO*AT<,A
MGQ>I;K6C[H%Z+H=UZD/5![#MH=I'&&=&93GB0M4]77Y9"BF'8T9]C6@MQ2.'
M/3NDAM%,4I<6/YT3*A0IDZ42DA%Q5=R(MV?XU8_$+X'CZ$]^>M.^6P 9!@X
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MU?L,_;#[\94_-Z>E_P!7[#/VP^_&57,4H*9_S>GI?]7[#/VP^_&5/S>GI?\
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H*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4'_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
